Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abortion, Habitual
Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature.
Abortion, Habitual
Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.
Abortion, Habitual
Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage.
Abortion, Habitual
Factor XIII deficiency causing mutation, Ser295Arg, in exon 7 of the factor XIIIA gene.
Abortion, Habitual
Fibrinolytic defects and recurrent miscarriage: a systematic review and meta-analysis.
Abortion, Habitual
Genetic factors in fetal growth restriction and miscarriage.
Abortion, Habitual
Management of pregnancy and delivery in women with inherited bleeding disorders.
Abortion, Habitual
Premarital Screening Program for Congenital Factor XIII Deficiency in Iran.
Abortion, Habitual
Prevalence of coagulation factor XIII and plasminogen activator inhibitor-1 gene polymorphisms among Egyptian women suffering from unexplained primary recurrent miscarriage.
Abortion, Habitual
Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage.
Abortion, Habitual
The burden and management of FXIII deficiency.
Abortion, Habitual
Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency.
Abortion, Habitual
[Congenital factor XIII deficiency in pregnancy. A case report]
Abortion, Spontaneous
An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.
Abortion, Spontaneous
Celiac Disease and Gyneco-obstetrics Complications: Can Serum Antibodies Modulate Tissue Transglutaminase Functions and Contribute to Clinical Pattern?
Abortion, Spontaneous
Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.
Abortion, Spontaneous
Corifact/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
Abortion, Spontaneous
Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage.
Abortion, Spontaneous
Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages.
Abortion, Spontaneous
Fibrinolysis and factor XIII in women with spontaneous abortion.
Abortion, Spontaneous
Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency.
Abortion, Spontaneous
Immunohistochemical detection of factor XIII subunit a in histiocytes of human uterus.
Abortion, Spontaneous
Impact of Rare Bleeding Disorders during Pregnancy on Maternal and Fetal Outcomes: Review of 29 Pregnancies at a Single Center.
Abortion, Spontaneous
Inherited bleeding disorders in pregnancy.
Abortion, Spontaneous
Management of pregnancy, labour and delivery in women with inherited bleeding disorders.
Abortion, Spontaneous
Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell.
Abortion, Spontaneous
Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.
Abortion, Spontaneous
Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion.
Abortion, Spontaneous
Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.
Abortion, Spontaneous
Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.
Abortion, Spontaneous
The Val34Leu genetic variation in the A Subunit of Coagulation Factor XIII in recurrent spontaneous abortion.
Abortion, Spontaneous
Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency.
Abruptio Placentae
Management of pregnancy, labour and delivery in women with inherited bleeding disorders.
Abruptio Placentae
[Role of the fibrin stabilizing factor (factor XIII) in early placental abruption]
Abscess
Effects of transfusion on gastrointestinal anastomotic wound healing and leukocyte function in rats.
Acantholysis
Are acantholysis and transglutaminase inhibition related phenomena?
Acidosis
Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteers.
Acne Vulgaris
Hormonal and dietary factors in acne vulgaris versus controls.
Acne Vulgaris
Transglutaminase activity in human and rabbit ear comedogenesis: a histochemical study.
Acquired Immunodeficiency Syndrome
"Tissue" transglutaminase in AIDS.
Acquired Immunodeficiency Syndrome
A novel transglutaminase-catalyzed posttranslational modification of HIV-1 aspartyl protease.
Acquired Immunodeficiency Syndrome
Biomarkers for diagnosis and monitoring of celiac disease.
Acquired Immunodeficiency Syndrome
Evaluating the roles of thrombin and calcium in the activation of coagulation factor XIII using H/D exchange and MALDI-TOF MS.
Acquired Immunodeficiency Syndrome
Identification of the autoantigen of celiac disease.
Acquired Immunodeficiency Syndrome
Role of transglutaminase in keratinization of vaginal epithelial cells in oestrous cycling rats.
Acquired Immunodeficiency Syndrome
The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes.
Acquired Immunodeficiency Syndrome
Vertebrate keratinization evolved into cornification mainly due to transglutaminase and sulfhydryl oxidase activities on epidermal proteins: An immunohistochemical survey.
Acute Coronary Syndrome
Antitissue transglutaminase antibodies in acute coronary syndrome: an alert signal of myocardial tissue lesion?
Acute Coronary Syndrome
Expression of tissue transglutaminase and elafin in human coronary artery: implication for plaque instability.
Acute Coronary Syndrome
Myocardial infarctions and other acute coronary syndromes in rare congenital bleeding disorders: a critical analysis of all reported cases.
Acute Kidney Injury
Acute kidney injury is associated with low factor XIII in decompensated cirrhosis.
Acute Kidney Injury
Early response as shown by enhancement of transglutaminase 1 expression after cisplatin-induced acute kidney injury.
Addison Disease
A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency.
Addison Disease
Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.
Addison Disease
Coeliac disease and autoimmune Addison's disease: a clinical pitfall.
Addison Disease
One-Third of Patients Have Evidence for an Additional Autoimmune Disease at Type 1 Diabetes Diagnosis.
Addison Disease
Prolactin and autoimmunity.
Adenocarcinoma
Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells.
Adenocarcinoma
Immunophenotypic Characterization of Benign and Malignant Prostatic Lesions.
Adenocarcinoma
Immunoprofile of endocervical and endometrial stromal cells and its potential application in localization of tumor involvement.
Adenocarcinoma
Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis.
Adenocarcinoma
Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma.
Adenocarcinoma
Mass spectrum analysis of membrane proteins reveals that CASK, CD36 and EPB42 are differentially expressed in pancreatic adenocarcinoma.
Adenocarcinoma
Suppression of macrophage cytostatic activation by serum retinoids: a possible role for transglutaminase.
Adenocarcinoma
The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis).
Adenocarcinoma
Transglutaminase activity of cultured human prostatic epithelium.
Adenocarcinoma of Lung
Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells.
Adenocarcinoma, Bronchiolo-Alveolar
[Bronchiolo-alveolar carcinoma complicating systemic scleroderma under long-term treatment with factor XIII]
Adenoma
Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytes.
Adenoma
Transglutaminase activity in human brain tumors.
Adenoma, Pleomorphic
Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
Adrenal Insufficiency
Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes.
Afibrinogenemia
Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.
Afibrinogenemia
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
Afibrinogenemia
Clinical audit of inherited bleeding disorders in a developing country.
Afibrinogenemia
Congenital afibrinogenemia in a new born: a rare cause for bleeding.
Afibrinogenemia
Congenital hemorrhagic disorders in Jordan.
Afibrinogenemia
Effect of early cryoprecipitate transfusion versus standard care in women who develop severe postpartum haemorrhage (ACROBAT) in the UK: a protocol for a pilot cluster randomised trial.
Afibrinogenemia
Hemophiliacs--a picture from a developing country: Karnataka, a south Indian state.
Afibrinogenemia
Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy.
Afibrinogenemia
Impaired factor XIII activation in patients with congenital afibrinogenemia.
Afibrinogenemia
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Afibrinogenemia
[Etiology of factor XIII, factor V and fibrinogen deficiency in acute leukemias]
Airway Obstruction
Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patients.
Albuminuria
Transglutaminase inhibition ameliorates experimental diabetic nephropathy.
Alopecia
[Studies on enzyme activities in the hair root in male pattern baldness: glycolytic enzyme, acid hydrolase, transglutaminase and ornithine decarboxylase activities of plucked hair roots]
Alzheimer Disease
A nonradioactive dot blot assay for transglutaminase activity.
Alzheimer Disease
Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.
Alzheimer Disease
Catalytically active tissue transglutaminase colocalises with A? pathology in Alzheimer's disease mouse models.
Alzheimer Disease
Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease.
Alzheimer Disease
Cerebrospinal fluid tissue transglutaminase in vascular dementia.
Alzheimer Disease
Coagulation factor XIII Val34Leu gene polymorphism and Alzheimer's disease.
Alzheimer Disease
Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology.
Alzheimer Disease
Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease.
Alzheimer Disease
Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques.
Alzheimer Disease
In vitro neurotoxicity of amyloid ?-peptide cross-linked by transglutaminase.
Alzheimer Disease
Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord.
Alzheimer Disease
Introducing transglutaminase into the study of Alzheimer's disease. A personal look back.
Alzheimer Disease
Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease.
Alzheimer Disease
Isolation and characterization of brain-specific transglutaminases from rat.
Alzheimer Disease
Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease.
Alzheimer Disease
Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.
Alzheimer Disease
Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
Alzheimer Disease
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Alzheimer Disease
Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
Alzheimer Disease
Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases.
Alzheimer Disease
Possible role of the transglutaminases in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases.
Alzheimer Disease
Possible roles of transglutaminases in Alzheimer's disease.
Alzheimer Disease
Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
Alzheimer Disease
Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination.
Alzheimer Disease
Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
Alzheimer Disease
The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures.
Alzheimer Disease
The influence of psychotropic drugs on cerebral cell death: female neurovulnerability to antipsychotics.
Alzheimer Disease
Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains.
Alzheimer Disease
Tissue transglutaminase in Alzheimer's disease - facts and fiction: a reply to "Tissue transglutaminase is a biochemical marker for Alzheimer's disease".
Alzheimer Disease
Tissue Transglutaminase in Alzheimer's Disease: Involvement in Pathogenesis and its Potential as a Therapeutic Target.
Alzheimer Disease
Tissue transglutaminase is a biochemical marker for Alzheimer's disease.
Alzheimer Disease
Tissue transglutaminase is not a biochemical marker for Alzheimer's disease.
Alzheimer Disease
Tissue Transglutaminase, Protein Cross-linking and Alzheimer's Disease: Review and Views.
Alzheimer Disease
Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
Alzheimer Disease
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.
Alzheimer Disease
Tissue transglutaminase: a possible role in neurodegenerative diseases.
Alzheimer Disease
Transglutaminase 2 is involved in homocysteine-induced activation of human THP-1 monocytes.
Alzheimer Disease
Transglutaminase activation in neurodegenerative diseases.
Alzheimer Disease
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Alzheimer Disease
Transglutaminase activity is increased in Alzheimer's disease brain.
Alzheimer Disease
Transglutaminase and the neuronal cytoskeleton in Alzheimer's disease.
Alzheimer Disease
Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
Alzheimer Disease
Transglutaminase catalyzes differential crosslinking of small heat shock proteins and amyloid-beta.
Alzheimer Disease
Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau.
Alzheimer Disease
Transglutaminase cross-linking of the tau protein.
Alzheimer Disease
Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide.
Alzheimer Disease
Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
Alzheimer Disease
Transglutaminase is linked to neurodegenerative diseases.
Alzheimer Disease
Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
Alzheimer Disease
Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic.
Alzheimer Disease
Transglutaminases - possible drug targets in human diseases.
Alzheimer Disease
Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
Amyloidosis
A possible pivotal role for transglutaminase 2 in the pathophysiology of cutaneous amyloidosis.
Amyloidosis, Familial
Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide.
Amyotrophic Lateral Sclerosis
New target against inflammatory diseases: transglutaminase 2.
Amyotrophic Lateral Sclerosis
Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1.
Amyotrophic Lateral Sclerosis
Transglutaminase 2 is involved in homocysteine-induced activation of human THP-1 monocytes.
Amyotrophic Lateral Sclerosis
Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis.
Amyotrophic Lateral Sclerosis
Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss.
Anaphylaxis
Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation.
Anaphylaxis
Wheat allergy.
Anemia
A case of giant expanding cephalhematoma: does the administration of blood coagulation factor XIII reverse symptoms?
Anemia
A novel mutation in the erythrocyte protein 4.2 gene of Japanese patients with hereditary spherocytosis (protein 4.2 Fukuoka).
Anemia
Anemia in Pediatric Celiac Disease: Association with Clinical and Histological Features and Response to Gluten-free Diet.
Anemia
Anti tissue transglutaminase antibody in idiopathic autoimmune haemolytic anemia.
Anemia
Celiac disease prevalence in patients with iron deficiency anemia of obscure origin.
Anemia
Diagnosis and treatment of unexplained anemia with iron deficiency without overt bleeding.
Anemia
Genetic disorders of the red cell membranes.
Anemia
HLA-DQ2/DQ8 frequency in adult patients with celiac disease, their first-degree relatives, and normal population in Turkey.
Anemia
Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40glutamic acid-->lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore).
Anemia
Lonomia genus caterpillar toxins: biochemical aspects.
Anemia
Patients with celiac disease may have normal weight or may even be overweight.
Anemia
Pericardial effusion in celiac disease.
Anemia
Presence of anemia in patients with celiac disease suggests more severe disease.
Anemia
The use of real-time PCR technique in the detection of novel protein 4.2 gene mutations that coexist with thalassaemia alpha in a single patient.
Anemia
Ultra-short Celiac Disease Is a Distinct and Milder Phenotype of the Disease in Children.
Anemia
[Prevalence of polyglandular autoimmune syndrome in patients with diabetes mellitus type 1]
Anemia, Aplastic
Complete hemostasis achieved by factor XIII concentrate administration in a patient with bleeding after teeth extraction as a complication of aplastic anemia and chronic disseminated intravascular coagulation.
Anemia, Aplastic
[The state of homeostasis system in patients with aplastic anemia in the period of full-fledged clinical manifestation of disease].
Anemia, Hemolytic
A point mutation in the protein 4.2 gene (allele 4.2 Tozeur) associated with hereditary haemolytic anaemia.
Anemia, Hemolytic
An alanine-to-threonine substitution in protein 4.2 cDNA is associated with a Japanese form of hereditary hemolytic anemia (protein 4.2NIPPON).
Anemia, Hemolytic
Band 3 Tuscaloosa: Pro327----Arg327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2.
Anemia, Hemolytic
Deficiency of protein 4.2 in erythrocytes from a patient with a Coombs negative hemolytic anemia. Evidence for a role of protein 4.2 in stabilizing ankyrin on the membrane.
Anemia, Hemolytic
Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients.
Anemia, Hemolytic
Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40glutamic acid-->lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore).
Anemia, Hemolytic
Mapping of a palmitoylatable band 3-binding domain of human erythrocyte membrane protein 4.2.
Anemia, Hemolytic
Mapping of a spectrin-binding domain of human erythrocyte membrane protein 4.2.
Anemia, Hemolytic
Proteomic identification of erythrocyte membrane protein deficiency in hereditary spherocytosis.
Anemia, Hemolytic
Structure of the cytoplasmic domain of erythrocyte band 3 hereditary spherocytosis variant P327R: band 3 Tuscaloosa.
Anemia, Hemolytic, Congenital
A deletional frameshift mutation in protein 4.2 gene (allele 4.2 Lisboa) associated with hereditary hemolytic anemia.
Anemia, Hemolytic, Congenital
An alanine-to-threonine substitution in protein 4.2 cDNA is associated with a Japanese form of hereditary hemolytic anemia (protein 4.2NIPPON).
Anemia, Hemolytic, Congenital
Genetic disorders of the red cell membranes.
Anemia, Hemolytic, Congenital
Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40glutamic acid-->lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore).
Anemia, Hypochromic
"Strongyloides stercoralis infestation in a severely malnourished (SAM) celiac disease child:" A rare case report from Western Rajasthan.
Anemia, Hypochromic
Primary infertility as a rare presentation of celiac disease.
Anemia, Iron-Deficiency
Celiac disease prevalence in patients with iron deficiency anemia of obscure origin.
Anemia, Iron-Deficiency
Pericardial effusion in celiac disease.
Anemia, Iron-Deficiency
THE PREVALENCE OF CELIAC DISEASE IN PATIENTS WITH IRON-DEFICIENCY ANEMIA IN CENTER AND SOUTH AREA OF IRAN.
Anemia, Refractory
Cold urticaria and celiac disease.
Aneurysm
Effects of blood coagulation factor XIII on the development of experimental cerebral aneurysms in rats.
Aneurysm
Experimentally induced cerebral aneurysms as model for non-surgical treatment.
Aneurysm
Histological Investigation of Endothelial Cell Proliferation on the Coil Surface after Endovascular Treatment Using FactorXIII. Preliminary Results in Swine Model.
Aneurysm
Morphologic changes in neo-intimal proliferation in an experimental aneurysm after coil embolization: effect of factor XIII administration.
Angiofibroma
Phenotypic characterisation of stellate and giant cells in giant cell fibroma by immunocytochemistry.
Angiofibroma
Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34.
Angiofibroma
Unilateral facial angiofibromas--a segmental form of tuberous sclerosis.
Angiolymphoid Hyperplasia with Eosinophilia
Ultrastructural localization of factor XIIIa.
Angiomyolipoma
Factor XIIIa in the hamartomas of tuberous sclerosis.
Antiphospholipid Syndrome
Factor XIII in primary antiphospholipid syndrome.
Antiphospholipid Syndrome
Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.
Antiphospholipid Syndrome
Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with anti-thrombin antibody from a patient with antiphospholipid syndrome.
Antiphospholipid Syndrome
[Diagnosis and treatment of coagulation disorders]
Antiphospholipid Syndrome
[Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus].
Antiphospholipid Syndrome
[Recurrent miscarriage and inherited thrombophilia: diagnostic work-out and therapeutic management]
Aortic Aneurysm
Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm.
Aortic Aneurysm, Abdominal
Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Aortic Aneurysm, Abdominal
Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
Aortic Valve Stenosis
Factor XIII and alternatively activated macrophages - new targets in aortic valve stenosis.
Aortic Valve Stenosis
Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of disease.
Arnold-Chiari Malformation
Karyotype-Phenotype Correlation in Partial Trisomies of the Short Arm of Chromosome 6: A Family Case Report and Review of the Literature.
Arteriosclerosis
[Pathogenesis of arteriosclerosis. Thrombin, factor XIII and fibronectin as regulators of fibroblast proliferation, endothelial cells and smooth muscle cells]
Arteriovenous Malformations
Unusual presentation of factor XIII deficiency.
Arteritis
Differential behavior of coagulation factor XIII in patients with inflammatory bowel disease and in patients with giant cell arteritis.
Arthralgia
Adult Henoch-Schönlein purpura with severe abdominal pain treated with dapsone and factor XIII concentrate.
Arthritis
Evaluation of screening for celiac disease in children with juvenile idiopathic arthritis.
Arthritis
Factor XIII insufficiency in a patient with severe psoriasis vulgaris, arthritis, and infirmity.
Arthritis
Fibrin dissolution in synovial fluid.
Arthritis
IgA transglutaminase levels in children with Juvenile Idiopathic Arthritis.
Arthritis
New target against inflammatory diseases: transglutaminase 2.
Arthritis
Participation of transglutaminase in the activation of latent transforming growth factor beta1 in aging articular cartilage.
Arthritis
Tissue transglutaminase enhances collagen type II-induced arthritis and modifies the immunodominant T-cell epitope CII260-270.
Arthritis
Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis.
Arthritis
Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.
Arthritis
[Behavior of factor XIII in progressive chronic polyarthritis]
Arthritis, Juvenile
Evaluation of screening for celiac disease in children with juvenile idiopathic arthritis.
Arthritis, Juvenile
IgA transglutaminase levels in children with Juvenile Idiopathic Arthritis.
Arthritis, Psoriatic
Antibodies to human tissue transglutaminase and alterations of vitamin D metabolism in ankylosing spondylitis and psoriatic arthritis.
Arthritis, Psoriatic
Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis.
Arthritis, Rheumatoid
Adult variant of self-healing papular mucinosis in a patient with rheumatoid arthritis: Predominant proliferation of dermal dendritic cells expressing CD34 or factor XIIIa in association with dermal deposition of mucin.
Arthritis, Rheumatoid
Fibrin degradation in the synovial fluid of rheumatoid arthritis patients: a model for extravascular fibrinolysis.
Arthritis, Rheumatoid
Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.
Arthritis, Rheumatoid
Immunohistochemical detection of factor XIIIa and factor XIIIs in synovial membranes of patients with rheumatoid arthritis or osteoarthritis.
Arthritis, Rheumatoid
Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients.
Arthritis, Rheumatoid
Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab).
Arthritis, Rheumatoid
Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease.
Arthritis, Rheumatoid
Significance of diminished factor XIII in Crohn's disease.
Arthritis, Rheumatoid
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis.
Arthritis, Rheumatoid
Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
Arthritis, Rheumatoid
[Desmofibrinogenic activity of factor XIII and thiol group levels of the plasma of patients with rheumatoid arthritis treated with levamisole]
Ascorbic Acid Deficiency
[The significance of changes in the functional properties of blood platelets, factor XIII activity and fibrin clot quality in the pathogenesis of hemorrhagic diathesis secondary to experimental vitamin C deficiency]
Asthma
An initial assessment of the involvement of transglutaminase2 in eosinophilic bronchitis using a disease model developed in C57BL/6 mice.
Asthma
Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin.
Asthma
Association of TG2 from mast cells and chronic spontaneous urticaria pathogenesis.
Asthma
Asthma is associated with reduced fibrinolytic activity, abnormal clot architecture, and decreased clot retraction rate.
Asthma
Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expression.
Asthma
Circulating autoantibodies in patients with aspirin-intolerant asthma: an epiphenomenon related to airway inflammation.
Asthma
Epithelial regulation of eicosanoid production in asthma.
Asthma
IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma.
Asthma
PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation.
Asthma
Tranglutaminase 2 contributes to the asthmatic inflammation by modulating activation of alveolar macrophages.
Asthma
Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes.
Asthma
Triterpenoid compound betulin attenuates allergic airway inflammation by modulating antioxidants, inflammatory cytokines and tissue transglutaminase in ovalbumin-induced asthma mice model.
Asthma
Unusual allergen in a butcher with respiratory symptoms.
Asthma, Occupational
Tissue Transglutaminase Can Be Involved in Airway Inflammation of Toluene Diisocyanate-Induced Occupational Asthma.
Astrocytoma
Factor XIIIa in the hamartomas of tuberous sclerosis.
Astrocytoma
Increased endothelial expression of transglutaminase in glioblastomas.
Ataxia
A case report of late-onset cerebellar ataxia associated with a rare p.R342W TGM6 (SCA35) mutation.
Ataxia
Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia.
Ataxia
Anti transglutaminase antibodies cause ataxia in mice.
Ataxia
Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase.
Ataxia
Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia.
Ataxia
Coeliac disease patients do not produce antibodies to a common cerebellar epitope.
Ataxia
Epilepsy, cerebral calcifications, and gluten-related disorders: Are anti-transglutaminase 6 antibodies the missing link?
Ataxia
Transglutaminase 6 antibodies in the diagnosis of gluten ataxia.
Ataxia
Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis.
Ataxia Telangiectasia
Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor ? light chain enhancer of activated B cells (NF?B) signaling controls basal and DNA damage-induced transglutaminase 2 expression.
Atherosclerosis
Alterations of haemostasis parameters with special reference to fibrin stabilization, factor XIII and fibronectin in patients with obliterative atherosclerosis.
Atherosclerosis
Erythrocyte transglutaminase activity in patients with obliterative atherosclerosis of the lower limbs.
Atherosclerosis
Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of disease.
Atherosclerosis
Factor XIIIA (cross)links AT1 receptors to atherosclerosis.
Atherosclerosis
Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis.
Atherosclerosis
Factor XIIIA Val34Leu polymorphism does not predict risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study.
Atherosclerosis
Increase in transglutaminase and its extracellular products in response to an inflammatory stimulus by lipopolysaccharide.
Atherosclerosis
Increased tissue transglutaminase expression in human atherosclerotic coronary arteries.
Atherosclerosis
Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression.
Atherosclerosis
Nitric oxide regulates non-classical secretion of tissue transglutaminase.
Atherosclerosis
Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial.
Atherosclerosis
Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy.
Atherosclerosis
Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.
Atherosclerosis
Roles of transglutaminases in cardiac and vascular diseases.
Atherosclerosis
Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stress.
Atherosclerosis
[Inhibition of factor XIII as a preventive and therapeutic possibility in atherosclerosis]
Atrial Fibrillation
alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.
Atrial Fibrillation
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Atrial Fibrillation
Platelet factor XIII gene expression and embolic propensity in atrial fibrillation.
Autoimmune Diseases
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases.
Autoimmune Diseases
Autoimmunity to heat shock proteins and vitamin D status in patients with celiac disease without associated dermatitis herpetiformis.
Autoimmune Diseases
Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): a population control study.
Autoimmune Diseases
Gluten ataxia: passive transfer in a mouse model.
Autoimmune Diseases
IFN-gamma induces transglutaminase 2 expression in rat small intestinal cells.
Autoimmune Diseases
In vitro and in vivo models of celiac disease.
Autoimmune Diseases
Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease.
Autoimmune Diseases
Linear ?-(1???6)-d-glucan from Bifidobacterium bifidum BIM ?-733D is low molecular mass biopolymer with unique immunochemical properties.
Autoimmune Diseases
Microbial transglutaminase should be considered as an environmental inducer of celiac disease.
Autoimmune Diseases
New target against inflammatory diseases: transglutaminase 2.
Autoimmune Diseases
NON-CELIAC SPRUE: A CASE OF OLMESARTAN-INDUCED ENTEROPATHY.
Autoimmune Diseases
Orbital myositis associated with celiac disease.
Autoimmune Diseases
Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
Autoimmune Diseases
Pathomechanisms in celiac disease.
Autoimmune Diseases
Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
Autoimmune Diseases
Potential of transglutaminase 2 as a therapeutic target.
Autoimmune Diseases
Similarities and differences between older and young adult patients with celiac disease.
Autoimmune Diseases
Synthetic Neoepitopes of the Transglutaminase-Deamidated Gliadin Complex as Biomarkers for Diagnosing and Monitoring Celiac Disease.
Autoimmune Diseases
Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive disease.
Autoimmune Diseases
Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems.
Autoimmune Diseases
Transglutaminases as targets for pharmacological inhibition.
Autoimmune Diseases
[Celiac disease as a model for autoimmune disease. Transglutaminase has the key role--stress reaction triggers the vicious circle]
Autoimmune Diseases
[Celiac sprue (review)]
Autoimmune Diseases
[Changing clinical image of celiac sprue in childhood]
Avitaminosis
Celiac Disease: Ten Things That Every Gastroenterologist Should Know.
Axial Spondyloarthritis
Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis.
Axial Spondyloarthritis
Relation of ?2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis.
Azoospermia
Identification of genes expressed in primate primordial oocytes.
Azotemia
Feline chronic kidney disease is associated with upregulation of transglutaminase 2: a collagen cross-linking enzyme.
Bacteremia
Factor XIII as a modulator of plasma fibronectin alterations during experimental bacteremia.
Bacterial Infections
Cellular and molecular modification of egg envelope hardening in fertilization.
Bacterial Infections
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.
Balanitis
Expression of Transglutaminase in Foreskin of Children with Balanitis Xerotica Obliterans.
Balanitis Xerotica Obliterans
Expression of Transglutaminase in Foreskin of Children with Balanitis Xerotica Obliterans.
Basal Ganglia Diseases
Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.
Battered Child Syndrome
Factor XIII deficiency mistaken for battered child syndrome: case of "correct" test ordering negated by a commonly accepted qualitative test with limited negative predictive value.
Behcet Syndrome
Prevalence of Celiac Disease Among Patients with Behcet's Disease in Iran.
Bell Palsy
Diagnosis and management of idiopathic facial palsy in children.
Bernard-Soulier Syndrome
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Bernard-Soulier Syndrome
On the retraction of collagen and fibrin induced by normal, defective and modified platelets.
beta-Thalassemia
Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia.
Blister
Dermatitis herpetiformis and vitiligo.
Blister
Effects of androgen deprivation and estrogen treatment on the structure and protein expression of the rat coagulating gland.
Blister
Hormonally induced changes in apocrine secretion of transglutaminase in the rat dorsal prostate and coagulating gland.
Blister
Simultaneous apocrine and merocrine secretion in the rat coagulating gland.
Blood Coagulation Disorders
Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations.
Blood Coagulation Disorders
[Blood coagulation disorder in a patient with moderate factor XIII and IX deficiency]
Blood Coagulation Disorders
[Characterization of a large deletion that leads to congenital factor XIII deficiency]
Blood Platelet Disorders
[Pre-hospital diagnosis of nosebleed in children]
Bone Marrow Failure Disorders
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
Brain Edema
Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits.
Brain Infarction
The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction.
Brain Infarction
The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
Brain Injuries
Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia.
Brain Injuries, Traumatic
Up-regulation of tissue-type transglutaminase after traumatic brain injury.
Brain Ischemia
Excitotoxic and post-ischemic neurodegeneration: Involvement of transglutaminases.
Brain Ischemia
Transglutaminase activity and transglutaminase mRNA transcripts in gerbil brain ischemia.
Brain Ischemia
Transglutaminase activity in reversible cerebral ischemia in the rat.
Brain Neoplasms
An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes.
Brain Neoplasms
Application of a Global Proteomic Approach to Archival Precursor Lesions: Deleted in Malignant Brain Tumors 1 and Tissue Transglutaminase 2 Are Upregulated in Pancreatic Cancer Precursors.
Brain Neoplasms
Transglutaminase activity in human brain tumors.
Brain Neoplasms
[Tissue transglutaminase protein expression in human brain tumors]
Breast Neoplasms
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.
Breast Neoplasms
Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells.
Breast Neoplasms
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer.
Breast Neoplasms
Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells.
Breast Neoplasms
Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report.
Breast Neoplasms
Correlation between immunoreactivity for transglutaminase K and for markers of proliferation and differentiation in normal breast tissue and breast carcinomas.
Breast Neoplasms
Correlation of tissue transglutaminase expression on breast cancer tissue with time to relapse, overall survival, and clinical and molecular prognostic factors: a preliminary report.
Breast Neoplasms
Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis.
Breast Neoplasms
Expression and Activity of Transglutaminase II in Spontaneous Tumours of Dogs and Cats.
Breast Neoplasms
Fibrinogen deposition without thrombin generation in primary human breast cancer tissue.
Breast Neoplasms
Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.
Breast Neoplasms
High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells.
Breast Neoplasms
I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.
Breast Neoplasms
IL-1? induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells.
Breast Neoplasms
Immunocytochemical demonstration of tissue transglutaminase indicative of programmed cell death (apoptosis) in hormone sensitive mammary tumours.
Breast Neoplasms
Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
Breast Neoplasms
Implications of tissue transglutaminase expression in malignant melanoma.
Breast Neoplasms
In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model.
Breast Neoplasms
Increase in transglutaminase 2 expression is associated with NF-kappaB activation in breast cancer tissues.
Breast Neoplasms
Increased tissue transglutaminase expression in human atherosclerotic coronary arteries.
Breast Neoplasms
Increased transglutaminase 2 and GLUT-1 expression in breast tumors not susceptible to chemoprevention with antioxidants.
Breast Neoplasms
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells.
Breast Neoplasms
Interplay between membrane lipid peroxidation, transglutaminase activity and cyclooxygenase 2 expression in the tissue adjoining to breast cancer.
Breast Neoplasms
Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools.
Breast Neoplasms
Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
Breast Neoplasms
Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma.
Breast Neoplasms
Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.
Breast Neoplasms
Role of TG2 and TGF-?1 in the pathogenesis of human breast cancer.
Breast Neoplasms
Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors.
Breast Neoplasms
Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel.
Breast Neoplasms
Targeting p70S6K Prevented Lung Metastasis in a Breast Cancer Xenograft Model.
Breast Neoplasms
The 55?kDa tissue transglutaminase cross-linking active isoform TG induces cell death.
Breast Neoplasms
The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205.
Breast Neoplasms
The tissue transglutaminase: a potential target regulating MDR in breast cancer.
Breast Neoplasms
The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.
Breast Neoplasms
Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer.
Breast Neoplasms
Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer.
Breast Neoplasms
Tissue transglutaminase expression in breast carcinomas.
Breast Neoplasms
Tissue transglutaminase expression in human breast cancer.
Breast Neoplasms
Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.
Breast Neoplasms
Tissue transglutaminase is an essential participant in the EGF-stimulated signaling pathway leading to cancer cell migration and invasion.
Breast Neoplasms
Transglutaminase 2 and NF-?B: an odd couple that shapes breast cancer phenotype.
Breast Neoplasms
Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells.
Breast Neoplasms
Treatment of postmenopausal osteoporosis in a patient with celiac disease.
Bronchitis
An initial assessment of the involvement of transglutaminase2 in eosinophilic bronchitis using a disease model developed in C57BL/6 mice.
Bronchopulmonary Dysplasia
Targeting transglutaminase 2 partially restores extracellular matrix structure but not alveolar architecture in experimental bronchopulmonary dysplasia.
Bulbo-Spinal Atrophy, X-Linked
Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases.
Candidiasis
Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice.
Carcinogenesis
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.
Carcinogenesis
Aging process is accompanied by increase of transglutaminase C.
Carcinogenesis
Alteration of Rb binding to HPV 18 E7 modified by transglutaminase 2 with different type of polyamines.
Carcinogenesis
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
Carcinogenesis
Apoptosis induction by S-allylcysteine, a garlic constituent, during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.
Carcinogenesis
Distribution and activity of transglutaminase in rat brain carcinogenesis and in gliomas.
Carcinogenesis
Effects of C-Phycocyanin on the representative genes of tumor development in mouse skin exposed to 12-O-tetradecanoyl-phorbol-13-acetate.
Carcinogenesis
Expression of epidermal growth factor receptor, polyamine levels, ornithine decarboxylase activity, micronuclei, and transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model.
Carcinogenesis
Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis.
Carcinogenesis
Garlic induces apoptosis during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.
Carcinogenesis
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells.
Carcinogenesis
Interplay between membrane lipid peroxidation, transglutaminase activity and cyclooxygenase 2 expression in the tissue adjoining to breast cancer.
Carcinogenesis
Ovarian cancer, the coagulation pathway, and inflammation.
Carcinogenesis
Study of tumor transglutaminase 2 expression in gallbladder cancer - Is it a novel predictor of survival?
Carcinogenesis
The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.
Carcinogenesis
The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression.
Carcinogenesis
Tissue transglutaminase is an essential participant in the EGF-stimulated signaling pathway leading to cancer cell migration and invasion.
Carcinogenesis
Transglutaminase 2 expression and its prognostic significance in clear cell renal cell carcinoma.
Carcinogenesis
Transglutaminase in azoxymethane-induced colon cancer in the rat.
Carcinogenesis
[Study on the loss of heterozygosity and expression of transglutaminase 3 gene in laryngeal carcinoma]
Carcinogenesis
[Tissue transglutaminase protein expression in human brain tumors]
Carcinoma
A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2.
Carcinoma
A unique role for heat shock protein 70 and its binding partner tissue transglutaminase in cancer cell migration.
Carcinoma
Agminated Clear Cell Tumor: An Impostor of PEComa and Distinctive Dermal Clear Cell Mesenchymal Neoplasm.
Carcinoma
Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus.
Carcinoma
Alterations in cholesterol sulfate and its biosynthetic enzyme during multistage carcinogenesis in mouse skin.
Carcinoma
Annexin I and involucrin are cross-linked by particulate transglutaminase into the cornified cell envelope of squamous cell carcinoma Y1.
Carcinoma
Biochemistry of transglutaminases and cross-linking in the skin.
Carcinoma
Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: correlation with tissue transglutaminase.
Carcinoma
Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells.
Carcinoma
Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
Carcinoma
Clinical Significance of GPR56, Transglutaminase 2, and NF-κB in Esophageal Squamous Cell Carcinoma.
Carcinoma
Comparative immunohistochemistry of malignant fibrous histiocytoma and sarcomatoid carcinoma of the urinary tract.
Carcinoma
Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1.
Carcinoma
Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines.
Carcinoma
Differences in transglutaminase mRNA after polyamine depletion in two cell lines.
Carcinoma
Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia.
Carcinoma
Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester.
Carcinoma
Discovery of a novel target for renal cell carcinoma: transglutaminase 2.
Carcinoma
E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line.
Carcinoma
E3 ligase STUB1 attenuates stemness and tumorigenicity of oral carcinoma cells via transglutaminase 2 regulation.
Carcinoma
Expression and Activity of Transglutaminase II in Spontaneous Tumours of Dogs and Cats.
Carcinoma
Expression of epidermal growth factor receptor, polyamine levels, ornithine decarboxylase activity, micronuclei, and transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model.
Carcinoma
Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
Carcinoma
Expression of tissue transglutaminase in human bladder carcinoma.
Carcinoma
Expression of transglutaminase K in normal cervix tissue and cervix carcinomas.
Carcinoma
Fibrin stabilizing factor activity of the skin carcinoma.
Carcinoma
Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.
Carcinoma
Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma.
Carcinoma
Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes.
Carcinoma
Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
Carcinoma
Immunohistochemical markers informing the diagnosis of sebaceous carcinoma and its distinction from its mimics: Adipophilin and factor XIIIa to the rescue?
Carcinoma
Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines.
Carcinoma
Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.
Carcinoma
Influences of clotting factors (thrombin, factor XIII) and of fibronectin on the growth of tumor cells and leukemic cells in vitro.
Carcinoma
Influences of thrombin, factor XIII and fibronectin on the growth of tumor cells and leukemic cells in vitro.
Carcinoma
Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma.
Carcinoma
Keratinocyte differentiation markers: involucrin, transglutaminase, and toxicity.
Carcinoma
Keratinocyte transglutaminase expression varies in squamous cell carcinomas.
Carcinoma
Keratinocyte transglutaminase in human skin and oral mucosa: cytoplasmic localization and uncoupling of differentiation markers.
Carcinoma
New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds.
Carcinoma
Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytes.
Carcinoma
Phenotypic characterization of macrophage subpopulations and localization of factor XIII in the stromal cells of carcinomas.
Carcinoma
Prognostic role of tissue transglutaminase 2 in colon carcinoma.
Carcinoma
Purification of keratinocyte transglutaminase and its expression during squamous differentiation.
Carcinoma
Rapid increases in the transglutaminase activity of A431 cells following treatment with epidermal growth factor.
Carcinoma
Regulation of type I and type II transglutaminase in normal human bronchial epithelial and lung carcinoma cells.
Carcinoma
Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.
Carcinoma
Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition.
Carcinoma
Retinoid suppression of transglutaminase activity and envelope competence in cultured human epidermal carcinoma cells. Hydrocortisone is a potent antagonist or retinyl acetate but not retinoic acid.
Carcinoma
Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression.
Carcinoma
Sebaceous Carcinoma in Situ Masquerading Clinically and Histologically as Paget Disease of the Breast.
Carcinoma
The expression of transglutaminase 2 (TG-2) in oral squamous cell carcinoma and its clinical significance.
Carcinoma
The hamster cheek pouch carcinogenesis model.
Carcinoma
The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.
Carcinoma
The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
Carcinoma
The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Carcinoma
Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer.
Carcinoma
Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma.
Carcinoma
Tissue transglutaminase is an essential participant in the EGF-stimulated signaling pathway leading to cancer cell migration and invasion.
Carcinoma
Tissue transglutaminase links TGF-?, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
Carcinoma
Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma.
Carcinoma
Tissue transglutaminase was up-regulated by EGF-retinoid interplay in epithelial carcinoma cells.
Carcinoma
TPA induces transglutaminase C and inhibits cell growth in the colon carcinoma cell line SW620.
Carcinoma
Transglutaminase 2 expression and its prognostic significance in clear cell renal cell carcinoma.
Carcinoma
Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
Carcinoma
Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.
Carcinoma
Transglutaminase 2 Promotes Autophagy by LC3 Induction through p53 Depletion in Cancer Cell.
Carcinoma
Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1?-p300 Binding in Renal Cell Carcinoma.
Carcinoma
Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma.
Carcinoma
Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Carcinoma
Transglutaminase 3 is expressed in basal cell carcinoma of the skin.
Carcinoma
Transglutaminase Interaction with ?6/?4-Integrin Stimulates YAP1-Dependent ?Np63? Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation.
Carcinoma
Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
Carcinoma
Ultrastructural localization of factor XIIIa.
Carcinoma
Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma.
Carcinoma
[Disseminated intravascular coagulation syndrome (D.I.C.) and carcinoma of the prostate (author's transl)]
Carcinoma
[Factor XIII (fibrin stabilizing factor) in cutaneous epitheliomas]
Carcinoma
[Is the use of factor XIII for delayed wound healing in patients with head-neck tumors of value?]
Carcinoma
[Study on the loss of heterozygosity and expression of transglutaminase 3 gene in laryngeal carcinoma]
Carcinoma in Situ
Sebaceous Carcinoma in Situ Masquerading Clinically and Histologically as Paget Disease of the Breast.
Carcinoma, Acinar Cell
Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
Carcinoma, Adenoid Cystic
Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
Carcinoma, Basal Cell
Biochemistry of transglutaminases and cross-linking in the skin.
Carcinoma, Basal Cell
Fibrin stabilizing factor activity of the skin carcinoma.
Carcinoma, Basal Cell
Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes.
Carcinoma, Basal Cell
Transglutaminase 3 is expressed in basal cell carcinoma of the skin.
Carcinoma, Basal Cell
Ultrastructural localization of factor XIIIa.
Carcinoma, Ductal
Interplay between membrane lipid peroxidation, transglutaminase activity and cyclooxygenase 2 expression in the tissue adjoining to breast cancer.
Carcinoma, Ductal
Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.
Carcinoma, Embryonal
Transglutaminase activity and embryonal carcinoma cell differentiation.
Carcinoma, Hepatocellular
Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia.
Carcinoma, Hepatocellular
Alterations in the distribution and activity of transglutaminase during tumour growth and metastasis.
Carcinoma, Hepatocellular
Biosynthesis of factor XIII B subunit by human hepatoma cell lines.
Carcinoma, Hepatocellular
Biosynthesis of plasma factor XIII: evidence for transcription and translation in hepatoma cells.
Carcinoma, Hepatocellular
Cancer-associated Fibroblasts induce epithelial-mesenchymal transition via the Transglutaminase 2-dependent IL-6/IL6R/STAT3 axis in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Characterisation of the cellular substrates for transglutaminase in normal liver and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Construction of a pH/TGase "Dual Key"-Responsive Gold Nano-radiosensitizer with Liver Tumor-Targeting Ability.
Carcinoma, Hepatocellular
Differential regulation of tissue transglutaminase in rat hepatoma cell lines McA-RH7777 and McA-RH8994: relation to growth rate and cell death.
Carcinoma, Hepatocellular
Differential transglutaminase distribution in normal rat liver and rat hepatoma.
Carcinoma, Hepatocellular
Effects of phenyl saligenin phosphate on cell viability and transglutaminase activity in N2a neuroblastoma and HepG2 hepatoma cell lines.
Carcinoma, Hepatocellular
Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis.
Carcinoma, Hepatocellular
Induction of apoptosis by transforming growth factor-beta 1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression.
Carcinoma, Hepatocellular
Molecular mechanism by which acyclic retinoid induces nuclear localization of transglutaminase 2 in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Multifunctional nanocatalyst-based ultrasensitive detection of human tissue transglutaminase 2.
Carcinoma, Hepatocellular
Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
Carcinoma, Hepatocellular
Properties of particulate transglutaminase from Yoshida tumor cells.
Carcinoma, Hepatocellular
Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Tissue transglutaminase 2 exerts a tumor-promoting role in hepatitis B virus-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Transglutaminase 2 is upregulated in primary hepatocellular carcinoma with early recurrence as determined by proteomic profiles.
Carcinoma, Hepatocellular
Transglutaminase and epsilon-(gamma-glutamyl) lysine isopeptide bonds in eukaryotic cells.
Carcinoma, Hepatocellular
[High expressions of tissue transglutaminase in human hepatocellular carcinomas]
Carcinoma, Intraductal, Noninfiltrating
Interplay between membrane lipid peroxidation, transglutaminase activity and cyclooxygenase 2 expression in the tissue adjoining to breast cancer.
Carcinoma, Mucoepidermoid
Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
Carcinoma, Non-Small-Cell Lung
Association between TGM5, PPAP2B and PSMA4 polymorphisms and NSCLC in never-smoking Chinese population.
Carcinoma, Non-Small-Cell Lung
Clinical value of exogenous factor XIII for prolonged air leak following pulmonary lobectomy: a case control study.
Carcinoma, Non-Small-Cell Lung
Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines.
Carcinoma, Non-Small-Cell Lung
Dynamics of coagulation factor XIII activity after video-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.
Carcinoma, Non-Small-Cell Lung
Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor.
Carcinoma, Ovarian Epithelial
Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.
Carcinoma, Ovarian Epithelial
Tissue transglutaminase regulates MMP-2 in ovarian cancer by modulating CREB activity.
Carcinoma, Renal Cell
A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2.
Carcinoma, Renal Cell
Agminated Clear Cell Tumor: An Impostor of PEComa and Distinctive Dermal Clear Cell Mesenchymal Neoplasm.
Carcinoma, Renal Cell
Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus.
Carcinoma, Renal Cell
Discovery of a novel target for renal cell carcinoma: transglutaminase 2.
Carcinoma, Renal Cell
Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.
Carcinoma, Renal Cell
Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma.
Carcinoma, Renal Cell
New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds.
Carcinoma, Renal Cell
Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.
Carcinoma, Renal Cell
Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition.
Carcinoma, Renal Cell
Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression.
Carcinoma, Renal Cell
The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.
Carcinoma, Renal Cell
The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
Carcinoma, Renal Cell
Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma.
Carcinoma, Renal Cell
Transglutaminase 2 expression and its prognostic significance in clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
Carcinoma, Renal Cell
Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.
Carcinoma, Renal Cell
Transglutaminase 2 Promotes Autophagy by LC3 Induction through p53 Depletion in Cancer Cell.
Carcinoma, Renal Cell
Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1?-p300 Binding in Renal Cell Carcinoma.
Carcinoma, Renal Cell
Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma.
Carcinoma, Squamous Cell
2,3,7,8-Tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons suppress retinoid-induced tissue transglutaminase in SCC-4 cultured human squamous carcinoma cells.
Carcinoma, Squamous Cell
Alterations in cholesterol sulfate and its biosynthetic enzyme during multistage carcinogenesis in mouse skin.
Carcinoma, Squamous Cell
Annexin I and involucrin are cross-linked by particulate transglutaminase into the cornified cell envelope of squamous cell carcinoma Y1.
Carcinoma, Squamous Cell
Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1.
Carcinoma, Squamous Cell
Differential regulation by retinoic acid and calcium of transglutaminases in cultured neoplastic and normal human keratinocytes.
Carcinoma, Squamous Cell
Differentiation of normal and tumoral human keratinocytes cultured on dermis: reconstruction of either normal or tumoral architecture.
Carcinoma, Squamous Cell
E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line.
Carcinoma, Squamous Cell
Expression of epidermal growth factor receptor, polyamine levels, ornithine decarboxylase activity, micronuclei, and transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model.
Carcinoma, Squamous Cell
Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
Carcinoma, Squamous Cell
Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
Carcinoma, Squamous Cell
Keratinocyte transglutaminase expression varies in squamous cell carcinomas.
Carcinoma, Squamous Cell
Keratinocyte transglutaminase in human skin and oral mucosa: cytoplasmic localization and uncoupling of differentiation markers.
Carcinoma, Squamous Cell
Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytes.
Carcinoma, Squamous Cell
Purification of keratinocyte transglutaminase and its expression during squamous differentiation.
Carcinoma, Squamous Cell
Regulation of type I and type II transglutaminase in normal human bronchial epithelial and lung carcinoma cells.
Carcinoma, Squamous Cell
Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways.
Carcinoma, Squamous Cell
Retinoid suppression of transglutaminase activity and envelope competence in cultured human epidermal carcinoma cells. Hydrocortisone is a potent antagonist or retinyl acetate but not retinoic acid.
Carcinoma, Squamous Cell
Suppression of keratinocyte differentiation in SSC-9 human squamous carcinoma cells by benzo[a]pyrene, 12-O-tetradecanoylphorbol-13-acetate and hydroxyurea.
Carcinoma, Squamous Cell
TCDD suppression of tissue transglutaminase stimulation by retinoids in malignant human keratinocytes.
Carcinoma, Squamous Cell
Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma.
Carcinoma, Squamous Cell
Transglutaminase Interaction with ?6/?4-Integrin Stimulates YAP1-Dependent ?Np63? Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation.
Carcinoma, Squamous Cell
Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
Carcinoma, Squamous Cell
Type I keratinocyte transglutaminase: expression in human skin and psoriasis.
Carcinoma, Transitional Cell
Expression of tissue transglutaminase in human bladder carcinoma.
Cardiomegaly
Involvement of tissue transglutaminase in endothelin 1-induced hypertrophy in cultured neonatal rat cardiomyocytes.
Cardiomyopathies
Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy.
Cardiomyopathy, Dilated
Damaged myocytes as detected by the colocalization of DNA fragmentation and tissue transglutaminase and their prognostic significance in enterovirus-associated dilated cardiomyopathy.
Cardiovascular Diseases
Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.
Cardiovascular Diseases
Combined measurement of factor XIII and D-dimer is helpful for differential diagnosis in patients with suspected pulmonary embolism.
Cardiovascular Diseases
Combined presence of coagulation factor XIII V34L and plasminogen activator inhibitor 1 4G/5G gene polymorphisms significantly contribute to recurrent pregnancy loss in Serbian population.
Cardiovascular Diseases
Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey.
Cardiovascular Diseases
Factor XIII gene V34L mutation in the Lebanese population: another unique feature in this community?
Cardiovascular Diseases
Nitric oxide regulates tissue transglutaminase localization and function in the vasculature.
Cardiovascular Diseases
Pathophysiologic roles of the fibrinogen gamma chain.
Cardiovascular Diseases
Role of inherited thrombophilic profile on survival of patients with sepsis.
Cardiovascular Diseases
The effects of genetic polymorphisms and diabetes mellitus on the development of peripheral artery disease.
Cardiovascular Diseases
The genetics of haemostasis: a twin study.
Cardiovascular Diseases
[Effect of mercurial diuretics on heparin contents fibrinolysis and activity of blood fibrin stabilizing factor in patients with cardiovascular diseases]
Cartilage Diseases
Participation of transglutaminase in the activation of latent transforming growth factor beta1 in aging articular cartilage.
Cataract
Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis.
Cataract
Cysteamine prevents the development of lens opacity in a rat model of selenite-induced cataract.
Cataract
Endoplasmic reticulum stress activates transglutaminase 2 leading to protein aggregation.
Cataract
Enhanced expression of transglutaminase 2 in anterior polar cataracts and its induction by TGF-beta in vitro.
Cataract
Exposure of beta H-crystallin to hydroxyl radicals enhances the transglutaminase-susceptibility of its existing amine-donor and amine-acceptor sites.
Cataract
Exposure of beta L-crystallin to oxidizing free radicals enhances its susceptibility to transglutaminase activity.
Cataract
Expression and rapid purification of highly active hexahistidine-tagged guinea pig liver transglutaminase.
Cataract
Identification and functional clustering of global gene expression differences between human age-related cataract and clear lenses.
Cataract
Lamellar ichthyosis associated with pseudoainhum of the toes and eye changes.
Cataract
Lens transglutaminase and cataract formation.
Cataract
Localization of transglutaminase in human lenses.
Cataract
Novel inhibitors against the transglutaminase-catalysed crosslinking of lens proteins.
Cataract
Polyamine Oxidase Is Involved in Spermidine Reduction of Transglutaminase Type 2-Catalyzed ?H-Crystallins Polymerization in Calcium-Induced Experimental Cataract.
Cataract
Properties of purified lens transglutaminase and regulation of its transamidase/crosslinking activity by GTP.
Cataract
Transglutaminase activity in normal human lenses and in senile cataracts.
Cataract
Transglutaminases as targets for pharmacological inhibition.
Celiac Disease
A Comparison of Antibody Testing, Permeability Testing, and Zonulin Levels with Small-Bowel Biopsy in Celiac Disease Patients on a Gluten-Free Diet.
Celiac Disease
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies.
Celiac Disease
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases.
Celiac Disease
A limp in a pregnant woman as a first presentation of celiac disease.
Celiac Disease
A modified ELISA for improved detection of IgA, IgG, and IgM anti-tissue transglutaminase antibodies in celiac disease.
Celiac Disease
A molecular warhead and its target: tissue transglutaminase and Celiac Sprue.
Celiac Disease
A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease.
Celiac Disease
A new dot immunoassay for simultaneous detection of celiac specific antibodies and IgA-deficiency.
Celiac Disease
A new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodies.
Celiac Disease
A non-human primate model for gluten sensitivity.
Celiac Disease
A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Celiac Disease
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
Celiac Disease
A Randomized, Double-Blind Study of Larazotide Acetate to Prevent the Activation of Celiac Disease During Gluten Challenge.
Celiac Disease
A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease.
Celiac Disease
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
Celiac Disease
A Single Institution's Experience of Primary Headache in Children With Celiac Disease.
Celiac Disease
A study on early developing celiac disease in children with cerebral palsy.
Celiac Disease
Accumulation of Heavy Metals in People on a Gluten-Free Diet.
Celiac Disease
Accuracy of Anti-Tissue Transglutaminase IgA Antibody in the Diagnosis of Paediatric Celiac Disease.
Celiac Disease
Accuracy of HLA-DQ genotyping in combination with IgA anti-tissue transglutaminase serology and a "scoring system" for the diagnosis of celiac disease in Turkish children.
Celiac Disease
Accuracy of Screening Tests for Celiac Disease in Asymptomatic Patients With Type 1 Diabetes.
Celiac Disease
Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
Celiac Disease
Acylideneoxoindoles: A new class of reversible inhibitors of human transglutaminase 2.
Celiac Disease
Addition of a Short Course of Prednisolone to a Gluten-Free Diet vs. Gluten-Free Diet Alone in Recovery of Celiac Disease: A Pilot Randomized Controlled Trial.
Celiac Disease
Adherence to a Gluten-Free Diet: Assessment by Dietician Interview and Serology.
Celiac Disease
Adult celiac disease followed by onset of systemic lupus erythematosus.
Celiac Disease
AGA Clinical Practice Update on the Evaluation and Management of Seronegative Enteropathies.
Celiac Disease
AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Celiac Disease
Alpha-enolase involvement in intestinal and extraintestinal manifestations of celiac disease.
Celiac Disease
Alternative RNA splicing of leukocyte tissue transglutaminase in celiac disease.
Celiac Disease
An amperometric immunosensor for diagnosis of celiac disease based on covalent immobilization of open conformation tissue transglutaminase for determination of anti-tTG antibodies in human serum.
Celiac Disease
An explorative study identifies miRNA signatures for the diagnosis of non-celiac wheat sensitivity.
Celiac Disease
An Unusual "OR" Gate for Allosteric Regulation of Mammalian Transglutaminase 2 in the Extracellular Matrix.
Celiac Disease
An update on the diagnostics of celiac disease.
Celiac Disease
Analysis of celiac disease autoreactive gut plasma cells and their corresponding memory compartment in peripheral blood using high-throughput sequencing.
Celiac Disease
Angiogenesis-related gene expression analysis in celiac disease.
Celiac Disease
Anthropometric, Serologic, and Laboratory Correlation With Villous Blunting in Pediatric Celiac Disease: Diabetics are Different.
Celiac Disease
Anti-gliadin antibodies identify celiac patients overlooked by tissue transglutaminase antibodies.
Celiac Disease
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis.
Celiac Disease
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence.
Celiac Disease
Anti-tissue transglutaminase antibody as the first line screening for celiac disease: good-bye antigliadin tests?
Celiac Disease
Anti-tissue transglutaminase antibody inhibits apoptotic cell clearance by macrophages in pregnant NOD mice.
Celiac Disease
Anti-tissue Transglutaminase Normalization Post Diagnosis in Children With Celiac Disease.
Celiac Disease
Anti-tissue transglutaminase titers are associated with endoscopic findings and severity of mucosal damage in children with celiac disease.
Celiac Disease
Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis.
Celiac Disease
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Celiac Disease
Antibodies Against Deamidated Gliadin Peptides and Tissue Transglutaminase for Diagnosis of Pediatric Celiac Disease - Diagnostic Performance and Cost in Clinical Practice.
Celiac Disease
Antibodies Against Deamidated Gliadin Peptides in Early-stage Celiac Disease.
Celiac Disease
Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease.
Celiac Disease
Antibodies against neo-epitope tTg complexed to gliadin are different and more reliable then anti-tTg for the diagnosis of pediatric celiac disease.
Celiac Disease
Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Celiac Disease
Antibodies in celiac disease: implications beyond diagnostics.
Celiac Disease
Antibodies to Deamidated Gliadin Peptide in Diagnosis of Celiac Disease in Children.
Celiac Disease
Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease.
Celiac Disease
Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: evidence for high diagnostic sensitivity for celiac disease.
Celiac Disease
Antibodies to human tissue transglutaminase for the diagnosis of celiac disease.
Celiac Disease
Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis.
Celiac Disease
Antibody Concentrations Decrease 14-Fold in Children With Celiac Disease on a Gluten-Free Diet but Remain High at 3 Months.
Celiac Disease
Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease.
Celiac Disease
Antibody testing in Indian children with celiac disease.
Celiac Disease
Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity.
Celiac Disease
Antitissue transglutaminase and antithyroid autoantibodies in children with Down syndrome and celiac disease.
Celiac Disease
Antitissue transglutaminase antibodies outside celiac disease.
Celiac Disease
Antitissue Transglutaminase IgA for Celiac Disease Testing.
Celiac Disease
Are Immunoglobulin A anti-gliadin antibodies of any help in the diagnosis of coeliac disease in children below 2 years-old? a French multicenter study.
Celiac Disease
Assessment of a combination screening assay for celiac disease.
Celiac Disease
Association between Celiac Disease and Intussusceptions in Children: Two Case Reports and Literature Review.
Celiac Disease
Association of Anti-tissue Transglutaminase Antibody Titers and Duodenal Biopsy Findings in Pediatric Patients of Celiac Disease.
Celiac Disease
Association of celiac disease in patients with multiple sclerosis in Tuscany.
Celiac Disease
Association of Gluten Intake During the First 5 Years of Life With Incidence of Celiac Disease Autoimmunity and Celiac Disease Among Children at Increased Risk.
Celiac Disease
Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease.
Celiac Disease
Atypical Presentation of Celiac Disease: Recurrent Acute Small Bowel Obstruction.
Celiac Disease
Autism Spectrum Disorders and Celiac Disease: Is there an Association?
Celiac Disease
Autoantibodies against soluble and immobilized human recombinant tissue transglutaminase in children with celiac disease.
Celiac Disease
Autoantibodies and CD: past and future of celiac antibody testing.
Celiac Disease
Autoantibodies and histogenesis of celiac disease.
Celiac Disease
Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion.
Celiac Disease
Autoantibodies in celiac disease.
Celiac Disease
Autoantibodies in the Extraintestinal Manifestations of Celiac Disease.
Celiac Disease
Autoantibodies to tissue transglutaminase as predictors of celiac disease.
Celiac Disease
Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.
Celiac Disease
Autoantibody screen in inflammatory myopathies high prevalence of antibodies to gliadin.
Celiac Disease
Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia.
Celiac Disease
Autoimmunity to heat shock proteins and vitamin D status in patients with celiac disease without associated dermatitis herpetiformis.
Celiac Disease
B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
Celiac Disease
Beneficial effects of gluten free diet on IgA tissue transglutaminase levels and various growth parameters in celiac disease patients.
Celiac Disease
Beneficial Effects of Human Anti-Interleukin-15 Antibody in Gluten-Sensitive Rhesus Macaques with Celiac Disease.
Celiac Disease
Beta-cell autoimmunity in pediatric celiac disease: the case for routine screening?
Celiac Disease
Beyond the Intestinal Celiac Mucosa: Diagnostic Role of Anti-TG2 Deposits, a Systematic Review.
Celiac Disease
Blocking Peptides Decrease Tissue Transglutaminase Processing of Gliadin in Vitro.
Celiac Disease
Bone pain and extremely low bone mineral density due to severe vitamin D deficiency in celiac disease.
Celiac Disease
Calcium activation of tissue transglutaminase in radioligand binding and enzyme-linked autoantibody immunoassays in childhood celiac disease.
Celiac Disease
Can head trauma trigger celiac disease? Nation-wide case-control study.
Celiac Disease
Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations?
Celiac Disease
Candida albicans in celiac disease: A wolf in sheep's clothing.
Celiac Disease
Carpal spasm in a girl as initial presentation of celiac disease: a case report.
Celiac Disease
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells.
Celiac Disease
Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Celiac Disease
Celiac disease : risk assessment, diagnosis, and monitoring.
Celiac Disease
Celiac disease and childhood stroke.
Celiac Disease
Celiac disease and endocrine autoimmunity - the genetic link.
Celiac Disease
Celiac Disease and Glandular Autoimmunity.
Celiac Disease
Celiac Disease and Gyneco-obstetrics Complications: Can Serum Antibodies Modulate Tissue Transglutaminase Functions and Contribute to Clinical Pattern?
Celiac Disease
Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications.
Celiac Disease
Celiac disease and multiple sclerosis in the northwest of Iran.
Celiac Disease
Celiac Disease and Nonceliac Gluten Sensitivity: A Review.
Celiac Disease
Celiac disease and severe vitamin D deficiency: the case for anti-tissue transglutaminase antibody screening.
Celiac Disease
Celiac disease and the endocrinologist: a diagnostic opportunity.
Celiac Disease
Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders.
Celiac Disease
Celiac disease as an autoimmune condition.
Celiac Disease
Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population.
Celiac Disease
Celiac Disease Can be Predicted by High Levels of Anti-Tissue Transglutaminase Antibodies in Population-Based Screening.
Celiac Disease
Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes.
Celiac Disease
Celiac disease could be a frequent disease in Mexico: prevalence of tissue transglutaminase antibody in healthy blood donors.
Celiac Disease
Celiac disease detection using a transglutaminase electrochemical immunosensor fabricated on nanohybrid screen-printed carbon electrodes.
Celiac Disease
Celiac Disease Diagnosis Without Biopsy: Is a 10× ULN Antitransglutaminase Result Suitable for a Chemiluminescence Method?
Celiac Disease
Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.
Celiac Disease
Celiac Disease in an Adult Presenting as Behavioral Disturbances.
Celiac Disease
Celiac Disease in an Urban VA Population with Iron Deficiency: The Case Against Routine Duodenal Biopsy.
Celiac Disease
Celiac Disease in Children with Functional Constipation: A School-Based Multicity Study.
Celiac Disease
Celiac Disease in Children with Severe Acute Malnutrition (SAM): A Hospital Based Study.
Celiac Disease
Celiac disease in non-clinical populations of Japan.
Celiac Disease
Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure.
Celiac Disease
Celiac disease in patients with type-1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran.
Celiac Disease
Celiac disease in Type 1 diabetic children and adults: IgA class transglutaminase autoantibodies as the best screening marker.
Celiac Disease
Celiac disease in Williams-Beuren syndrome.
Celiac Disease
Celiac disease is not more prevalent in patients undergoing in vitro fertilization and does not affect reproductive outcomes with or without treatment: a large prospective cohort study.
Celiac Disease
Celiac Disease Management in the United Kingdom Specialist Pediatric Gastroenterology Centers-A Service Survey.
Celiac Disease
Celiac disease manifested by polyneuropathy and swollen ankles.
Celiac Disease
Celiac Disease on FDG PET/CT.
Celiac Disease
Celiac disease or positive tissue transglutaminase antibodies in patients undergoing renal biopsies.
Celiac Disease
Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2.
Celiac Disease
Celiac disease screening by immunochromatographic visual assays: results of a multicenter study.
Celiac Disease
Celiac disease with diffuse cutaneous vitamin K-deficiency bleeding.
Celiac Disease
Celiac disease-associated antibodies in patients with psoriasis and correlation with HLA Cw6.
Celiac Disease
Celiac disease-associated transglutaminase autoantibody target domains at diagnosis are age and sex dependent.
Celiac Disease
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics.
Celiac Disease
Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy.
Celiac Disease
Celiac disease.
Celiac Disease
Celiac disease: a comprehensive current review.
Celiac Disease
Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.
Celiac Disease
Celiac disease: Association with adult-onset Still's disease: Apropos of a clinical case.
Celiac Disease
Celiac disease: diagnosis and management.
Celiac Disease
Celiac disease: diagnosis, autoimmune mechanisms and treatment.
Celiac Disease
Celiac Disease: Ten Things That Every Gastroenterologist Should Know.
Celiac Disease
Celiac disease: what to do when the tissue transglutaminase is positive.
Celiac Disease
Central Pontine Myelinolysis Presenting With Tremor in a Child With Celiac Disease.
Celiac Disease
Cervical esophageal web and celiac disease.
Celiac Disease
Changing patterns of serological testing for celiac disease in Latvia.
Celiac Disease
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice.
Celiac Disease
Characterization of the heparin binding site of tissue transglutaminase: its importance in the enzyme's cell surface targeting, matrix deposition and cell signalling.
Celiac Disease
Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.
Celiac Disease
Chronic Diarrhea in Adults: Evaluation and Differential Diagnosis.
Celiac Disease
Chronic Hepatitis Due to Gluten Enteropathy - a Case Report.
Celiac Disease
Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease.
Celiac Disease
Clinical accuracy of anti-tissue transglutaminase as screening test for celiac disease under 2?years.
Celiac Disease
Clinical and histopathological correlation of duodenal biopsy with IgA anti-tissue transglutaminase titers in children with celiac disease.
Celiac Disease
Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up.
Celiac Disease
Clinical evaluation of the BioPlex 2200 Celiac IgA and IgG Kits - A novel multiplex screen incorporating an integral check for IgA deficiency.
Celiac Disease
Clinical value of immunoglobulin A antitransglutaminase assay in the diagnosis of celiac disease.
Celiac Disease
Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis.
Celiac Disease
Co-Silencing of Tissue Transglutaminase-2 and Interleukin-15 Genes in a Celiac Disease Mimetic Mouse Model Using a Nanoparticle-in-Microsphere Oral System.
Celiac Disease
Combining antibody tests and taking into account antibody levels improves serologic diagnosis of celiac disease.
Celiac Disease
Community-Based Study of Celiac Disease Autoimmunity Progression in Adults.
Celiac Disease
Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization.
Celiac Disease
Comparison of a novel whole blood transglutaminase-based ELISA with a whole blood rapid antibody test and established conventional serological celiac disease assays.
Celiac Disease
Comparison of a tissue transglutaminase ELISA with the endomysium antibody test in the diagnosis of gluten-sensitive enteropathy.
Celiac Disease
Comparison of Commercially Available Serologic Kits for the Detection of Celiac Disease.
Celiac Disease
Comparison of ELISA for tissue transglutaminase autoantibodies with antiendomysium antibodies in pediatric and adult patients with celiac disease.
Celiac Disease
Comparison of IgA endomysium antibody and IgA tissue transglutaminase antibody in celiac disease.
Celiac Disease
Concurrent cerebral arterial and venous sinus thrombosis revealing celiac disease- a case report and literature review.
Celiac Disease
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models.
Celiac Disease
Contribution of celiac disease autoantibodies to the disease process.
Celiac Disease
Controversies in the laboratory diagnosis of celiac disease in children; new haplotypes discovered.
Celiac Disease
Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA.
Celiac Disease
Correlation between antibodies and histology in celiac disease: Incidence of celiac disease is higher than expected in the pediatric population.
Celiac Disease
Correlation Between Cut-off Level of Tissue Transglutaminase Antibody and Marsh Classification.
Celiac Disease
Correlation Between IgA Tissue Transglutaminase Antibody Ratio And Histological Finding In Celiac Disease: A Multicentre Study.
Celiac Disease
Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease.
Celiac Disease
Correlation of tissue transglutaminase antibody with duodenal histologic marsh grading.
Celiac Disease
Correlation of Tissue Transglutaminase with Modified Marsh Grading in Celiac Disease: A Prospective Cohort Study.
Celiac Disease
Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.
Celiac Disease
Cow's Milk Protein Allergy Causing Persistent Elevation of Antitissue Transglutaminase Antibodies in a Child With Celiac Disease.
Celiac Disease
Current Espghan Guidelines for Celiac Disease in Pediatric Age, Tertiary Care Center Experience: A Proposal for Further Simplification.
Celiac Disease
Current trends and investigative developments in celiac disease.
Celiac Disease
Daily Intake of Milk Powder and Risk of Celiac Disease in Early Childhood: A Nested Case-Control Study.
Celiac Disease
Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
Celiac Disease
Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Celiac Disease
Decrease by 50% of plasma IgA tissue transglutaminase antibody concentrations within 2 months after start of gluten-free diet in children with celiac disease used as a confirming diagnostic test.
Celiac Disease
Defining thresholds of antibody levels improves diagnosis of celiac disease.
Celiac Disease
Dermatitis herpetiformis.
Celiac Disease
Dermatitis herpetiformis: close to unravelling a disease.
Celiac Disease
Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase.
Celiac Disease
Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis.
Celiac Disease
Determination of Autoantibodies to Transglutaminase by Electrochemiluminescence (ECL) Assay.
Celiac Disease
Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase.
Celiac Disease
Diagnosing celiac disease: a comparison of human tissue transglutaminase antibodies with antigliadin and antiendomysium antibodies.
Celiac Disease
Diagnosis and treatment of unexplained anemia with iron deficiency without overt bleeding.
Celiac Disease
Diagnosis of celiac disease.
Celiac Disease
Diagnosis of gluten-related enteropathy in a newborn: how and when?
Celiac Disease
Diagnostic accuracies for celiac disease of four tissue transglutaminase autoantibody tests using human antigen.
Celiac Disease
Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency.
Celiac Disease
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.
Celiac Disease
Diagnostic immunology in celiac disease.
Celiac Disease
Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review.
Celiac Disease
Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
Celiac Disease
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease.
Celiac Disease
Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy.
Celiac Disease
Diagnostic yield of endoscopic markers for celiac disease.
Celiac Disease
Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.
Celiac Disease
Diagnostic Yield of Upper Gastrointestinal Endoscopy in the Evaluation of Iron Deficiency Anemia in Older Children and Adolescents.
Celiac Disease
Dietary Patterns After the Weaning and Lactation Period Associate with Celiac Disease Autoimmunity in Children.
Celiac Disease
Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease.
Celiac Disease
Does aspirin use reduce cardiovascular risk in diabetes?
Celiac Disease
Does celiac disease trigger autoimmune thyroiditis?
Celiac Disease
Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment.
Celiac Disease
Early diagnosis of celiac disease in IgA deficient children: contribution of a point-of-care test.
Celiac Disease
Effects of Probiotic Bacteria Lactobacillaceae on the Gut Microbiota in Children With Celiac Disease Autoimmunity: A Placebo-Controlled and Randomized Clinical Trial.
Celiac Disease
Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
Celiac Disease
Electrochemical detection of celiac disease-related anti-tissue transglutaminase antibodies using thiol based surface chemistry.
Celiac Disease
ELISA of anti-endomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti-endomysial antibodies and tissue transglutaminase antibodies.
Celiac Disease
Endocrinological disorders and celiac disease.
Celiac Disease
Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
Celiac Disease
Epitope mapping of the N-terminal portion of tissue transglutaminase protein antigen to identify linear epitopes in celiac disease.
Celiac Disease
Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
Celiac Disease
Erythrocytic transglutaminase inhibition hemolysis at presentation of celiac disease.
Celiac Disease
Estimating the Impact of Verification Bias on Celiac Disease Testing.
Celiac Disease
Evaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children.
Celiac Disease
Evaluation of BioPlex 2200 tTG-IgA Diagnostic Performance for Serology-Based Diagnosis of Celiac Disease.
Celiac Disease
Evaluation of screening for celiac disease in children with juvenile idiopathic arthritis.
Celiac Disease
Evaluation of the Correlation Between tTG-IgA Titer and Duodenal Biopsy Findings in Children With Suspected Celiac Disease.
Celiac Disease
Evidence That Pathogenic Transglutaminase 2 in Celiac Disease Derives From Enterocytes.
Celiac Disease
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease.
Celiac Disease
Expression and rapid purification of highly active hexahistidine-tagged guinea pig liver transglutaminase.
Celiac Disease
Factors That Increase Risk of Celiac Disease Autoimmunity After a Gastrointestinal Infection in Early Life.
Celiac Disease
Family recognition of celiac disease.
Celiac Disease
Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study.
Celiac Disease
Fertility disorder associated with celiac disease in males and females: fact or fiction?
Celiac Disease
Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease.
Celiac Disease
Food Processing, Dysbiosis, Gastrointestinal Inflammatory Diseases, and Antiangiogenic Functional Foods or Beverages.
Celiac Disease
Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis.
Celiac Disease
Frequency of celiac disease is not increased among multiple sclerosis patients.
Celiac Disease
Frontiers in Celiac Disease: Where Autoimmunity and Environment Meet.
Celiac Disease
Fully-automated, chemiluminescence IgA and IgG anti-tissue transglutaminase (tTG) antibodies serum assays for the screening of celiac disease.
Celiac Disease
Galactosylation of Serum IgA1 O-Glycans in Celiac Disease.
Celiac Disease
Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction.
Celiac Disease
Genetic and immunological processes in the pathomechanism of gluten-sensitive enteropathy and associated metabolic bone disorders.
Celiac Disease
Giardiasis mimicking celiac disease in a patient of common variable immunodeficiency.
Celiac Disease
Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
Celiac Disease
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis.
Celiac Disease
Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity.
Celiac Disease
Gluten ataxia: passive transfer in a mouse model.
Celiac Disease
Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease.
Celiac Disease
Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia.
Celiac Disease
Growth trajectories and bone mineral density in anti-tissue transglutaminase antibody-positive children: the Generation R Study.
Celiac Disease
Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
Celiac Disease
Gut microbes and adverse food reactions: Focus on gluten related disorders.
Celiac Disease
Gut mucosal immunity to tissue transglutaminase in untreated celiac disease and other gastrointestinal disorders.
Celiac Disease
Gut-liver axis: an immune link between celiac disease and primary biliary cirrhosis.
Celiac Disease
Hearing evaluation with ABR in pediatric patients with celiac disease.
Celiac Disease
Help Desk: Is an intestinal biopsy necessary when the blood work suggests celiac disease?
Celiac Disease
Hemolysis and IgA-antibodies against tissue transglutaminase: When are antibody test results no longer reliable?
Celiac Disease
Hemolysis Interferes with the Detection of Anti-Tissue Transglutaminase Antibodies in Celiac Disease.
Celiac Disease
Hemolysis may cause false negative results and underdiagnosis of celiac disease when measuring anti-tissue transglutaminase antibodies in serum by immunoassays.
Celiac Disease
High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
Celiac Disease
High Incidence of Celiac Disease in a Long-term Study of Adolescents With Susceptibility Genotypes.
Celiac Disease
High Prevalence of Celiac Disease Among Screened First-Degree Relatives.
Celiac Disease
High prevalence of celiac disease in Brazilian blood donor volunteers based on screening by IgA antitissue transglutaminase antibody.
Celiac Disease
High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase.
Celiac Disease
High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease.
Celiac Disease
High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue.
Celiac Disease
High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac Disease.
Celiac Disease
Higher Sensitivity and Earlier Identification of Celiac Disease Autoimmunity by a Nonradioactive Assay for Transglutaminase Autoantibodies.
Celiac Disease
HLA-DPB1*04:01 Protects Genetically Susceptible Children from Celiac Disease Autoimmunity in the TEDDY Study.
Celiac Disease
HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.
Celiac Disease
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease.
Celiac Disease
Human tissue transglutaminase antibody screening by immunochromatographic line immunoassay for early diagnosis of celiac disease in Turkish children.
Celiac Disease
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease.
Celiac Disease
Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study.
Celiac Disease
Identification of Deamidated Peptides in Cytokine-Exposed MIN6 Cells through LC-MS/MS Using a Shortened Digestion Time and Inspection of MS2 Spectra.
Celiac Disease
Identification of Non-HLA Genes Associated with Celiac Disease and Country-Specific Differences in a Large, International Pediatric Cohort.
Celiac Disease
Identification of Pediatric Patients With Celiac Disease Based on Serology and a Classification and Regression Tree Analysis.
Celiac Disease
Identification of the autoantigen of celiac disease.
Celiac Disease
Identification of tissue transglutaminase as the autoantigen of celiac disease.
Celiac Disease
Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies.
Celiac Disease
IFN-gamma induces transglutaminase 2 expression in rat small intestinal cells.
Celiac Disease
IgA anti-Actin antibodies in children with celiac disease: comparison of immunofluorescence with Elisa assay in predicting severe intestinal damage.
Celiac Disease
IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease.
Celiac Disease
IgA anti-tissue transglutaminase antibodies and IgG antibodies against deamidated gliadin peptides as predictors of celiac disease.
Celiac Disease
IgA anti-tissue transglutaminase antibodies, first line in the diagnosis of celiac disease.
Celiac Disease
IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy.
Celiac Disease
IgA antibodies against tissue transglutaminase in the diagnosis of celiac disease: concordance with intestinal biopsy in children and adults.
Celiac Disease
IgA antibodies to tissue transglutaminase: An effective diagnostic test for celiac disease.
Celiac Disease
IgA cross-reactivity between a nuclear autoantigen and wheat proteins suggests molecular mimicry as a possible pathomechanism in celiac disease.
Celiac Disease
IgA-class autoantibodies against neuronal transglutaminase, TG6 in celiac disease: No evidence for gluten dependency.
Celiac Disease
IgA-tissue transglutaminase (tTG)-antibodies are highly sensitive serum markers for celiac disease.
Celiac Disease
IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency.
Celiac Disease
IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue.
Celiac Disease
IgG-F-actin antibodies in celiac disease and dermatitis herpetiformis.
Celiac Disease
Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
Celiac Disease
Immunoassay for detection of IgA antitissue transglutaminase in patients with celiac disease.
Celiac Disease
Immunoassays for the detection of IgA antibodies to tissue transglutaminase: significance of multiples of the upper limit of normal and inter-assay correlations.
Celiac Disease
Immunochromatographic sticks for tissue transglutaminase and antigliadin antibody screening in celiac disease.
Celiac Disease
Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals.
Celiac Disease
Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
Celiac Disease
Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients.
Celiac Disease
Immunoglobulin G autoantibodies against tissue-transglutaminase. A sensitive, cost-effective assay for the screening of celiac disease.
Celiac Disease
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Celiac Disease
Immunohistologic analysis of the duodenal bulb: a new method for celiac disease diagnosis in children.
Celiac Disease
Immunoreactivity of antibodies against transglutaminase-deamidated gliadins in adult celiac disease.
Celiac Disease
Immunoreactivity of Gluten-Sensitized Sera Toward Wheat, Rice, Corn, and Amaranth Flour Proteins Treated With Microbial Transglutaminase.
Celiac Disease
Impact of celiac autoimmunity on children with type 1 diabetes.
Celiac Disease
Improved efficacy by using the pTnT-rhtTG plasmid for the detection of celiac disease specific tissue transglutaminase autoantibodies in radioligand binding assays.
Celiac Disease
In Celiac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-Like Receptor 4 and Induces Activation of Monocytes.
Celiac Disease
In Screening For Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal.
Celiac Disease
In Situ Gluten-Chitosan Interlocked Self-Assembled Supramolecular Architecture Reduces T-Cell-Mediated Immune Response to Gluten in Celiac Disease.
Celiac Disease
In vitro and in vivo models of celiac disease.
Celiac Disease
Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III.
Celiac Disease
Increased Prevalence of Antibodies Against Dietary Proteins In Children And Young Adults With Cerebral Palsy.
Celiac Disease
Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis.
Celiac Disease
Increased prevalence of celiac disease in girls with Turner syndrome detected using antibodies to endomysium and tissue transglutaminase.
Celiac Disease
Increased Prevalence of Celiac Disease in School-age Children in Italy.
Celiac Disease
Increased prevalence of silent celiac disease among Greek epileptic children.
Celiac Disease
INCREASED TISSUE TRANSGLUTAMINASE LEVELS ARE ASSOCIATED WITH INCREASED EPILEPTIFORM ACTIVITY IN ELECTROENCEPHALOGRAPHY AMONG PATIENTS WITH CELIAC DISEASE.
Celiac Disease
Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study.
Celiac Disease
Influence of Age and Type 1 Diabetes Mellitus on Serological Test for Celiac Disease in Children.
Celiac Disease
Insights in the laboratory diagnosis of celiac disease.
Celiac Disease
Interferon-? Activates Transglutaminase 2 via a Phosphatidylinositol-3-Kinase-Dependent Pathway: Implications for Celiac Sprue Therapy.
Celiac Disease
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
Celiac Disease
Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.
Celiac Disease
Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease.
Celiac Disease
Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease.
Celiac Disease
Intestinal intraepithelial lymphocyte cytometric pattern is more accurate than subepithelial deposits of anti-tissue transglutaminase IgA for the diagnosis of celiac disease in lymphocytic enteritis.
Celiac Disease
Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
Celiac Disease
Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease.
Celiac Disease
Intraepithelial lymphocytes in celiac disease immunopathology.
Celiac Disease
Iron deficiency, Helicobacter infection and gastritis.
Celiac Disease
Is celiac disease an autoimmune disorder?
Celiac Disease
Is Celiac Disease an Etiological Factor in Children With Migraine?
Celiac Disease
Is Celiac Disease an Etiological Factor in Children with Nonsyndromic Intellectual Disability?
Celiac Disease
Is it necessary to use capsular endoscopy to diagnose celiac disease?
Celiac Disease
Is There a Role of Using a Rapid Finger Prick Antibody Test in Screening for Celiac Disease in Children?
Celiac Disease
Is tissue transglutaminase autoantibody the best for diagnosing celiac disease in children of developing countries?
Celiac Disease
Isolated positive anti-gliadin immunoglobin-A antibody in children with gastrointestinal symptoms.
Celiac Disease
Isolated short stature as a presentation of celiac disease in Saudi children.
Celiac Disease
Kinetic and functional characterisation of the heparin-binding peptides from human transglutaminase 2.
Celiac Disease
Lack of Utility of Anti-tTG IgG to Diagnose Celiac Disease When Anti-tTG IgA Is Negative.
Celiac Disease
Latent and Potential Celiac Disease in Epileptic Turkish Children.
Celiac Disease
LFRET, a novel rapid assay for anti-tissue transglutaminase antibody detection.
Celiac Disease
Limitations of anti-guinea pig liver transglutaminase IgA in screening of celiac disease.
Celiac Disease
Linear ?-(1???6)-d-glucan from Bifidobacterium bifidum BIM ?-733D is low molecular mass biopolymer with unique immunochemical properties.
Celiac Disease
Longevity, clonal relationship, and transcriptional program of celiac disease-specific plasma cells.
Celiac Disease
Lower economic status and inferior hygienic environment may protect against celiac disease.
Celiac Disease
Lower Prevalence of Celiac Disease and Gluten-Related Disorders in Persons Living in Southern vs Northern Latitudes of the United States.
Celiac Disease
Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia.
Celiac Disease
Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity.
Celiac Disease
Metalloelastase (MMP-12) is upregulated in the gut of pediatric patients with potential celiac disease and in type 1 diabetes.
Celiac Disease
Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease.
Celiac Disease
Microbial transglutaminase should be considered as an environmental inducer of celiac disease.
Celiac Disease
Microbial transglutaminase treatment in pasta-production does not affect the immunoreactivity of gliadin with celiac disease patients' sera.
Celiac Disease
Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated Gliadin.
Celiac Disease
Microbial transglutaminase: A new potential player in celiac disease.
Celiac Disease
Microbial transglutaminases generate T cell stimulatory epitopes involved in celiac disease
Celiac Disease
Micropipette Tip-Based Immunoassay with Electrochemical Detection of Antitissue Transglutaminase to Diagnose Celiac Disease Using Staples and a Paper-Based Platform.
Celiac Disease
MicroRNA profiles in celiac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts.
Celiac Disease
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease.
Celiac Disease
Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: Celiac Disease.
Celiac Disease
Monitoring of Anti-transglutaminase Autoantibodies in Pediatric Celiac Disease Using a Sensitive Radiobinding Assay.
Celiac Disease
Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998.
Celiac Disease
Most Children with Potential Celiac Disease Are Healthy but 1 Third of Them Develop Villous Atrophy at 3-Years Follow-Up.
Celiac Disease
Mucosal immunity.
Celiac Disease
Mucosal Molecular Pattern of Tissue Transglutaminase and Interferon Gamma in Suspected Seronegative Celiac Disease at Marsh 1 and 0 Stages.
Celiac Disease
Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages.
Celiac Disease
MUCOSAL TISSUE TRANSGLUTAMINASE EXPRESSION IN CELIAC DISEASE.
Celiac Disease
Nanoparticle-enhanced sensitivity of a nanogap-interdigitated electrode array impedimetric biosensor.
Celiac Disease
Natural hidden autoantibodies to tissue transglutaminase cross-react with fibrinogen.
Celiac Disease
Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease.
Celiac Disease
Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility.
Celiac Disease
Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children.
Celiac Disease
Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis.
Celiac Disease
Neurologic Deficits in Patients With Newly Diagnosed Celiac Disease Are Frequent and Linked With Autoimmunity to Transglutaminase 6.
Celiac Disease
New celiac disease biomarkers.
Celiac Disease
New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract.
Celiac Disease
New serology assays can detect gluten sensitivity among enteropathy patients seronegative for anti-tissue transglutaminase.
Celiac Disease
New target against inflammatory diseases: transglutaminase 2.
Celiac Disease
No significant difference in antigenicity or tissue transglutaminase substrate specificity of Irish and US wheat gliadins.
Celiac Disease
NON-CELIAC SPRUE: A CASE OF OLMESARTAN-INDUCED ENTEROPATHY.
Celiac Disease
Non-Invasive Biomarkers for Celiac Disease.
Celiac Disease
Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides.
Celiac Disease
Novel immune response to gluten in individuals with schizophrenia.
Celiac Disease
Occurrence of Hypothyroidism, Diabetes Mellitus, and Celiac Disease in Emirati Children with Down's Syndrome.
Celiac Disease
Old and new serological tests for celiac disease screening.
Celiac Disease
Olmesartan-Induced Enteropathy.
Celiac Disease
One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.
Celiac Disease
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease.
Celiac Disease
One-step immunochromatographic visual assay for anti-transglutaminase detection in organ culture system: An easy and prompt method to simplify the in vitro diagnosis of celiac disease.
Celiac Disease
One-Third of Patients Have Evidence for an Additional Autoimmune Disease at Type 1 Diabetes Diagnosis.
Celiac Disease
Pathomechanisms in celiac disease.
Celiac Disease
Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: meta-analysis.
Celiac Disease
Performance of two commercial ELISAs for detecting IgA anti-human and anti-guinea pig tissue transglutaminase antibodies.
Celiac Disease
Pericardial effusion in celiac disease.
Celiac Disease
Pharmacokinetics and Biodistribution Analysis of Small Interference RNA for Silencing Tissue Transglutaminase-2 in Celiac Disease After Oral Administration in Mice Using Gelatin-Based Multicompartmental Delivery Systems.
Celiac Disease
Pharmacological approaches in celiac disease.
Celiac Disease
Positive celiac disease serology and reduced bone mineral density in adult women.
Celiac Disease
Positive predictive value of serological diagnostic measures in celiac disease.
Celiac Disease
Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease.
Celiac Disease
Positive tissue transglutaminase antibodies with negative endomysial antibodies: Unresolved issues in diagnosing celiac disease.
Celiac Disease
Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis.
Celiac Disease
Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
Celiac Disease
Potential of transglutaminase 2 as a therapeutic target.
Celiac Disease
Precision medicine and machine learning towards the prediction of the outcome of potential celiac disease.
Celiac Disease
Prediction of silent celiac disease at diagnosis of childhood type 1 diabetes by tissue transglutaminase autoantibodies and HLA.
Celiac Disease
Predictive value of "Marsh 1" type histology in subjects with suspected cealic disease.
Celiac Disease
Preliminary Notes on Equine Tissue Transglutaminase Serology and A Case of Equine Gluten-Sensitive Enteropathy and Dermatitis in an 11-Year-Old Dutch Warmblood Horse.
Celiac Disease
Presence of tissue transglutaminase IgA antibody as a celiac disease marker in a sample of patients with irritable bowel syndrome.
Celiac Disease
Prevalence and clinical significance of IgA anti tissue transglutaminase antibodies in patients with chronic liver disease.
Celiac Disease
Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases.
Celiac Disease
Prevalence and Morbidity of Undiagnosed Celiac Disease From a Community-Based Study.
Celiac Disease
Prevalence and natural history of potential celiac disease in adult patients.
Celiac Disease
Prevalence of Anti-tissue Transglutaminase (tTG) Antibodies and Celiac Disease in Children with IBD.
Celiac Disease
Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease.
Celiac Disease
Prevalence of Celiac disease among children in Finland.
Celiac Disease
Prevalence of celiac disease among first-degree relatives of Indian celiac disease patients.
Celiac Disease
Prevalence of Celiac Disease Among Patients with Behcet's Disease in Iran.
Celiac Disease
Prevalence of celiac disease among school children in Punjab, North India.
Celiac Disease
Prevalence of celiac disease among type 1 diabetic Egyptian patients and the association with autoimmune thyroid disease.
Celiac Disease
Prevalence of celiac disease in children with Down syndrome screened by anti-tissue transglutaminase antibodies.
Celiac Disease
Prevalence of celiac disease in children with type 1 diabetes mellitus screened by anti-tissue transglutaminase antibody from Western Saudi Arabia.
Celiac Disease
Prevalence of celiac disease in collagenous and lymphocytic colitis.
Celiac Disease
Prevalence of celiac disease in Iranian children with idiopathic short stature.
Celiac Disease
Prevalence of Celiac disease in Turkish children with type 1 diabetes mellitus and their non-diabetic first-degree relatives.
Celiac Disease
Prevalence of IgA antitissue transglutaminase antibodies in children with type 1 diabetes mellitus.
Celiac Disease
Prevalence of Inflammatory Bowel Disease and Celiac Disease in Patients with IgA Nephropathy over Time.
Celiac Disease
Processed Food Additive Microbial Transglutaminase and Its Cross-Linked Gliadin Complexes Are Potential Public Health Concerns in Celiac Disease.
Celiac Disease
Progress in the serology-based diagnosis and management of adult celiac disease.
Celiac Disease
Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.
Celiac Disease
Progression of pediatric celiac disease from potential celiac disease to celiac disease: a retrospective cohort study.
Celiac Disease
Prolactin and autoimmunity.
Celiac Disease
Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome.
Celiac Disease
Protein A and protein G ELISA for the detection of IgG autoantibodies against tissue transglutaminase in childhood celiac disease.
Celiac Disease
Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.
Celiac Disease
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line. Implications for celiac disease.
Celiac Disease
Psychological Manifestations of Celiac Disease Autoimmunity in Young Children.
Celiac Disease
Raising the Cut-Off Level of Anti-Tissue Transglutaminase Antibodies to Detect Celiac Disease Reduces the Number of Small Bowel Biopsies in Children with Type 1 Diabetes: A Retrospective Study.
Celiac Disease
Recent advances in biosensors for diagnosis of celiac disease: A review.
Celiac Disease
Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists.
Celiac Disease
Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy.
Celiac Disease
Recombinant human tissue transglutaminase for diagnosis and follow-up of childhood coeliac disease.
Celiac Disease
Recurrent Fever and Failure to Thrive in an 11-Year-Old Boy.
Celiac Disease
Redox signaling in the gastrointestinal tract.
Celiac Disease
Relationship Between Villous Atrophy and tTGA Levels in Dyspeptic Patients: A Case Series.
Celiac Disease
Relationships between Clinical Presentation, Serology, Histology, and Duodenal Deposits of Tissue Transglutaminase Antibodies in Pediatric Celiac Disease.
Celiac Disease
Reliability of Autoantibodies Against a Tissue Transglutaminase Neo-Epitope for the Diagnosis of Pediatric Celiac Disease.
Celiac Disease
Repeated Screening Can Be Restricted to At-Genetic-Risk Birth Cohorts.
Celiac Disease
Reproductive changes associated with celiac disease.
Celiac Disease
Response to: In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal. J Pediatr Gastroenterol Nutr. 2019;68(1):20-25.
Celiac Disease
Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease.
Celiac Disease
Review: dermatitis herpetiformis.
Celiac Disease
Rising prevalence of celiac disease is not universal and repeated testing is needed for population screening.
Celiac Disease
Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease.
Celiac Disease
Risk of pediatric celiac disease according to HLA haplotype and country.
Celiac Disease
Role of anti-tissue transglutaminase IgA+IgG antibodies in detection of potential celiac disease in patients with type 1 diabetes.
Celiac Disease
Role of HLA-DQ typing and anti-tissue transglutaminase antibody titers in diagnosing celiac disease without duodenal biopsy in type 1 diabetes: A study of the population-based pediatric type 1 diabetes cohort of Western Australia.
Celiac Disease
Role of pro-neurotensin as marker of paediatric celiac disease.
Celiac Disease
Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
Celiac Disease
Role of tissue transglutaminase in celiac disease.
Celiac Disease
Role of transglutaminase 2 in celiac disease pathogenesis.
Celiac Disease
Role of transglutaminase-catalyzed reactions in the post-translational modifications of proteins responsible for immunological disorders.
Celiac Disease
Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study.
Celiac Disease
Screening children with severe short stature for celiac disease using tissue transglutaminase.
Celiac Disease
Screening detects a high proportion of celiac disease in young HLA-genotyped children.
Celiac Disease
Screening for autoantibodies to tissue transglutaminase reveals a low prevalence of celiac disease in blood donors with cryptogenic hypertransaminasemia.
Celiac Disease
Screening for Celiac Disease in a North American Population: Sequential Serology and Gastrointestinal Symptoms.
Celiac Disease
Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies.
Celiac Disease
Screening for celiac disease in short bowel syndrome.
Celiac Disease
Screening for celiac disease in Tunisian patients with Graves' disease using anti-endomysium and anti-tissue transglutaminase antibodies.
Celiac Disease
Screening for Celiac Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Celiac Disease
Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.
Celiac Disease
Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population.
Celiac Disease
Screening tests using serum tissue transglutaminase IgA may facilitate the identification of undiagnosed celiac disease among Japanese population.
Celiac Disease
Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Celiac Disease
Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice.
Celiac Disease
Sequential testing with different tissue transglutaminase antibodies, a new approach for diagnosis of celiac disease.
Celiac Disease
Sera of patients with celiac disease and neurologic disorders evoke a mitochondrial-dependent apoptosis in vitro.
Celiac Disease
Serodiagnostic Assays for Celiac Disease Based on the Open or Closed Conformation of the Autoantigen, Transglutaminase 2.
Celiac Disease
Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody.
Celiac Disease
Serologic markers of gluten sensitivity in a healthy population from the western region of Saudi Arabia.
Celiac Disease
Serological responses to microbial antigens in celiac disease patients during a gluten-free diet.
Celiac Disease
Serological screening for celiac disease in symptomatic 12 to 36 month-old children.
Celiac Disease
Serological screening for celiac disease using IgA-tissue transglutaminase antibody in patients with recurrent aphthous stomatitis.
Celiac Disease
Serological testing for celiac disease in women undergoing assisted reproduction techniques.
Celiac Disease
Serological Tests in Gluten Sensitivity (Nonceliac Gluten Intolerance).
Celiac Disease
Seronegative celiac disease: where is the specific setting?
Celiac Disease
Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age.
Celiac Disease
Serum anti-endomysial and anti-tissue transglutaminase for screening of celiac disease.
Celiac Disease
Serum auto-antibodies directed against transglutaminase-2 have a low avidity as compared to allo-antibodies against gliadin in celiac disease.
Celiac Disease
Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation.
Celiac Disease
Serum intestinal fatty acid-binding protein in the noninvasive diagnosis of celiac disease.
Celiac Disease
Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosis.
Celiac Disease
Serum transglutaminase antibodies do not always detect the persistent villous atrophy in patients with celiac disease on a gluten-free diet.
Celiac Disease
Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes.
Celiac Disease
Should stored serum of patients previously tested for celiac disease serology be retested for transglutaminase antibodies?
Celiac Disease
Simultaneous detection of celiac disease-specific IgA antibodies and total IgA.
Celiac Disease
Simultaneous detection of IgA and IgG antibodies against tissue transglutaminase: The preferred pre-biopsy test in childhood celiac disease.
Celiac Disease
Slow Decrease of Anti-Tissue Transglutaminase Antibody Positivity In Children With Celiac Disease After Starting the Gluten-Free Diet.
Celiac Disease
Small intestinal bacterial overgrowth in North Indian patients with celiac disease.
Celiac Disease
Solid-phase ELISA for tissue transglutaminase, an endomysial target for possible serological diagnosis of celiac disease.
Celiac Disease
Sourdough fermentation of wheat flour does not prevent the interaction of transglutaminase 2 with ?2-gliadin or gluten.
Celiac Disease
Specificity of tissue transglutaminase explains cereal toxicity in celiac disease.
Celiac Disease
Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis.
Celiac Disease
Stereotyped antibody responses target posttranslationally modified gluten in celiac disease.
Celiac Disease
Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.
Celiac Disease
Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins.
Celiac Disease
Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease.
Celiac Disease
Strongly positive tissue transglutaminase antibody assays without celiac disease.
Celiac Disease
Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease.
Celiac Disease
Structural basis for gluten intolerance in celiac sprue.
Celiac Disease
Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.
Celiac Disease
Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity.
Celiac Disease
Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles.
Celiac Disease
Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.
Celiac Disease
Suboptimal Performance of IgG Anti-tissue Transglutaminase in the Diagnosis of Celiac Disease in a Tropical Country.
Celiac Disease
Symptoms and biomarkers associated with undiagnosed celiac seropositivity.
Celiac Disease
Synthetic Neoepitopes of the Transglutaminase-Deamidated Gliadin Complex as Biomarkers for Diagnosing and Monitoring Celiac Disease.
Celiac Disease
Synthetic Peptides Reproducing Tissue Transglutaminase-Gliadin Complex Neo-epitopes as Probes for Antibody Detection in Celiac Disease Patients' Sera.
Celiac Disease
T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Celiac Disease
Tailoring the immune response to wheat gliadin by enzymatic transamidation.
Celiac Disease
Testing for anti-human transglutaminase antibodies in saliva is not useful for diagnosis of celiac disease.
Celiac Disease
Testing for antireticulin antibodies in patients with celiac disease is obsolete: a review of recommendations for serologic screening and the literature.
Celiac Disease
Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity.
Celiac Disease
Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays.
Celiac Disease
Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Celiac Disease
TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.
Celiac Disease
The adaptive immune response in celiac disease.
Celiac Disease
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments.
Celiac Disease
The association between de novo inflammatory bowel disease and celiac disease.
Celiac Disease
The diagnosis and treatment of celiac disease.
Celiac Disease
The function of tissue transglutaminase in celiac disease.
Celiac Disease
The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.
Celiac Disease
The iceberg of celiac disease: what is below the waterline?
Celiac Disease
The incidence of celiac disease antibodies in plasma specimens with low hemoglobin levels.
Celiac Disease
The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ.
Celiac Disease
The industrial food additive, microbial transglutaminase, mimics tissue transglutaminase and is immunogenic in celiac disease patients.
Celiac Disease
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Celiac Disease
The Lack of Utility of Anti-tTG IgG in the Diagnosis of Celiac Disease When Anti-tTG IgA Is Negative.
Celiac Disease
The many-faced gluten sensitivity: Gluten-induced autoimmunity from dermatological point of view
Celiac Disease
The measurement of IgA and IgG transglutaminase antibodies in celiac disease: a comparison with current diagnostic methods.
Celiac Disease
The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
Celiac Disease
The prevalence of celiac disease among patients with familial mediterranean Fever.
Celiac Disease
The prevalence of celiac disease in children and adolescents in Germany.
Celiac Disease
The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.
Celiac Disease
THE PREVALENCE OF CELIAC DISEASE IN PATIENTS WITH IRON-DEFICIENCY ANEMIA IN CENTER AND SOUTH AREA OF IRAN.
Celiac Disease
The Prevalence of the Celiac Disease in Patients with Dyspepsia: A Systematic Review and Meta-Analysis.
Celiac Disease
The Role of Capsule Endoscopy in Suspected Celiac Disease Patients with Positive Celiac Serology.
Celiac Disease
The role of tissue transglutaminase (transglutaminase type II) for the intestinal manifestations of murine semi-allogenic graft-versus-host disease.
Celiac Disease
The roles of MHC class II genes and post-translational modification in celiac disease.
Celiac Disease
The tissue transglutaminase gene is not a primary factor predisposing to celiac disease.
Celiac Disease
The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors.
Celiac Disease
The use of microbial transglutaminase in a bread system: A study of gluten protein structure, deamidation state and protein digestion.
Celiac Disease
Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA.
Celiac Disease
Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE.
Celiac Disease
Timing of initial exposure to cereal grains and the risk of wheat allergy.
Celiac Disease
Tissue transglutaminase and celiac disease.
Celiac Disease
Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis.
Celiac Disease
Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome.
Celiac Disease
Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
Celiac Disease
Tissue transglutaminase antibodies in celiac disease.
Celiac Disease
Tissue transglutaminase antibodies in celiac disease: assessment of a commercial kit.
Celiac Disease
Tissue transglutaminase antibodies in celiac disease: focus on the pediatric population.
Celiac Disease
Tissue transglutaminase antibodies in individuals with celiac disease bind to thyroid follicles and extracellular matrix and may contribute to thyroid dysfunction.
Celiac Disease
Tissue transglutaminase antibodies in patients with end-stage heart failure.
Celiac Disease
Tissue transglutaminase antibodies in the diagnosis of celiac disease in Indian children.
Celiac Disease
Tissue Transglutaminase Antibody and Its Association with Duodenal Biopsy in Diagnosis of Pediatric Celiac Disease.
Celiac Disease
Tissue transglutaminase antibody determination in celiac disease. Analysis of diagnostic specificity of anti-human IgA-type assays.
Celiac Disease
Tissue transglutaminase auto-antibodies in cord blood from children to become celiacs.
Celiac Disease
Tissue transglutaminase autoantibodies in patients with non-Hodgkin's lymphoma. Case reports.
Celiac Disease
Tissue transglutaminase autoantibody detection in human saliva: a powerful method for celiac disease screening.
Celiac Disease
Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease.
Celiac Disease
Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients.
Celiac Disease
Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study.
Celiac Disease
Tissue transglutaminase expression in duodenal mucosa of patients with celiac disease and of normal subjects.
Celiac Disease
Tissue transglutaminase immunoglobulin isotypes in children with untreated and treated celiac disease.
Celiac Disease
Tissue transglutaminase in celiac disease: role of autoantibodies.
Celiac Disease
Tissue transglutaminase is the target in both rodent and primate tissues for celiac disease-specific autoantibodies.
Celiac Disease
Tissue transglutaminase levels above 100 U/mL and celiac disease: A prospective study.
Celiac Disease
Tissue Transglutaminase Levels Are Not Sufficient to Diagnose Celiac Disease in North America Without Intestinal Biopsies: Don't Throw the Baby Out with the Bathwater.
Celiac Disease
Tissue Transglutaminase Levels Are Not Sufficient to Diagnose Celiac Disease in North American Practices Without Intestinal Biopsies.
Celiac Disease
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
Celiac Disease
Tissue transglutaminase: the Holy Grail for the diagnosis of celiac disease, at last?
Celiac Disease
Titers of Anti-tissue Transglutaminase Antibody Correlate Well With Severity of Villous Abnormalities in Celiac Disease.
Celiac Disease
Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl
Celiac Disease
Transamidation Down-Regulates Intestinal Immunity of Recombinant ?-Gliadin in HLA-DQ8 Transgenic Mice.
Celiac Disease
Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
Celiac Disease
Transglutaminase 2 dysfunctions in the development of autoimmune disorders: celiac disease and TG2-/- mouse.
Celiac Disease
Transglutaminase 2 in celiac disease: minireview article.
Celiac Disease
Transglutaminase 2 Inhibition for Prevention of Mucosal Damage in Celiac Disease.
Celiac Disease
Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies.
Celiac Disease
Transglutaminase 2 regulates the GTPase-activating activity of Bcr.
Celiac Disease
Transglutaminase 2 undergoes a large conformational change upon activation.
Celiac Disease
Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells.
Celiac Disease
Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Celiac Disease
Transglutaminase activity along the rat small bowel and cellular location.
Celiac Disease
Transglutaminase antibodies and celiac disease in children with type 1 diabetes and in their family members.
Celiac Disease
Transglutaminase antibodies in children with a genetic risk for celiac disease.
Celiac Disease
Transglutaminase as a therapeutic target for celiac disease.
Celiac Disease
Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue.
Celiac Disease
Transglutaminase IgA Antibodies in a Celiac Disease Mass Screening and the Role of HLA-DQ Genotyping and Endomysial Antibodies in Sequential Testing.
Celiac Disease
Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
Celiac Disease
Transglutaminase treatment of wheat and maize prolamins of bread increases the serum IgA reactivity of celiac disease patients.
Celiac Disease
Transglutaminase, gluten and celiac disease: food for thought. Transglutaminase is identified as the autoantigen of celiac disease.
Celiac Disease
Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
Celiac Disease
Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic.
Celiac Disease
Transglutaminases - possible drug targets in human diseases.
Celiac Disease
Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
Celiac Disease
Transglutaminases as targets for pharmacological inhibition.
Celiac Disease
Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver.
Celiac Disease
Trend of Antitissue Transglutaminase Antibody Normalization in Children With Celiac Disease Started on Gluten-free Diet: A Comparative Study Between Chemiluminescence and ELISA Serum Assays.
Celiac Disease
Tricks of the trade: How to avoid histological Pitfalls in celiac disease.
Celiac Disease
Two thymus-related autoimmune disorders: a case report and review of the literature.
Celiac Disease
Type 1 Diabetes and Celiac Disease: Can (and Should) We Raise the Cut-off of Tissue Transglutaminase Immunoglobulin A to Decide Whether to Biopsy?
Celiac Disease
Ultrasensitive transglutaminase based nanosensor for early detection of celiac disease in human.
Celiac Disease
Unexpected role of surface transglutaminase type II in celiac disease.
Celiac Disease
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
Celiac Disease
Update on mucosal immunoglobulin A in gastrointestinal disease.
Celiac Disease
Update on the evaluation and diagnosis of celiac disease.
Celiac Disease
Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes.
Celiac Disease
Use of likelihood ratios improves clinical interpretation of IgA anti-tTG antibody testing for celiac disease.
Celiac Disease
Use of low concentrations of human IgA anti-tissue transglutaminase to rule out selective IgA deficiency in patients with suspected celiac disease.
Celiac Disease
Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up.
Celiac Disease
Usefulness of Small-bowel Mucosal Transglutaminase-2 Specific Autoantibody Deposits in the Diagnosis and Follow-up of Celiac Disease.
Celiac Disease
Utility in clinical practice of immunoglobulin a anti-tissue transglutaminase antibody for the diagnosis of celiac disease.
Celiac Disease
Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study.
Celiac Disease
Variability of anti-human transglutaminase testing in celiac disease across Mediterranean countries.
Celiac Disease
Variant mannose-binding lectin alleles are associated with celiac disease.
Celiac Disease
Video capsule enteroscopy in the diagnosis of celiac disease: a multicenter study.
Celiac Disease
Warfarin hypersensitivity due to gluten-sensitive enteropathy: a case study.
Celiac Disease
Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis.
Celiac Disease
Zinc is the modulator of the calcium-dependent activation of post-translationally acting thiol-enzymes in autoimmune diseases.
Celiac Disease
[Anti-deamidated gliadin peptides antibodies and coeliac disease: state of art and analysis of false-positive results from five assays]
Celiac Disease
[Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies]
Celiac Disease
[Antibodies against tissue transglutaminase as a serological marker in dermatitis herpetiformis During]
Celiac Disease
[Atypical celiac disease - diagnostic difficulties.]
Celiac Disease
[Atypical manifestations of celiac disease in an adult woman]
Celiac Disease
[Celiac disease and "gluten sensitivity"].
Celiac Disease
[Celiac disease and fertility disorders in women]
Celiac Disease
[Celiac disease as a model for autoimmune disease. Transglutaminase has the key role--stress reaction triggers the vicious circle]
Celiac Disease
[Celiac disease in adults: new aspects]
Celiac Disease
[Celiac disease--a diagnostic and therapeutic challenge]
Celiac Disease
[Celiac disease--a severe disease]
Celiac Disease
[Celiac disease:a case report detailing clinical and pathological improvement with a gluten-free diet].
Celiac Disease
[Celiac sprue (review)]
Celiac Disease
[Clinical courses of celiac disease]
Celiac Disease
[Dermatitis herpetiformis: A review.]
Celiac Disease
[Dermatitis herpetiformis]
Celiac Disease
[Dermatitis herpetiformis].
Celiac Disease
[Determination of subepithelial deposits of IgA antibodies to tissue transglutaminase: practical experience with application for diagnosis of gluten-sensitive celiac disease].
Celiac Disease
[Diagnostic validity of anti-tissue transglutaminase and anti-endomysium antibodies in children with celiac disease]
Celiac Disease
[Evidence of intraepithelial lymphocytes through immunocytochemistry stains in children with celiac disease]
Celiac Disease
[First determination of the prevalence of celiac disease in a Portuguese population]
Celiac Disease
[Genetic and immunological processes in the pathomechanism of gluten-sensitive enteropathy and associated metabolic bone disorders]
Celiac Disease
[Immunological screening and follow-up of celiac disease: Experience of the University Hospital of Marseille.]
Celiac Disease
[Impact of diagnosis of celiac disease on metabolic control of type 1 diabetes]
Celiac Disease
[Improving the management of celiac disease: An urgent challenge.]
Celiac Disease
[Prevalence of celiac disease in apparently healthy blood donors in the autonomous community of Madrid]
Celiac Disease
[Rectal prolapse as an unusual presentation of celiac disease. Report of two cases].
Celiac Disease
[Serological screening of relatives of celiac disease patients: antiendomysium antibodies, anti-tissue transglutaminase or both?]
Celiac Disease
[Serological tests for celiac disease in Moroccan patients with type 1 diabetes].
Celiac Disease
[Seronegative celiac disease: A case report].
Celiac Disease
[Serum antibodies in celiac disease]
Celiac Disease
[The role of celiac disease and type 1 diabetes coexistance. Is celiac disease responsible for diabetic status?]
Celiac Disease
[Tissue transglutaminase as autoantigen in endemic sprue. New aspects in diagnosis and etiopathogenesis]
Celiac Disease
[Transglutaminase antibody: usefulness in the diagnosis of celiac disease]
Central Nervous System Diseases
Transglutaminase 2: A Novel Autoantigen in Canine Idiopathic Central Nervous System Inflammatory Diseases.
Cerebellar Diseases
A case report of late-onset cerebellar ataxia associated with a rare p.R342W TGM6 (SCA35) mutation.
Cerebral Amyloid Angiopathy
Lobar Hemorrhage Induced by Acquired Factor XIII Deficiency in a Patient with Cerebral Amyloid Angiopathy.
Cerebral Amyloid Angiopathy
The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (A?) and colocalizes with deposited A? in cerebral amyloid angiopathy.
Cerebral Amyloid Angiopathy
Tissue transglutaminase colocalizes with extracellular matrix proteins in cerebral amyloid angiopathy.
Cerebral Amyloid Angiopathy
Tissue Transglutaminase: A Novel Therapeutic Target in Cerebral Amyloid Angiopathy.
Cerebral Hemorrhage
Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage.
Cerebral Hemorrhage
Ethnic heterogeneity of the factor XIII Val34Leu polymorphism.
Cerebral Hemorrhage
Factor XIII deficiency related recurrent spontaneous intracerebral hemorrhage: A case and literature review.
Cerebral Hemorrhage
Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage.
Cerebral Hemorrhage
No association of factor XIII Val34Leu polymorphism with primary intracerebral hemorrhage and healthy controls in Korean population.
Cerebral Hemorrhage
Prevention of postoperative intracerebral hemorrhage with topical recombinant factor XIII in the rat.
Cerebral Hemorrhage
Red blood cell lysis and brain tissue-type transglutaminase upregulation in a hippocampal model of intracerebral hemorrhage.
Cerebral Hemorrhage
The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
Cerebral Hemorrhage
Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits.
Cerebral Hemorrhage
[Intracerebral hemorrhage associated with long-lasting deficiency of factor XIII]
Cerebral Hemorrhage
[Two cases of congenital deficiency of coagulation factor XIII causing intracerebral hemorrhage (author's transl)]
Cerebral Infarction
Early fibrinogen degradation coagulopathy: a predictive factor of parenchymal hematomas in cerebral rt-PA thrombolysis.
Cerebral Infarction
Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage.
Cerebral Infarction
Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders.
Cerebral Palsy
A study on early developing celiac disease in children with cerebral palsy.
Cerebral Palsy
Increased Prevalence of Anti-gliadin Antibodies and Anti-tissue Transglutaminase Antibodies in Children With Cerebral Palsy.
Cerebrospinal Fluid Leak
Treatment of spontaneous intracranial hypotension with intravenous Factor XIII administration: initial clinical experience.
Cerebrospinal Fluid Rhinorrhea
A Case of Traumatic Cerebrospinal Fluid Rhinorrhea Successfully Treated Using Intravenous Factor XIII Administration.
Cerebrovascular Disorders
Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.
Cerebrovascular Disorders
Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency.
Cerebrovascular Disorders
Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage.
Cerebrovascular Disorders
Role of factor XIII Val 34 Leu polymorphism in patients with migraine.
Cerebrovascular Disorders
The V34L polymorphism of factor XIII and peripheral arterial disease.
Cerebrovascular Disorders
[Role of coagulation factor XIII in cardio- and cerebrovascular diseases]
Cervical Intraepithelial Neoplasia
Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression.
Cholangiocarcinoma
Transglutaminase 2 Mediates the Cytotoxicity of Resveratrol in a Human Cholangiocarcinoma and Gallbladder Cancer Cell Lines.
Cholangitis
Celiac disease in autoimmune cholestatic liver disorders.
Cholangitis
Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete.
Cholangitis, Sclerosing
Celiac disease in autoimmune cholestatic liver disorders.
Cholestasis
Celiac disease in autoimmune cholestatic liver disorders.
Cholesteatoma
Differentiation characteristics of cholesteatoma epithelium determined by expression of transglutaminase isoenzymes.
Cholesteatoma
Expressions of isopeptide bonds and corneodesmosin in middle ear cholesteatoma.
Cholesteatoma
Keratinization of middle ear cholesteatomas. I. A histochemical study of epidermal transglutaminase.
Cholesteatoma
Keratinization of middle ear cholesteatomas. II. A histochemical study of epidermal transglutaminase substrates.
Cholesteatoma, Middle Ear
Differentiation characteristics of cholesteatoma epithelium determined by expression of transglutaminase isoenzymes.
Cholesteatoma, Middle Ear
Keratinization of middle ear cholesteatomas. I. A histochemical study of epidermal transglutaminase.
Cholesteatoma, Middle Ear
Keratinization of middle ear cholesteatomas. II. A histochemical study of epidermal transglutaminase substrates.
Chondrocalcinosis
Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinician.
Chondrosarcoma
Cellular transglutaminase. The particulate-associated transglutaminase from chondrosarcoma and liver: partial purification and characterization.
Choriocarcinoma
Developmental regulation of tissue transglutaminase during human placentation and expression in neoplastic trophoblast.
Chronic Periodontitis
Differential expression of transglutaminase genes in patients with chronic periodontitis.
Chronic Urticaria
Serum transglutaminase 2 activity as a potential biomarker of disease severity and response to omalizumab in chronic spontaneous urticaria.
Chylothorax
Successful factor XIII administration for persistent chylothorax after lung transplantation for lymphangioleiomyomatosis.
Chylothorax
Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy.
coagulation factor viia deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
coagulation factor viia deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
coagulation factor viia deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
coagulation factor viia deficiency
Clinical audit of inherited bleeding disorders in a developing country.
coagulation factor viia deficiency
Genetic diagnosis of haemophilia and other inherited bleeding disorders.
coagulation factor viia deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
coagulation factor viia deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
coagulation factor viia deficiency
Rare inherited coagulation disorders in India.
coagulation factor xa deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
coagulation factor xa deficiency
Advances in treatment of bleeding disorders.
coagulation factor xa deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
coagulation factor xa deficiency
Clinical audit of inherited bleeding disorders in a developing country.
coagulation factor xa deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
coagulation factor xa deficiency
Intracranial haemorrhage in patients with congenital haemostatic defects.
coagulation factor xa deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
coagulation factor xa deficiency
Rare inherited coagulation disorders in India.
coagulation factor xia deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
coagulation factor xia deficiency
Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.
coagulation factor xia deficiency
Congenital hemorrhagic disorders in Jordan.
coagulation factor xia deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
coagulation factor xia deficiency
Platelet and coagulation studies in Ehlers-Danlos syndrome.
coagulation factor xia deficiency
The rare inherited coagulation disorders.
coagulation factor xiia deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
coagulation factor xiia deficiency
Occurrence of coagulation factor deficiency in post-tonsillectomy hemorrhage.
Colitis
Apple polyphenols extract (APE) improves colon damage in a rat model of colitis.
Colitis
Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model.
Colitis
Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity.
Colitis
Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis.
Colitis
Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis.
Colitis
Lack of clinical efficacy of additional factor XIII treatment in patients with steroid refractory colitis. The Factor XIII Study Group.
Colitis
Mucosal capillary thrombi in rectal biopsies.
Colitis
Myenteric neuronal loss in rats with experimental colitis: Role of tissue transglutaminase-induced apoptosis.
Colitis
Peptide Hp(2-20) accelerates healing of TNBS-induced colitis in the rat.
Colitis
Recombinant factor XIII improves established experimental colitis in rats.
Colitis
Serological differentiation of inflammatory bowel diseases.
Colitis
Serum and tissue transglutaminase correlates with the severity of inflammation in induced colitis in the rat.
Colitis
Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis.
Colitis
Significance of diminished factor XIII in Crohn's disease.
Colitis
Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis.
Colitis, Collagenous
Prevalence of celiac disease in collagenous and lymphocytic colitis.
Colitis, Lymphocytic
Prevalence of celiac disease in collagenous and lymphocytic colitis.
Colitis, Microscopic
Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis.
Colitis, Ulcerative
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence.
Colitis, Ulcerative
Apple polyphenols extract (APE) improves colon damage in a rat model of colitis.
Colitis, Ulcerative
Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity.
Colitis, Ulcerative
Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis.
Colitis, Ulcerative
Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate.
Colitis, Ulcerative
Factor XIII in chronic inflammatory bowel diseases.
Colitis, Ulcerative
Factor XIII modulates intestinal epithelial wound healing in vitro.
Colitis, Ulcerative
Factor XIII substitution in ulcerative colitis.
Colitis, Ulcerative
Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis.
Colitis, Ulcerative
Histological changes in the colonic mucosa following irrigation with short-chain fatty acids.
Colitis, Ulcerative
How autophagy controls the intestinal epithelial barrier.
Colitis, Ulcerative
Lack of clinical efficacy of additional factor XIII treatment in patients with steroid refractory colitis. The Factor XIII Study Group.
Colitis, Ulcerative
Mucosal capillary thrombi in rectal biopsies.
Colitis, Ulcerative
New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract.
Colitis, Ulcerative
Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.
Colitis, Ulcerative
Serological differentiation of inflammatory bowel diseases.
Colitis, Ulcerative
Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis.
Colitis, Ulcerative
Significance of diminished factor XIII in Crohn's disease.
Colitis, Ulcerative
Substitution of factor XIII: a therapeutic approach to ulcerative colitis.
Colitis, Ulcerative
Ulcerative colitis and Crohn's disease: factor XIII, inflammation and haemostasis.
Colitis, Ulcerative
[Blood coagulation factors in ulcerative colitis with special reference to factor XIII]
Colitis, Ulcerative
[Substitution of factor XIII concentrate in treatment refractory ulcerative colitis. A prospective pilot study]
Colonic Neoplasms
Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and ?1 integrin/FAK-mediated signalling.
Colonic Neoplasms
Identification of transglutaminase substrates in HT29 colon cancer cells: use of 5-(biotinamido)pentylamine as a transglutaminase-specific probe.
Colonic Neoplasms
Induction of tissue transglutaminase expression by propionate and n-butyrate in colon cancer cell lines.
Colonic Neoplasms
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53.
Colonic Neoplasms
Transglutaminase in azoxymethane-induced colon cancer in the rat.
Colorectal Neoplasms
Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer.
Colorectal Neoplasms
Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk.
Colorectal Neoplasms
Effects of exogenous transglutaminase on spreading of human colorectal carcinoma cells.
Colorectal Neoplasms
How autophagy controls the intestinal epithelial barrier.
Colorectal Neoplasms
MicroRNA?214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
Colorectal Neoplasms
miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.
Colorectal Neoplasms
Pharmacological alterations of cellular transglutaminase activity and invasiveness in human colorectal carcinoma cells.
Colorectal Neoplasms
Role of tissue transglutaminase and effect of cantharidinate in human colorectal cancer.
Colorectal Neoplasms
Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
Colorectal Neoplasms
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition.
Colorectal Neoplasms
Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
Colorectal Neoplasms
Transglutaminase activity in human colorectal carcinomas of differing metastatic potential.
Colorectal Neoplasms
Transglutaminase-2 Mediates the Biomechanical Properties of the Colorectal Cancer Tissue Microenvironment that Contribute to Disease Progression.
Coma
Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen.
Communicable Diseases
TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.
Compartment Syndromes
Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
Congenital Abnormalities
Hypercoagulability as a cause of stroke in adults.
Congenital Abnormalities
The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation.
Congenital Abnormalities
[Congenital defect of factor XIII. Report of a case]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Spontaneous Acute Subdural Hematoma and Chronic Epidural Hematoma in a Child with F XIII Deficiency.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Surgery in severe factor XIII deficiency: report of a case of epilepsy neurosurgery and review.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
[Congenital factor XIII deficiency in the south of Tunisia]
Conjunctivitis, Allergic
Developments in ocular allergy.
Conjunctivitis, Allergic
Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis.
Connective Tissue Diseases
IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis.
Contracture
Transglutaminase levels in Dupuytren's disease.
Coronary Artery Disease
Association of factor XIII Val34Leu polymorphism and coronary artery disease: A meta-analysis.
Coronary Artery Disease
Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease.
Coronary Artery Disease
Coagulation factor XIII levels in UK Asian subjects with type 2 diabetes mellitus and coronary artery disease.
Coronary Artery Disease
Coagulation Factor XIII-A Val34Leu Polymorphism and the Risk of Coronary Artery Disease and Myocardial Infarction in a Chinese Han Population.
Coronary Artery Disease
Correction: Mezei, Z.A., et al; Factor XIII B subunit polymorphisms and the risk of coronary artery disease. Int. J. Mol. Sci. 2015, 16, 1143-1159.
Coronary Artery Disease
Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Coronary Artery Disease
Factor XIII activity and antigen levels in patients with coronary artery disease.
Coronary Artery Disease
Factor XIII B subunit polymorphisms and the risk of coronary artery disease.
Coronary Artery Disease
Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
Coronary Artery Disease
Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Coronary Artery Disease
Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.
Coronary Artery Disease
Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study.
Coronary Artery Disease
Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability.
Coronary Artery Disease
Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease.
Coronary Artery Disease
Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel.
Coronary Artery Disease
Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease.
Coronary Artery Disease
The V34L polymorphism of factor XIII and peripheral arterial disease.
Coronary Artery Disease
Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease.
Coronary Disease
Associations of tissue transglutaminase antibody seropositivity with coronary heart disease: Findings from a prospective cohort study.
Coronary Disease
Factor XIIIA Val34Leu polymorphism does not predict risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study.
Coronary Thrombosis
Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator.
COVID-19
COVID-19 is Associated with an Acquired Factor XIII Deficiency.
COVID-19
Severe bleeding in a patient with factor XIII deficiency and COVID-19.
COVID-19
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
Craniocerebral Trauma
Factor XIII deficiency and head trauma: management and therapy.
Craniocerebral Trauma
Spontaneous Epidural Hematoma in a Child With Inherited Factor XIII Deficiency.
Crohn Disease
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence.
Crohn Disease
Clinical significance of measuring blood coagulation factor XIIIA regularly and continuously in patients with Crohn's disease.
Crohn Disease
Combined use of factor XIII and endoscopic balloon dilatation in a patient with Crohn's disease, duodenal stenosis, and associated internal fistulas: the efficacy of coagulation factor XIII for the internal fistulas.
Crohn Disease
Deficiency of blood coagulation factor XIII in Crohn's disease.
Crohn Disease
Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease.
Crohn Disease
Factor XIIIA subunit and Crohn's disease.
Crohn Disease
Hemostasis in Crohn's disease: low factor XIII levels in active disease.
Crohn Disease
How autophagy controls the intestinal epithelial barrier.
Crohn Disease
Mucosal capillary thrombi in rectal biopsies.
Crohn Disease
Screening for celiac disease in short bowel syndrome.
Crohn Disease
Serological differentiation of inflammatory bowel diseases.
Crohn Disease
Significance of diminished factor XIII in Crohn's disease.
Crohn Disease
The characterization of the repertoire of wheat antigens and peptides involved in the humoral immune responses in patients with gluten sensitivity and Crohn's disease.
Crohn Disease
The usefulness of factor XIII levels in Crohn's disease.
Crohn Disease
Transglutaminases in Crohn's disease.
Crohn Disease
Treatment of Crohn's disease fistulas with coagulation factor XIII.
Crohn Disease
Ulcerative colitis and Crohn's disease: factor XIII, inflammation and haemostasis.
Cystic Fibrosis
A novel regulatory role for tissue transglutaminase in epithelial-mesenchymal transition in cystic fibrosis.
Cystic Fibrosis
Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease.
Cystic Fibrosis
Gut-Ex-Vivo system as a model to study gluten response in celiac disease.
Cystic Fibrosis
How autophagy controls the intestinal epithelial barrier.
Cystic Fibrosis
Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation.
Cystic Fibrosis
Transglutaminase 2 and nucleoside diphosphate kinase activity are correlated in epithelial membranes and are abnormal in cystic fibrosis.
Cystic Fibrosis
Transglutaminase in erythrocytes of cystic fibrosis patients.
Cystitis
Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases.
Cystitis
[The clinical effect of factor XIII on drug-induced hemorrhagic cystitis]
Cysts
Dependence of Giardia lamblia encystation on novel transglutaminase activity.
Darier Disease
Expression of transglutaminase 5 in normal and pathologic human epidermis.
Dehydration
Dehydration leads to a phase transition in monoclinic factor XIII crystals.
Dehydration
Polyamine concentration, transglutaminase activity and changes in protein synthesis during cryopreservation of shoot tips of apple variety Annurca.
Dementia, Vascular
Cerebrospinal fluid tissue transglutaminase in vascular dementia.
Demyelinating Diseases
Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination.
Demyelinating Diseases
Tissue Transglutaminase Promotes Early Differentiation of Oligodendrocyte Progenitor Cells.
Dermatitis
Atypical cells in radiation dermatitis express factor XIIIa.
Dermatitis
Increased Prevalence of Transglutaminase 6 Antibodies in Sera From Schizophrenia Patients.
Dermatitis
Preliminary Notes on Equine Tissue Transglutaminase Serology and A Case of Equine Gluten-Sensitive Enteropathy and Dermatitis in an 11-Year-Old Dutch Warmblood Horse.
Dermatitis
Recognition of epidermal transglutaminase by IgA and tissue transglutaminase 2 antibodies in a rare case of Rhesus dermatitis.
Dermatitis Herpetiformis
A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings.
Dermatitis Herpetiformis
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis.
Dermatitis Herpetiformis
Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis.
Dermatitis Herpetiformis
Are anti-epidermal transglutaminase (eTG) antibodies titre correlated with dermatitis herpetiformis lesions during the disease follow-up?
Dermatitis Herpetiformis
Association between levels of IgA antibodies to tissue transglutaminase and gliadin-related nonapeptides in dermatitis herpetiformis.
Dermatitis Herpetiformis
Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet.
Dermatitis Herpetiformis
Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia.
Dermatitis Herpetiformis
Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease.
Dermatitis Herpetiformis
Clinical, histological and immunpathological findings in 32 patients with dermatitis herpetiformis Duhring.
Dermatitis Herpetiformis
Co-localization of IgA and TG3 on healthy skin of coeliac patients.
Dermatitis Herpetiformis
Coeliac disease.
Dermatitis Herpetiformis
Concomitant bullous pemphigoid and dermatitis herpetiformis.
Dermatitis Herpetiformis
Cutaneous expressions of interleukin-6 and neutrophil elastase as well as levels of serum IgA antibodies to gliadin nonapeptides, tissue transglutaminase and epidermal transglutaminase: implications for both autoimmunity and autoinflammation involvement in dermatitis herpetiformis.
Dermatitis Herpetiformis
Dermatitis herpetiformis: close to unravelling a disease.
Dermatitis Herpetiformis
Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.
Dermatitis Herpetiformis
Detection of antibodies to epidermal transglutaminase but not tissue transglutaminase in Japanese patients with dermatitis herpetiformis.
Dermatitis Herpetiformis
Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis.
Dermatitis Herpetiformis
Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of dermatitis herpetiformis patients after a long-term gluten-free diet.
Dermatitis Herpetiformis
Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis.
Dermatitis Herpetiformis
Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis.
Dermatitis Herpetiformis
Epidermal transglutaminase deposits in perilesional and uninvolved skin in patients with dermatitis herpetiformis.
Dermatitis Herpetiformis
Evaluation of a Bi-Analyte Immunoblot as a Useful Tool for Diagnosing Dermatitis Herpetiformis.
Dermatitis Herpetiformis
Evaluation of IgA epidermal transglutaminase ELISA in suspected dermatitis herpetiformis patients.
Dermatitis Herpetiformis
Ex vivo Culture of Duodenal Biopsies from Patients with Dermatitis Herpetiformis Indicates that Transglutaminase 3 Antibody Production Occurs in the Gut.
Dermatitis Herpetiformis
Gluten ataxia: passive transfer in a mouse model.
Dermatitis Herpetiformis
IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease.
Dermatitis Herpetiformis
IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients.
Dermatitis Herpetiformis
Iga anti-epidermal transglutaminase autoantibodies: a simple test to improve differential diagnosis between dermatitis herpetiformis and atopic dermatitis.
Dermatitis Herpetiformis
IgA antiepidermal transglutaminase antibodies in dermatitis herpetiformis: a significant but not complete response to a gluten-free diet treatment.
Dermatitis Herpetiformis
IgG-F-actin antibodies in celiac disease and dermatitis herpetiformis.
Dermatitis Herpetiformis
Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis.
Dermatitis Herpetiformis
In patients with dermatitis herpetiformis distribution of transglutaminase in cutaneous tissue does not differ from controls.
Dermatitis Herpetiformis
In vitro and in vivo models of celiac disease.
Dermatitis Herpetiformis
Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
Dermatitis Herpetiformis
Medical pearl: Using tissue transglutaminase antibodies to diagnose dermatitis herpetiformis.
Dermatitis Herpetiformis
Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding.
Dermatitis Herpetiformis
Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides.
Dermatitis Herpetiformis
Prediction of Clinical and Mucosal Severity of Coeliac Disease and Dermatitis Herpetiformis by Quantification of IgA/IgG Serum Antibodies to Tissue Transglutaminase.
Dermatitis Herpetiformis
Recent advances in dermatitis herpetiformis.
Dermatitis Herpetiformis
Sensitivity of Transglutaminase 3 in the IgA Aggregates in Dermatitis Herpetiformis Skin to Potassium Iodide.
Dermatitis Herpetiformis
Small Bowel Transglutaminase 2-specific IgA Deposits in Dermatitis Herpetiformis.
Dermatitis Herpetiformis
T-Cell Response in Dermatitis Herpetiformis: May Epidermal Transglutaminase Play a Role in Predicting Clinical Relapse?
Dermatitis Herpetiformis
TG6 Auto-Antibodies in Dermatitis Herpetiformis.
Dermatitis Herpetiformis
The Decreasing Prevalence of Severe Villous Atrophy in Dermatitis Herpetiformis: A 45-Year Experience in 393 Patients.
Dermatitis Herpetiformis
The many-faced gluten sensitivity: Gluten-induced autoimmunity from dermatological point of view
Dermatitis Herpetiformis
Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis.
Dermatitis Herpetiformis
Tissue transglutaminase antibodies in dermatitis herpetiformis.
Dermatitis Herpetiformis
Tissue transglutaminase antibody assessment in dermatitis herpetiformis.
Dermatitis Herpetiformis
Transglutaminase 3 present in the IgA aggregates in dermatitis herpetiformis skin is enzymatically active and binds soluble fibrinogen.
Dermatitis Herpetiformis
Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue.
Dermatitis Herpetiformis
Update on mucosal immunoglobulin A in gastrointestinal disease.
Dermatitis Herpetiformis
[A girl with an itchy skin disease].
Dermatitis Herpetiformis
[Antibodies against tissue transglutaminase as a serological marker in dermatitis herpetiformis During]
Dermatitis Herpetiformis
[Dermatitis herpetiformis]
Dermatitis Herpetiformis
[Dermatitis herpetiformis].
Dermatitis, Atopic
Genetic variation in the epidermal transglutaminase genes is not associated with atopic dermatitis.
Dermatitis, Atopic
Iga anti-epidermal transglutaminase autoantibodies: a simple test to improve differential diagnosis between dermatitis herpetiformis and atopic dermatitis.
Dermatitis, Atopic
Transglutaminase 3 promotes skin inflammation in atopic dermatitis by activating monocyte-derived dendritic cells via DC-SIGN.
Dermatitis, Atopic
Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation.
Dermatitis, Contact
Factor XIIIa positive dendritic cells are a major accessory cell population in the elicitation phase of DNCB-induced contact hypersensitivity.
Dermatitis, Exfoliative
Different TGM1 mutation spectra in Italian and Portuguese patients with autosomal recessive congenital ichthyosis: evidence of founder effects in Portugal.
Dermatitis, Exfoliative
Identification of two novel nonsense mutations in the transglutaminase 1 gene in a Hungarian patient with congenital ichthyosiform erythroderma.
Dermatitis, Exfoliative
Knocking-in the R142C mutation in transglutaminase 1 disrupts the stratum corneum barrier and postnatal survival of mice.
Dermatitis, Exfoliative
Novel mutations of TGM1 in a child with congenital ichthyosiform erythroderma.
Dermatitis, Exfoliative
Strong founder effect for a transglutaminase 1 gene mutation in lamellar ichthyosis and congenital ichthyosiform erythroderma from Norway.
Dermatitis, Exfoliative
Structural changes in epidermal scale and appendages as indicators of defective TGM1 activity.
Dermatitis, Exfoliative
The clinical spectrum of congenital ichthyosis in Sweden: a review of 127 cases.
Dermatitis, Exfoliative
The pathogenesis of severe congenital ichthyosis of the neonate.
Dermatofibrosarcoma
A light microscopic and immunohistochemical evaluation of scars.
Dermatofibrosarcoma
A study of factor XIIIa and MAC 387 immunolabeling in normal and pathological skin.
Dermatofibrosarcoma
Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
Dermatofibrosarcoma
CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
Dermatofibrosarcoma
D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
Dermatofibrosarcoma
Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa.
Dermatofibrosarcoma
Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Dermatofibrosarcoma
Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Dermatofibrosarcoma
High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Dermatofibrosarcoma
S100A6 expression in fibrohistiocytic lesions.
Dermatofibrosarcoma
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Dermatofibrosarcoma
Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Dermatofibrosarcoma
When Immunohistochemistry Deceives Us: The Pitfalls of CD34 and Factor XIIIa Stains in Dermatofibroma and Dermatofibrosarcoma Protuberans.
Diabetes Complications
Celiac Autoimmunity Is Associated With Lower Blood Pressure and Renal Risk in Type 1 Diabetes.
Diabetes Mellitus
Anthropometric, Serologic, and Laboratory Correlation With Villous Blunting in Pediatric Celiac Disease: Diabetics are Different.
Diabetes Mellitus
Antibodies to tissue transglutaminase C in newly diagnosed and long-standing type I diabetes mellitus.
Diabetes Mellitus
Antibodies to tissue transglutaminase C in type I diabetes.
Diabetes Mellitus
Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine.
Diabetes Mellitus
Autoantibodies to GAD65 and IA-2 antibodies are increased, but not tissue transglutaminase (TTG-Ab) in type 2 diabetes mellitus (T2DM) patients from South India.
Diabetes Mellitus
Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus.
Diabetes Mellitus
Autoantibodies to tissue transglutaminase in patients from eastern India with malnutrition-modulated diabetes mellitus, insulin-dependent diabetes mellitus, and non-insulin-dependent diabetes mellitus.
Diabetes Mellitus
Celiac antibodies in children with type 1 diabetes - A diagnostic validation study.
Diabetes Mellitus
Celiac disease in African American children with type 1 diabetes mellitus in inner city Brooklyn.
Diabetes Mellitus
Celiac disease in patients with type-1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran.
Diabetes Mellitus
Celiac Disease: Ten Things That Every Gastroenterologist Should Know.
Diabetes Mellitus
Coagulation factor XIII levels in UK Asian subjects with type 2 diabetes mellitus and coronary artery disease.
Diabetes Mellitus
Coeliac disease.
Diabetes Mellitus
Concomitant autoantibodies in newly diagnosed diabetic children with transient celiac serology or proven celiac disease.
Diabetes Mellitus
Frequency of HLA-DQB1*0201/02 and DQB1*0302 alleles and tissue transglutaminase antibody seropositivity in children with type 1 diabetes mellitus.
Diabetes Mellitus
Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity.
Diabetes Mellitus
Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families.
Diabetes Mellitus
High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes: a prospective study.
Diabetes Mellitus
Influence of Age and Type 1 Diabetes Mellitus on Serological Test for Celiac Disease in Children.
Diabetes Mellitus
Lymphocyte transglutaminase function may be impaired in type 2 diabetes mellitus.
Diabetes Mellitus
Prevalence of celiac disease in children with type 1 diabetes mellitus screened by anti-tissue transglutaminase antibody from Western Saudi Arabia.
Diabetes Mellitus
Prevalence of Celiac disease in Turkish children with type 1 diabetes mellitus and their non-diabetic first-degree relatives.
Diabetes Mellitus
Prevalence of IgA antitissue transglutaminase antibodies in children with type 1 diabetes mellitus.
Diabetes Mellitus
Prolactin and autoimmunity.
Diabetes Mellitus
Raising the Cut-Off Level of Anti-Tissue Transglutaminase Antibodies to Detect Celiac Disease Reduces the Number of Small Bowel Biopsies in Children with Type 1 Diabetes: A Retrospective Study.
Diabetes Mellitus
Screening for Celiac Disease In Diabetic Children from Iran.
Diabetes Mellitus
Spontaneous Normalization of Anti-Tissue Transglutaminase Antibody Levels Is Common in Children with Type 1 Diabetes Mellitus.
Diabetes Mellitus
The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity.
Diabetes Mellitus
Transglutaminase-dependent lymphocyte transformation in type 2 diabetes mellitus.
Diabetes Mellitus
[Activity of factor XIII and various lipid components of blood serum in patients with diabetes mellitus]
Diabetes Mellitus
[Celiac disease in a group of children and adolescents with type 1 diabetes mellitus]
Diabetes Mellitus, Type 1
A diabetes-specific HLA-DR restricted pro-inflammatory T cell response to wheat polypeptides in tissue transglutaminase antibody negative patients with type 1 diabetes.
Diabetes Mellitus, Type 1
Anti-tissue transglutaminase antibodies (IgA and IgG) in both Crohn´s disease and autoimmune diabetes.
Diabetes Mellitus, Type 1
Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine.
Diabetes Mellitus, Type 1
Associations of breastfeeding with childhood autoimmunity, allergies, and overweight: The Environmental Determinants of Diabetes in the Young (TEDDY) study.
Diabetes Mellitus, Type 1
Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Autoantibodies to tissue transglutaminase in patients from eastern India with malnutrition-modulated diabetes mellitus, insulin-dependent diabetes mellitus, and non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 1
Celiac antibodies in children with type 1 diabetes - A diagnostic validation study.
Diabetes Mellitus, Type 1
Celiac autoantibody positivity in relation to clinical characteristics in children with type 1 diabetes.
Diabetes Mellitus, Type 1
Celiac Autoimmunity in Children with Type 1 Diabetes: A Two-Year Follow-Up.
Diabetes Mellitus, Type 1
Celiac Autoimmunity Is Associated With Lower Blood Pressure and Renal Risk in Type 1 Diabetes.
Diabetes Mellitus, Type 1
Celiac disease and endocrine autoimmunity - the genetic link.
Diabetes Mellitus, Type 1
Celiac Disease and Glandular Autoimmunity.
Diabetes Mellitus, Type 1
Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population.
Diabetes Mellitus, Type 1
Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes.
Diabetes Mellitus, Type 1
Celiac Disease: Ten Things That Every Gastroenterologist Should Know.
Diabetes Mellitus, Type 1
Coeliac disease in China, a field waiting for exploration.
Diabetes Mellitus, Type 1
Coeliac disease.
Diabetes Mellitus, Type 1
Concomitant autoantibodies in newly diagnosed diabetic children with transient celiac serology or proven celiac disease.
Diabetes Mellitus, Type 1
Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding.
Diabetes Mellitus, Type 1
Elevated anti-tissue transglutaminase antibodies in children newly diagnosed with type 1 diabetes do not always indicate coeliac disease.
Diabetes Mellitus, Type 1
Frequency of HLA-DQB1*0201/02 and DQB1*0302 alleles and tissue transglutaminase antibody seropositivity in children with type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6).
Diabetes Mellitus, Type 1
General screening for celiac disease is advisable in children with type 1 diabetes.
Diabetes Mellitus, Type 1
Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity.
Diabetes Mellitus, Type 1
Gluten ataxia: passive transfer in a mouse model.
Diabetes Mellitus, Type 1
High Incidence of Celiac Disease in a Long-term Study of Adolescents With Susceptibility Genotypes.
Diabetes Mellitus, Type 1
High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase.
Diabetes Mellitus, Type 1
High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes: a prospective study.
Diabetes Mellitus, Type 1
Identification of Deamidated Peptides in Cytokine-Exposed MIN6 Cells through LC-MS/MS Using a Shortened Digestion Time and Inspection of MS2 Spectra.
Diabetes Mellitus, Type 1
Impact of celiac autoimmunity on children with type 1 diabetes.
Diabetes Mellitus, Type 1
In vitro and in vivo models of celiac disease.
Diabetes Mellitus, Type 1
Influence of Age and Type 1 Diabetes Mellitus on Serological Test for Celiac Disease in Children.
Diabetes Mellitus, Type 1
Investigating the potential impact of post translational modification of auto-antigens by tissue transglutaminase on humoral islet autoimmunity in type 1 diabetes.
Diabetes Mellitus, Type 1
Islet, thyroid and transglutaminase antibodies in adult Bulgarian patients with type 1 diabetes.
Diabetes Mellitus, Type 1
Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients.
Diabetes Mellitus, Type 1
Nationwide study of childhood celiac disease incidence over a 35-year period in Estonia.
Diabetes Mellitus, Type 1
One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.
Diabetes Mellitus, Type 1
One-Third of Patients Have Evidence for an Additional Autoimmune Disease at Type 1 Diabetes Diagnosis.
Diabetes Mellitus, Type 1
Prediction of silent celiac disease at diagnosis of childhood type 1 diabetes by tissue transglutaminase autoantibodies and HLA.
Diabetes Mellitus, Type 1
Prevalence of celiac disease in children with type 1 diabetes mellitus screened by anti-tissue transglutaminase antibody from Western Saudi Arabia.
Diabetes Mellitus, Type 1
Prevalence of Celiac disease in Turkish children with type 1 diabetes mellitus and their non-diabetic first-degree relatives.
Diabetes Mellitus, Type 1
Prevalence of IgA antitissue transglutaminase antibodies in children with type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Prolactin and autoimmunity.
Diabetes Mellitus, Type 1
Raising the Cut-Off Level of Anti-Tissue Transglutaminase Antibodies to Detect Celiac Disease Reduces the Number of Small Bowel Biopsies in Children with Type 1 Diabetes: A Retrospective Study.
Diabetes Mellitus, Type 1
Role of anti-tissue transglutaminase IgA+IgG antibodies in detection of potential celiac disease in patients with type 1 diabetes.
Diabetes Mellitus, Type 1
Role of HLA-DQ typing and anti-tissue transglutaminase antibody titers in diagnosing celiac disease without duodenal biopsy in type 1 diabetes: A study of the population-based pediatric type 1 diabetes cohort of Western Australia.
Diabetes Mellitus, Type 1
Screening for Celiac Disease In Diabetic Children from Iran.
Diabetes Mellitus, Type 1
Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice.
Diabetes Mellitus, Type 1
Silent coeliac disease is over-represented in children with type 1 diabetes and their siblings.
Diabetes Mellitus, Type 1
Spontaneous Normalization of Anti-Tissue Transglutaminase Antibody Levels Is Common in Children with Type 1 Diabetes Mellitus.
Diabetes Mellitus, Type 1
The great majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine.
Diabetes Mellitus, Type 1
The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.
Diabetes Mellitus, Type 1
Tissue transglutaminase autoantibodies in children with newly diagnosed type 1 diabetes are related to human leukocyte antigen but not to islet autoantibodies: A Swedish nationwide prospective population-based cohort study.
Diabetes Mellitus, Type 1
Transglutaminase antibodies and celiac disease in children with type 1 diabetes and in their family members.
Diabetes Mellitus, Type 1
Type 1 Diabetes and Celiac Disease: Can (and Should) We Raise the Cut-off of Tissue Transglutaminase Immunoglobulin A to Decide Whether to Biopsy?
Diabetes Mellitus, Type 1
Type 1 diabetes associated and tissue transglutaminase autoantibodies in patients without type 1 diabetes and coeliac disease with confirmed viral infections.
Diabetes Mellitus, Type 1
Young Age at Diagnosis of Type 1 Diabetes Is Associated with the Development of Celiac Disease-Associated Antibodies in Children Living in Newfoundland and Labrador, Canada.
Diabetes Mellitus, Type 1
[Serological tests for celiac disease in Moroccan patients with type 1 diabetes].
Diabetes Mellitus, Type 1
[Study of celiac disease in adults with type 1 diabetes mellitus.]
Diabetes Mellitus, Type 2
Autoantibodies to GAD65 and IA-2 antibodies are increased, but not tissue transglutaminase (TTG-Ab) in type 2 diabetes mellitus (T2DM) patients from South India.
Diabetes Mellitus, Type 2
Autoantibodies to tissue transglutaminase in patients from eastern India with malnutrition-modulated diabetes mellitus, insulin-dependent diabetes mellitus, and non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives.
Diabetes Mellitus, Type 2
Coagulation factor XIII levels in UK Asian subjects with type 2 diabetes mellitus and coronary artery disease.
Diabetes Mellitus, Type 2
Endocrine autoimmunity in patients with Latent Autoimmune Diabetes in Adults (LADA) - association with HLA genotype.
Diabetes Mellitus, Type 2
Functional Characterization of Naturally Occurring Transglutaminase 2 Mutants Implicated in Early-Onset Type 2 Diabetes.
Diabetes Mellitus, Type 2
GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6).
Diabetes Mellitus, Type 2
Glucose homeostasis in mice is transglutaminase 2 independent.
Diabetes Mellitus, Type 2
Islet autoantibodies in Latvian subjects with non-insulin-dependent diabetes mellitus: slow-onset type 1 diabetes or polyendocrine autoimmunity?
Diabetes Mellitus, Type 2
Lymphocyte transglutaminase function may be impaired in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online.
Diabetes Mellitus, Type 2
Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient.
Diabetes Mellitus, Type 2
The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity.
Diabetes Mellitus, Type 2
Transglutaminase-dependent lymphocyte transformation in type 2 diabetes mellitus.
Diabetic Angiopathies
Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy.
Diabetic Cardiomyopathies
Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin.
Diabetic Foot
Factor XIII Val34Leu polymorphism is associated with increased factor XIII activation and decreased transcutaneous oxygen readings in patients with diabetic foot ulcers.
Diabetic Foot
[Factor XIII: experimental and clinical results in diabetic foot ulcer]
Diabetic Ketoacidosis
Islet autoantibody types mark differential clinical characteristics at diagnosis of pediatric type 1 diabetes.
Diabetic Nephropathies
Elevated epsilon-(gamma-glutamyl)lysine in human diabetic nephropathy results from increased expression and cellular release of tissue transglutaminase.
Diabetic Nephropathies
Ginkgo biloba leaf extract prevents diabetic nephropathy through the suppression of tissue transglutaminase.
Diabetic Nephropathies
Increases in renal epsilon-(gamma-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: pathologic implications.
Diabetic Nephropathies
Inhibition of collagen I accumulation reduces glomerulosclerosis by a Hic-5-dependent mechanism in experimental diabetic nephropathy.
Diabetic Nephropathies
Tissue transglutaminase inhibition as treatment for diabetic glomerular scarring: it's good to be glueless.
Diabetic Nephropathies
Transglutaminase inhibition ameliorates experimental diabetic nephropathy.
Diabetic Retinopathy
[Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases]
Disseminated Intravascular Coagulation
A contribution to the pathology of acquired plasma factor XIII deficiency.
Disseminated Intravascular Coagulation
Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Complete hemostasis achieved by factor XIII concentrate administration in a patient with bleeding after teeth extraction as a complication of aplastic anemia and chronic disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding.
Disseminated Intravascular Coagulation
Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran.
Disseminated Intravascular Coagulation
Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
Disseminated Intravascular Coagulation
Failure to measure plasma activated factor XIII during disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Fibrin stabilizing factor (factor XIII) consumption as an indicator of disseminated intravascular coagulation (DIC).
Disseminated Intravascular Coagulation
Molecular subunits and transamidase activity of factor XIII during disseminated intravascular coagulation in acute leukaemia.
Disseminated Intravascular Coagulation
Plasma factor XIII activity in patients with disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders.
Disseminated Intravascular Coagulation
[Changes of factor XIII a and b subunit in patients with disseminated intravascular coagulation syndrome]
Disseminated Intravascular Coagulation
[Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer]
Diverticulitis
Significance of diminished factor XIII in Crohn's disease.
Diverticulum
Evaluation of spontaneous intracranial hypotension: assessment on ICP monitoring and radiological imaging.
Down Syndrome
Adherence to Symptom-Based Care Guidelines for Down Syndrome.
Down Syndrome
Antitissue transglutaminase and antithyroid autoantibodies in children with Down syndrome and celiac disease.
Down Syndrome
Prevalence of celiac disease in children with Down syndrome screened by anti-tissue transglutaminase antibodies.
Down Syndrome
Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome.
Down Syndrome
Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies.
Down Syndrome
Tissue transglutaminase antibodies are a useful serological marker for the diagnosis of celiac disease in patients with Down syndrome.
Down Syndrome
Tissue transglutaminase autoantibodies and human leucocyte antigen in Down's syndrome patients with coeliac disease.
Drug-Related Side Effects and Adverse Reactions
Transglutaminase may mediate certain physiological effects of endogenous amines and of amine-containing therapeutical agents.
Dry Eye Syndromes
Lacritin and other autophagy associated proteins in ocular surface health.
Dry Eye Syndromes
Lacritin and the tear proteome as natural replacement therapy for dry eye.
Dry Eye Syndromes
Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease.
Duodenitis
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Duodenitis
[Evidence of intraepithelial lymphocytes through immunocytochemistry stains in children with celiac disease]
Dupuytren Contracture
Dermal dendrocytes in Dupuytren's disease: a link between the skin and pathogenesis?
Dupuytren Contracture
Transglutaminase levels in Dupuytren's disease.
Dyskinesias
Characterization of Paroxysmal Gluten-Sensitive Dyskinesia in Border Terriers Using Serological Markers.
Dyskinesias
Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine.
Eczema
Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
Edema, Cardiac
Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease.
Ehlers-Danlos Syndrome
[Anesthesia for a patient with Ehlers-Danlos syndrome and factor XIII deficiency]
Elephantiasis, Filarial
Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
Elephantiasis, Filarial
Immune responses generated by intramuscular DNA immunization of Brugia malayi transglutaminase (BmTGA) in mice.
Elliptocytosis, Hereditary
DNA methylation in promoter regions of red cell membrane protein genes in healthy individuals and patients with hereditary membrane disorders.
Elliptocytosis, Hereditary
Genetic disorders of the red cell membranes.
Elliptocytosis, Hereditary
Hereditary Red Cell Membrane Disorders in Japan: Their Genotypic and Phenotypic Features in 1014 Cases Studied.
Embolic Stroke
Common genetic coagulation variants are not associated with ischemic stroke in a casecontrol study.
Embolic Stroke
Genetic Factors Influencing Coagulation Factor XIII B-Subunit Contribute to Risk of Ischemic Stroke.
Embolism
Elimination of fibrin ?-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.
Embolism, Air
[Lethal air embolism after spray of tissue adhesive-fibrinogen and factor XIII aerosol during laparoscopic partial nephrectomy]
Encephalitis
The first case report of a patient with acquired factor XIII deficiency in the context of autoimmune encephalitis.
Encephalomyelitis
Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1(gfp/gfp) mice.
Encephalomyelitis
Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Encephalomyelitis
Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Encephalomyelitis, Autoimmune, Experimental
Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1(gfp/gfp) mice.
Encephalomyelitis, Autoimmune, Experimental
Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Encephalomyelitis, Autoimmune, Experimental
Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Encephalomyelitis, Autoimmune, Experimental
Transglutaminase and experimental allergic encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Transglutaminase and experimental allergic encephalomyelitis. The effects of encephalitogenic components in mice and guinea pigs.
Encephalomyelitis, Autoimmune, Experimental
Transglutaminase levels in brain and reticuloendothelial cells during allergic encephalomyelitis determined by a radiochemical method.
Endometrial Hyperplasia
Immunoprofile of endocervical and endometrial stromal cells and its potential application in localization of tumor involvement.
Endometrial Neoplasms
Immunoprofile of endocervical and endometrial stromal cells and its potential application in localization of tumor involvement.
Endometriosis
Autoantibodies common in patients with gastrointestinal diseases are not found in patients with endometriosis: A cross-sectional study.
Endometriosis
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.
Endometriosis
Serological testing for celiac disease in women with endometriosis. A pilot study.
Endotoxemia
Effects of coagulation factor XIII on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation in experimental endotoxemia.
Endotoxemia
Role of antithrombin and factor XIII in leukocyte-independent plasma extravasation during endotoxemia: an intravital-microscopic study in the rat.
Endotoxemia
The combinations C1 esterase inhibitor with coagulation factor XIII and N-acetylcysteine with tirilazad mesylate reduce the leukocyte adherence in an experimental endotoxemia in rats.
Enteritis
COELIAC DISEASE AND PSORIASIS COMBINATION IN 5-YEAR-OLD CHILD.
Enteritis
Evidence of anti-gliadin and transglutaminase antibodies in sera of dogs affected by lymphoplasmacytic enteritis.
Enteritis
IgA Antibodies Against Gliadin and Tissue Transglutaminase in Dogs With Chronic Enteritis and Intestinal T-Cell Lymphoma.
Enteritis
Intestinal intraepithelial lymphocyte cytometric pattern is more accurate than subepithelial deposits of anti-tissue transglutaminase IgA for the diagnosis of celiac disease in lymphocytic enteritis.
Enteritis
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis?
Enterocolitis, Necrotizing
Impaired Activity of Blood Coagulant Factor XIII in Patients with Necrotizing Enterocolitis.
Enterocolitis, Pseudomembranous
Factor XIII deficiency in antibiotic-associated pseudomembranous colitis and its treatment with factor XIII concentrate.
Enterovirus Infections
Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study.
Enthesopathy
The enthesopathy of celiac patients: effects of gluten-free diet.
Eosinophilia
Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine.
Eosinophilia
Ultrastructural localization of factor XIIIa.
Eosinophilic Esophagitis
Elevated Serum Tissue Transglutaminase Antibodies in Children With Eosinophilic Esophagitis.
Epidermolysis Bullosa
Research in practice: diagnosis of subepidermal autoimmune bullous disorders.
Epidermolysis Bullosa, Junctional
The genetics of human skin diseases.
Epilepsy
Celiac Disease in Children: An Association With Drug-Resistant Epilepsy.
Epilepsy
Celiac disease prevalence in epileptic children from Serbia.
Epilepsy
Celiac disease-related antibodies in an epilepsy cohort and matched reference population.
Epilepsy
Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
Epilepsy
Epilepsy, cerebral calcifications, and gluten-related disorders: Are anti-transglutaminase 6 antibodies the missing link?
Epilepsy
Latent and Potential Celiac Disease in Epileptic Turkish Children.
Epilepsy
Surgery in severe factor XIII deficiency: report of a case of epilepsy neurosurgery and review.
Epilepsy, Generalized
Is there a genetic relationship between epilepsy and birth defects?
Epiretinal Membrane
[Thrombospondin and its importance in proliferative retinal diseases]
Epistaxis
Glanzmann's thrombasthenia associated with a transient deficiency of factor XIII.
Erythema Infectiosum
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman--reply.
Erythema Infectiosum
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman.
Esophageal and Gastric Varices
Effects of endoscopic variceal sclerotherapy using GT XIII on blood coagulation tests and the renal kallikrein-kinin system.
Esophageal and Gastric Varices
[Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)]
Esophageal Neoplasms
Impact of perioperative peripheral blood values on postoperative complications after esophageal surgery.
Esophageal Neoplasms
Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics.
Esophageal Neoplasms
Transglutaminase 3 protein modulates human esophageal cancer cell growth by targeting the NF-?B signaling pathway.
Esophageal Squamous Cell Carcinoma
Clinical Significance of GPR56, Transglutaminase 2, and NF-κB in Esophageal Squamous Cell Carcinoma.
Esophageal Squamous Cell Carcinoma
Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.
Exanthema
Gluten Challenge Induces Skin and Small Bowel Relapse in Long-Term Gluten-Free Diet-Treated Dermatitis Herpetiformis.
Exanthema
Successful treatment with leukocytapheresis in refractory Henoch-Schönlein purpura: case report.
Factor V Deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Factor V Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor V Deficiency
Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.
Factor V Deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
Factor V Deficiency
Clinical audit of inherited bleeding disorders in a developing country.
Factor V Deficiency
Mining of mortality-related findings in rare bleeding disorders: a retrospective study from two centers.
Factor V Deficiency
Rare inherited coagulation disorders in India.
Factor V Deficiency
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection.
Factor VII Deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Factor VII Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor VII Deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
Factor VII Deficiency
Clinical audit of inherited bleeding disorders in a developing country.
Factor VII Deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
Factor VII Deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Factor VII Deficiency
Rare inherited coagulation disorders in India.
Factor X Deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Factor X Deficiency
Advances in treatment of bleeding disorders.
Factor X Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor X Deficiency
Clinical audit of inherited bleeding disorders in a developing country.
Factor X Deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
Factor X Deficiency
Intracranial haemorrhage in patients with congenital haemostatic defects.
Factor X Deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Factor X Deficiency
Rare inherited coagulation disorders in India.
Factor XI Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor XI Deficiency
Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.
Factor XI Deficiency
Congenital hemorrhagic disorders in Jordan.
Factor XI Deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Factor XI Deficiency
Platelet and coagulation studies in Ehlers-Danlos syndrome.
Factor XI Deficiency
The rare inherited coagulation disorders.
Factor XII Deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
Factor XIII Deficiency
A case of congenital factor XIII deficiency.
Factor XIII Deficiency
A case of deficiency of plasma plasminogen activator inhibitor-1 related to Ala15Thr mutation in its signal peptide.
Factor XIII Deficiency
A case of factor XIII deficiency in an adult male.
Factor XIII Deficiency
A case of giant expanding cephalhematoma: does the administration of blood coagulation factor XIII reverse symptoms?
Factor XIII Deficiency
A child with acquired factor XIII deficiency: case report and literature review.
Factor XIII Deficiency
A clinical and family study of factor XIII deficiency in a New Zealand family.
Factor XIII Deficiency
A common F13A1 intron 1 variant IVS1+12(A) is associated with mild FXIII deficiency in Caucasian population.
Factor XIII Deficiency
A contribution to the pathology of acquired plasma factor XIII deficiency.
Factor XIII Deficiency
A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
Factor XIII Deficiency
A fluorescent spot test for coagulation factor XIII.
Factor XIII Deficiency
A large case series on surgical outcomes in congenital factor XIII deficiency patients in Iran.
Factor XIII Deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Factor XIII Deficiency
A new era of therapy for congenital factor XIII deficiency.
Factor XIII Deficiency
A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiency.
Factor XIII Deficiency
A novel compound heterozygous mutation in the F13A gene causing hereditary factor XIII deficiency in a Chinese family.
Factor XIII Deficiency
A novel Cys328-terminator mutant implicated in severe coagulation factor XIII deficiency: a case report.
Factor XIII Deficiency
A Rare Case of Factor XIII Deficiency in the Setting of Cancer Immunotherapy.
Factor XIII Deficiency
A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency.
Factor XIII Deficiency
A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiency.
Factor XIII Deficiency
A tentative classification of factor XIII deficiency in two groups.
Factor XIII Deficiency
Acquired coagulation factor XIII deficiency: a case report.
Factor XIII Deficiency
Acquired factor XIII deficiency after desensitization as a potential contributor to postoperative bleeding: more than meets the eye.
Factor XIII Deficiency
Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature.
Factor XIII Deficiency
Acquired factor XIII deficiency in a child with pure erythroid leukemia.
Factor XIII Deficiency
Acquired factor XIII deficiency in patients under therapeutic plasma exchange: A poorly explored etiology.
Factor XIII Deficiency
Acquired factor XIII deficiency in two patients with bleeding events during veno-venous extracorporeal membrane oxygenation treatment.
Factor XIII Deficiency
Acquired Factor XIII Deficiency Inducing Recurrent and Fatal Bleeding, Description of a Case.
Factor XIII Deficiency
Acquired factor XIII deficiency with chronic myelomonocytic leukemia.
Factor XIII Deficiency
Acquired factor XIII deficiency: A review.
Factor XIII Deficiency
Acquired factor XIII deficiency: a therapeutic challenge.
Factor XIII Deficiency
Acquired Factor Xiii Deficiency: An Uncommon But Easily Missed Cause Of Severe Bleeding
Factor XIII Deficiency
Acquired factor XIII deficiency: still a clinical challenge in the era of novel therapy.
Factor XIII Deficiency
Acquired plasma factor XIII deficiencies.
Factor XIII Deficiency
Acute Abdomen in a Young Girl with Factor XIII Deficiency Perianesthetic Issues.
Factor XIII Deficiency
Acute abdomen in a young girl with factor XIII deficiency: Perianesthetic issues.
Factor XIII Deficiency
Acute and diffuse postoperative bleeding after free latissimus dorsi flap--Factor XIII deficiency: a case report and review of the literature.
Factor XIII Deficiency
Acute kidney injury is associated with low factor XIII in decompensated cirrhosis.
Factor XIII Deficiency
Acute promyelocytic leukaemia associated Factor XIII deficiency presenting as retro-bulbar haematoma.
Factor XIII Deficiency
An acquired inhibitor to factor XIII A case report.
Factor XIII Deficiency
An electrophoretic and quantitative analysis of coagulation factor XIII in normal and deficient subjects.
Factor XIII Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor XIII Deficiency
An unusual case of factor xiii deficiency.
Factor XIII Deficiency
An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.
Factor XIII Deficiency
An update of the mutation profile of Factor 13 A and B genes.
Factor XIII Deficiency
Analytical and clinical utility of a photometric assay for blood coagulation factor XIII.
Factor XIII Deficiency
Application of HUMF13A01 (AAAG)n STR polymorphism to the genetic diagnosis of coagulation factor XIII deficiency.
Factor XIII Deficiency
Arg260-Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics.
Factor XIII Deficiency
Arthropathy associated with factor XIII deficiency.
Factor XIII Deficiency
As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan.
Factor XIII Deficiency
Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency.
Factor XIII Deficiency
Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine.
Factor XIII Deficiency
Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients.
Factor XIII Deficiency
Autoimmune Acquired Factor XIII Deficiency: A Case Report.
Factor XIII Deficiency
Autoimmune factor XIII deficiency with unusual laboratory and clinical phenotype.
Factor XIII Deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
Factor XIII Deficiency
Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies.
Factor XIII Deficiency
Benefits of thromboelastometry for monitoring replacement therapy in patients with severe inherited factor XIII deficiency: 3 illustrative cases.
Factor XIII Deficiency
Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.
Factor XIII Deficiency
Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
Factor XIII Deficiency
Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature.
Factor XIII Deficiency
Blood coagulation factor XIII and factor XIII deficiency.
Factor XIII Deficiency
Blood factor XIII deficiency: review of literature and report of case.
Factor XIII Deficiency
Case report of an acquired factor XIII inhibitor: diagnosis and management.
Factor XIII Deficiency
Central nervous system bleeding in pediatric patients with factor XIII deficiency: A study on 23 new cases.
Factor XIII Deficiency
Cerebral thrombosis associated with heterozygous factor V Leiden mutation and high lipoprotein(a) level in a girl with factor XIII deficiency.
Factor XIII Deficiency
Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran.
Factor XIII Deficiency
Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder.
Factor XIII Deficiency
Choroid Plexus Papilloma and Factor XIII Deficiency: Case Report.
Factor XIII Deficiency
Claw toes correction and factor XIII deficiency--a case report.
Factor XIII Deficiency
Clinical and laboratory features of congenital factor XIII deficiency.
Factor XIII Deficiency
Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
Factor XIII Deficiency
Clinical audit of inherited bleeding disorders in a developing country.
Factor XIII Deficiency
Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency.
Factor XIII Deficiency
Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.
Factor XIII Deficiency
Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiency.
Factor XIII Deficiency
Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
Factor XIII Deficiency
Coagulation factor XIII in pregnant smokers and non-smokers.
Factor XIII Deficiency
Coagulation management in patients undergoing mechanical circulatory support.
Factor XIII Deficiency
Combined occurrence of von Willebrand's disease and factor XIII deficiency: a case report.
Factor XIII Deficiency
Comparison of 2 Methods of Clot Solubility Testing in Detection of Factor XIII Deficiency.
Factor XIII Deficiency
Concurrent hematoma and venous thrombosis in a patient with autoimmune acquired factor XIII deficiency.
Factor XIII Deficiency
Congenital afibrinogenemia in a new born: a rare cause for bleeding.
Factor XIII Deficiency
Congenital blood coagulation factor XIII deficiency and perinatal management.
Factor XIII Deficiency
Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.
Factor XIII Deficiency
Congenital deficiency of factor XIII with normal subunit S and lack of subunit A. Report of a new family.
Factor XIII Deficiency
Congenital factor XIII deficiency and increased fibrinolysis. A case report.
Factor XIII Deficiency
Congenital factor XIII deficiency associated with von Willebrand disease.
Factor XIII Deficiency
Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect.
Factor XIII Deficiency
Congenital factor XIII deficiency in a neonate.
Factor XIII Deficiency
Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations.
Factor XIII Deficiency
Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005.
Factor XIII Deficiency
Congenital factor XIII deficiency in women: a systematic review of literature.
Factor XIII Deficiency
Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report.
Factor XIII Deficiency
Congenital Factor XIII Deficiency With the Presence of Inhibitor: A Case Study.
Factor XIII Deficiency
Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery.
Factor XIII Deficiency
Congenital factor XIII deficiency.
Factor XIII Deficiency
Congenital factor XIII deficiency. A family report.
Factor XIII Deficiency
Congenital factor XIII deficiency. Report of 2 cases.
Factor XIII Deficiency
Congenital factor XIII deficiency: a case report and review of literature.
Factor XIII Deficiency
Congenital factor XIII deficiency: A commentary on 'Homozygous intronic mutation leading to inefficient transcription combined with a novel frame-shift mutation in F13A1 gene causes FXIII deficiency'.
Factor XIII Deficiency
Congenital factor XIII deficiency: a patient report and review of the literature.
Factor XIII Deficiency
Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort.
Factor XIII Deficiency
Congenital factor XIII deficiency: report of a case and literature review.
Factor XIII Deficiency
Congenital factor XIII deficiency: two case reports.
Factor XIII Deficiency
Congenital factor XIII deficiency: type I and type II disease.
Factor XIII Deficiency
Congenital hemorrhagic disorders in Jordan.
Factor XIII Deficiency
Corifact/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
Factor XIII Deficiency
Corpus luteal hemorrhage: an unusual manifestation of congenital factor XIII deficiency.
Factor XIII Deficiency
COVID-19 is Associated with an Acquired Factor XIII Deficiency.
Factor XIII Deficiency
Cranial hemophilic pseudotumor associated with factor IX deficiency: case report.
Factor XIII Deficiency
Current understanding in diagnosis and management of factor XIII deficiency.
Factor XIII Deficiency
De Novo Precursor B-Lymphoblastic Leukemia/Lymphoma With Double-Hit Gene Rearrangements (MYC/BCL-2) Presented With Spinal Cord Compression and Acquired Factor XIII Deficiency.
Factor XIII Deficiency
Defective ?2 antiplasmin cross-linking and thrombus stability in a case of acquired factor XIII deficiency.
Factor XIII Deficiency
Defective fibrin crosslinking in acute leukemia.
Factor XIII Deficiency
Deficiency of factor XIII gene in Chinese: 3 novel mutations.
Factor XIII Deficiency
Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding.
Factor XIII Deficiency
Delayed umbilical bleeding--a presenting feature for factor XIII deficiency: clinical features, genetics, and management.
Factor XIII Deficiency
Dental Management of Factor XIII Deficiency Patients: A Case Series.
Factor XIII Deficiency
Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories.
Factor XIII Deficiency
Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
Factor XIII Deficiency
Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes.
Factor XIII Deficiency
Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.
Factor XIII Deficiency
Diagnosis and management of severe congenital factor XIII deficiency in the Emergency Department: lessons from a "model" family.
Factor XIII Deficiency
Diagnosis of factor XIII deficiency.
Factor XIII Deficiency
Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran.
Factor XIII Deficiency
Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency.
Factor XIII Deficiency
Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders.
Factor XIII Deficiency
Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran.
Factor XIII Deficiency
Documentation of the plasma factor XIII deficiency in man.
Factor XIII Deficiency
Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
Factor XIII Deficiency
Effect of four missense mutations in the factor XIII A-subunit gene on protein stability: studies with recombinant proteins.
Factor XIII Deficiency
Effect of Social Factors on the Highest Global Incidence of Congenital Factor XIII Deficiency in Southeast of Iran.
Factor XIII Deficiency
Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests.
Factor XIII Deficiency
Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
Factor XIII Deficiency
Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Factor XIII Deficiency
Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran.
Factor XIII Deficiency
ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group.
Factor XIII Deficiency
Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage.
Factor XIII Deficiency
Factor concentrates for the treatment of factor XIII deficiency.
Factor XIII Deficiency
Factor XIII and its deficiency - review literature and the case report of a Thai boy with congenital factor XIII deficiency.
Factor XIII Deficiency
Factor XIII as a modulator of plasma fibronectin alterations during experimental bacteremia.
Factor XIII Deficiency
Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results.
Factor XIII Deficiency
Factor XIII deficiency (fibrin stabilizing factor).
Factor XIII Deficiency
Factor XIII deficiency and head trauma: management and therapy.
Factor XIII Deficiency
Factor XIII deficiency and intracranial hemorrhages in infancy.
Factor XIII Deficiency
Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures.
Factor XIII Deficiency
Factor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit.
Factor XIII Deficiency
Factor XIII deficiency as a potential cause of supratentorial haemorrhage after posterior fossa surgery.
Factor XIII Deficiency
Factor XIII deficiency associated with Klippel-Weber disease, platelet dysfunction and cryofibrinogenemia.
Factor XIII Deficiency
Factor XIII Deficiency Associated With Noonan Syndrome.
Factor XIII Deficiency
Factor XIII deficiency associated with valproate treatment.
Factor XIII Deficiency
Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction.
Factor XIII Deficiency
Factor XIII deficiency causing mutation, Ser295Arg, in exon 7 of the factor XIIIA gene.
Factor XIII Deficiency
Factor XIII deficiency diagnosis: Challenges and tools.
Factor XIII Deficiency
Factor XIII deficiency does not prevent FeCl3-induced carotid artery thrombus formation in mice.
Factor XIII Deficiency
Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit-a gene in three unrelated Palestinian Arab families.
Factor XIII Deficiency
Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
Factor XIII Deficiency
Factor XIII deficiency in adult polycystic kidney disease.
Factor XIII Deficiency
Factor XIII deficiency in antibiotic-associated pseudomembranous colitis and its treatment with factor XIII concentrate.
Factor XIII Deficiency
Factor XIII deficiency in BALB/c mice with plasmacytoma.
Factor XIII Deficiency
Factor XIII Deficiency in Children-Clinical Presentation and Outcome.
Factor XIII Deficiency
Factor XIII deficiency in Henoch-Schönlein purpura - report on two cases and literature review.
Factor XIII Deficiency
Factor XIII Deficiency in Iran: A Comprehensive Review of the Literature.
Factor XIII Deficiency
Factor XIII deficiency in Pakistan.
Factor XIII Deficiency
Factor XIII Deficiency in Siblings: Importance of Prophylactic Replacement.
Factor XIII Deficiency
Factor XIII deficiency in south of Tunisia.
Factor XIII Deficiency
Factor XIII deficiency in south-east Iran.
Factor XIII Deficiency
Factor XIII deficiency in two Melanesian families from Papua New Guinea.
Factor XIII Deficiency
Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management.
Factor XIII Deficiency
Factor XIII Deficiency in Western Afghanistan due to a Novel F13A Gene Mutation.
Factor XIII Deficiency
Factor XIII deficiency leading to preseptal haematoma post-strabismus surgery.
Factor XIII Deficiency
Factor XIII deficiency management: a review of the literature.
Factor XIII Deficiency
Factor XIII deficiency mistaken for battered child syndrome: case of "correct" test ordering negated by a commonly accepted qualitative test with limited negative predictive value.
Factor XIII Deficiency
Factor XIII deficiency presenting with intracerebral bleed.
Factor XIII Deficiency
Factor XIII deficiency related recurrent spontaneous intracerebral hemorrhage: A case and literature review.
Factor XIII Deficiency
Factor XIII deficiency revealed by spontaneous intramedullary hemorrhage: confirmation of a severe mutation.
Factor XIII Deficiency
Factor XIII Deficiency with a Novel Nonsense Mutation.
Factor XIII Deficiency
Factor XIII deficiency with intracranial haemorrhage.
Factor XIII Deficiency
Factor XIII deficiency.
Factor XIII Deficiency
Factor XIII Deficiency.
Factor XIII Deficiency
Factor XIII deficiency. A family study by measurement of factor XIII subunits A and S.
Factor XIII Deficiency
Factor XIII deficiency. A rare haemorrhagic disease.
Factor XIII Deficiency
Factor XIII deficiency. Treatment with monthly plasma infusions.
Factor XIII Deficiency
Factor XIII deficiency: a differential diagnosis to be considered in suspected nonaccidental injury presenting with intracranial hemorrhage.
Factor XIII Deficiency
Factor XIII deficiency: a genetic study of two affected kindreds in Finland.
Factor XIII Deficiency
Factor XIII deficiency: a rare cause of repeated abortions.
Factor XIII Deficiency
Factor XIII Deficiency: An Update.
Factor XIII Deficiency
Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
Factor XIII Deficiency
Factor XIII deficiency: new nonsense and deletion mutations in the human factor XIIIA gene.
Factor XIII Deficiency
Factor XIII deficiency: pathogenic mechanisms and clinical significance.
Factor XIII Deficiency
Factor XIII deficiency: report of a case complicated by splenic rupture.
Factor XIII Deficiency
Factor XIII deficiency: report of two cases.
Factor XIII Deficiency
Factor XIII levels in five families of patients with inherited factor XIII deficiency: support for an autosomal recessive inheritance.
Factor XIII Deficiency
Factor XIII mutation spectrum in Iranian patients with hereditary factor XIII deficiency: Detection of 3 novel mutations.
Factor XIII Deficiency
Factor XIII.
Factor XIII Deficiency
Factor XIIIA Calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit.
Factor XIII Deficiency
Fibrin cross-linking in congenital factor XIII deficiency.
Factor XIII Deficiency
Fibrinogen but not factor XIII deficiency is associated with bleeding after craniotomy.
Factor XIII Deficiency
Fibronectin and wound healing.
Factor XIII Deficiency
First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran.
Factor XIII Deficiency
Fracture neck of femur in Factor XIII deficiency: Was better outcome possible?
Factor XIII Deficiency
Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency.
Factor XIII Deficiency
FXIII deficiency due to base exchange Thr 449 (ACT) --> Ile (ATT) in exon 11 of the factor 13A gene. A cause of bleeding?
Factor XIII Deficiency
Gene defects in congenital factor XIII deficiency.
Factor XIII Deficiency
Genetic aspects of factor XIII deficiency.
Factor XIII Deficiency
Genetic basis of severe factor XIII deficiency in a large cohort of Indian patients: Identification of fourteen novel mutations.
Factor XIII Deficiency
Genetic heterogeneity of factor XIII deficiency: first description of unstable A subunits.
Factor XIII Deficiency
Glanzmann's thrombasthenia in a Melanesian.
Factor XIII Deficiency
Guidelines for laboratory diagnosis of factor XIII deficiency.
Factor XIII Deficiency
Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency.
Factor XIII Deficiency
Hemophiliacs--a picture from a developing country: Karnataka, a south Indian state.
Factor XIII Deficiency
Hemorrhagic Shock after Neonatal Circumcision: Severe Congenital Factor XIII Deficiency.
Factor XIII Deficiency
Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.
Factor XIII Deficiency
Hemostasis in Crohn's disease: low factor XIII levels in active disease.
Factor XIII Deficiency
Hereditary factor XIII deficiency.
Factor XIII Deficiency
Hereditary factor XIII deficiency: report of four families and definition of the carrier state.
Factor XIII Deficiency
How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency.
Factor XIII Deficiency
How to deal with medical and social aspects of bleeding disorders--preparing women and the family in developing countries.
Factor XIII Deficiency
Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies.
Factor XIII Deficiency
Identification of a new Leu354Pro mutation responsible for factor XIII deficiency.
Factor XIII Deficiency
Identification of a new mutation (Gly420Ser), distal to the active site, that leads to factor XIII deficiency.
Factor XIII Deficiency
Identification of a Novel Mutation Combination in Factor XIII Deficiency: Genetic Update to the First Reported Case in the United States.
Factor XIII Deficiency
Identification of a novel nonsense mutation leading to congenital factor XIII deficiency.
Factor XIII Deficiency
Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy.
Factor XIII Deficiency
Identification of an inframe deletion and a missense mutation in the factor XIIIA gene in two Turkish patients.
Factor XIII Deficiency
Identification of novel pathogenic F13A1 mutation and novel NBEAL2 gene missense mutation in a pedigree with hereditary congenital factor XIII deficiency.
Factor XIII Deficiency
Identification of two novel missense mutations causing severe factor XIII deficiency.
Factor XIII Deficiency
Immunotolerance approach to refractory CNS bleeding in a patient with congenital factor XIII deficiency and acquired alloantibody.
Factor XIII Deficiency
Impact of Rare Bleeding Disorders during Pregnancy on Maternal and Fetal Outcomes: Review of 29 Pregnancies at a Single Center.
Factor XIII Deficiency
Impaired dimer assembly and decreased stability of naturally recurring R260C mutant A subunit for coagulation factor XIII.
Factor XIII Deficiency
Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis.
Factor XIII Deficiency
In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
Factor XIII Deficiency
Induction of hemodialysis therapy in a case with factor XIII deficiency.
Factor XIII Deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
Factor XIII Deficiency
Inherited bleeding disorders in pregnancy.
Factor XIII Deficiency
Inherited factor XIII deficiency.
Factor XIII Deficiency
International registry on factor XIII deficiency: a basis formed mostly on European data.
Factor XIII Deficiency
Intracranial haemorrhage in patients with congenital haemostatic defects.
Factor XIII Deficiency
Intracranial hemorrhage in congenital deficiency of factor XIII.
Factor XIII Deficiency
Intracranial hemorrhage pattern in the patients with factor XIII deficiency.
Factor XIII Deficiency
Intracranial Hemorrhage: A Devastating Outcome of Congenital Bleeding Disorders-Prevalence, Diagnosis, and Management, with a Special Focus on Congenital Factor XIII Deficiency.
Factor XIII Deficiency
Intraspinal hemorrhage in a child with factor XIII deficiency.
Factor XIII Deficiency
Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening tests.
Factor XIII Deficiency
Is Embolization an Effective Treatment for Recurrent Hemorrhage After Hip or Knee Arthroplasty?
Factor XIII Deficiency
Is extracorporeal CO2-Removal really "safe" and "less" invasive? Observation of blood injury and coagulation impairment during ECCO2R.
Factor XIII Deficiency
Laboratory Diagnosis of Factor XIII Deficiency in Developing Countries: An Iranian Experience.
Factor XIII Deficiency
Laboratory Diagnosis of Factor XIII Deficiency, Routine Coagulation Tests with Quantitative and Qualitative Methods.
Factor XIII Deficiency
Laboratory testing for bleeding disorders: strategic uses of high and low-yield tests.
Factor XIII Deficiency
Lobar Hemorrhage Induced by Acquired Factor XIII Deficiency in a Patient with Cerebral Amyloid Angiopathy.
Factor XIII Deficiency
Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®.
Factor XIII Deficiency
Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran.
Factor XIII Deficiency
Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.
Factor XIII Deficiency
Low levels of fibrin-stabilizing factor (factor XIII) in human Plasmodium falciparum malaria: correlation with clinical severity.
Factor XIII Deficiency
Low prevalence of antibodies against human immunodeficiency virus in Finnish haemophiliacs.
Factor XIII Deficiency
Male fertility in factor XIII deficiency.
Factor XIII Deficiency
Management of acute myocardial infarction in a patient with factor XIII deficiency using prophylactic factor replacement therapy.
Factor XIII Deficiency
Management of Dilutional Coagulopathy during Pediatric Major Surgery.
Factor XIII Deficiency
Management of Neuraxial Analgesia in a Parturient with Factor XIII Deficiency: A Case Report and Proposed Management Algorithm.
Factor XIII Deficiency
Management of pregnancy and delivery in women with inherited bleeding disorders.
Factor XIII Deficiency
Massive recurrent post-tonsillectomy bleedings revealing a transient factor XIII deficiency in a 10-year-old boy. A case report.
Factor XIII Deficiency
Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell.
Factor XIII Deficiency
Medical and Surgical Management of Postpartum Hemorrhage in a Woman with Factor XIII Deficiency.
Factor XIII Deficiency
Melanoma associated with subacute primitive fibrinolysis.
Factor XIII Deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Factor XIII Deficiency
Mild Acquired Factor XIII Deficiency and Clinical Relevance at the ICU-A Retrospective Analysis.
Factor XIII Deficiency
Mild factor XIII deficiency and concurrent hypofibrinogenemia: effect of pregnancy.
Factor XIII Deficiency
Mining of mortality-related findings in rare bleeding disorders: a retrospective study from two centers.
Factor XIII Deficiency
Molecular and genetic mechanisms of factor XIII A subunit deficiency.
Factor XIII Deficiency
Molecular Basis of Congenital Factor XIII Deficiency in Iran.
Factor XIII Deficiency
Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function.
Factor XIII Deficiency
Molecular characterization of five Italian families with inherited severe factor XIII deficiency.
Factor XIII Deficiency
Molecular diagnosis of factor XIII deficiency, data from comprehensive coagulation laboratory in Iran.
Factor XIII Deficiency
Molecular genetic analysis of ten unrelated Iranian patients with congenital factor XIII deficiency.
Factor XIII Deficiency
Molecular mechanisms of mutations in factor XIII A-subunit deficiency: in vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins.
Factor XIII Deficiency
Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system.
Factor XIII Deficiency
Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency.
Factor XIII Deficiency
Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency.
Factor XIII Deficiency
Mutations causing coagulation factor XIII subunit A deficiency: characterization of the mutant proteins after expression in yeast.
Factor XIII Deficiency
Mutations in coagulation factor XIII A gene in eight unrelated Indians. Five novel mutations identified by a novel PCR-CSGE approach.
Factor XIII Deficiency
Mutations in coagulation factor XIII subunit A in severe factor XIII deficiency patients: five novel mutations detected.
Factor XIII Deficiency
Neonatal factor XIII deficiency.
Factor XIII Deficiency
Neoplasm-induced bleeding in inherited, heterozygous FXIII-A deficiency.
Factor XIII Deficiency
New developments in the management of congenital Factor XIII deficiency.
Factor XIII Deficiency
New mutations causing the premature termination of translation in the A subunit gene of coagulation factor XIII.
Factor XIII Deficiency
Nonhemophiliac musculoskeletal pseudotumor.
Factor XIII Deficiency
Nonimmune-acquired factor XIII deficiency: a cause of high volume and delayed postoperative hemorrhage.
Factor XIII Deficiency
Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency.
Factor XIII Deficiency
Novel aspects of factor XIII deficiency.
Factor XIII Deficiency
Novel deep intronic mutation in the coagulation factor XIII a chain gene leading to unexpected RNA splicing in a patient with factor XIII deficiency.
Factor XIII Deficiency
Novel deletion and insertion mutations cause splicing defects, leading to severe reduction in mRNA levels of the A subunit in severe factor XIII deficiency.
Factor XIII Deficiency
Novel Factor XIII variant identified through whole-genome sequencing in a child with intracranial hemorrhage.
Factor XIII Deficiency
Novel human pathological mutations. Gene symbol: F13A1. Disease: Factor XIII Deficiency.
Factor XIII Deficiency
Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk.
Factor XIII Deficiency
Novel Y283C mutation of the A subunit for coagulation factor XIII: molecular modelling predicts its impaired protein folding and dimer formation.
Factor XIII Deficiency
Occurrence and recurrence of spontaneous chronic subdural haematoma is associated with a factor XIII deficiency.
Factor XIII Deficiency
Ocular complications of factor XIII deficiency.
Factor XIII Deficiency
On the retraction of collagen and fibrin induced by normal, defective and modified platelets.
Factor XIII Deficiency
Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection.
Factor XIII Deficiency
Optimisation of a new continuous UV assay for the determination of blood coagulation factor XIII activity in human plasma.
Factor XIII Deficiency
Original tandem duplication in FXIIIA gene with splicing site modification and four amino acids insertion causes factor XIII deficiency.
Factor XIII Deficiency
Ovarian haemorrhage: a rare presentation and diagnostic dilemma in factor XIII deficiency.
Factor XIII Deficiency
Pathogenicity analysis of variations and prenatal diagnosis in a hereditary coagulation factor XIII deficiency family.
Factor XIII Deficiency
Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies.
Factor XIII Deficiency
Patient-centered approach to managing factor XIII deficiency.
Factor XIII Deficiency
Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency.
Factor XIII Deficiency
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report.
Factor XIII Deficiency
Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Factor XIII Deficiency
Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement.
Factor XIII Deficiency
Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency.
Factor XIII Deficiency
Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations.
Factor XIII Deficiency
Physiopathology and regulation of factor XIII.
Factor XIII Deficiency
Platelet aggregation in congenital factor XIII deficiency.
Factor XIII Deficiency
Platelet and coagulation studies in Ehlers-Danlos syndrome.
Factor XIII Deficiency
Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency.
Factor XIII Deficiency
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman--reply.
Factor XIII Deficiency
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman.
Factor XIII Deficiency
Postoperative bleeding in a patient with normal screening coagulation tests.
Factor XIII Deficiency
Posttraumatic subgaleal and orbital hematoma due to factor XIII deficiency.
Factor XIII Deficiency
Pregnancy complications and obstetric care in women with inherited bleeding disorders.
Factor XIII Deficiency
Premarital Screening Program for Congenital Factor XIII Deficiency in Iran.
Factor XIII Deficiency
Prenatal diagnosis in factor XIII-A deficiency.
Factor XIII Deficiency
Prenatal diagnosis of factor 13 deficiency and its recurrence.
Factor XIII Deficiency
Prevalence of factor XIII deficiency in patients presenting with a bleeding disorder in Pakistan.
Factor XIII Deficiency
Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta.
Factor XIII Deficiency
Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study.
Factor XIII Deficiency
Proceedings: Factor XIII concentrate in the long term management of congenital factor XIII deficiency.
Factor XIII Deficiency
Procoagulant platelets form an ?-granule protein-covered 'cap' on their surface that promotes their attachment to aggregates.
Factor XIII Deficiency
Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency.
Factor XIII Deficiency
Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency: reply to a rebuttal.
Factor XIII Deficiency
Prophylaxis in factor XIII deficiency.
Factor XIII Deficiency
Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
Factor XIII Deficiency
Pubertal Menorrhagia - A Rare Presentation of Congenital Factor XIII Deficiency.
Factor XIII Deficiency
Quality of life of people with hereditary factor XIII deficiency treated at a reference centre.
Factor XIII Deficiency
Rare bleeding disorders in children: identification and primary care management.
Factor XIII Deficiency
Rare inherited coagulation disorders in India.
Factor XIII Deficiency
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency.
Factor XIII Deficiency
Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss.
Factor XIII Deficiency
Recurrent bleeding following rhinoplasty due to factor XIII deficiency.
Factor XIII Deficiency
Recurrent episodes of severe bleeding caused by congenital factor XIII deficiency in a dog.
Factor XIII Deficiency
Recurrent Hematomas following a Revision Total Hip Arthroplasty in Acquired Coagulation Factor XIII Deficiency.
Factor XIII Deficiency
Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update.
Factor XIII Deficiency
Recurrent Post Tonsillectomy Secondary Hemorrhage in Patients with Factor XIII Deficiency: A Case Series and Review of Literature.
Factor XIII Deficiency
Recurrent Spontaneous Splenic Rupture in a Patient With Congenital Factor XIII Deficiency.
Factor XIII Deficiency
Recurrent ulcerations on both legs since early childhood due to a factor V gene mutation.
Factor XIII Deficiency
Reduced difference of ?(2)-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies.
Factor XIII Deficiency
Reduced levels of coagulation factor XIII in patients with advanced tumor disease.
Factor XIII Deficiency
Relevant bleeding diathesis due to acquired factor XIII deficiency.
Factor XIII Deficiency
Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.
Factor XIII Deficiency
Rotational thromboelastometry can detect factor XIII deficiency and bleeding diathesis in patients with liver cirrhosis.
Factor XIII Deficiency
Rotational Thromboelastometry for Assessing Bleeding Complications and Factor XIII Deficiency in Cardiac Surgery Patients.
Factor XIII Deficiency
Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.
Factor XIII Deficiency
SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available.
Factor XIII Deficiency
Segmental uniparental disomy as a rare cause of congenital severe factor XIII deficiency in a girl with only one heterozygous carrier parent.
Factor XIII Deficiency
Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families.
Factor XIII Deficiency
Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
Factor XIII Deficiency
Severe bleeding in a patient with factor XIII deficiency and COVID-19.
Factor XIII Deficiency
Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines.
Factor XIII Deficiency
Solubility fo fibrin clots in monochloroacetic acid. A reflection of serum pepsinogen levels.
Factor XIII Deficiency
Spectrum of hereditary coagulation factor deficiencies in eastern province, Saudi Arabia.
Factor XIII Deficiency
Spinal anaesthesia and caesarean section in a patient with hypofibrinogenaemia and factor XIII deficiency*
Factor XIII Deficiency
Spontaneous Acute Cerebral Hematoma in a Child with Factor XIII Deficiency.
Factor XIII Deficiency
Spontaneous Epidural Hematoma in a Child With Inherited Factor XIII Deficiency.
Factor XIII Deficiency
Spontaneous intracerebral hematoma in a adolescent with factor XIII deficiency. Case report.
Factor XIII Deficiency
Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency.
Factor XIII Deficiency
Spontaneous rupture of the spleen in Factor XIII deficiency: A report of two cases.
Factor XIII Deficiency
Spontaneous splenic rupture in a patient with factor XIII deficiency and a novel mutation.
Factor XIII Deficiency
State of the art in factor XIII laboratory assessment.
Factor XIII Deficiency
Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups.
Factor XIII Deficiency
Subgaleal hematoma presenting as a manifestation of Factor XIII deficiency.
Factor XIII Deficiency
Subunits A and S inheritance in four families with congenital factor XIII deficiency.
Factor XIII Deficiency
Successful completion of transurethral lithotripsy in a patient with factor XIII deficiency: A case report.
Factor XIII Deficiency
Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study.
Factor XIII Deficiency
Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case.
Factor XIII Deficiency
Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm.
Factor XIII Deficiency
Successful treatment of severe gastrointestinal manifestations of Henoch-Schonlein Purpura and factor XIII deficiency using cryoprecipitate transfusion.
Factor XIII Deficiency
Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
Factor XIII Deficiency
Surgery in severe factor XIII deficiency: report of a case of epilepsy neurosurgery and review.
Factor XIII Deficiency
Symptomatic factor XIII deficiency with normal urea solubility test.
Factor XIII Deficiency
The first case report of a patient with acquired factor XIII deficiency in the context of autoimmune encephalitis.
Factor XIII Deficiency
The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose.
Factor XIII Deficiency
The normal and abnormal genes of the a and b subunits in coagulation factor XIII.
Factor XIII Deficiency
The perioperative course of factor XIII and associated chest tube drainage in newborn and infants undergoing cardiac surgery.
Factor XIII Deficiency
The rare inherited coagulation disorders.
Factor XIII Deficiency
The role of fibrin matrices and tissue factor in early-term trophoblast proliferation and spreading.
Factor XIII Deficiency
The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunoelectrophoresis.
Factor XIII Deficiency
Therapeutic factor XIII preparations and perspectives for recombinant factor XIII.
Factor XIII Deficiency
Thromboelastometric detection of clotting Factor XIII deficiency in cardiac surgery patients.
Factor XIII Deficiency
Thromboelastometry Identified Alteration of Clot Stabilization and Factor XIII Supplementation Need in a Patient with Decompensated Liver Disease Undergoing Liver Biopsy.
Factor XIII Deficiency
Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
Factor XIII Deficiency
Tooth extraction in two patients who had a congenital deficiency of factor XIII.
Factor XIII Deficiency
Training Program for Home Therapy of People With Factor XIII Deficiency.
Factor XIII Deficiency
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection.
Factor XIII Deficiency
Treatment of factor XIII deficiency with cryoprecipitate.
Factor XIII Deficiency
Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency.
Factor XIII Deficiency
Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation.
Factor XIII Deficiency
Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiency.
Factor XIII Deficiency
Type I and type II disease in congenital factor XIII deficiency. A further demonstration of the correctness of the classification.
Factor XIII Deficiency
Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain.
Factor XIII Deficiency
Unusual presentation of factor XIII deficiency.
Factor XIII Deficiency
Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery.
Factor XIII Deficiency
Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding.
Factor XIII Deficiency
Valproic Acid-Induced Coagulopathy.
Factor XIII Deficiency
Viral markers and use of factor products among Finnish patients with bleeding disorders.
Factor XIII Deficiency
[2 patients with congenital factor XIII deficiency. Contribution to the problem of factor XIII determination]
Factor XIII Deficiency
[A case of congenital factor XIII deficiency and acquired factor XIII deficiency (author's transl)]
Factor XIII Deficiency
[A clinical study of congenital factor XIII deficiency (author's transl)]
Factor XIII Deficiency
[A novel genetic defect in a Chinese family with inherited coagulation factor XIII deficiency]
Factor XIII Deficiency
[A report of two cases with congenital factor XIII deficiency]
Factor XIII Deficiency
[Acquired coagulation disorders].
Factor XIII Deficiency
[Acquired factor XIII deficiency and chronic myeloid splenomegaly]
Factor XIII Deficiency
[Acquired factor XIII deficiency and clinical surgery]
Factor XIII Deficiency
[Acquired factor XIII deficiency and postoperative aseptic wound healing disorders]
Factor XIII Deficiency
[Acquired von Willebrand syndrome in a patient with immune thrombocytopenic purpura].
Factor XIII Deficiency
[Acute malignant myelofibrosis complicated by factor XIII deficiency, protein C decrease and skin necroses]
Factor XIII Deficiency
[An infant with umbilical cord and intracranial hemorrhage--severe factor XIII deficiency]
Factor XIII Deficiency
[Anesthesia for a patient with Ehlers-Danlos syndrome and factor XIII deficiency]
Factor XIII Deficiency
[Bleeding and coagulation disorders in tonsillectomies.]
Factor XIII Deficiency
[Blood clotting factor XIII substitution in acute leukaemia: result of a randomized and controlled study]
Factor XIII Deficiency
[Blood coagulation factor XIII and fibrin stabilization (author's transl)]
Factor XIII Deficiency
[Case of factor XIII deficiency]
Factor XIII Deficiency
[Case suspected to be factor XIII deficiency]
Factor XIII Deficiency
[Cephalohemoatoma as the first manifestation of congenital factor XIII deficiency]
Factor XIII Deficiency
[Characterization of a large deletion that leads to congenital factor XIII deficiency]
Factor XIII Deficiency
[Clinical course and management of severe congenital factor XIII deficiency]
Factor XIII Deficiency
[Congenital factor XIII deficiency in pregnancy. A case report]
Factor XIII Deficiency
[Congenital factor XIII deficiency in the south of Tunisia]
Factor XIII Deficiency
[Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy]
Factor XIII Deficiency
[Congenital factor XIII deficiency. Report of a new family (author's transl)]
Factor XIII Deficiency
[Congenital factor XIII deficiency: studies in an infant and his family]
Factor XIII Deficiency
[Congenital factor XIII deficiency]
Factor XIII Deficiency
[Detection of factor XIII deficiency in acute leukemia with resonance thrombography]
Factor XIII Deficiency
[Factor XIII deficiency as the cause of postoperative hemorrhage]
Factor XIII Deficiency
[Factor XIII deficiency due to lack of both the S and A subunits. (Classification of factor XIII deficiency in 2 groups)]
Factor XIII Deficiency
[Factor XIII deficiency in a newborn]
Factor XIII Deficiency
[Factor XIII deficiency in adults with acute leukemia: results of a substitution therapy with factor XIII (author's transl)]
Factor XIII Deficiency
[Factor XIII deficiency in burns]
Factor XIII Deficiency
[Factor XIII deficiency in various patients with acute leukemia]
Factor XIII Deficiency
[Factor XIII deficiency: blood coagulation defect in pregnancy]
Factor XIII Deficiency
[Factor XIII deficiency]
Factor XIII Deficiency
[Factor XIII-guided treatment algorithm reduces blood transfusion in burn surgery].
Factor XIII Deficiency
[Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)]
Factor XIII Deficiency
[Hereditary coagulation factor XIII deficiency: three cases report and literaure review].
Factor XIII Deficiency
[Identification of a novel mutation of F (13) A gene in a pedigree with factor XIII deficiency]
Factor XIII Deficiency
[Identification of genetic defects in a Chinese pedigree with factor XIII deficiency: case report and literature review].
Factor XIII Deficiency
[Identification of two novel mutation in two Chinese hereditary coagulation factor XIII deficiency families]
Factor XIII Deficiency
[Importance, diagnosis and substitution in acquired factor XIII deficiency in the postoperative course]
Factor XIII Deficiency
[Intracranial hematoma accompanying bleeding tendency: therapeutic practice and analysis of literature]
Factor XIII Deficiency
[Intradural hematoma of the foramen magnum associated with factor XIII deficiency]
Factor XIII Deficiency
[Is the use of factor XIII for delayed wound healing in patients with head-neck tumors of value?]
Factor XIII Deficiency
[Leukocytoclastic vasculitis and factor XIII deficiency]
Factor XIII Deficiency
[Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate]
Factor XIII Deficiency
[Molecular mechanisms of two novel mutations of factor XIII gene resulting in hereditary coagulation deficiency]
Factor XIII Deficiency
[Pathogenesis of tracheal stenosis following long-term intubation of patients with multiple injuries]
Factor XIII Deficiency
[Plasma transglutaminase activity in congenital total and partial factor XIII deficiency (a contribution to the problem of factor XIII determination)]
Factor XIII Deficiency
[Postoperative complications due to acquired factor XIII deficiency]
Factor XIII Deficiency
[Pre-hospital diagnosis of nosebleed in children]
Factor XIII Deficiency
[Presence of a plasma antigen indispensable to the stabilization of fibrin in 2 cases on congenital factor XIII deficiency]
Factor XIII Deficiency
[Primary myelofibrosis with fatal mesenteric arterial thromboembolism caused by antiphospholipid syndrome]
Factor XIII Deficiency
[Recurrent hematomas and normal standard hemostasis tests]
Factor XIII Deficiency
[Role of thrombelastometry for the monitoring of factor XIII. A prospective observational study in neurosurgical patients.]
Factor XIII Deficiency
[Severe factor XIII-deficiency. Studies on subunits and turnover of the fibrin stabilizing factor (author's transl)]
Factor XIII Deficiency
[Simplified radiologic factor XIII determination and its clinical use in congenital factor XIII deficiency (I)]
Factor XIII Deficiency
[Spontaneous splenic rupture in a patient with congenital factor XIII deficiency]
Factor XIII Deficiency
[Stenosing ureteritis and factor XIII deficiency in anaphylactoid purpura]
Factor XIII Deficiency
[Studies on abnormal protein in seven patients with congenital factor XIII deficiency (author's transl)]
Factor XIII Deficiency
[Studies on congenital factor XIII deficiency and detection of the carrier in his family (author's transl)]
Factor XIII Deficiency
[Study on the molecular mechanisms of a novel large deletion of FXIIIA mRNA in a new hereditary factor XIII deficiency].
Factor XIII Deficiency
[Substitution treatment of factor XIII deficiency with a new factor XIII concentrate]
Factor XIII Deficiency
[Surgical treatment of intracranial hematoma with congenital factor XIII deficiency. Case report]
Factor XIII Deficiency
[Thrombelastometric detection of factor XIII deficiency]
Factor XIII Deficiency
[Wound healing disorders and factor XIII deficiency after tumor operations in the floor of the mouth]
Fanconi Anemia
The functional interactome of GSTP: A regulatory biomolecular network at the interface with the Nrf2 adaption response to oxidative stress.
Fasciitis
Proliferative myositis and fasciitis. Report of five cases with an ultrastructural and immunohistochemical study.
Fatty Liver
Lamin aggregation is an early sensor of porphyria-induced liver injury.
Fatty Liver
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2.
Fatty Liver
Searching for coeliac disease in patients with non-alcoholic fatty liver disease.
Fatty Liver, Alcoholic
Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Fetal Death
[Activity of plasma fibrin stabilizing factor in intra-uterine fetal death]
Fetal Growth Retardation
Parent-of-origin transmission of thrombophilic alleles to intrauterine growth-restricted newborns and transmission-ratio distortion in unaffected newborns.
Fetal Growth Retardation
Thrombophilic polymorphisms and intrauterine growth restriction.
Fetal Growth Retardation
Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy.
Fibroadenoma
Interplay between membrane lipid peroxidation, transglutaminase activity and cyclooxygenase 2 expression in the tissue adjoining to breast cancer.
Fibroma
Phenotypic characterisation of stellate and giant cells in giant cell fibroma by immunocytochemistry.
Fibroma
Pleomorphic Fibroma: A Clinicopathologic Case Series With the Review of the Literature.
Fibroma
S100A6 expression in fibrohistiocytic lesions.
Fibrosarcoma
Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression.
Fibrosarcoma
Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis).
Fibrosarcoma
Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis.
Fibrosarcoma
Factor XIII cross-linking of fibronectin at cellular matrix assembly sites.
Fibrosarcoma
Identification of the autoantigen of celiac disease.
Fibrosarcoma
Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas.
Fibrosarcoma
Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion.
Fibrosarcoma
The existence of an inactive form of transglutaminase within metastasising tumours.
Fibrosarcoma
Tissue transglutaminase is not increased during apoptosis of HT-1080 human fibrosarcoma cells.
Fibrosarcoma
Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth.
Filariasis
Molecular characterization of a Brugia malayi transglutaminase.
Foot Ulcer
Factor XIII Val34Leu polymorphism is associated with increased factor XIII activation and decreased transcutaneous oxygen readings in patients with diabetic foot ulcers.
Foot Ulcer
[Factor XIII: experimental and clinical results in diabetic foot ulcer]
Foramen Ovale, Patent
Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale.
Gallbladder Neoplasms
Study of tumor transglutaminase 2 expression in gallbladder cancer - Is it a novel predictor of survival?
Gallbladder Neoplasms
Transglutaminase 2 Mediates the Cytotoxicity of Resveratrol in a Human Cholangiocarcinoma and Gallbladder Cancer Cell Lines.
Gastritis
Erosive hemorrhagic gastroduodenitis with fibrinolysis and low factor XIII.
Gastritis
Iron deficiency, Helicobacter infection and gastritis.
Gastritis
Letter: the coeliac stomach - a significant increase in tissue transglutaminase antibodies is associated with gastritis.
Gastritis
Patients with psoriatic arthritis have an increased number of lymphocytes in the duodenal mucosa in comparison with patients with psoriasis vulgaris.
Gastritis
Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes.
Gastritis, Atrophic
New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract.
Gastrointestinal Diseases
Autoantibody screen in inflammatory myopathies high prevalence of antibodies to gliadin.
Gastrointestinal Diseases
Gut mucosal immunity to tissue transglutaminase in untreated celiac disease and other gastrointestinal disorders.
Gastrointestinal Diseases
Serum IgA tissue transglutaminase antibodies in coeliac disease and other gastrointestinal diseases.
Gastrointestinal Diseases
The Prevalence of the Celiac Disease in Patients with Dyspepsia: A Systematic Review and Meta-Analysis.
Gastrointestinal Hemorrhage
Factor XIII in chronic inflammatory bowel diseases.
Gastrointestinal Hemorrhage
Hemostasis in Crohn's disease: low factor XIII levels in active disease.
Genetic Diseases, Inborn
Factor XIII Deficiency in Children-Clinical Presentation and Outcome.
Genetic Diseases, Inborn
Ovarian haemorrhage: a rare presentation and diagnostic dilemma in factor XIII deficiency.
Giant Cell Arteritis
Differential behavior of coagulation factor XIII in patients with inflammatory bowel disease and in patients with giant cell arteritis.
Giant Cell Tumor of Bone
Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Giant Cell Tumors
Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Giardiasis
Isolated short stature as a presentation of celiac disease in Saudi children.
Giardiasis
Transient elevation of anti-transglutaminase and anti-endomysium antibodies in Giardia infection.
Giardiasis
Treatment of giardiasis reverses "active" coeliac disease to "latent" coeliac disease.
Gingival Diseases
Accumulation of cells containing factor XIII subunit a around the foci of intense fibrosis in human epulides.
Gingival Overgrowth
Gingival Crevicular Fluid and Plasma Levels of Transglutaminase-2 and Oxidative Stress Markers in Cylosporin A-Induced Gingival Overgrowth.
Gingival Overgrowth
Transglutaminase 2 expression is significantly increased in cyclosporine-induced gingival overgrowth.
Gingival Overgrowth
Transglutaminase 2 May Be Associated with Peri-implant Gingival Overgrowth: Preliminary Assessments.
Glaucoma
Corneal Stiffness and Collagen Cross-Linking Proteins in Glaucoma: Potential for Novel Therapeutic Strategy.
Glaucoma
Potential role of tissue transglutaminase in glaucoma filtering surgery.
Glioblastoma
A mechanism for the upregulation of EGF receptor levels in glioblastomas.
Glioblastoma
Increased endothelial expression of transglutaminase in glioblastomas.
Glioblastoma
Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.
Glioblastoma
The complex role of transglutaminase 2 in glioblastoma proliferation.
Glioblastoma
Tissue transgluaminase 2 expression in meningiomas.
Glioblastoma
Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas.
Glioblastoma
Tissue transglutaminase inhibition.
Glioblastoma
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
Glioma
Activation and de novo synthesis of transglutaminase in cultured glioma cells.
Glioma
An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes.
Glioma
Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells.
Glioma
Distribution and activity of transglutaminase in rat brain carcinogenesis and in gliomas.
Glioma
Effects of chlorpyrifos on transglutaminase activity in differentiating rat C6 glioma cells.
Glioma
G?(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
Glioma
Intracellular distribution of active and inactive transglutaminase in stimulated cultured C6 glioma cells.
Glioma
Isolation and characterization of brain-specific transglutaminases from rat.
Glioma
Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion.
Glioma
Serotonin--more than a neurotransmitter: transglutaminase-mediated serotonylation of C6 glioma cells and fibronectin.
Glioma
The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2.
Glioma
The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
Glioma
The transglutaminase 2 gene is aberrantly hypermethylated in glioma.
Glioma
Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBP? Signaling.
Glomerulonephritis
Elevated epsilon-(gamma-glutamyl)lysine in human diabetic nephropathy results from increased expression and cellular release of tissue transglutaminase.
Glomerulonephritis
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Glomerulonephritis
Localization of tissue transglutaminase (tTG) in kidney of ICR-derived glomerulonephritis (ICGN) mice.
Glomerulonephritis
Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarring.
Glomerulonephritis
Plasma factor XIII levels in children with renal disease.
Glomerulonephritis
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman--reply.
Glomerulonephritis
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman.
Glomerulonephritis
Successful Treatment of IgA Vasculitis Complicated with Bowel Perforation and Crescentic Glomerulonephritis by Combination Therapy of Glucocorticoid, Cyclosporine and Factor XIII Replacement.
Glomerulonephritis
The protective role of uteroglobin through the modulation of tissue transglutaminase in the experimental crescentic glomerulonephritis.
Glomerulonephritis
Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment.
Glomerulonephritis, IGA
Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy.
Glomerulonephritis, IGA
Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney.
Glomerulonephritis, IGA
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.
Glomerulonephritis, IGA
Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and henoch-Schönlein purpura nephritis.
Glomerulonephritis, Membranous
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Glomerulosclerosis, Focal Segmental
Increase in extracellular cross-linking by tissue transglutaminase and reduction in expression of MMP-9 contribute differentially to focal segmental glomerulosclerosis in rats.
Glucose Intolerance
Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient.
Gout
Fibrin dissolution in synovial fluid.
Graft vs Host Disease
Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
Graft vs Host Disease
Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut.
Graft vs Host Disease
Factor XIII replacement in stem cell transplant (SCT) recipients with severe graft-versus-host disease of the bowel: report of an initial experience.
Graft vs Host Disease
The role of tissue transglutaminase (transglutaminase type II) for the intestinal manifestations of murine semi-allogenic graft-versus-host disease.
Granular Cell Tumor
Granular cell dermatofibroma.
Granuloma
Involvement of IL-13 and tissue transglutaminase in liver granuloma and fibrosis after schistosoma japonicum infection.
Granuloma Annulare
Granuloma annulare: an immunohistochemical study.
Graves Disease
IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy.
Graves Disease
Screening for celiac disease in Tunisian patients with Graves' disease using anti-endomysium and anti-tissue transglutaminase antibodies.
Graves Disease
[Prevalence of polyglandular autoimmune syndrome in patients with diabetes mellitus type 1]
Hamartoma
Factor XIIIa in the hamartomas of tuberous sclerosis.
Hamartoma
Medallion-like dermal dendrocyte hamartoma: a case misdiagnosed as neurofibroma.
Hammer Toe Syndrome
Claw toes correction and factor XIII deficiency--a case report.
Hand-Foot Syndrome
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.
Head and Neck Neoplasms
TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.
Heart Arrest
Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen.
Heart Defects, Congenital
Dynamics of Factor XIII Levels After Open Heart Surgery for Congenital Heart Defects: Do Cyanotic and Acyanotic Patients Differ?
Heart Defects, Congenital
Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease.
Heart Failure
Genes up-regulated in hypertrophied ventricle.
Heart Failure
Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2.
Heart Failure
Tissue transglutaminase antibodies in patients with end-stage heart failure.
Heart Failure
Tissue transglutaminase in the pathogenesis of heart failure.
Heart Rupture
Does FXIII deficiency impair wound healing after myocardial infarction?
Heart Rupture
Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction.
Heart Valve Diseases
Concentrations of factor VIII-related antigen and factor XIII during open heart surgery.
Hemangioma
Hemangiopericytoma of the liver: immunohistochemical observations, expression of angiogenic factors, and review of the literature.
Hemangioma, Cavernous
[Fibrinolysis and the level of fibrin stabilizing factor in patients with cavernous hemangiomas of the maxillofacial region]
Hemangiopericytoma
Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Hemangiopericytoma
Hemangiopericytoma of the cerebello-pontine angle. Diagnostic pitfalls and the diagnostic value of the subunit A of factor XIII as a tumor marker.
Hemangiopericytoma
Surgical resection of sinonasal hemangiopericytoma involving anterior skull base: Case reports and literature review.
Hemarthrosis
Arthropathy associated with factor XIII deficiency.
Hemarthrosis
Knee hemarthrosis after arthroscopic surgery in an athlete with low factor XIII activity.
Hemarthrosis
Minimal Factor XIII Activity Level to Prevent Major Spontaneous Bleeds: comment.
Hematologic Diseases
[Plasma factor XIII in various hematologic diseases]
Hematoma, Subdural
Spontaneous Acute Subdural Hematoma and Chronic Epidural Hematoma in a Child with F XIII Deficiency.
Hematoma, Subdural
Spontaneous subdural hematomas particularly with a decreased coagulation factor XIII activity require follow-ups of the neuroradiological diagnostic.
Hematoma, Subdural, Chronic
Impact of low coagulation factor XIII activity in patients with chronic subdural hematoma associated with cerebrospinal fluid hypovolemia: A retrospective study.
Hematoma, Subdural, Chronic
Spontaneous chronic subdural hematomas in young adults with a deficiency in coagulation factor XIII. Report of three cases.
Hematuria
Acquired glomerular lesions in patients with Down syndrome.
Hematuria
Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
Hemochromatosis
Clinical implications of gene polymorphisms in venous leg ulcer: a model in tissue injury and reparative process.
Hemophilia A
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Hemophilia A
Acquired haemophilia A and concomitant factor XIII consumption.
Hemophilia A
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Hemophilia A
Arthropathy associated with factor XIII deficiency.
Hemophilia A
Clinical audit of inherited bleeding disorders in a developing country.
Hemophilia A
Congenital hemorrhagic disorders in Jordan.
Hemophilia A
Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A.
Hemophilia A
Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin ?-chain crosslinking.
Hemophilia A
Factor XIII in the treatment of hemophilia A.
Hemophilia A
Glanzmann's thrombasthenia in a Melanesian.
Hemophilia A
Hemophiliacs--a picture from a developing country: Karnataka, a south Indian state.
Hemophilia A
Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia.
Hemophilia A
Mechanistic rationale for factor XIII cotreatment in haemophilia.
Hemophilia A
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Hemophilia A
Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection.
Hemophilia A
Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
Hemophilia A
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection.
Hemophilia A
Treatment of refractory hemorrhage with factor XIII in a patient with hemophilia A with inhibitor.
Hemophilia A
Viral markers and use of factor products among Finnish patients with bleeding disorders.
Hemophilia A
[Intracranial hematoma accompanying bleeding tendency: therapeutic practice and analysis of literature]
Hemophilia B
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Hemophilia B
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Hemophilia B
Clinical audit of inherited bleeding disorders in a developing country.
Hemophilia B
Congenital hemorrhagic disorders in Jordan.
Hemophilia B
Hemophiliacs--a picture from a developing country: Karnataka, a south Indian state.
Hemophilia B
Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection.
Hemophilia B
Surgical wound healing in bleeding disorders.
Hemorrhagic Disorders
A case of congenital factor XIII deficiency.
Hemorrhagic Disorders
A Unique Factor XIII Mutation in Southeastern Iran with an Unexpectedly High Prevalence: Khash Factor XIII.
Hemorrhagic Disorders
Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples.
Hemorrhagic Disorders
Choroid Plexus Papilloma and Factor XIII Deficiency: Case Report.
Hemorrhagic Disorders
Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.
Hemorrhagic Disorders
Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.
Hemorrhagic Disorders
Congenital hemorrhagic diathesis with deficiency of factor XIII. A case report and a family study.
Hemorrhagic Disorders
ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group.
Hemorrhagic Disorders
Factor XIII.
Hemorrhagic Disorders
Guidelines for laboratory diagnosis of factor XIII deficiency.
Hemorrhagic Disorders
Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
Hemorrhagic Disorders
Identification of a Novel Mutation Combination in Factor XIII Deficiency: Genetic Update to the First Reported Case in the United States.
Hemorrhagic Disorders
Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®.
Hemorrhagic Disorders
Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome - characterization of the antibody.
Hemorrhagic Disorders
Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
Hemorrhagic Disorders
[3 operated cases of congenital deficiency of Factor XIII associated with intracranial hematomas]
Hemorrhagic Disorders
[Congenital factor XIII deficiency in pregnancy. A case report]
Hemorrhagic Disorders
[Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy]
Hemorrhagic Disorders
[The significance of changes in the functional properties of blood platelets, factor XIII activity and fibrin clot quality in the pathogenesis of hemorrhagic diathesis secondary to experimental vitamin C deficiency]
Hemorrhagic Stroke
Hematology-neurology connection: Association between Factor XIII and hemorrhagic stroke in young women through genetic polymorphism.
Hemorrhagic Stroke
Mass spectrometric phenotyping of Val34Leu polymorphism of blood coagulation factor XIII by differential peptide display.
Hemorrhagic Stroke
Novel Factor XIII variant identified through whole-genome sequencing in a child with intracranial hemorrhage.
Hemorrhagic Stroke
Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women.
Hemostatic Disorders
[Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)]
Hepatitis
A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency.
Hepatitis
Factor XIII Val34Leu mutation and liver fibrosis rate in viral hepatitis.
Hepatitis
High levels of immunoglobulin A anti-tissue transglutaminase antibodies at diagnosis are a predictive factor for celiac hepatitis.
Hepatitis
Inactivation of HTLV-III/LAV, hepatitis B and non-A/non-B viruses by pasteurization in human plasma protein preparations.
Hepatitis
Intracerebral haemorrhage due to acquired factor XIII inhibitor--successful response to factor XIII concentrate.
Hepatitis A
The regulatory actions of retinoic acid on M2 polarization of porcine macrophages.
Hepatitis B
Hepatitis B surface antigen binds to human serum albumin cross-linked by transglutaminase.
Hepatitis B
Inactivation of HTLV-III/LAV, hepatitis B and non-A/non-B viruses by pasteurization in human plasma protein preparations.
Hepatitis B
Plasma derivatives and viral hepatitis.
Hepatitis B
Tissue transglutaminase 2 exerts a tumor-promoting role in hepatitis B virus-related hepatocellular carcinoma.
Hepatitis B
[Impact of small molecules on intermolecular interactions underlying the ligand technologies in laboratory diagnosis]
Hepatitis B
[Inactivation of viruses in Factor XIII concentrate by pasteurization]
Hepatitis B, Chronic
Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C.
Hepatitis B, Chronic
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Hepatitis B, Chronic
The prevalence of celiac autoantibodies in hepatitis patients.
Hepatitis C
Celiac sprue: another autoimmune syndrome associated with hepatitis C.
Hepatitis C
Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase.
Hepatitis C
[Factor XIII and hepatitis C virus infection]
Hepatitis C, Chronic
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection.
Hepatitis C, Chronic
Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.
Hepatitis C, Chronic
Pharmaceutical approval update.
Hepatitis, Autoimmune
High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies.
Hepatitis, Autoimmune
The prevalence of celiac autoantibodies in hepatitis patients.
Hepatoblastoma
Analysis of catalytic action of transglutaminase induced in human promyelocytic leukemia (HL-60) and human hepatoblastoma (HepG2) cells.
Hepatoblastoma
Expression induced by interleukin-6 of tissue-type transglutaminase in human hepatoblastoma HepG2 cells.
Hepatoblastoma
Increase caused by interleukin-6 in promoter activity of guinea pig liver transglutaminase gene.
Hepatomegaly
Genetic disorder in carbohydrates metabolism: hereditary fructose intolerance associated with celiac disease.
Hermanski-Pudlak Syndrome
On the retraction of collagen and fibrin induced by normal, defective and modified platelets.
Herpes Simplex
[Inactivation of viruses in Factor XIII concentrate by pasteurization]
Herpes Zoster
Cellular and molecular modification of egg envelope hardening in fertilization.
Herpesviridae Infections
Herpesvirus Infections and Transglutaminase type 2 Antibody Positivity in Childhood: The Generation R Study.
Histiocytoma
A study of factor XIIIa and MAC 387 immunolabeling in normal and pathological skin.
Histiocytoma
Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions.
Histiocytoma
Epithelioid cell histiocytoma. A report of 10 cases including a new cellular variant.
Histiocytoma
Histiocytoma cutis: a tumour of dermal dendrocytes (dermal dendrocytoma).
Histiocytoma
Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
Histiocytoma
Indeterminate cell histiocytosis--a clinicopathological entity with features of both X- and non-X histiocytosis.
Histiocytoma, Benign Fibrous
"Juvenile" xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis.
Histiocytoma, Benign Fibrous
A light microscopic and immunohistochemical evaluation of scars.
Histiocytoma, Benign Fibrous
Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
Histiocytoma, Benign Fibrous
CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
Histiocytoma, Benign Fibrous
Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans.
Histiocytoma, Benign Fibrous
Characterization of factor XIIIa+ dendritic cells in dermatofibroma: Immunohistochemical, electron and immunoelectron microscopical observations.
Histiocytoma, Benign Fibrous
Cytological alterations in dermal dendrocytes in vitro: evidence for transformation to a non-dendritic phenotype.
Histiocytoma, Benign Fibrous
D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
Histiocytoma, Benign Fibrous
Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa.
Histiocytoma, Benign Fibrous
Dermatofibrosarcoma protuberans--an update.
Histiocytoma, Benign Fibrous
Dermatofibrosarcoma Protuberans: The Current State of Multidisciplinary Management.
Histiocytoma, Benign Fibrous
Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Histiocytoma, Benign Fibrous
Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions.
Histiocytoma, Benign Fibrous
Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Histiocytoma, Benign Fibrous
Granular cell dermatofibroma.
Histiocytoma, Benign Fibrous
High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Histiocytoma, Benign Fibrous
Melanoma associated with a dermatofibroma.
Histiocytoma, Benign Fibrous
S100A6 expression in fibrohistiocytic lesions.
Histiocytoma, Benign Fibrous
Small Benign Storiform Fibrous Tumor (Fibrous Histiocytoma) of the Conjunctival Substantia Propria in a Child: Review and Clarification of Biologic Behavior.
Histiocytoma, Benign Fibrous
Solitary (juvenile) xanthogranuloma: a comprehensive immunohistochemical study emphasizing recently developed markers of histiocytic lineage.
Histiocytoma, Benign Fibrous
Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34.
Histiocytoma, Benign Fibrous
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Histiocytoma, Benign Fibrous
Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Histiocytoma, Benign Fibrous
Tenosynovial Giant Cell Tumor in the Dermis of the External Auditory Meatus.
Histiocytoma, Benign Fibrous
Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa.
Histiocytoma, Benign Fibrous
Ultrastructural localization of factor XIIIa.
Histiocytoma, Benign Fibrous
Verocay body--prominent cutaneous schwannoma.
Histiocytoma, Benign Fibrous
When Immunohistochemistry Deceives Us: The Pitfalls of CD34 and Factor XIIIa Stains in Dermatofibroma and Dermatofibrosarcoma Protuberans.
Histiocytoma, Malignant Fibrous
An unusual soft tissue tumor with features of angiomatoid malignant fibrous histiocytoma composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets. CD34 and factor XIIIa in angiomatoid MFH.
Histiocytoma, Malignant Fibrous
Comparative immunohistochemistry of malignant fibrous histiocytoma and sarcomatoid carcinoma of the urinary tract.
Histiocytoma, Malignant Fibrous
Congenital, infiltrating giant-cell angioblastoma. A new entity?
Histiocytoma, Malignant Fibrous
Dermatofibrosarcoma protuberans--an update.
Histiocytoma, Malignant Fibrous
Evaluation of CD68 and other histiocytic antigens in angiomatoid malignant fibrous histiocytoma.
Histiocytoma, Malignant Fibrous
Factor XIIIa and the classic histiocytic markers in malignant fibrous histiocytoma: a comparative immunohistochemical study.
Histiocytoma, Malignant Fibrous
Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Histiocytoma, Malignant Fibrous
High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Histiocytoma, Malignant Fibrous
Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
Histiocytosis
Nonlipidized juvenile xanthogranuloma: a histologic and immunohistochemical study.
Histiocytosis, Langerhans-Cell
Histologic and immunohistochemical study comparing xanthoma disseminatum and histiocytosis X.
Histiocytosis, Langerhans-Cell
Nonlipidized juvenile xanthogranuloma: a histologic and immunohistochemical study.
Histiocytosis, Non-Langerhans-Cell
Histologic and immunohistochemical study comparing xanthoma disseminatum and histiocytosis X.
HIV Infections
"Tissue" transglutaminase in AIDS.
HIV Infections
Antitissue transglutaminase antibodies in HIV infection and effect of highly active antiretroviral therapy.
HIV Infections
Intracerebral haemorrhage due to acquired factor XIII inhibitor--successful response to factor XIII concentrate.
Hodgkin Disease
Characterization of factor XIII containing-macrophages in lymph nodes with Hodgkin's disease.
Hodgkin Disease
Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Hodgkin Disease
Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease.
Hodgkin Disease
Monocyte activation in patients with Hodgkin's disease.
Hookworm Infections
Environmental and lifestyle influences on disorders of the large and small intestine: implications for treatment.
Huntington Disease
'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease.
Huntington Disease
A nonradioactive dot blot assay for transglutaminase activity.
Huntington Disease
A Profiling Platform for the Characterization of Transglutaminase 2 (TG2) Inhibitors.
Huntington Disease
Cell cycle and cell death in disease: past, present and future.
Huntington Disease
Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease.
Huntington Disease
Cerebrospinal fluid tissue transglutaminase in vascular dementia.
Huntington Disease
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.
Huntington Disease
Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease.
Huntington Disease
Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.
Huntington Disease
Evidence for a role for transglutaminase in Huntington's disease and the potential therapeutic implications.
Huntington Disease
Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's disease.
Huntington Disease
Impaired mitochondrial function results in increased tissue transglutaminase activity in situ.
Huntington Disease
Increased levels of gamma-glutamylamines in Huntington disease CSF.
Huntington Disease
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.
Huntington Disease
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.
Huntington Disease
Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain.
Huntington Disease
N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease.
Huntington Disease
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Huntington Disease
Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
Huntington Disease
Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases.
Huntington Disease
Possible role of the transglutaminases in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases.
Huntington Disease
Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine.
Huntington Disease
Protective effects of interrupting the binding of calmodulin to mutant huntingtin.
Huntington Disease
Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
Huntington Disease
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.
Huntington Disease
TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.
Huntington Disease
The end product of transglutaminase crosslinking: simultaneous quantitation of [Nepsilon-(gamma-glutamyl) lysine] and lysine by HPLC-MS3.
Huntington Disease
The influence of psychotropic drugs on cerebral cell death: female neurovulnerability to antipsychotics.
Huntington Disease
The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase.
Huntington Disease
Therapeutic advances in the management of Huntington's disease.
Huntington Disease
Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms.
Huntington Disease
Tissue transglutaminase is increased in Huntington's disease brain.
Huntington Disease
Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's disease.
Huntington Disease
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.
Huntington Disease
Tissue transglutaminase: a possible role in neurodegenerative diseases.
Huntington Disease
Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.
Huntington Disease
Transglutaminase 6 Is Colocalized and Interacts with Mutant Huntingtin in Huntington Disease Rodent Animal Models.
Huntington Disease
Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine.
Huntington Disease
Transglutaminase activation in neurodegenerative diseases.
Huntington Disease
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Huntington Disease
Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease.
Huntington Disease
Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.
Huntington Disease
Transglutaminase cross-links in intranuclear inclusions in Huntington disease.
Huntington Disease
Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
Huntington Disease
Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation.
Huntington Disease
Transglutaminase is linked to neurodegenerative diseases.
Huntington Disease
Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
Huntington Disease
Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic.
Huntington Disease
Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases.
Huntington Disease
Transglutaminases - possible drug targets in human diseases.
Huntington Disease
Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
Huntington Disease
Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.
Huntington Disease
Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois.
Huntington Disease
Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases.
Hydatidiform Mole
Developmental regulation of tissue transglutaminase during human placentation and expression in neoplastic trophoblast.
Hydranencephaly
[Posthemorrhagic hydranencephaly in the fetal period with deficiency of factor XIII (fibrin stabilizing factor)]
Hydrocephalus
[Severe factor XIII-deficiency. Studies on subunits and turnover of the fibrin stabilizing factor (author's transl)]
Hypercholesterolemia
Aspirin resistance.
Hyperglycemia
Celiac crisis presenting with status epilepticus and encephalopathy.
Hyperglycemia
Essential Role of Transglutaminase 2 in Vascular Endothelial Growth Factor-Induced Vascular Leakage in the Retina of Diabetic Mice.
Hyperglycemia
Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice.
Hyperlipidemias
Clinical studies concerning factor XIII; with special reference to hyperlipemia.
Hyperlipidemias
Factor XIII, fibronectin and clot lysis in hyperlipidemia.
Hyperlipidemias
Genetic variants of the hemostatic system and development of transplant coronary artery disease.
Hyperlipoproteinemia Type II
Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia.
Hyperlipoproteinemias
Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia.
Hyperpigmentation
Involvement of Transglutaminase-2 in ?-MSH-Induced Melanogenesis in SK-MEL-2 Human Melanoma Cells.
Hyperpigmentation
Minocycline hyperpigmentation: model for in situ phagocytic activity of factor XIIIa positive dermal dendrocytes.
Hyperprolactinemia
Prolactin and autoimmunity.
Hypersensitivity
Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine.
Hypersensitivity
Associations of breastfeeding with childhood autoimmunity, allergies, and overweight: The Environmental Determinants of Diabetes in the Young (TEDDY) study.
Hypersensitivity
Cow's Milk Protein Allergy Causing Persistent Elevation of Antitissue Transglutaminase Antibodies in a Child With Celiac Disease.
Hypersensitivity
Developments in ocular allergy.
Hypersensitivity
Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation.
Hypersensitivity
Unusual allergen in a butcher with respiratory symptoms.
Hypersplenism
Splenectomy and partial splenectomy improve hematopoietic stem cell engraftment in hypersplenic mice.
Hypertension
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.
Hypertension
Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis.
Hypertension
Cystamine slows but not inverses the progression of monocrotaline-induced pulmonary arterial hypertension in rats.
Hypertension
Henoch-Schönlein purpura with intracerebral hemorrhage.
Hypertension
Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment.
Hypertension
Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families.
Hypertension
Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.
Hypertension
Pharmacological treatment for keloids.
Hypertension
Roles of transglutaminases in cardiac and vascular diseases.
Hypertension
Small Artery Remodeling and Erythrocyte Deformability in L-NAME-Induced Hypertension: Role of Transglutaminases.
Hypertension
Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension.
Hypertension
The redox state of transglutaminase 2 controls arterial remodeling.
Hypertension
Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.
Hypertension
Transglutaminase is a Critical Link Between Inflammation and Hypertension.
Hypertension, Pulmonary
Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
Hypertension, Pulmonary
Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice.
Hypertension, Pulmonary
Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation.
Hypertension, Pulmonary
Transglutaminase 2 in Pulmonary and Cardiac Tissue Remodeling in Experimental Pulmonary Hypertension.
Hypertension, Pulmonary
Transglutaminase 2-mediated serotonylation in pulmonary hypertension.
Hyperthyroidism
Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
Hypertriglyceridemia
Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia.
Hypertriglyceridemia
Hyperlipoproteinemia, hemostatic variables and thromboatherosclerosis.
Hypertrophy, Right Ventricular
Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
Hypoalbuminemia
"Strongyloides stercoralis infestation in a severely malnourished (SAM) celiac disease child:" A rare case report from Western Rajasthan.
Hypoalbuminemia
Celiac Disease and Secondary Amyloidosis: A Possible Causal Association?
Hypoalbuminemia
Celiac Disease as a Rare Cause of Membranous Nephropathy: A Case Report.
Hypocalcemia
Psoriasis in autoimmune polyendocrine syndrome type I: A possible complication or a non-endocrine minor component?
Hypoglycemia
Extrapancreatic action of sulfonylureas: hypoglycemic effects are not dependent on altered insulin binding or inhibition of transglutaminase.
Hypoglycemia
Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient.
Hypogonadism
[Prevalence of polyglandular autoimmune syndrome in patients with diabetes mellitus type 1]
Hypoparathyroidism
Psoriasis in autoimmune polyendocrine syndrome type I: A possible complication or a non-endocrine minor component?
Hypophysitis
[Prevalence of polyglandular autoimmune syndrome in patients with diabetes mellitus type 1]
Hypothyroidism
Frequency of celiac disease in patients with hypothyroidism.
Hypothyroidism
Occurrence of Hypothyroidism, Diabetes Mellitus, and Celiac Disease in Emirati Children with Down's Syndrome.
Hypothyroidism
Polyendocrine syndrome type 3C in a family from Pakistan.
Ichthyosiform Erythroderma, Congenital
Different TGM1 mutation spectra in Italian and Portuguese patients with autosomal recessive congenital ichthyosis: evidence of founder effects in Portugal.
Ichthyosiform Erythroderma, Congenital
Identification of two novel nonsense mutations in the transglutaminase 1 gene in a Hungarian patient with congenital ichthyosiform erythroderma.
Ichthyosiform Erythroderma, Congenital
Knocking-in the R142C mutation in transglutaminase 1 disrupts the stratum corneum barrier and postnatal survival of mice.
Ichthyosiform Erythroderma, Congenital
Novel mutations of TGM1 in a child with congenital ichthyosiform erythroderma.
Ichthyosiform Erythroderma, Congenital
Strong founder effect for a transglutaminase 1 gene mutation in lamellar ichthyosis and congenital ichthyosiform erythroderma from Norway.
Ichthyosiform Erythroderma, Congenital
Structural changes in epidermal scale and appendages as indicators of defective TGM1 activity.
Ichthyosiform Erythroderma, Congenital
The pathogenesis of severe congenital ichthyosis of the neonate.
Ichthyosis
Abnormal transglutaminase 1 expression pattern in a subset of patients with erythrodermic autosomal recessive ichthyosis.
Ichthyosis
Activation of Molecular Signatures for Antimicrobial and Innate Defense Responses in Skin with Transglutaminase 1 Deficiency.
Ichthyosis
Autosomal recessive congenital ichthyosis in Sweden and Estonia: clinical, genetic and ultrastructural findings in eighty-three patients.
Ichthyosis
Bricks and mortar of the epidermal barrier.
Ichthyosis
Characterization of bovine TGM1 and exclusion as candidate gene for ichthyosis in Chianina.
Ichthyosis
Clinical and morphological correlations for transglutaminase 1 gene mutations in autosomal recessive congenital ichthyosis.
Ichthyosis
Comparing histopathology from patients with X-linked recessive ichthyosis and autosomal recessive congenital ichthyosis with transglutaminase 1 mutation: A report from the National Registry for Ichthyosis and Related Skin Disorders.
Ichthyosis
Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1.
Ichthyosis
Epidermal transglutaminase in the ichthyoses.
Ichthyosis
Expression of transglutaminase 5 in normal and pathologic human epidermis.
Ichthyosis
Human stratum corneum proteomics reveals cross-linking of a broad spectrum of proteins in cornified envelopes.
Ichthyosis
Identification and functional characterization of a novel transglutaminase 1 gene mutation associated with autosomal recessive congenital ichthyosis.
Ichthyosis
In vitro and rapid in situ transglutaminase assays for congenital ichthyoses--a comparative study.
Ichthyosis
Knocking-in the R142C mutation in transglutaminase 1 disrupts the stratum corneum barrier and postnatal survival of mice.
Ichthyosis
Multiple local and recent founder effects of TGM1 in Spanish families.
Ichthyosis
Mutations in transglutaminase 1 gene in autosomal recessive congenital ichthyosis in Egyptian families.
Ichthyosis
Novel mutations of the transglutaminase 1 gene in lamellar ichthyosis.
Ichthyosis
Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis.
Ichthyosis
Proteomic Analysis of Loricrin Knockout Mouse Epidermis.
Ichthyosis
The clinical spectrum of congenital ichthyosis in Sweden: a review of 127 cases.
Ichthyosis
Transglutaminase 1 deficiency and corneocyte collapse: an indication for targeted molecular screening in autosomal recessive congenital ichthyosis.
Ichthyosis
Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population.
Ichthyosis
Transglutaminase 1 Replacement Therapy Successfully Mitigates the Autosomal Recessive Congenital Ichthyosis Phenotype in Full-Thickness Skin Disease Equivalents.
Ichthyosis
Transglutaminase 1-deficient recessive lamellar ichthyosis associated with a LINE-1 insertion in Jack Russell terrier dogs.
Ichthyosis
Type I transglutaminase accumulation in the endoplasmic reticulum may be an underlying cause of autosomal recessive congenital ichthyosis.
Ichthyosis
Updated molecular genetics and pathogenesis of ichthiyoses.
Ichthyosis
Visual detection of single-base mismatches in DNA using hairpin oligonucleotide with double-target DNA binding sequences and gold nanoparticles.
Ichthyosis Vulgaris
Expression of transglutaminase 5 in normal and pathologic human epidermis.
Ichthyosis, Lamellar
A Japanese patient with a mild form of lamellar ichthyosis harbouring two missense mutations in the core domain of the transglutaminase 1 gene.
Ichthyosis, Lamellar
A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma.
Ichthyosis, Lamellar
A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation.
Ichthyosis, Lamellar
A novel homozygous mutation 371delA in TGM1 leads to a classic lamellar ichthyosis phenotype.
Ichthyosis, Lamellar
A novel in situ method for the detection of deficient transglutaminase activity in the skin.
Ichthyosis, Lamellar
A three-dimensional model of the human transglutaminase 1: insights into the understanding of lamellar ichthyosis.
Ichthyosis, Lamellar
Abnormal transglutaminase 1 expression pattern in a subset of patients with erythrodermic autosomal recessive ichthyosis.
Ichthyosis, Lamellar
Absent transglutaminase TGK expression in two of three patients with lamellar ichthyosis.
Ichthyosis, Lamellar
al mena: a comprehensive resource of human genetic variants integrating genomes and exomes from Arab, Middle Eastern and North African populations.
Ichthyosis, Lamellar
Altered expression of immunoreactive involucrin in lamellar ichthyosis.
Ichthyosis, Lamellar
Analyses of the transglutaminase 1 gene mutation and ultrastructural characteristics in a Japanese patient with lamellar ichthyosis.
Ichthyosis, Lamellar
Analysis of the cornified cell envelope in lamellar ichthyosis.
Ichthyosis, Lamellar
Assays for transglutaminases in cell death.
Ichthyosis, Lamellar
Autosomal recessive lamellar ichthyosis: identification of a new mutation in transglutaminase 1 and evidence for genetic heterogeneity.
Ichthyosis, Lamellar
Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein.
Ichthyosis, Lamellar
Cholesterol 3-sulfate interferes with cornified envelope assembly by diverting transglutaminase 1 activity from the formation of cross-links and esters to the hydrolysis of glutamine.
Ichthyosis, Lamellar
Clinical and morphological correlations for transglutaminase 1 gene mutations in autosomal recessive congenital ichthyosis.
Ichthyosis, Lamellar
Consequences of seven novel mutations on the expression and structure of keratinocyte transglutaminase.
Ichthyosis, Lamellar
Cross-linked envelopes in nail plate in lamellar ichthyosis.
Ichthyosis, Lamellar
Cuticle cell defects in lamellar ichthyosis hair and anomalous hair shaft syndromes visualized after detergent extraction.
Ichthyosis, Lamellar
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase).
Ichthyosis, Lamellar
Different TGM1 mutation spectra in Italian and Portuguese patients with autosomal recessive congenital ichthyosis: evidence of founder effects in Portugal.
Ichthyosis, Lamellar
Direct cutaneous gene delivery in a human genetic skin disease.
Ichthyosis, Lamellar
Expression of transglutaminase 1 (transglutaminase K) in harlequin ichthyosis.
Ichthyosis, Lamellar
Expression of transglutaminase 5 in normal and pathologic human epidermis.
Ichthyosis, Lamellar
Genetic and immunohistochemical detection of mutations inactivating the keratinocyte transglutaminase in patients with lamellar ichthyosis.
Ichthyosis, Lamellar
Genotype/phenotype correlation in autosomal recessive lamellar ichthyosis.
Ichthyosis, Lamellar
Haplotype association and mutation analysis of the transglutaminase 1 gene for prenatal exclusion of lamellar ichthyosis.
Ichthyosis, Lamellar
Identification and clinical consequences of a novel mutation in the gene for transglutaminase 1 in a patient with lamellar ichthyosis.
Ichthyosis, Lamellar
Identification of mutations in the transglutaminase 1 gene in lamellar ichthyosis.
Ichthyosis, Lamellar
Immunoelectron microscopy links molecules and morphology in the studies of keratinization.
Ichthyosis, Lamellar
Inability of keratinocytes lacking their specific transglutaminase to form cross-linked envelopes: absence of envelopes as a simple diagnostic test for lamellar ichthyosis.
Ichthyosis, Lamellar
Knocking-in the R142C mutation in transglutaminase 1 disrupts the stratum corneum barrier and postnatal survival of mice.
Ichthyosis, Lamellar
Lamellar ichthyosis associated with pseudoainhum of the toes and eye changes.
Ichthyosis, Lamellar
Lamellar ichthyosis is genetically heterogeneous--cases with normal keratinocyte transglutaminase.
Ichthyosis, Lamellar
Lamellar ichthyosis with pseudoexon activation in the transglutaminase 1 gene.
Ichthyosis, Lamellar
Lamellar ichthyosis: response to etretinate with transglutaminase 1 recovery.
Ichthyosis, Lamellar
Long-term faithful recapitulation of transglutaminase 1-deficient lamellar ichthyosis in a skin-humanized mouse model, and insights from proteomic studies.
Ichthyosis, Lamellar
Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis.
Ichthyosis, Lamellar
Mutations of keratinocyte transglutaminase in lamellar ichthyosis.
Ichthyosis, Lamellar
New mutations in the transglutaminase 1 gene in three families with lamellar ichthyosis.
Ichthyosis, Lamellar
Novel mutations of TGM1 in a child with congenital ichthyosiform erythroderma.
Ichthyosis, Lamellar
Novel mutations of the transglutaminase 1 gene in lamellar ichthyosis.
Ichthyosis, Lamellar
Novel transglutaminase 1 gene mutations (R348X/Y365D) in a Japanese family with lamellar ichthyosis.
Ichthyosis, Lamellar
Novel transglutaminase 1 mutations in a Chinese patient with severe lamellar ichthyosis phenotype.
Ichthyosis, Lamellar
Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis.
Ichthyosis, Lamellar
Prenatal diagnosis of lamellar ichthyosis by direct mutational analysis of the keratinocyte transglutaminase gene.
Ichthyosis, Lamellar
Prenatal exclusion of lamellar ichthyosis based on identification of two new mutations in the transglutaminase 1 gene.
Ichthyosis, Lamellar
Role of Sp1 response element in transcription of the human transglutaminase 1 gene.
Ichthyosis, Lamellar
Strong founder effect for a transglutaminase 1 gene mutation in lamellar ichthyosis and congenital ichthyosiform erythroderma from Norway.
Ichthyosis, Lamellar
Structural changes in epidermal scale and appendages as indicators of defective TGM1 activity.
Ichthyosis, Lamellar
The clinical spectrum of congenital ichthyosis in Sweden: a review of 127 cases.
Ichthyosis, Lamellar
The eta isoform of protein kinase C mediates transcriptional activation of the human transglutaminase 1 gene.
Ichthyosis, Lamellar
The genetics of human skin diseases.
Ichthyosis, Lamellar
The South African "bathing suit ichthyosis" is a form of lamellar ichthyosis caused by a homozygous missense mutation, p.R315L, in transglutaminase 1.
Ichthyosis, Lamellar
Three novel point mutations in the keratinocyte transglutaminase (TGK) gene in lamellar ichthyosis: significance for mutant transcript level, TGK immunodetection and activity.
Ichthyosis, Lamellar
Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes.
Ichthyosis, Lamellar
Transglutaminase 1 expression in a patient with features of harlequin ichthyosis: case report.
Ichthyosis, Lamellar
Transglutaminase 1 gene mutations in Italian patients with autosomal recessive lamellar ichthyosis.
Ichthyosis, Lamellar
Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing.
Ichthyosis, Lamellar
Transglutaminase 1-deficient recessive lamellar ichthyosis associated with a LINE-1 insertion in Jack Russell terrier dogs.
Ichthyosis, Lamellar
Transglutaminase diseases: from biochemistry to the bedside.
Idiopathic Pulmonary Fibrosis
Transglutaminase 2 and its Role in Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis
Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors.
IgA Deficiency
A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency.
IgA Deficiency
AGA Clinical Practice Update on the Evaluation and Management of Seronegative Enteropathies.
IgA Deficiency
CD69 expression on alpha-gliadin-specific T cells in coeliac disease.
IgA Deficiency
Celiac disease in Tunisian children: a second screening study using a "new generation" rapid test.
IgA Deficiency
Clinical presentation of celiac disease and the diagnostic accuracy of serologic markers in children.
IgA Deficiency
Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease.
IgA Deficiency
Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency.
IgA Deficiency
Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.
IgA Deficiency
High density of intraepithelial gammadelta lymphocytes and deposits of immunoglobulin (Ig)M anti-tissue transglutaminase antibodies in the jejunum of coeliac patients with IgA deficiency.
IgA Deficiency
Human tissue transglutaminase enzyme linked immunosorbent assay outperforms both the guinea pig based tissue transglutaminase assay and anti-endomysium antibodies when screening for coeliac disease.
IgA Deficiency
IgA-antitissue transglutaminase: validation of a commercial assay for diagnosing coeliac disease.
IgA Deficiency
IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue.
IgA Deficiency
Prevalence and Natural History of Potential Celiac Disease in At-Family-Risk Infants Prospectively Investigated from Birth.
IgA Deficiency
Prevalence of Celiac disease in Turkish children with type 1 diabetes mellitus and their non-diabetic first-degree relatives.
IgA Deficiency
Serologic and Genetic Markers of Celiac Disease: A Sequential Study in the Screening of First Degree Relatives.
IgA Deficiency
Serologic testing for celiac disease in young people with elevated transaminases.
IgA Deficiency
Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays.
IgA Deficiency
The prevalence of celiac disease in children and adolescents in Germany.
IgA Deficiency
The prevalence of coeliac disease in Libyan children with type 1 diabetes mellitus.
IgA Deficiency
Tissue transglutaminase antibody levels predict IgA deficiency.
IgA Deficiency
Undetectable anti-tissue transglutaminase IgA antibody measured with EliA Celikey indicates selective IgA deficiency.
IgA Deficiency
Use of low concentrations of human IgA anti-tissue transglutaminase to rule out selective IgA deficiency in patients with suspected celiac disease.
IgA Vasculitis
Atypical tumour-like involvement of the colon in Henoch-Schonlein purpura successfully treated with the administration of factor XIII.
IgA Vasculitis
Decreased factor XIII activity during severe Henoch-Schoenlein purpura -- does it play a role?
IgA Vasculitis
Factor XIII as a potential predictor of severe gastrointestinal involvement in Henoch Schoenlein purpura: A case study research.
IgA Vasculitis
Severe gastrointestinal vasculitis in Henoch-Schoenlein purpura: pathophysiologic mechanisms, the diagnostic value of factor XIII, and therapeutic options.
IgA Vasculitis
Successful Treatment of IgA Vasculitis Complicated with Bowel Perforation and Crescentic Glomerulonephritis by Combination Therapy of Glucocorticoid, Cyclosporine and Factor XIII Replacement.
IgA Vasculitis
Successful treatment of severe gastrointestinal manifestations of Henoch-Schonlein Purpura and factor XIII deficiency using cryoprecipitate transfusion.
IgA Vasculitis
Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
IgA Vasculitis
von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura.
IgA Vasculitis
[Factor XIII substitution in Henoch-Schoenlein purpura with severe gastro-intestinal symptoms]
IgA Vasculitis
[Stenosing ureteritis and factor XIII deficiency in anaphylactoid purpura]
Immune System Diseases
Intraepithelial lymphocytes in celiac disease immunopathology.
Immunoproliferative Small Intestinal Disease
Low serum transglutaminase in patients with intestinal lymphoma and alpha-chain disease.
Infant, Newborn, Diseases
Studies on the ontogeny and significance in neonatal disease of the fibrinolysin system and of fibrin stabilizing factor.
Infarction, Middle Cerebral Artery
Increased expression of tissue-type transglutaminase following middle cerebral artery occlusion in rats.
Infections
A Cell Proliferation and Inflammatory Signature Is Induced by Lawsonia intracellularis Infection in Swine.
Infections
A prawn transglutaminase: Molecular characterization and biochemical properties.
Infections
Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals.
Infections
Analysis of Litopenaeus vannamei hemocyanin interacting proteins reveals its role in hemolymph clotting.
Infections
AP-1/Fos-TGase2 axis mediates wounding-induced Plasmodium falciparum killing in Anopheles gambiae.
Infections
CD1a and factor XIIIa immunohistochemistry in leprosy: a possible role of dendritic cells in the pathogenesis of Mycobacterium leprae infection.
Infections
cDNA cloning, identification, tissue localisation, and transcription profile of a transglutaminase from white shrimp, Litopenaeus vannamei, after infection by Vibrio alginolyticus.
Infections
Contribution of tissue transglutaminase to the severity of hepatic fibrosis resulting from Schistosoma japonicum infection through the regulation of IL-33/ST2 expression.
Infections
Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.
Infections
Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis.
Infections
Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control.
Infections
Factor XIIIa expression in granulomatous lesions due to sarcoidosis or mycobacterial infection.
Infections
Fibroblastic reticular cell infection by hemorrhagic fever viruses.
Infections
Functional and Structural Characterization of the Antiphagocytic Properties of a Novel Transglutaminase from Streptococcus suis.
Infections
Gene expression in the chicken caecum in response to infections with non-typhoid Salmonella.
Infections
Gene expression profiling in Salmonella Choleraesuis-infected porcine lung using a long oligonucleotide microarray.
Infections
Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype.
Infections
Identification and cloning of a transglutaminase from giant freshwater prawn, Macrobrachium rosenbergii, and its transcription during pathogen infection and moulting.
Infections
Identification and cloning of the second type transglutaminase from Litopenaeus vannamei, and its transcription following pathogen infection and in relation to the haemolymph coagulation.
Infections
Identification of genes expressed in response to yellow head virus infection in the black tiger shrimp, Penaeus monodon, by suppression subtractive hybridization.
Infections
Increase of a calcium independent transglutaminase activity in the erythrocyte during the infection with Plasmodium falciparum.
Infections
Involvement of IL-13 and tissue transglutaminase in liver granuloma and fibrosis after schistosoma japonicum infection.
Infections
Local activation of coagulation factor XIII reduces systemic complications and improves the survival of mice after Streptococcus pyogenes M1 skin infection.
Infections
Multineuropathy in a patient with HBV infection, polyarteritis nodosa and celiac disease.
Infections
Parechovirus Infection in Early Childhood and Association With Subsequent Celiac Disease.
Infections
Pharmaceutical approval update.
Infections
Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis.
Infections
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman--reply.
Infections
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman.
Infections
Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen.
Infections
Rapid activation of protein tyrosine kinase and phospholipase C-gamma2 and increase in cytosolic free calcium are required by Ehrlichia chaffeensis for internalization and growth in THP-1 cells.
Infections
Scientifically advanced solutions for chestnut ink disease.
Infections
SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation.
Infections
The effect of banana (Musa acuminata) peels hot-water extract on the immunity and resistance of giant freshwater prawn, Macrobrachium rosenbergii via dietary administration for a long term: Activity and gene transcription.
Infections
The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes.
Infections
Tissue transglutaminase activity in human gastric mucosa according to Helicobacter pylori infection.
Infections
Tissue Transglutaminase Elevates Intraocular Pressure in Mice.
Infections
Tissue transglutaminase in HCV infection.
Infections
Transglutaminase as a target for novel anti-filarial agents.
Infections
Transglutaminase Cross-Linked Gelatin-Alginate-Antibacterial Hydrogel as the Drug Delivery-Coatings for Implant-Related Infections.
Infections
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection.
Infections
Treatment of giardiasis reverses "active" coeliac disease to "latent" coeliac disease.
Infertility
Celiac Disease and Gyneco-obstetrics Complications: Can Serum Antibodies Modulate Tissue Transglutaminase Functions and Contribute to Clinical Pattern?
Infertility
Coeliac disease and reproductive disorders.
Infertility
Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
Infertility
Fertility disorder associated with celiac disease in males and females: fact or fiction?
Infertility
Prevalence of celiac disease in a cohort of women with unexplained infertility.
Infertility
Requirement for transglutaminase in progesterone-induced decidualization of human endometrial stromal cells.
Infertility
The role of fibrin matrices and tissue factor in early-term trophoblast proliferation and spreading.
Infertility, Male
The prostate-specific protein, transglutaminase 4 (TG4), is an autoantigen associated with male subfertility.
Infertility, Male
Transglutaminase 4 as a prostate autoantigen in male subfertility.
Inflammatory Bowel Diseases
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence.
Inflammatory Bowel Diseases
Anti-tissue transglutaminase in inflammatory bowel diseases: An activity disease-related phenomenon?
Inflammatory Bowel Diseases
Arg506Gln factor V mutation and Val34Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease.
Inflammatory Bowel Diseases
Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease.
Inflammatory Bowel Diseases
Celiac Disease: From Pathogenesis to Novel Therapies.
Inflammatory Bowel Diseases
Chronic Diarrhea in Adults: Evaluation and Differential Diagnosis.
Inflammatory Bowel Diseases
Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease.
Inflammatory Bowel Diseases
Differential behavior of coagulation factor XIII in patients with inflammatory bowel disease and in patients with giant cell arteritis.
Inflammatory Bowel Diseases
Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut.
Inflammatory Bowel Diseases
Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease.
Inflammatory Bowel Diseases
Factor XIII in chronic inflammatory bowel diseases.
Inflammatory Bowel Diseases
Factor XIII modulates intestinal epithelial wound healing in vitro.
Inflammatory Bowel Diseases
Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease.
Inflammatory Bowel Diseases
Food Processing, Dysbiosis, Gastrointestinal Inflammatory Diseases, and Antiangiogenic Functional Foods or Beverages.
Inflammatory Bowel Diseases
How autophagy controls the intestinal epithelial barrier.
Inflammatory Bowel Diseases
Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease.
Inflammatory Bowel Diseases
IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis.
Inflammatory Bowel Diseases
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Inflammatory Bowel Diseases
Mucosal capillary thrombi in rectal biopsies.
Inflammatory Bowel Diseases
Reduced levels of factor XIII in patients with chronic inflammatory bowel disease.
Inflammatory Bowel Diseases
Serum and tissue transglutaminase correlates with the severity of inflammation in induced colitis in the rat.
Inflammatory Bowel Diseases
Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis.
Inflammatory Bowel Diseases
Serum transglutaminase in inflammatory bowel diseases.
Inflammatory Bowel Diseases
The association between de novo inflammatory bowel disease and celiac disease.
Inflammatory Bowel Diseases
Transglutaminases in Crohn's disease.
Inflammatory Bowel Diseases
Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease.
Inflammatory Bowel Diseases
[A-subunit, b-subunit and a2b2-complex of coagulation factor XIII in inflammatory bowel disease]
Influenza, Human
[The role of influenza virus hemagglutinin in blood anticoagulation processes]
Insulin Resistance
Coagulation factor XIII and atherothrombosis. A mini-review.
Insulin Resistance
Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.
Insulin Resistance
Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet.
Insulin Resistance
Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease.
Insulin Resistance
Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling.
Insulinoma
Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes.
Insulinoma
Inherent ER stress in pancreatic islet ? cells causes self-recognition by autoreactive T cells in type 1 diabetes.
Insulinoma
Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes.
Insulinoma
Organ-specific autoimmunity in relation to clinical characteristics in children with long-lasting type 1 diabetes.
Insulinoma
Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes.
Intellectual Disability
Is Celiac Disease an Etiological Factor in Children with Nonsyndromic Intellectual Disability?
Intestinal Diseases
Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis.
Intestinal Diseases
Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Intestinal Diseases
Presence of anti-"tissue" transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event?
Intestinal Diseases
[Autoimmune reactions in gastrointestinal diseases]
Intestinal Volvulus
Transglutaminase-catalyzed reaction is important for molting of Onchocerca volvulus third-stage larvae.
Intracranial Aneurysm
Effects of blood coagulation factor XIII on the development of experimental cerebral aneurysms in rats.
Intracranial Hemorrhages
Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency.
Intracranial Hemorrhages
Association of a common polymorphism in the factor XIII gene with venous thrombosis.
Intracranial Hemorrhages
Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature.
Intracranial Hemorrhages
Blood coagulation findings and the efficacy of factor XIII concentrate in premature infants with intracranial hemorrhages.
Intracranial Hemorrhages
Choroid Plexus Papilloma and Factor XIII Deficiency: Case Report.
Intracranial Hemorrhages
Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect.
Intracranial Hemorrhages
Corifact/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
Intracranial Hemorrhages
Dental Management of Factor XIII Deficiency Patients: A Case Series.
Intracranial Hemorrhages
Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage.
Intracranial Hemorrhages
Factor XIII deficiency and intracranial hemorrhages in infancy.
Intracranial Hemorrhages
Factor XIII deficiency: a differential diagnosis to be considered in suspected nonaccidental injury presenting with intracranial hemorrhage.
Intracranial Hemorrhages
Factor XIII deficiency: report of two cases.
Intracranial Hemorrhages
Hemorrhagic Shock after Neonatal Circumcision: Severe Congenital Factor XIII Deficiency.
Intracranial Hemorrhages
Intracranial hemorrhage in congenital bleeding disorders.
Intracranial Hemorrhages
Intracranial hemorrhage in congenital deficiency of factor XIII.
Intracranial Hemorrhages
Intracranial hemorrhage pattern in the patients with factor XIII deficiency.
Intracranial Hemorrhages
Intracranial Hemorrhage: A Devastating Outcome of Congenital Bleeding Disorders-Prevalence, Diagnosis, and Management, with a Special Focus on Congenital Factor XIII Deficiency.
Intracranial Hemorrhages
New developments in the management of congenital Factor XIII deficiency.
Intracranial Hemorrhages
Novel Factor XIII variant identified through whole-genome sequencing in a child with intracranial hemorrhage.
Intracranial Hemorrhages
Prevention of postoperative intracerebral hemorrhage with topical recombinant factor XIII in the rat.
Intracranial Hemorrhages
Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.
Intracranial Hemorrhages
Spontaneous Acute Cerebral Hematoma in a Child with Factor XIII Deficiency.
Intracranial Hemorrhages
[3 operated cases of congenital deficiency of Factor XIII associated with intracranial hematomas]
Intracranial Hemorrhages
[Factor XIII deficiency in a newborn]
Intracranial Hypotension
Evaluation of spontaneous intracranial hypotension: assessment on ICP monitoring and radiological imaging.
Intracranial Hypotension
Impact of low coagulation factor XIII activity in patients with chronic subdural hematoma associated with cerebrospinal fluid hypovolemia: A retrospective study.
Intracranial Hypotension
Treatment of spontaneous intracranial hypotension with intravenous Factor XIII administration: initial clinical experience.
Intracranial Thrombosis
Cerebral thrombosis associated with heterozygous factor V Leiden mutation and high lipoprotein(a) level in a girl with factor XIII deficiency.
Iron Deficiencies
Celiac Disease: Ten Things That Every Gastroenterologist Should Know.
Iron Deficiencies
Diagnosis and treatment of unexplained anemia with iron deficiency without overt bleeding.
Iron Deficiencies
Hemoglobin types, erythrocyte membrane skeleton and plasma iron concentration in calves with poikilocytosis.
Iron Deficiencies
Recurrent Fever and Failure to Thrive in an 11-Year-Old Boy.
Iron Overload
DNA-array of gene variants in venous leg ulcers: detection of prognostic indicators.
Irritable Bowel Syndrome
Coeliac disease.
Irritable Bowel Syndrome
Presence of tissue transglutaminase IgA antibody as a celiac disease marker in a sample of patients with irritable bowel syndrome.
Irritable Bowel Syndrome
Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis.
Irritable Bowel Syndrome
The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.
Ischemic Stroke
Celiac disease and childhood stroke.
Ischemic Stroke
Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: a pilot study.
Ischemic Stroke
Coagulation factor XIII B subunit antigen, FXIIIVal34Leu genotype and ischaemic stroke in South Asians.
Ischemic Stroke
Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke.
Ischemic Stroke
Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.
Ischemic Stroke
Common genetic coagulation variants are not associated with ischemic stroke in a casecontrol study.
Ischemic Stroke
Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, ?-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.
Ischemic Stroke
Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.
Ischemic Stroke
Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke.
Ischemic Stroke
Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale.
Ischemic Stroke
Genetic Factors Influencing Coagulation Factor XIII B-Subunit Contribute to Risk of Ischemic Stroke.
Ischemic Stroke
Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.
Ischemic Stroke
Mass spectrometric phenotyping of Val34Leu polymorphism of blood coagulation factor XIII by differential peptide display.
Ischemic Stroke
Predictive value of coagulation factor XIII on bleeding risk in ischemic stroke patients treated with intravenous thrombolysis.
Ischemic Stroke
Transglutaminase 2 protects against ischemic stroke.
Joint Diseases
Arthropathy associated with factor XIII deficiency.
Joint Diseases
[Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies]
Joint Instability
Prevalence of celiac disease in children with joint hypermobility.
Keloid
A study of factor XIIIa and MAC 387 immunolabeling in normal and pathological skin.
Keloid
Clinical and laboratory features of congenital factor XIII deficiency.
Keloid
Factor XIIIa-positive dermal dendritic cells in keloids and hypertrophic and mature scars.
Keratosis
An immunohistochemical and histochemical study of cytokeratin, involucrin and transglutaminase in seborrhoeic keratosis.
Keratosis, Actinic
Does imiquimod histologically rejuvenate ultraviolet radiation-damaged skin?
Kidney Failure, Chronic
Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
Kidney Failure, Chronic
Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
Kidney Failure, Chronic
Plasma factor XIII levels in children with renal disease.
Kidney Neoplasms
CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
Kidney Neoplasms
Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitors.
Leg Ulcer
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
Leg Ulcer
Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers.
Leg Ulcer
Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers.
Leg Ulcer
Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers.
Leg Ulcer
Topical treatment of venous ulcer with fibrin stabilizing factor: experimental investigation of effects on vascular permeability.
Leg Ulcer
Treatment of nonhealing leg ulcers with fibrin-stabilizing factor XIII: a case report.
Leiomyoma
Fibrin stabilizing factor activity of the skin carcinoma.
Leiomyoma
Roles of plasma proteins in the formation of silicotic nodules in rats.
Leiomyoma
[Molecular mechanisms of two novel mutations of factor XIII gene resulting in hereditary coagulation deficiency]
Leiomyosarcoma
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract.
Leishmaniasis, Visceral
Deficiency of fibrin stabilizing factor (FSF) in kala-azar.
Lentigo
Alterations in the epidermal-dermal melanin axis and factor XIIIa melanophages in senile lentigo and ageing skin.
Leprosy
CD1a and factor XIIIa immunohistochemistry in leprosy: a possible role of dendritic cells in the pathogenesis of Mycobacterium leprae infection.
Leukemia
A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII.
Leukemia
A contribution to the pathology of acquired plasma factor XIII deficiency.
Leukemia
Acquired factor XIII deficiency in a child with pure erythroid leukemia.
Leukemia
Acquired factor XIII deficiency with chronic myelomonocytic leukemia.
Leukemia
Acute megakaryoblastic leukemia with erythrophagocytosis and thrombosis in a dog.
Leukemia
Analysis of catalytic action of transglutaminase induced in human promyelocytic leukemia (HL-60) and human hepatoblastoma (HepG2) cells.
Leukemia
Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2.
Leukemia
Defective fibrin crosslinking in acute leukemia.
Leukemia
Differentiation of U937 myelomonocytic cell line by all-trans retinoic acid and 1,25-dihydroxyvitamin D3: synergistic effects on tissue transglutaminase.
Leukemia
Disturbances of desmofibrinogenesis in pateints suffering from acute myeloblastic leukemia.
Leukemia
Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia.
Leukemia
Expression of tissue transglutaminase in cultured monocytic leukemia (THP-1) cells during differentiation.
Leukemia
Factor XIII Subunit A Immunohistochemical Expression is Associated With Inferior Outcomes in Acute Promyelocytic Leukemia.
Leukemia
Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO.
Leukemia
Immunocytochemical detection of factor XIII A--subunit in acute leukemia.
Leukemia
Plasma levels of human granulocytic elastase alpha 1-proteinase inhibitor complex (E-alpha 1-PI) in leukemia.
Leukemia
Regulation of tissue transglutaminase gene expression as a molecular model for retinoid effects on proliferation and differentiation.
Leukemia
Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells.
Leukemia
Retinoic acid-induced gene expression in normal and leukemic myeloid cells.
Leukemia
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
Leukemia
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
Leukemia
Tissue transglutaminase contributes to the all-trans retinoic acid induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia.
Leukemia
Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins alpha 9beta 1 and alpha 4beta 1.
Leukemia
Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-kB activation.
Leukemia
Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation.
Leukemia
[A study of oral mucosal ulcers in leukemia patients (changes in plasma coagulation factor XIII levels]
Leukemia
[Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)]
Leukemia
[Detection of factor XIII deficiency in acute leukemia with resonance thrombography]
Leukemia
[Etiology of factor XIII, factor V and fibrinogen deficiency in acute leukemias]
Leukemia
[Factor XIII deficiency in adults with acute leukemia: results of a substitution therapy with factor XIII (author's transl)]
Leukemia
[Factor XIII deficiency in various patients with acute leukemia]
Leukemia
[Molecular markers of the oral mucosa damage in patients with leukemia.]
Leukemia
[Substitution with blood coagulation factor XIII concentrates in patients with acute leukemia]
Leukemia, Erythroblastic, Acute
A retinoic acid-inducible mRNA from human erythroleukemia cells encodes a novel tissue transglutaminase homologue.
Leukemia, Erythroblastic, Acute
A third human tissue transglutaminase homologue as a result of alternative gene transcripts.
Leukemia, Erythroblastic, Acute
Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.
Leukemia, Erythroblastic, Acute
Differential expression of transglutaminase in human erythroleukemia cells in response to retinoic acid.
Leukemia, Erythroblastic, Acute
Dimethyl sulfoxide-induced transglutaminase activity in murine-derived Friend erythroleukemia cells.
Leukemia, Erythroblastic, Acute
Induction and translocation of tissue transglutaminase isoforms increased phosphorylation in retinoic Acid treated erythroleukemia cells.
Leukemia, Erythroblastic, Acute
Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells.
Leukemia, Lymphocytic, Chronic, B-Cell
Alterations in ornithine decarboxylase and transglutaminase activities in lymphocytes from untreated patients with chronic lymphocytic leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Disialoganglioside GD3 synthase expression recruits membrane transglutaminase 2 during erythroid differentiation of the human chronic myelogenous leukemia K562 cells.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Induction of GD3/?1-adrenergic receptor/transglutaminase 2-mediated erythroid differentiation in chronic myelogenous leukemic K562 cells.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway.
Leukemia, Myeloid
Characteristics of cyclic AMP enhancement of retinoic acid induction of increased transglutaminase activity in HL60 cells.
Leukemia, Myeloid
Modulation of transglutaminase activity in mononuclear phagocytes and macrophage-like tumor cell lines by differentiation agents.
Leukemia, Myeloid
Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells.
Leukemia, Myeloid, Acute
Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias.
Leukemia, Myeloid, Acute
Disturbances of desmofibrinogenesis in pateints suffering from acute myeloblastic leukemia.
Leukemia, Myeloid, Acute
High Expression of AHSP, EPB42, GYPC and HEMGN Predicts Favorable Prognosis in FLT3-ITD-Negative Acute Myeloid Leukemia.
Leukemia, Myeloid, Acute
Transglutaminase 2 expression in acute myeloid leukemia: association with adhesion molecule expression and leukemic blast motility.
Leukemia, Myelomonocytic, Chronic
Acquired factor XIII deficiency with chronic myelomonocytic leukemia.
Leukemia, Promyelocytic, Acute
Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2.
Leukemia, Promyelocytic, Acute
Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia.
Leukemia, Promyelocytic, Acute
Factor XIII Subunit A Immunohistochemical Expression is Associated With Inferior Outcomes in Acute Promyelocytic Leukemia.
Leukemia, Promyelocytic, Acute
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
Leukemia, Promyelocytic, Acute
Tissue transglutaminase contributes to the all-trans retinoic acid induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia.
Leukemia, Promyelocytic, Acute
Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-kB activation.
Leukemia, Promyelocytic, Acute
[Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)]
Leukoencephalopathies
The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
Leukoplakia
Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia.
Leukoplakia
The hamster cheek pouch carcinogenesis model.
Leukoplakia, Oral
Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Lichen Planus
Abnormal Bcl-2 and "tissue" transglutaminase expression in psoriatic skin.
Lichen Planus
Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
Lichen Planus
Lymphocyte and macrophage subsets in active and inactive lesions of lichen planus.
Lichen Planus
Reduced expression of programmed cell death 1 and programmed cell death ligand 1 in infiltrating inflammatory cells of lichen planus without administration of immune checkpoint inhibitors.
Lichen Planus, Oral
Ectopic transglutaminase 1 and 3 expression accelerating keratinization in oral lichen planus.
Liver Cirrhosis
A contribution to the pathology of acquired plasma factor XIII deficiency.
Liver Cirrhosis
Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism.
Liver Cirrhosis
Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.
Liver Cirrhosis
Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
Liver Cirrhosis
Contribution of tissue transglutaminase to the severity of hepatic fibrosis resulting from Schistosoma japonicum infection through the regulation of IL-33/ST2 expression.
Liver Cirrhosis
Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase.
Liver Cirrhosis
Effects of Fructus Piperis Longi extract on fibrotic liver of gamma-irradiated rats.
Liver Cirrhosis
Expression of cytosolic and membrane associated tissue transglutaminase in rat hepatic stellate cells and its upregulation during transdifferentiation to myofibroblasts in culture.
Liver Cirrhosis
Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C.
Liver Cirrhosis
Factor XIII Val34Leu mutation and liver fibrosis rate in viral hepatitis.
Liver Cirrhosis
False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent.
Liver Cirrhosis
Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis.
Liver Cirrhosis
Fibrin stabilizing factor (factor XIII) activity in liver cirrhosis.
Liver Cirrhosis
Garlic extract attenuating rat liver fibrosis by inhibiting TGF-?1.
Liver Cirrhosis
Garlic extract prevents CCl(4)-induced liver fibrosis in rats: The role of tissue transglutaminase.
Liver Cirrhosis
Hepatic encephalopathy is linked to alterations of autophagic flux in astrocytes.
Liver Cirrhosis
Impaired proteolysis of collagen I inhibits proliferation of hepatic stellate cells: implications for regulation of liver fibrosis.
Liver Cirrhosis
Positive Feedback Regulation between Transglutaminase 2 and Toll-Like Receptor 4 Signaling in Hepatic Stellate Cells Correlates with Liver Fibrosis Post
Liver Cirrhosis
Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion.
Liver Cirrhosis
Rotational thromboelastometry can detect factor XIII deficiency and bleeding diathesis in patients with liver cirrhosis.
Liver Cirrhosis
Structure of fibrin and fibrinmonomer in renal and hepatic failure.
Liver Cirrhosis
Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis.
Liver Cirrhosis
Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in Mice.
Liver Cirrhosis
Tissue Transglutaminase-Regulated Transformed Growth Factor-?1 in the Parasite Links Schistosoma japonicum Infection with Liver Fibrosis.
Liver Cirrhosis
[Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)]
Liver Cirrhosis, Biliary
Celiac disease in autoimmune cholestatic liver disorders.
Liver Cirrhosis, Biliary
IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete.
Liver Cirrhosis, Biliary
[Autoimmune reactions in gastrointestinal diseases]
Liver Diseases
Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?
Liver Diseases
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection.
Liver Diseases
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation.
Liver Diseases
Celiac sprue: another autoimmune syndrome associated with hepatitis C.
Liver Diseases
Chronic Hepatitis Due to Gluten Enteropathy - a Case Report.
Liver Diseases
Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
Liver Diseases
Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis.
Liver Diseases
Coeliac disease and the liver: spectrum of liver histology, serology and treatment response at a tertiary referral centre.
Liver Diseases
Discordance Between Serology and Histology for Celiac Disease in a Cohort with Coexisting Liver Disorders.
Liver Diseases
Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease.
Liver Diseases
High Rate of Positive Anti-Tissue Transglutaminase Antibodies in Chronic Liver Disease.
Liver Diseases
High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source.
Liver Diseases
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Liver Diseases
Involvement of IL-13 and tissue transglutaminase in liver granuloma and fibrosis after schistosoma japonicum infection.
Liver Diseases
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2.
Liver Diseases
Prevalence and clinical significance of IgA anti tissue transglutaminase antibodies in patients with chronic liver disease.
Liver Diseases
Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases.
Liver Diseases
Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete.
Liver Diseases
Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen.
Liver Diseases
Regulation of transglutaminase-mediated hepatic cell death in alcoholic steatohepatitis and non-alcoholic steatohepatitis.
Liver Diseases
Rotational thromboelastometry can detect factor XIII deficiency and bleeding diathesis in patients with liver cirrhosis.
Liver Diseases
Searching for coeliac disease in patients with non-alcoholic fatty liver disease.
Liver Diseases
Systematic review: the liver in coeliac disease.
Liver Diseases
The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury.
Liver Diseases
Thromboelastometry Identified Alteration of Clot Stabilization and Factor XIII Supplementation Need in a Patient with Decompensated Liver Disease Undergoing Liver Biopsy.
Liver Diseases
Tissue transglutaminase, a key enzyme involved in liver diseases.
Liver Diseases
Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver.
Liver Diseases
[BEHAVIOR OF FIBRIN STABILIZING FACTOR IN LIVER DISEASES.]
Liver Diseases
[Is the use of factor XIII for delayed wound healing in patients with head-neck tumors of value?]
Liver Diseases
[Summary of work session 1: Blood coagulation in gastroenterology]
Liver Diseases, Alcoholic
Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis.
Liver Diseases, Alcoholic
[Immunohistochemical study of the distribution of collagens (type I, III, IV), fibronectin, factor XIIIa and factor VIII related antigen in alcoholic liver disease]
Liver Failure, Acute
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Liver Neoplasms
Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma.
Liver Neoplasms
Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Liver Neoplasms, Experimental
Differential transglutaminase distribution in normal rat liver and rat hepatoma.
Lung Injury
Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice.
Lung Injury
Role of crosslinked protein in lung injury following total body irradiation and bone marrow transplantation.
Lung Neoplasms
Alterations of the Platelet Proteome in Lung Cancer: Accelerated F13A1 and ER Processing as New Actors in Hypercoagulability.
Lung Neoplasms
Association between TGM5, PPAP2B and PSMA4 polymorphisms and NSCLC in never-smoking Chinese population.
Lung Neoplasms
Clinical value of exogenous factor XIII for prolonged air leak following pulmonary lobectomy: a case control study.
Lung Neoplasms
Dynamics of coagulation factor XIII activity after video-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Lung Neoplasms
Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells.
Lung Neoplasms
Ethacrynic Acid Inhibits Sphingosylphosphorylcholine-Induced Keratin 8 Phosphorylation and Reorganization via Transglutaminase-2 Inhibition.
Lung Neoplasms
Hydrogen peroxide mediates doxorubicin-induced transglutaminase 2 expression in PC-14 human lung cancer cell line.
Lung Neoplasms
In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer.
Lung Neoplasms
Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5.
Lung Neoplasms
Nuclear Transglutaminase 2 interacts with topoisomerase II? to promote DNA damage repair in lung cancer cells.
Lung Neoplasms
Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.
Lung Neoplasms
Ras association domain family 1C protein stimulates human lung cancer cell proliferation.
Lung Neoplasms
Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line.
Lung Neoplasms
Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer.
Lung Neoplasms
Tissue transglutaminase 2 expression is epigenetically regulated in human lung cancer cells and prevents reactive oxygen species-induced apoptosis.
Lung Neoplasms
Transglutaminase 2 activity promotes membrane resealing after mechanical damage in the lung cancer cell line A549.
Lung Neoplasms
Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.
Lung Neoplasms
Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.
Lung Neoplasms
Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor.
Lung Neoplasms
Transglutaminase 2 Promotes Migration and Invasion of Lung Cancer Cells.
Lung Neoplasms
Transglutaminase-2 induces N-cadherin expression in TGF-?1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Lung Neoplasms
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells.
Lupus Erythematosus, Systemic
Adult celiac disease followed by onset of systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients.
Lupus Erythematosus, Systemic
TG or not TG: IgG-anti-tissue transglutaminase in systemic lupus erythematosus: new role for an old enzyme.
Lupus Erythematosus, Systemic
Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure.
Lupus Erythematosus, Systemic
[Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus].
Lymphadenopathy
Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy.
Lymphangioleiomyomatosis
Successful factor XIII administration for persistent chylothorax after lung transplantation for lymphangioleiomyomatosis.
Lymphangioleiomyomatosis
Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy.
Lymphocytosis
[An analysis of clinical features of celiac disease patients in different ethnic].
Lymphoma
Acquired Factor XIII inhibitor associated with mantle cell lymphoma.
Lymphoma
Calcifying fibrous tumor of the adrenal gland.
Lymphoma
Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities.
Lymphoma
Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions.
Lymphoma
Localization of collagen modifying enzymes on fibroblastic reticular cells and follicular dendritic cells in non-neoplastic and neoplastic lymphoid tissues.
Lymphoma
Low serum transglutaminase in patients with intestinal lymphoma and alpha-chain disease.
Lymphoma
Multiple calcifying fibrous tumors of the pleura.
Lymphoma
Pulmonary "inflammatory myofibroblastic" tumors: a critical examination of the diagnostic category based on quantitative immunohistochemical analysis.
Lymphoma
TG2 and NF-kB signaling coordinates the survival of mantle cell lymphoma cells via IL-6-mediated autophagy.
Lymphoma, Follicular
Localization of collagen modifying enzymes on fibroblastic reticular cells and follicular dendritic cells in non-neoplastic and neoplastic lymphoid tissues.
Lymphoma, Mantle-Cell
Acquired Factor XIII inhibitor associated with mantle cell lymphoma.
Lymphoma, Mantle-Cell
Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities.
Lymphoma, Mantle-Cell
TG2 and NF-kB signaling coordinates the survival of mantle cell lymphoma cells via IL-6-mediated autophagy.
Lymphoma, Non-Hodgkin
Granulomatous reaction in mediastinal B-cell non-Hodgkin lymphoma and intracardiac thrombosis.
Lymphoma, Non-Hodgkin
Tissue transglutaminase autoantibodies in patients with non-Hodgkin's lymphoma. Case reports.
Lymphoma, T-Cell
IgA Antibodies Against Gliadin and Tissue Transglutaminase in Dogs With Chronic Enteritis and Intestinal T-Cell Lymphoma.
Lymphoproliferative Disorders
[Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders]
Machado-Joseph Disease
Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases.
Macular Degeneration
Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration.
Malabsorption Syndromes
Current Espghan Guidelines for Celiac Disease in Pediatric Age, Tertiary Care Center Experience: A Proposal for Further Simplification.
Malabsorption Syndromes
[Reproductive disorders in women with celiac disease: effect of etiotropic therapy].
Malaria
CpG-containing oligodeoxynucleotides increases resistance of Anopheles mosquitoes to Plasmodium infection.
Malaria
Low levels of fibrin-stabilizing factor (factor XIII) in human Plasmodium falciparum malaria: correlation with clinical severity.
Malaria
Transglutaminase in Plasmodium parasites: activity and putative role in oocysts and blood stages.
Malnutrition
Intestinal Pseudo-Obstruction and Total Villous Atrophy of the Terminal Ileum: An Unusual Presentation of Untreated Celiac Disease.
Malnutrition
Reliability of anti-tissue transglutaminase antibodies in children with malnutrition.
Mastocytosis
Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
Mastocytosis
Ultrastructural localization of factor XIIIa.
Measles
[Inactivation of viruses in Factor XIII concentrate by pasteurization]
Melanoma
A light microscopic and immunohistochemical evaluation of scars.
Melanoma
Aloin enhances cisplatin antineoplastic activity in B16-F10 melanoma cells by transglutaminase-induced differentiation.
Melanoma
Antineoplastic activity of strawberry (Fragaria × ananassa Duch.) crude extracts on B16-F10 melanoma cells.
Melanoma
Antitumor properties of aloe-emodin and induction of transglutaminase 2 activity in B16-F10 melanoma cells.
Melanoma
Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression.
Melanoma
Computerized analysis of tumor cells flowing in a parallel plate chamber to determine their adhesion stabilization lag time.
Melanoma
Decrease of polyamine levels and enhancement of transglutaminase activity in selective reduction of B16-F10 melanoma cell proliferation induced by atrial natriuretic peptide.
Melanoma
Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells.
Melanoma
Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential.
Melanoma
Evaluation of polyamines as marker of melanoma cell proliferation and differentiation by an improved high-performance liquid chromatographic method.
Melanoma
Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines.
Melanoma
Factor XIIIa in nodular malignant melanoma and Spitz naevi.
Melanoma
Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomas.
Melanoma
GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
Melanoma
GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.
Melanoma
Heparin interacts with the adhesion GPCR GPR56, reduces receptor shedding, and promotes cell adhesion and motility.
Melanoma
Heterogeneity of peritoneal macrophages in hamsters-bearing transplantable melanomas in relation to their transglutaminase.
Melanoma
Heterogeneity of transplantable melanomas differing in the rate of growth and cellular differentiation in relation to their cell transglutaminase activity.
Melanoma
Hyaluronic acid induces transglutaminase II to enhance cell motility; role of Rac1 and FAK in the induction of transglutaminase II.
Melanoma
Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel.
Melanoma
Implications of tissue transglutaminase expression in malignant melanoma.
Melanoma
In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
Melanoma
Involvement of Transglutaminase-2 in ?-MSH-Induced Melanogenesis in SK-MEL-2 Human Melanoma Cells.
Melanoma
Melanoma associated with a dermatofibroma.
Melanoma
Melanoma cell adhesion to injured arterioles: mechanisms of stabilized tethering.
Melanoma
Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
Melanoma
Presence and maturity of dendritic cells in melanoma lymph node metastases.
Melanoma
Reduction of COX-2 through modulating miR-124/SPHK1 axis contributes to the antimetastatic effect of alpinumisoflavone in melanoma.
Melanoma
Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells and hairless mouse skin in vivo.
Melanoma
Retinoids increase transglutaminase activity and inhibit ornithine decarboxylase activity in Chinese hamster ovary cells and in melanoma cells stimulated to differentiate.
Melanoma
Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells.
Melanoma
Specific and direct modulation of the interaction between adhesion GPCR GPR56/ADGRG1 and tissue transglutaminase 2 using synthetic ligands.
Melanoma
The genetics of human skin diseases.
Melanoma
Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: an in vivo study.
Melanoma
Transglutaminase stabilizes melanoma adhesion under laminar flow.
Melanoma
Transglutaminase-dependent antiproliferative and differentiative properties of nimesulide on B16-F10 mouse melanoma cells.
Melanoma
Transglutaminase-mediated oligomerization of galectin-3 modulates human melanoma cell interactions with laminin.
Melanoma, Amelanotic
Heterogeneity of transplantable melanomas differing in the rate of growth and cellular differentiation in relation to their cell transglutaminase activity.
Meningeal Neoplasms
Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Meningioma
Thioredoxin-Interact ing-Pro t e in [TXNIP] and Transglutaminase 2 [TGM2] Expression in Meningiomas of Different Grades and the Role of Their Expression in Meningioma Recurrence and Prognosis
Meningioma
Transglutaminase 2 expression is increased as a function of malignancy grade and negatively regulates cell growth in meningioma.
Meningioma
Transglutaminase activity in human brain tumors.
Meningitis
[Intradural hematoma of the foramen magnum associated with factor XIII deficiency]
Menorrhagia
Pubertal Menorrhagia - A Rare Presentation of Congenital Factor XIII Deficiency.
Mesothelioma
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia.
Mesothelioma
Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation.
Mesothelioma, Malignant
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia.
Microphthalmos
Multiple myxoid cellular neurothekeomas in a patient with systemic lupus erythematosus.
Microphthalmos
Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases.
Microvascular Angina
Factor XIII Val34Leu polymorphism in patients with Cardiac Syndrome X.
Migraine Disorders
Increased risk for coeliac disease in paediatric patients with migraine.
Migraine Disorders
Is Celiac Disease an Etiological Factor in Children With Migraine?
Migraine Disorders
Migraine and genetic polymorphisms: an overview.
Migraine Disorders
Role of factor XIII Val 34 Leu polymorphism in patients with migraine.
Milk Hypersensitivity
Cow's Milk Protein Allergy Causing Persistent Elevation of Antitissue Transglutaminase Antibodies in a Child With Celiac Disease.
Mitochondrial Diseases
Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.
Monoclonal Gammopathy of Undetermined Significance
Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure.
Mouth Neoplasms
Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII.
Mouth Neoplasms
The expression of transglutaminase 2 (TG-2) in oral squamous cell carcinoma and its clinical significance.
Mucolipidoses
Secretion of the lysosomal acid triacylglycerol hydrolase precursor by J774 macrophages.
Multiple Myeloma
Humoral immunoreactivity to gliadin and to tissue transglutaminase is present in some patients with multiple myeloma.
Multiple Myeloma
Incomplete fibrin formation and highly elevated Factor XIII activity in multiple myeloma.
Multiple Sclerosis
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Multiple Sclerosis
Appearance of Tissue Transglutaminase in Astrocytes in Multiple Sclerosis Lesions: A Role in Cell Adhesion and Migration?
Multiple Sclerosis
Association of celiac disease in patients with multiple sclerosis in Tuscany.
Multiple Sclerosis
Astrocyte loss and astrogliosis in neuroinflammatory disorders.
Multiple Sclerosis
Celiac disease and multiple sclerosis in the northwest of Iran.
Multiple Sclerosis
Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
Multiple Sclerosis
Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
Multiple Sclerosis
Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients.
Multiple Sclerosis
Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth?
Multiple Sclerosis
Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
Multiple Sclerosis
Multiple sclerosis and celiac disease: is there an increased risk?
Multiple Sclerosis
Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Multiple Sclerosis
Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
Multiple Sclerosis
Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions.
Multiple Sclerosis
Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
Multiple Sclerosis
Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis.
Multiple Sclerosis
Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.
Multiple Sclerosis
Transglutaminase 2 is involved in homocysteine-induced activation of human THP-1 monocytes.
Multiple Sclerosis, Chronic Progressive
Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients.
Mumps
[Inactivation of viruses in Factor XIII concentrate by pasteurization]
Muscle Weakness
Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy.
Muscular Atrophy
Modulation of transglutaminase expression in rat skeletal muscle by induction of atrophy and endurance training.
Muscular Dystrophies
Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy.
Myasthenia Gravis
Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Mycoplasma Infections
Idiopathic testicular infarction in a boy initially suspected to have acute epididymo-orchitis associated with mycoplasma infection and Henoch-Schönlein purpura.
Mycosis Fungoides
Cutaneous expression of Thy-1 in mycosis fungoides.
Mycosis Fungoides
Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis.
Myocardial Infarction
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Myocardial Infarction
An injectable peptide hydrogel with excellent self-healing ability to continuously release salvianolic acid B for myocardial infarction.
Myocardial Infarction
Association of a common polymorphism in the factor XIII gene with myocardial infarction.
Myocardial Infarction
Association of a common polymorphism in the factor XIII gene with venous thrombosis.
Myocardial Infarction
Coagulation factor XIII activity predicts left ventricular remodelling after acute myocardial infarction.
Myocardial Infarction
Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.
Myocardial Infarction
Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.
Myocardial Infarction
Coagulation Factor XIII-A Val34Leu Polymorphism and the Risk of Coronary Artery Disease and Myocardial Infarction in a Chinese Han Population.
Myocardial Infarction
Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.
Myocardial Infarction
Common polymorphisms and cardiovascular factors in patients with myocardial infarction of Costa Rica.
Myocardial Infarction
Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Myocardial Infarction
Does FXIII deficiency impair wound healing after myocardial infarction?
Myocardial Infarction
Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
Myocardial Infarction
Effect of factor XIII VAL34LEU polymorphism on thrombolytic therapy in premature myocardial infarction.
Myocardial Infarction
Elevated factor XIII level and the risk of myocardial infarction in women.
Myocardial Infarction
Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction.
Myocardial Infarction
F13A1 Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty.
Myocardial Infarction
Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction.
Myocardial Infarction
Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage.
Myocardial Infarction
Factor XIII val34leu and the risk of myocardial infarction.
Myocardial Infarction
Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
Myocardial Infarction
Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
Myocardial Infarction
Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
Myocardial Infarction
Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
Myocardial Infarction
Genetic variants of coagulation factor XIII and the risk of myocardial infarction in young women.
Myocardial Infarction
Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction.
Myocardial Infarction
Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response.
Myocardial Infarction
Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients.
Myocardial Infarction
Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
Myocardial Infarction
Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease?
Myocardial Infarction
Management of acute myocardial infarction in a patient with factor XIII deficiency using prophylactic factor replacement therapy.
Myocardial Infarction
Mass spectrometric phenotyping of Val34Leu polymorphism of blood coagulation factor XIII by differential peptide display.
Myocardial Infarction
Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
Myocardial Infarction
MR in mouse models of cardiac disease.
Myocardial Infarction
Myocardial infarctions and other acute coronary syndromes in rare congenital bleeding disorders: a critical analysis of all reported cases.
Myocardial Infarction
No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.
Myocardial Infarction
Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis.
Myocardial Infarction
Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders.
Myocardial Infarction
Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction.
Myocardial Infarction
Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
Myocardial Infarction
Significance of tissue transglutaminase in myocardial fibrosis after myocardial infarction in rats.
Myocardial Infarction
Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.
Myocardial Infarction
The Association Between Factor XIII Val34Leu Polymorphism and Early Myocardial Infarction.
Myocardial Infarction
Thrombin hydrolysis of V29F and V34L mutants of factor XIII (28-41) reveals roles of the P(9) and P(4) positions in factor XIII activation.
Myocardial Infarction
Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction.
Myocardial Infarction
Two factor XIII gene polymorphisms associated with a structural and functional defect and the risk of myocardial infarction in men.
Myocardial Infarction
[Factor XIII Val34Leu polymorphism and premature myocardial infarction]
Myocardial Infarction
[Measurement of factor XIII (FSF) as an indicator of thrombosis risk in chronic coronary insufficiency and myocardial infarction]
Myocardial Ischemia
[The effect of quantum hemotherapy on the plasma hemostatic indices and fibrinolysis in patients with unstable angina]
Myocarditis
Celiac disease associated with autoimmune myocarditis.
Myoclonic Epilepsies, Progressive
Selective colocalization of transglutaminase-like activity in ubiquitinated intranuclear inclusions of hereditary dentatorubral-pallidoluysian atrophy.
Myoclonic Epilepsies, Progressive
Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases.
Myositis
Can tissue transglutaminase be a marker of idiopathic inflammatory myopathies?
Myositis
Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy.
Myositis
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies.
Myositis
Increase in transglutaminase 2 in idiopathic inflammatory myopathies.
Myositis
Proliferative myositis and fasciitis. Report of five cases with an ultrastructural and immunohistochemical study.
Myositis
Transglutaminase catalyzes differential crosslinking of small heat shock proteins and amyloid-beta.
Myositis, Inclusion Body
Transglutaminase catalyzes differential crosslinking of small heat shock proteins and amyloid-beta.
Myxoma
Cardiac myxoma immunohistochemistry: value of CD34, CD31, and factor XIIIa staining.
Myxoma
Cardiac myxoma is rich in factor XIIIa positive dendrophages: immunohistochemical study of four cases.
Myxoma
Comparison of angiomyofibroblastoma and aggressive angiomyxoma in both sexes: four cases composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets.
Nasal Polyps
PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation.
Neoplasm Metastasis
A fluorescence anisotropy-based assay for determining the activity of tissue transglutaminase.
Neoplasm Metastasis
Alterations in the distribution and activity of transglutaminase during tumour growth and metastasis.
Neoplasm Metastasis
Coagulation factor XIII in plasma of patients with benign and malignant gynaecological tumours.
Neoplasm Metastasis
Correlation of changes in transglutaminase activity and polyamine content of neoplastic tissue during the metastatic process.
Neoplasm Metastasis
Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells.
Neoplasm Metastasis
Ethacrynic Acid Inhibits Sphingosylphosphorylcholine-Induced Keratin 8 Phosphorylation and Reorganization via Transglutaminase-2 Inhibition.
Neoplasm Metastasis
Extracellular tissue transglutaminase activates noncanonical NF-?B signaling and promotes metastasis in ovarian cancer.
Neoplasm Metastasis
Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function.
Neoplasm Metastasis
Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.
Neoplasm Metastasis
Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype.
Neoplasm Metastasis
GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.
Neoplasm Metastasis
In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
Neoplasm Metastasis
Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis.
Neoplasm Metastasis
miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.
Neoplasm Metastasis
Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
Neoplasm Metastasis
Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells.
Neoplasm Metastasis
Potential role for high and low molecular weight tissue transglutaminases in transforming mammalian cell properties.
Neoplasm Metastasis
Presence and maturity of dendritic cells in melanoma lymph node metastases.
Neoplasm Metastasis
Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice.
Neoplasm Metastasis
Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.
Neoplasm Metastasis
Reduction in transglutaminase activity associated with tumour metastasis is due to the presence of an inactive form of the enzyme.
Neoplasm Metastasis
Targeting p70S6K Prevented Lung Metastasis in a Breast Cancer Xenograft Model.
Neoplasm Metastasis
The G?h-PLC?1 signaling axis drives metastatic progression in triple-negative breast cancer.
Neoplasm Metastasis
The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205.
Neoplasm Metastasis
The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.
Neoplasm Metastasis
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
Neoplasm Metastasis
Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer.
Neoplasm Metastasis
Tissue transglutaminase expression in human breast cancer.
Neoplasm Metastasis
Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.
Neoplasm Metastasis
Tissue transglutaminase links TGF-?, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
Neoplasm Metastasis
Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells.
Neoplasm Metastasis
Tissue transglutaminase regulates MMP-2 in ovarian cancer by modulating CREB activity.
Neoplasm Metastasis
Tissue transglutaminase-interleukin-6 axis facilitates peritoneal tumor spreading and metastasis of human ovarian cancer cells.
Neoplasm Metastasis
Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells.
Neoplasm Metastasis
Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target.
Neoplasm Metastasis
Transglutaminase II/microRNA-218/-181a loop regulates positive feedback relationship between allergic inflammation and tumor metastasis.
Neoplasms
A case of aortic intimal sarcoma manifested with acutely occurring hypertension and aortic occlusion.
Neoplasms
A cooperative polymeric platform for tumor-targeted drug delivery.
Neoplasms
A fluorescence anisotropy-based assay for determining the activity of tissue transglutaminase.
Neoplasms
A homogeneous fluorescence anisotropy assay for measuring transglutaminase 2 activity.
Neoplasms
A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells.
Neoplasms
A Novel Chromosomal Translocation Associated With COL1A2-PDGFB Gene Fusion in Dermatofibrosarcoma Protuberans: PDGF Expression as a New Diagnostic Tool.
Neoplasms
A novel combined resveratrol/berberine phytochemotheraputic using the HePG2 cell line as a model for the treatment of hepatocarcinoma.
Neoplasms
A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival.
Neoplasms
A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase.
Neoplasms
A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2.
Neoplasms
A Rare Case of Atrophic Dermatofibroma Featuring Linear Skin Dimple.
Neoplasms
A Rare Case of Factor XIII Deficiency in the Setting of Cancer Immunotherapy.
Neoplasms
A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.
Neoplasms
A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells.
Neoplasms
A study of factor XIIIa and MAC 387 immunolabeling in normal and pathological skin.
Neoplasms
A unique role for heat shock protein 70 and its binding partner tissue transglutaminase in cancer cell migration.
Neoplasms
Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects.
Neoplasms
Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells.
Neoplasms
Acute megakaryoblastic leukemia with erythrophagocytosis and thrombosis in a dog.
Neoplasms
Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
Neoplasms
Acylideneoxoindoles: A new class of reversible inhibitors of human transglutaminase 2.
Neoplasms
Advances of Coagulation Factor XIII.
Neoplasms
Alterations in epidermal functions resulting from exposure to initiators and promoters of carcinogenesis.
Neoplasms
Alterations in the distribution and activity of transglutaminase during tumour growth and metastasis.
Neoplasms
An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes.
Neoplasms
An unusual soft tissue tumor with features of angiomatoid malignant fibrous histiocytoma composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets. CD34 and factor XIIIa in angiomatoid MFH.
Neoplasms
Analysis of differential gene expression caused by cervical intraepithelial neoplasia based on GEO database.
Neoplasms
Analysis of epidermal-type transglutaminase (TGase 3) expression in mouse tissues and cell lines.
Neoplasms
Analysis of the balance between proliferation and apoptosis of cultured vascular smooth muscle cells for tissue-engineering applications.
Neoplasms
Analysis of the vitamin D system in cutaneous malignancies.
Neoplasms
Aneurysmal fibrous histiocytoma of the skin. A histological, immunohistochemical, and ultrastructural study.
Neoplasms
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
Neoplasms
Anticancer activity of bovine ??lactalbumin treated with microbial transglutaminase
Neoplasms
Apoptosis induction by inhibitors of Ser/Thr phosphatases 1 and 2A is associated with transglutaminase activation in two different human epithelial tumour lines.
Neoplasms
Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression.
Neoplasms
Arguments against the prostatic origin of the R-3327 Dunning H tumor.
Neoplasms
Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor ? light chain enhancer of activated B cells (NF?B) signaling controls basal and DNA damage-induced transglutaminase 2 expression.
Neoplasms
Atypical fibrous histiocytoma of the scrotum.
Neoplasms
Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells.
Neoplasms
Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2.
Neoplasms
Benign neural tumors of the oral cavity: a comparative immunohistochemical study.
Neoplasms
Biological and therapeutic significance of tissue transglutaminase in pancreatic cancer.
Neoplasms
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer.
Neoplasms
Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model.
Neoplasms
Calcifying fibrous tumor of the adrenal gland.
Neoplasms
Calcifying fibrous tumor of the gastrointestinal tract: A clinicopathologic review and update.
Neoplasms
CAN IMMUNOHISTOCHEMISTRY DISTINGUISH BETWEEN PRIMARY AND METASTATIC HEPATIC CARCINOMA?
Neoplasms
Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells.
Neoplasms
Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking.
Neoplasms
Case of primary malignant hemangiopericytoma of the heart expressing basement membrane-degradable enzymes.
Neoplasms
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.
Neoplasms
CD34-reactive myxoid dermal dendrocytoma.
Neoplasms
CD68 and factor XIIIa expressions in granular-cell tumor of the skin.
Neoplasms
Cells containing factor XIII subunit a in benign and soft tissue tumours.
Neoplasms
Cellular neurothekeoma.
Neoplasms
Cellular solitary fibrous tumor (hemangiopericytoma) with anaplasia at cerebellopontine angle-A case report.
Neoplasms
Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells.
Neoplasms
Characterization of the heparin binding site of tissue transglutaminase: its importance in the enzyme's cell surface targeting, matrix deposition and cell signalling.
Neoplasms
Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis.
Neoplasms
Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.
Neoplasms
Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice.
Neoplasms
CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
Neoplasms
Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
Neoplasms
Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients.
Neoplasms
Coagulation factor XIII in plasma of patients with benign and malignant gynaecological tumours.
Neoplasms
Coagulation Factor XIII-A Subunit Missense Mutation in the Pathobiology of Autosomal Dominant Multiple Dermatofibromas.
Neoplasms
Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues.
Neoplasms
Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.
Neoplasms
Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment.
Neoplasms
Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement.
Neoplasms
Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report.
Neoplasms
Congenital, infiltrating giant-cell angioblastoma. A new entity?
Neoplasms
Congenital-infantile fibrosarcoma: a clinicopathological study of five patients entered on the Prague children's tumor registry.
Neoplasms
Construction of a pH/TGase "Dual Key"-Responsive Gold Nano-radiosensitizer with Liver Tumor-Targeting Ability.
Neoplasms
Correction to: Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
Neoplasms
Correlation between immunoreactivity for transglutaminase K and for markers of proliferation and differentiation in normal breast tissue and breast carcinomas.
Neoplasms
Correlation of changes in transglutaminase activity and polyamine content of neoplastic tissue during the metastatic process.
Neoplasms
Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines.
Neoplasms
Cutaneous clear-cell granular cell tumors: the histologic description of an unusual variant.
Neoplasms
Cutaneous sarcomatoid B-cell lymphoma.
Neoplasms
Cytological alterations in dermal dendrocytes in vitro: evidence for transformation to a non-dendritic phenotype.
Neoplasms
Deep juvenile xanthogranuloma presenting as a chest wall mass: a case report.
Neoplasms
Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. A clinicopathologic comparison.
Neoplasms
Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.
Neoplasms
Dermatofibroma of the Eyelid: Immunohistochemical Diagnosis.
Neoplasms
Dermatofibroma-like granular cell tumor.
Neoplasms
Dermatomyofibroma (Plaqueförmige Dermale Fibromatose).
Neoplasms
Dermo-epidermal stimulation elicited by a beta-lipohydroxyacid: a comparison with salicylic acid and all-trans-retinoic acid.
Neoplasms
Desmoplastic fibroblastoma (collagenous fibroma) of the oral cavity.
Neoplasms
Detection of factor XIII-A is a valuable tool for distinguishing dendritic cells and tissue macrophages in granuloma annulare and necrobiosis lipoidica.
Neoplasms
Development of an 18F-Labeled Irreversible Inhibitor of Transglutaminase 2 as Radiometric Tool for Quantitative Expression Profiling in Cells and Tissues.
Neoplasms
Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase.
Neoplasms
Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity.
Neoplasms
Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells.
Neoplasms
Different Protein Expressions between Peripheral Ameloblastoma and Oral Basal Cell Carcinoma Occurred at the Same Mandibular Molar Area.
Neoplasms
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.
Neoplasms
Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors.
Neoplasms
Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. correlation with apoptosis.
Neoplasms
Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester.
Neoplasms
Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
Neoplasms
DNA-binding proteins in Yoshida ascites tumor fluid.
Neoplasms
Down-regulation of transglutaminase II leads to impaired motility of cancer cells by inactivation of the protein kinase, Akt, and decrease of reactive oxygen species.
Neoplasms
Effects of diesel exhaust particles on macrophage polarization.
Neoplasms
Effects of exogenous transglutaminase on spreading of human colorectal carcinoma cells.
Neoplasms
Effects of nicotinamide on mouse skin tumor development and its mode of action.
Neoplasms
Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis.
Neoplasms
Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia.
Neoplasms
Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.
Neoplasms
Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells.
Neoplasms
Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.
Neoplasms
Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions.
Neoplasms
Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report.
Neoplasms
Ethacrynic Acid Inhibits Sphingosylphosphorylcholine-Induced Keratin 8 Phosphorylation and Reorganization via Transglutaminase-2 Inhibition.
Neoplasms
Evaluation and comparison of staining patterns of factor XIIIa (AC-1A1), adipophilin and GATA3 in sebaceous neoplasia.
Neoplasms
Evaluation of CD68 and other histiocytic antigens in angiomatoid malignant fibrous histiocytoma.
Neoplasms
Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis.
Neoplasms
Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.
Neoplasms
Examination of oral cancer biomarkers by tissue microarray analysis.
Neoplasms
Expression and Activity of Transglutaminase II in Spontaneous Tumours of Dogs and Cats.
Neoplasms
Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes.
Neoplasms
Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis.
Neoplasms
Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma.
Neoplasms
Expression of transglutaminase K in normal cervix tissue and cervix carcinomas.
Neoplasms
Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer.
Neoplasms
Expression of transglutaminases in human breast cancer and their possible clinical significance.
Neoplasms
Extracellular localization of catalase is associated with the transformed state of malignant cells.
Neoplasms
Factor XIII deficiency in BALB/c mice with plasmacytoma.
Neoplasms
Factor XIII does not stimulate growth of human cultured tumor cells.
Neoplasms
Factor XIII expression in the skin: observations and a hypothesis.
Neoplasms
Factor XIII of blood coagulation in human monocytes.
Neoplasms
Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding.
Neoplasms
Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function.
Neoplasms
Factor XIIIa and the classic histiocytic markers in malignant fibrous histiocytoma: a comparative immunohistochemical study.
Neoplasms
Factor XIIIa immunoreactivity in primary and secondary tumours of the meninges.
Neoplasms
Factor XIIIa in fibrovascular tumors.
Neoplasms
Factor XIIIa is expressed by fibroblasts in fibrovascular tumors.
Neoplasms
Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Neoplasms
Factor XIIIa-positive dendrocytes and proliferative activity of cutaneous cancers.
Neoplasms
Fibrin deposition in primary and metastatic human brain tumours.
Neoplasms
Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
Neoplasms
Fibrin stabilizing factor activity of the skin carcinoma.
Neoplasms
Fibrinogen deposition without thrombin generation in primary human breast cancer tissue.
Neoplasms
Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease.
Neoplasms
Fibroblast migration in fibrin gel matrices.
Neoplasms
Fibronectin in Layer-by-Layer Assembled Films Switches Tumor Cells between 2D and 3D Morphology.
Neoplasms
Fibrous papule: a tumor of fibrohistiocytic cells that contain factor XIIIa.
Neoplasms
Follicular lymphoma of the skin and superficial soft tissues associated with a prominent follicular dendritic cell proliferation: an unusual pattern which may represent a diagnostic pitfall.
Neoplasms
Food Processing, Dysbiosis, Gastrointestinal Inflammatory Diseases, and Antiangiogenic Functional Foods or Beverages.
Neoplasms
Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype.
Neoplasms
Genetics of intracerebral hemorrhage: Insights from candidate gene approaches.
Neoplasms
Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.
Neoplasms
GPR56 in cancer progression: current status and future perspective.
Neoplasms
GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.
Neoplasms
Granular cell dermatofibroma.
Neoplasms
Growth regulation of vessel wall cells and of tumor cells by thrombin, factor XIII and fibronectin.
Neoplasms
Hemangiopericytoma of the cerebello-pontine angle. Diagnostic pitfalls and the diagnostic value of the subunit A of factor XIII as a tumor marker.
Neoplasms
Hemangiopericytoma-like dermatofibroma with mast cells.
Neoplasms
Hepatic epithelioid hemangioendothelioma: biological questions based on pattern of recurrence in an allograft and tumor immunophenotype.
Neoplasms
High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells.
Neoplasms
High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Neoplasms
High salinity induced expression profiling of differentially expressed genes in shrimp (Penaeus monodon).
Neoplasms
HIV-1 infection and modulation of cytokine and growth factor expression in Kaposi's sarcoma-derived cells in vitro.
Neoplasms
How autophagy controls the intestinal epithelial barrier.
Neoplasms
Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells.
Neoplasms
Hyalinizing spindle cell tumor with giant rosettes and low-grade fibromyxoid sarcoma: an immunohistochemical and ultrastructural comparative investigation.
Neoplasms
Hyalinizing spindle cell tumors with giant rosette-like structures.
Neoplasms
Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies.
Neoplasms
Hypoxia-Dependent Expression of TG2 Isoforms in Neuroblastoma Cells as Consequence of Different MYCN Amplification Status.
Neoplasms
Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response.
Neoplasms
Immunocytochemical demonstration of tissue transglutaminase indicative of programmed cell death (apoptosis) in hormone sensitive mammary tumours.
Neoplasms
Immunohistochemical analysis of 1,25-dihydroxyvitamin D3 receptor in cervical carcinoma.
Neoplasms
Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas.
Neoplasms
Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
Neoplasms
Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas.
Neoplasms
Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis.
Neoplasms
Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
Neoplasms
Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.
Neoplasms
In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model.
Neoplasms
In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
Neoplasms
In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer.
Neoplasms
Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations.
Neoplasms
Incidental calcifying fibrous tumor of the stomach presenting as a polyp.
Neoplasms
Increased cytotoxic sensitivity of YPC-1 tumor cells from mice treated with nitrosoureas.
Neoplasms
Increased endothelial expression of transglutaminase in glioblastomas.
Neoplasms
Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis.
Neoplasms
Increased factor XIIIa transglutaminase expression in dermal dendrocytes after treatment with alpha-hydroxy acids: potential physiologic significance.
Neoplasms
Increased transglutaminase 2 and GLUT-1 expression in breast tumors not susceptible to chemoprevention with antioxidants.
Neoplasms
Influences of clotting factors (thrombin, factor XIII) and of fibronectin on the growth of tumor cells and leukemic cells in vitro.
Neoplasms
Influences of thrombin, factor XIII and fibronectin on the growth of tumor cells and leukemic cells in vitro.
Neoplasms
Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of epidermal transglutaminase activity by protease inhibitors.
Neoplasms
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells.
Neoplasms
Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy.
Neoplasms
Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa.
Neoplasms
Intracranial suprasellar angiolipoma: ultrastructural and immunohistochemical features.
Neoplasms
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA.
Neoplasms
Keratinocyte transglutaminase expression varies in squamous cell carcinomas.
Neoplasms
Keratinocyte transglutaminase in human skin and oral mucosa: cytoplasmic localization and uncoupling of differentiation markers.
Neoplasms
Lipomatous hemangiopericytoma: a rare variant of hemangiopericytoma that may be confused with liposarcoma.
Neoplasms
Local expression of inflammatory cytokines in human atherosclerotic plaques.
Neoplasms
Localization of blood coagulation factors in situ in pancreatic carcinoma.
Neoplasms
Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma.
Neoplasms
Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case study.
Neoplasms
Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma.
Neoplasms
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study.
Neoplasms
Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
Neoplasms
Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Neoplasms
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
Neoplasms
Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth.
Neoplasms
Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion.
Neoplasms
Melanoma associated with a dermatofibroma.
Neoplasms
Melanoma cell adhesion to injured arterioles: mechanisms of stabilized tethering.
Neoplasms
Meningeal solitary fibrous tumor as an unusual cause of expohthalmos: case report and review of the literature.
Neoplasms
Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Neoplasms
Metastasizing fibrous histiocytoma of the skin: a clinicopathologic and immunohistochemical analysis of three cases.
Neoplasms
Microarray analysis uncovers retinoid targets in human bronchial epithelial cells.
Neoplasms
miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.
Neoplasms
Modulation of tissue and epidermal transglutaminases in mouse epidermal cells after treatment with 12-O-tetradecanoylphorbol-13-acetate and/or retinoic acid in vivo and in culture.
Neoplasms
Modulation of transglutaminase activity in mononuclear phagocytes and macrophage-like tumor cell lines by differentiation agents.
Neoplasms
Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
Neoplasms
MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response.
Neoplasms
Multifunctional nanocatalyst-based ultrasensitive detection of human tissue transglutaminase 2.
Neoplasms
Multinucleated giant stromal tumor of the omentum: report of a case with immunohistochemical and ultrastructural investigation.
Neoplasms
Multiple cutaneous myxomas. Report of a case without other elements of Carney's complex.
Neoplasms
Myxomas and angiomyxomas of the orbit: a clinicopathologic study of 6 cases.
Neoplasms
New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds.
Neoplasms
NF-?B addiction and its role in cancer: 'one size does not fit all'.
Neoplasms
Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitors.
Neoplasms
Novel MRI and fluorescent probes responsive to the Factor XIII transglutaminase activity.
Neoplasms
Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells.
Neoplasms
Novel suppressive effects of cardamonin on the activity and expression of transglutaminase-2 lead to blocking the migration and invasion of cancer cells.
Neoplasms
Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms.
Neoplasms
Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.
Neoplasms
Orbital hemangiopericytoma and solitary fibrous tumor: a morphologic continuum.
Neoplasms
Overexpression of Tissue Transglutaminase Leads to Constitutive Activation of Nuclear Factor-{kappa}B in Cancer Cells: Delineation of a Novel Pathway.
Neoplasms
Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes.
Neoplasms
Palisading cutaneous fibrous histiocytoma. An immunohistochemical study demonstrating differentiation from dermal dendrocytes.
Neoplasms
Peptides in low molecular weight fraction of serum associated with hepatocellular carcinoma.
Neoplasms
Pharmacological separation of the expression of tissue transglutaminase and apoptosis after chemotherapeutic treatment of HepG2 cells.
Neoplasms
Phenotype and proliferation characteristics of cultured spindle-shaped cells obtained from normal human skin and lesions of dermatofibroma, Kaposi's sarcoma, and dermatofibrosarcoma protuberans: a comparison with fibroblast and endothelial cells of the dermis.
Neoplasms
Phenotypic characterization of macrophage subpopulations and localization of factor XIII in the stromal cells of carcinomas.
Neoplasms
Phorbol ester tumor promoters induce epidermal transglutaminase activity.
Neoplasms
Phosphorylation of transglutaminase 2 (TG2) at serine-216 plays a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.
Neoplasms
Phytochemicals and protein-polyamine conjugates by transglutaminase as chemopreventive and chemotherapeutic tools in cancer.
Neoplasms
Pigmented dermatofibrosarcoma protuberans (Bednár tumor) occurring in a Japanese infant.
Neoplasms
Plexiform fibrohistiocytic tumor.
Neoplasms
Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis.
Neoplasms
Potential role for high and low molecular weight tissue transglutaminases in transforming mammalian cell properties.
Neoplasms
Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.
Neoplasms
Prevalence of thrombophilic genetic factors among patients with retinitis pigmentosa.
Neoplasms
Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
Neoplasms
Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.
Neoplasms
Properties of particulate transglutaminase from Yoshida tumor cells.
Neoplasms
Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.
Neoplasms
Protein-polyamine conjugates by transglutaminase 2 as potential markers for antineoplastic screening of natural compounds.
Neoplasms
Protein-polyamine conjugation by transglutaminase in cancer cell differentiation: review article.
Neoplasms
Proteomic analysis of high-molecular-weight protein polymers in a doxorubicin-resistant breast-cancer cell line.
Neoplasms
Provocation with stress and electricity of patients with "sensitivity to electricity".
Neoplasms
Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma.
Neoplasms
Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors.
Neoplasms
Reduced levels of coagulation factor XIII in patients with advanced tumor disease.
Neoplasms
Reduction in transglutaminase activity associated with tumour metastasis is due to the presence of an inactive form of the enzyme.
Neoplasms
Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line.
Neoplasms
Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328.
Neoplasms
Regulation of transglutaminase activity by GTP in digitonin permeabilized Yoshida tumor cells.
Neoplasms
Relationship of factor XIIIa-positive dermal dendrocytes to Kaposi's sarcoma.
Neoplasms
Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer.
Neoplasms
Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.
Neoplasms
Response of carcinogen-altered mouse epidermal cells to phorbol ester tumor promoters and calcium.
Neoplasms
Restoration of differentiation and suppression of tumorigenicity in somatic cell hybrids of human squamous carcinoma cells and keratinocytes.
Neoplasms
Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line.
Neoplasms
Retinoic acid-induced transglutaminase in mouse epidermal cells is distinct from epidermal transglutaminase.
Neoplasms
Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.
Neoplasms
Role of fibrinogen covalently associated with cell membrane in blood-borne lung tumor colony formation of murine mammary carcinoma cells.
Neoplasms
Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.
Neoplasms
Role of tissue transglutaminase and effect of cantharidinate in human colorectal cancer.
Neoplasms
Role of Transglutaminase 2 in Migration of Tumor Cells and How Mouse Models Fit.
Neoplasms
S-100-negative atypical granular cell tumor: report of a case.
Neoplasms
Sarcomatous transformation in a cellular angiofibroma: a case report.
Neoplasms
Screening ,development of Transglutaminase-2 Inhibitors and its derivative as anti-lung cancer agent by insilico and invitro approach.
Neoplasms
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity.
Neoplasms
Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors.
Neoplasms
Simultaneous activity assay of two transglutaminase isozymes, blood coagulation factor XIII and transglutaminase 2, by use of fibrinogen arrays.
Neoplasms
Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic intervention.
Neoplasms
Sinonasal hemangiopericytomas: a clinicopathologic and immunohistochemical study of seven cases.
Neoplasms
Sinonasal-type hemangiopericytoma of the nasal cavity and paranasal sinus.
Neoplasms
siRNA-based Analysis of the Abrogation of the Protective Function of Membrane-associated Catalase of Tumor Cells.
Neoplasms
Small Benign Storiform Fibrous Tumor (Fibrous Histiocytoma) of the Conjunctival Substantia Propria in a Child: Review and Clarification of Biologic Behavior.
Neoplasms
Smart Collagen Hydrogels Based on 1-Ethyl-3-methylimidazolium Acetate and Microbial Transglutaminase for Potential Applications in Tissue Engineering and Cancer Therapy.
Neoplasms
Solitary fibrous tumor of the oral soft tissues: a clinicopathologic and immunohistochemical study of 16 cases.
Neoplasms
Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature.
Neoplasms
Solute removal capacity of high cut-off membrane plasma separators.
Neoplasms
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract.
Neoplasms
Sporadic sclerotic fibroma of the oral soft tissues.
Neoplasms
Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction.
Neoplasms
Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.
Neoplasms
Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity.
Neoplasms
Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles.
Neoplasms
Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity.
Neoplasms
Study of tumor transglutaminase 2 expression in gallbladder cancer - Is it a novel predictor of survival?
Neoplasms
Subungual pleomorphic fibroma.
Neoplasms
Superficial angiomyxoma (cutaneous myxoma): a clinicopathologic study of 17 cases arising in the genital region.
Neoplasms
Suppression of keratinocyte differentiation in SSC-9 human squamous carcinoma cells by benzo[a]pyrene, 12-O-tetradecanoylphorbol-13-acetate and hydroxyurea.
Neoplasms
Surgical resection of sinonasal hemangiopericytoma involving anterior skull base: Case reports and literature review.
Neoplasms
Synaptotagmin I expression in mast cells of normal human tissues, systemic mast cell disease, and a human mast cell leukemia cell line.
Neoplasms
Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
Neoplasms
Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.
Neoplasms
Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase.
Neoplasms
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer.
Neoplasms
Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Neoplasms
TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.
Neoplasms
TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
Neoplasms
TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection.
Neoplasms
TGM4: an immunogenic prostate-restricted antigen.
Neoplasms
The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment.
Neoplasms
The clinical and histologic spectrum of cutaneous fibrous perineuriomas.
Neoplasms
The complex role of transglutaminase 2 in glioblastoma proliferation.
Neoplasms
The existence of an inactive form of transglutaminase within metastasising tumours.
Neoplasms
The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis).
Neoplasms
The G?h-PLC?1 signaling axis drives metastatic progression in triple-negative breast cancer.
Neoplasms
The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205.
Neoplasms
The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.
Neoplasms
The induction of epidermal transglutaminase and terminal differentiation by tumor promoters in cultured epidermal cells.
Neoplasms
The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.
Neoplasms
The novel IGF-IR/Akt-dependent anticancer activities of glucosamine.
Neoplasms
The role of apoptosis in growing and stationary rat ascites hepatoma, Yoshida AH-130.
Neoplasms
The role of Lamin A in cytoskeleton organization in colorectal cancer cells: a proteomic investigation.
Neoplasms
The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Neoplasms
The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression.
Neoplasms
The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
Neoplasms
The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling.
Neoplasms
Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells.
Neoplasms
Tissue transglutaminase (TG2) in cancer biology.
Neoplasms
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Neoplasms
Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression.
Neoplasms
Tissue transglutaminase 2 exerts a tumor-promoting role in hepatitis B virus-related hepatocellular carcinoma.
Neoplasms
Tissue transglutaminase 2 expression is epigenetically regulated in human lung cancer cells and prevents reactive oxygen species-induced apoptosis.
Neoplasms
Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas.
Neoplasms
Tissue transglutaminase 2 regulates tumor cell tensional homeostasis by increasing contractility.
Neoplasms
Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: an in vivo study.
Neoplasms
Tissue transglutaminase and its role in human cancer progression.
Neoplasms
Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma.
Neoplasms
Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.
Neoplasms
Tissue transglutaminase in tumour progression: friend or foe?
Neoplasms
Tissue transglutaminase induces the release of apoptosis inducing factor and results in apoptotic death of pancreatic cancer cells.
Neoplasms
Tissue transglutaminase inhibition.
Neoplasms
Tissue transglutaminase inhibits autophagy in pancreatic cancer cells.
Neoplasms
Tissue transglutaminase is an essential participant in the EGF-stimulated signaling pathway leading to cancer cell migration and invasion.
Neoplasms
Tissue transglutaminase is expressed as a host response to tumor invasion and inhibits tumor growth.
Neoplasms
Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells.
Neoplasms
Tissue transglutaminase promotes or suppresses tumors depending on cell context.
Neoplasms
Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.
Neoplasms
Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.
Neoplasms
Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
Neoplasms
Tissue transglutaminase regulates interactions between ovarian cancer stem cells and the tumor niche.
Neoplasms
Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?
Neoplasms
Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
Neoplasms
Tissue transglutaminase-interleukin-6 axis facilitates peritoneal tumor spreading and metastasis of human ovarian cancer cells.
Neoplasms
Tissue transglutaminase-mediated chemoresistance in cancer cells.
Neoplasms
Tissue transglutaminase: a new target to reverse cancer drug resistance.
Neoplasms
Tissue-type transglutaminase expression in the Dunning tumor.
Neoplasms
Tissue-type transglutaminase is not a tumor-related marker.
Neoplasms
TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2.
Neoplasms
TRAIL-Induced Keratinocyte Differentiation Requires Caspase Activation and p63 Expression.
Neoplasms
Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
Neoplasms
Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth.
Neoplasms
Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.
Neoplasms
Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation.
Neoplasms
Transglutaminase 2 expression is enhanced synergistically by interferon-? and tumour necrosis factor-? in human small intestine.
Neoplasms
Transglutaminase 2 expression is increased as a function of malignancy grade and negatively regulates cell growth in meningioma.
Neoplasms
Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis.
Neoplasms
Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells.
Neoplasms
Transglutaminase 2 in cancer.
Neoplasms
Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
Neoplasms
Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.
Neoplasms
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition.
Neoplasms
Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.
Neoplasms
Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-kB activation.
Neoplasms
Transglutaminase 2 Promotes Autophagy by LC3 Induction through p53 Depletion in Cancer Cell.
Neoplasms
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53.
Neoplasms
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Neoplasms
Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target.
Neoplasms
Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1?-p300 Binding in Renal Cell Carcinoma.
Neoplasms
Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer.
Neoplasms
Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Neoplasms
Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer.
Neoplasms
Transglutaminase activity in Yoshida ascites tumor cells.
Neoplasms
Transglutaminase and tumor growth.
Neoplasms
Transglutaminase II/microRNA-218/-181a loop regulates positive feedback relationship between allergic inflammation and tumor metastasis.
Neoplasms
Transglutaminase in azoxymethane-induced colon cancer in the rat.
Neoplasms
Transglutaminase Interaction with ?6/?4-Integrin Stimulates YAP1-Dependent ?Np63? Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation.
Neoplasms
Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation.
Neoplasms
Transglutaminase is a tumor cell and cancer stem cell survival factor.
Neoplasms
Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
Neoplasms
Transglutaminase Participates in UVB-Induced Cell Death Pathways in Human Corneal Epithelial Cells.
Neoplasms
Transglutaminase stabilizes melanoma adhesion under laminar flow.
Neoplasms
Transglutaminase-2 Mediates the Biomechanical Properties of the Colorectal Cancer Tissue Microenvironment that Contribute to Disease Progression.
Neoplasms
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
Neoplasms
Transglutaminase-mediated activation of nuclear transcription factor-kappaB in cancer cells: a new therapeutic opportunity.
Neoplasms
Tri(n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives.
Neoplasms
Tumor bioengineering using a transglutaminase crosslinked hydrogel.
Neoplasms
Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition.
Neoplasms
Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
Neoplasms
Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.
Neoplasms
VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype.
Neoplasms
Xanthogranulomas with inconspicuous foam cells and giant cells mimicking malignant melanoma: a clinical, histologic, and immunohistochemical study of three cases.
Neoplasms
[Dermal nerve sheath myxoma. (Neurothekeoma)]
Neoplasms
[Extra-abdominal fibromatosis. An immunohistochemical analysis]
Neoplasms
[Fibrin stabilization and factor XIII substitution in malignant tumors (author's transl)]
Neoplasms
[Is the use of factor XIII for delayed wound healing in patients with head-neck tumors of value?]
Neoplasms
[Kaposi's disease in a female patient with acquired HIV-negative immunodeficiency]
Neoplasms
[Thrombin, factor XIII and fibronectin as regulators of the proliferation of tumor cells and vascular wall cells]
Neoplasms
[Wound healing disorders and factor XIII deficiency after tumor operations in the floor of the mouth]
Neoplastic Processes
N?-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic Profiling.
Nephritis
Plasma factor XIII levels in children with renal disease.
Nephritis
Therapy for children with henoch-schonlein purpura nephritis: a systematic review.
Nephritis
Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and henoch-Schönlein purpura nephritis.
Nephritis
[Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus].
Nephrosis
Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
Nephrosis, Lipoid
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Nephrotic Syndrome
Acquired glomerular lesions in patients with Down syndrome.
Nephrotic Syndrome
Celiac Disease as a Rare Cause of Membranous Nephropathy: A Case Report.
Nephrotic Syndrome
Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis.
Nephrotic Syndrome
Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia.
Nephrotic Syndrome
Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
Nephrotic Syndrome
Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment.
Nephrotic Syndrome
Plasma factor XIII levels in children with renal disease.
Nephrotic Syndrome
Plasma fibronectin and factor XIII in nephrotic syndrome.
Nervous System Diseases
The many-faced gluten sensitivity: Gluten-induced autoimmunity from dermatological point of view
Netherton Syndrome
LEKTI domains 6, 7 and 8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.
Neuralgia
Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet.
Neurilemmoma
Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas.
Neuroblastoma
Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells.
Neuroblastoma
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.
Neuroblastoma
Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.
Neuroblastoma
Changes in gene expression with increased transglutaminase 2 in a SH-SY5Y cell line.
Neuroblastoma
Correlation between transglutaminase activity and polyamine levels in human neuroblastoma cells. Effect of retinoic acid and alpha-difluoromethylornithine.
Neuroblastoma
Distinct nuclear localization and activity of tissue transglutaminase.
Neuroblastoma
Effects of phenyl saligenin phosphate on cell viability and transglutaminase activity in N2a neuroblastoma and HepG2 hepatoma cell lines.
Neuroblastoma
Heterogeneity in retinoic acid signaling in neuroblastomas: Role of matrix metalloproteinases in retinoic acid-induced differentiation.
Neuroblastoma
Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis.
Neuroblastoma
Intracellular transglutaminase-catalyzed polymerization and assembly for bioimaging of hypoxic neuroblastoma cells.
Neuroblastoma
Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.
Neuroblastoma
Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis.
Neuroblastoma
Protective role of tissue transglutaminase in the cell death induced by TNF-alpha in SH-SY5Y neuroblastoma cells.
Neuroblastoma
Retinoic acid receptors alpha and gamma mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells.
Neuroblastoma
Role of tissue transglutaminase in neuroblastoma cells undergoing apoptosis.
Neuroblastoma
Role of transglutaminase 2 in PAC1 receptor mediated protection against hypoxia-induced cell death and neurite outgrowth in differentiating N2a neuroblastoma cells.
Neuroblastoma
The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis).
Neuroblastoma
The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells.
Neuroblastoma
Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells.
Neuroblastoma
Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner.
Neuroblastoma
Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells.
Neuroblastoma
Tissue transglutaminase is not involved in the aggregate formation of stably expressed alpha-synuclein in SH-SY5Y human neuroblastoma cells.
Neuroblastoma
Transglutaminase 2 and NF-kappaB interplay during NGF-induced differentiation of neuroblastoma cells.
Neuroblastoma
Transglutaminase 2 interaction with small heat shock proteins mediate cell survival upon excitotoxic stress.
Neuroblastoma
Transglutaminase and neuronal differentiation.
Neuroblastoma
Transglutaminase catalyzed incorporation of putrescine into surface proteins of mouse neuroblastoma cells.
Neuroblastoma
Transglutaminase-2 Is Involved in All-Trans Retinoic Acid-Induced Invasion and Matrix Metalloproteinases Expression of SH-SY5Y Neuroblastoma Cells via NF-?B Pathway.
Neuroblastoma
VIP potentiates retinoic-acid effect on tissue transglutaminase activity in human neuroblastoma, the SK-N-SH cells.
Neurodegenerative Diseases
A fluorescence anisotropy-based assay for determining the activity of tissue transglutaminase.
Neurodegenerative Diseases
A homogeneous fluorescence anisotropy assay for measuring transglutaminase 2 activity.
Neurodegenerative Diseases
Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.
Neurodegenerative Diseases
Coagulation factor XIII Val34Leu gene polymorphism and Alzheimer's disease.
Neurodegenerative Diseases
Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells.
Neurodegenerative Diseases
Cytokines regulate neuronal gene expression: Differential effects of Th1, Th2 and monocyte/macrophage cytokines.
Neurodegenerative Diseases
Development of a mechanism-based assay for tissue transglutaminase--results of a high-throughput screen and discovery of inhibitors.
Neurodegenerative Diseases
Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase.
Neurodegenerative Diseases
Endoplasmic reticulum stress activates transglutaminase 2 leading to protein aggregation.
Neurodegenerative Diseases
Excitotoxic and post-ischemic neurodegeneration: Involvement of transglutaminases.
Neurodegenerative Diseases
Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation.
Neurodegenerative Diseases
Identification of brain substrates of transglutaminase by functional proteomics supports its role in neurodegenerative diseases.
Neurodegenerative Diseases
Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.
Neurodegenerative Diseases
Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase.
Neurodegenerative Diseases
Immunoblot analysis reveals that isopeptide antibodies do not specifically recognize the epsilon-(gamma-glutamyl)lysine bonds formed by transglutaminase activity.
Neurodegenerative Diseases
Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.
Neurodegenerative Diseases
Increased expression of tissue-type transglutaminase following middle cerebral artery occlusion in rats.
Neurodegenerative Diseases
Isolation and characterization of brain-specific transglutaminases from rat.
Neurodegenerative Diseases
Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
Neurodegenerative Diseases
Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: Celiac Disease.
Neurodegenerative Diseases
Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease.
Neurodegenerative Diseases
Mutations in TGM6 induce the unfolded protein response in SCA35.
Neurodegenerative Diseases
Neurodegenerative diseases and transglutaminase.
Neurodegenerative Diseases
New insight into transglutaminase 2 and link to neurodegenerative diseases.
Neurodegenerative Diseases
New target against inflammatory diseases: transglutaminase 2.
Neurodegenerative Diseases
NMDA-evoked excitotoxicity increases tissue transglutaminase in cerebellar granule cells.
Neurodegenerative Diseases
Polyamine Homeostasis in Snyder-Robinson Syndrome.
Neurodegenerative Diseases
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Neurodegenerative Diseases
Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
Neurodegenerative Diseases
Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases.
Neurodegenerative Diseases
Possible role of the transglutaminases in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases.
Neurodegenerative Diseases
Potential of transglutaminase 2 as a therapeutic target.
Neurodegenerative Diseases
Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.
Neurodegenerative Diseases
Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration.
Neurodegenerative Diseases
Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
Neurodegenerative Diseases
Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.
Neurodegenerative Diseases
Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activity.
Neurodegenerative Diseases
Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity.
Neurodegenerative Diseases
TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.
Neurodegenerative Diseases
The multifaceted role of transglutaminase in neurodegeneration: review article.
Neurodegenerative Diseases
The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase.
Neurodegenerative Diseases
Tissue transglutaminase promotes or suppresses tumors depending on cell context.
Neurodegenerative Diseases
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.
Neurodegenerative Diseases
Tissue transglutaminase: a possible role in neurodegenerative diseases.
Neurodegenerative Diseases
Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits.
Neurodegenerative Diseases
Transglutaminase 2 expression induced by lipopolysaccharide stimulation together with NO synthase induction in cultured astrocytes.
Neurodegenerative Diseases
Transglutaminase 2 expression is enhanced synergistically by interferon-? and tumour necrosis factor-? in human small intestine.
Neurodegenerative Diseases
Transglutaminase 2 in neurodegenerative disorders.
Neurodegenerative Diseases
Transglutaminase 2 interaction with small heat shock proteins mediate cell survival upon excitotoxic stress.
Neurodegenerative Diseases
Transglutaminase 2 is involved in homocysteine-induced activation of human THP-1 monocytes.
Neurodegenerative Diseases
Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
Neurodegenerative Diseases
Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.
Neurodegenerative Diseases
Transglutaminase activation in neurodegenerative diseases.
Neurodegenerative Diseases
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Neurodegenerative Diseases
Transglutaminase as the agent of neurodegenerative diseases due to polyglutamine expansion.
Neurodegenerative Diseases
Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
Neurodegenerative Diseases
Transglutaminase is linked to neurodegenerative diseases.
Neurodegenerative Diseases
Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
Neurodegenerative Diseases
Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic.
Neurodegenerative Diseases
Transglutaminases - possible drug targets in human diseases.
Neurodegenerative Diseases
Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
Neurodegenerative Diseases
Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection.
Neurodegenerative Diseases
Up-regulation of tissue-type transglutaminase after traumatic brain injury.
Neurodegenerative Diseases
Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases.
Neurofibroma
Factor-XIIIa-positive cells in normal peripheral nerves and cutaneous neurofibromas of type-1 neurofibromatosis.
Neurofibroma
Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas.
Neuroinflammatory Diseases
Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1.
Neuroinflammatory Diseases
Transglutaminase 2 and neuroinflammation.
Neuroinflammatory Diseases
Transglutaminase 2 is involved in amyloid-beta1-42-induced pro-inflammatory activation via AP1/JNK signalling pathways in THP-1 monocytes.
Neurologic Manifestations
Anti-transglutaminase 6 Antibody Development in Children With Celiac Disease Correlates With Duration of Gluten Exposure.
Neurologic Manifestations
Can head trauma trigger celiac disease? Nation-wide case-control study.
Neurologic Manifestations
Neurologic Deficits in Patients With Newly Diagnosed Celiac Disease Are Frequent and Linked With Autoimmunity to Transglutaminase 6.
Neuromyelitis Optica
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Neurothekeoma
Multiple desmoplastic cellular neurothekeomas localized to the face of a 16-year-old boy.
Nevus
Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomas.
Nevus
Fibrous papule: a tumor of fibrohistiocytic cells that contain factor XIIIa.
Nevus
Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas.
Nevus
Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Nevus, Pigmented
Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas.
Nevus, Pigmented
Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
Non-alcoholic Fatty Liver Disease
Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2.
Non-alcoholic Fatty Liver Disease
Searching for coeliac disease in patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
[Study of celiac disease in patients with non-alcoholic fatty liver and autoimmune hepatic diseases]
Noonan Syndrome
Factor XIII Deficiency Associated With Noonan Syndrome.
Obesity
Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
Obesity
F13A1 transglutaminase expression in human adipose tissue increases in acquired excess weight and associates with inflammatory status of adipocytes.
Obesity
Factor XIII-A transglutaminase acts as a switch between preadipocyte proliferation and differentiation.
Obesity
Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet.
Obesity
Reductions in plasmin inhibitor and fibrinogen predict the improved fibrin clot lysis 6?months after obesity surgery.
Obesity, Metabolically Benign
Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet.
Ocular Hypertension
Knockout of tissue transglutaminase ameliorates TGF?2-induced ocular hypertension: A novel therapeutic target for glaucoma?
Optic Nerve Injuries
A novel activation mechanism of cellular Factor XIII in zebrafish retina after optic nerve injury.
Optic Nerve Injuries
Reciprocal Changes in Factor XIII and Retinal Transglutaminase Expressions in the Fish Retina During Optic Nerve Regeneration.
Optic Nerve Injuries
Upregulation of retinal transglutaminase during the axonal elongation stage of goldfish optic nerve regeneration.
Orchitis
Transglutaminase levels during development of allergic orchitis.
Osteoarthritis
Comparison of tissue transglutaminase 2 and bone biological markers osteocalcin, osteopontin and sclerostin expression in human osteoporosis and osteoarthritis.
Osteoarthritis
Fibrin dissolution in synovial fluid.
Osteoarthritis
Immunohistochemical detection of factor XIIIa and factor XIIIs in synovial membranes of patients with rheumatoid arthritis or osteoarthritis.
Osteoarthritis
Regulation of transglutaminase activity in articular chondrocytes through thrombin receptor-mediated factor XIII synthesis.
Osteoarthritis
Role of transglutaminase 2 in apoptosis induced by hydrogen peroxide in human chondrocytes.
Osteoarthritis
The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis.
Osteoarthritis
Transglutaminase 2 as a biomarker of osteoarthritis: an update.
Osteoarthritis
Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis.
Osteoarthritis
Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA.
Osteoarthritis
Transglutaminase contributes to CPPD crystal formation in osteoarthritis.
Osteoarthritis
Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis.
Osteoarthritis
Transglutaminase-2 regulates Wnt and FoxO3a signaling to determine the severity of osteoarthritis.
Osteophyte
Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis.
Osteoporosis
Celiac Disease: Ten Things That Every Gastroenterologist Should Know.
Osteoporosis
Coeliac disease-specific tissue transglutaminase autoantibodies are associated with osteoporosis and related fractures in middle-aged women.
Osteoporosis
Comparison of tissue transglutaminase 2 and bone biological markers osteocalcin, osteopontin and sclerostin expression in human osteoporosis and osteoarthritis.
Osteoporosis
HLA-DQ2/DQ8 frequency in adult patients with celiac disease, their first-degree relatives, and normal population in Turkey.
Osteoporosis
Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis.
Osteoporosis
Treatment of postmenopausal osteoporosis in a patient with celiac disease.
Osteoporosis
[Celiac disease--a frequent cause of "idiopathic osteoporosis" in premenopausal and early postmenopausal women]
Osteosarcoma
Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Osteosarcoma
Study of the mechanism underlying the inhibitory effects of transglutaminase II on apoptosis in the osteosarcoma MG-63 cell line under hypoxic conditions.
Osteosarcoma
Transglutaminase-2 is Involved in Cell Apoptosis of Osteosarcoma Cell Line U2OS Under Hypoxia Condition.
Osteosarcoma
Transglutaminase-2 Is Involved in Expression of Osteoprotegerin in MG-63 Osteosarcoma Cells.
Osteosarcoma
Transglutaminase-2 promotes metastatic and stem-like phenotypes in osteosarcoma.
Ovarian Neoplasms
Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking.
Ovarian Neoplasms
Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.
Ovarian Neoplasms
Extracellular tissue transglutaminase activates noncanonical NF-?B signaling and promotes metastasis in ovarian cancer.
Ovarian Neoplasms
siRNA Delivery Using Dithiocarbamate-Anchored Oligonucleotides on Gold Nanorods.
Ovarian Neoplasms
Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer.
Ovarian Neoplasms
Tissue transglutaminase links TGF-?, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
Ovarian Neoplasms
Tissue transglutaminase regulates interactions between ovarian cancer stem cells and the tumor niche.
Ovarian Neoplasms
Tissue transglutaminase regulates MMP-2 in ovarian cancer by modulating CREB activity.
Ovarian Neoplasms
Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.
Overweight
Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
Overweight
Patients with celiac disease may have normal weight or may even be overweight.
Overweight
Thrombotic tendency in diabetes mellitus. Revisiting and revising a study initiated 30 years ago.
Pancreatic Neoplasms
Application of a Global Proteomic Approach to Archival Precursor Lesions: Deleted in Malignant Brain Tumors 1 and Tissue Transglutaminase 2 Are Upregulated in Pancreatic Cancer Precursors.
Pancreatic Neoplasms
Biological and therapeutic significance of tissue transglutaminase in pancreatic cancer.
Pancreatic Neoplasms
Ethacrynic Acid Inhibits Sphingosylphosphorylcholine-Induced Keratin 8 Phosphorylation and Reorganization via Transglutaminase-2 Inhibition.
Pancreatic Neoplasms
Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
Pancreatic Neoplasms
PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells.
Pancreatic Neoplasms
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
Pancreatic Neoplasms
Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer.
Pancreatic Neoplasms
Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.
Pancreatic Neoplasms
Tissue transglutaminase induces the release of apoptosis inducing factor and results in apoptotic death of pancreatic cancer cells.
Pancreatic Neoplasms
Tissue transglutaminase inhibits autophagy in pancreatic cancer cells.
Pancreatic Neoplasms
Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression.
Pancreatic Neoplasms
Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
Pancreatitis, Chronic
There Is No Association between Coeliac Disease and Autoimmune Pancreatitis.
Papilloma
Alterations in cholesterol sulfate and its biosynthetic enzyme during multistage carcinogenesis in mouse skin.
Papilloma
Choroid Plexus Papilloma and Factor XIII Deficiency: Case Report.
Papilloma
Cultivation and characterization of cells derived from mouse skin papillomas induced by an initiation-promotion protocol.
Papilloma, Choroid Plexus
Choroid Plexus Papilloma and Factor XIII Deficiency: Case Report.
Papillomavirus Infections
Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix.
Parakeratosis
Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14.
Parakeratosis
Changes in photo-aged human skin following topical application of all-trans retinoic acid.
Parakeratosis
Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin.
Paralysis
Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.
Paralysis
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Paralysis
Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
Paralysis
Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases.
Paralysis
Possible role of the transglutaminases in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases.
Paralysis
Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
Paralysis
Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
Paralysis
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Paralysis
Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy.
Paralysis
Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
Paralysis
Transglutaminase is linked to neurodegenerative diseases.
Paralysis
Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
Paralysis
Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic.
Paralysis
Transglutaminases - possible drug targets in human diseases.
Paralysis
Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
Paraplegia
Intraspinal hemorrhage in a child with factor XIII deficiency.
Paraproteinemias
Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure.
Paraproteinemias
Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
Paraproteinemias
[Intradural hematoma of the foramen magnum associated with factor XIII deficiency]
Parkinson Disease
Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of ?-synuclein in a cellular model of Parkinson's disease.
Parkinson Disease
Dissecting the Mechanisms of Tissue Transglutaminase-induced Cross-linking of {alpha}-Synuclein: IMPLICATIONS FOR THE PATHOGENESIS OF PARKINSON DISEASE.
Parkinson Disease
Elevated concentration of cerebrospinal fluid tissue transglutaminase in Parkinson's disease indicating apoptosis.
Parkinson Disease
Identification of brain substrates of transglutaminase by functional proteomics supports its role in neurodegenerative diseases.
Parkinson Disease
Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease.
Parkinson Disease
Inflammatory mediators resulting from transglutaminase 2 expressed in mast cells contribute to the development of Parkinson's disease in a mouse model.
Parkinson Disease
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Parkinson Disease
Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
Parkinson Disease
Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases.
Parkinson Disease
Possible role of the transglutaminases in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases.
Parkinson Disease
Presence of Tissue Transglutaminase in Granular Endoplasmic Reticulum is Characteristic of Melanized Neurons in Parkinson's Disease Brain.
Parkinson Disease
Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
Parkinson Disease
TGM6 variants in Parkinson's disease: clinical findings and functional evidence.
Parkinson Disease
The multifaceted role of transglutaminase in neurodegeneration: review article.
Parkinson Disease
Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease.
Parkinson Disease
Tissue transglutaminase cross-links beclin 1 and regulates autophagy in MPP(+)-treated human SH-SY5Y cells.
Parkinson Disease
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.
Parkinson Disease
Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.
Parkinson Disease
Transglutaminase 2 is involved in homocysteine-induced activation of human THP-1 monocytes.
Parkinson Disease
Transglutaminase activation in neurodegenerative diseases.
Parkinson Disease
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Parkinson Disease
Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
Parkinson Disease
Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation.
Parkinson Disease
Transglutaminase is linked to neurodegenerative diseases.
Parkinson Disease
Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
Parkinson Disease
Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic.
Parkinson Disease
Transglutaminases - possible drug targets in human diseases.
Parkinson Disease
Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
Pemphigoid Gestationis
A subset of patients with pemphigoid (herpes) gestationis has serological evidence of celiac disease.
Pemphigoid, Bullous
Concomitant bullous pemphigoid and dermatitis herpetiformis.
Pemphigoid, Bullous
Differentiation of normal and tumoral human keratinocytes cultured on dermis: reconstruction of either normal or tumoral architecture.
Pemphigoid, Bullous
Reconstructed human epidermis: a model to study in vitro the barrier function of the skin.
Pemphigoid, Bullous
Selective plasma exchange can reduce auto-antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogen.
Pemphigoid, Bullous
The genetics of human skin diseases.
Pemphigus
Selective Plasma Exchange for the Removal of Pemphigus Autoantibodies, Fibrinogen, and Factor XIII in Pemphigus Vulgaris.
Peptic Ulcer
Frequency of Celiac Disease in Children with Peptic Ulcers.
Peptic Ulcer
[The healing process of peptic ulcer and coagulation factor XIII]
Perinatal Death
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase).
Periodontal Diseases
Gingival crevicular fluid and plasma oxidative stress markers and TGM-2 levels in chronic periodontitis.
Periodontitis
Inhibition of transglutaminase activity in periodontitis rescues periodontal ligament collagen content and architecture.
Periodontitis
[?linicmolecular indicators of inflammatory destructive damage of the oral cavity in periodontitis in persons with various group accessories of blood.]
Peripheral Arterial Disease
Elevated factor XIII level and the risk of peripheral artery disease.
Peripheral Arterial Disease
The V34L polymorphism of factor XIII and peripheral arterial disease.
Peripheral Nerve Injuries
Retrograde changes in transglutaminase activity after peripheral nerve injuries.
Peripheral Nervous System Diseases
Anti-tissue transglutaminase IgA antibodies in peripheral neuropathy and motor neuronopathy.
Peripheral Nervous System Diseases
Neuropathy associated with gluten sensitivity.
Peripheral Nervous System Diseases
Quality of Life in Patients with Gluten Neuropathy: A Case-Controlled Study.
Peripheral Nervous System Diseases
Transglutaminase 6 antibodies in gluten neuropathy.
Peripheral Vascular Diseases
Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular disease.
Pheochromocytoma
Isolation and characterization of brain-specific transglutaminases from rat.
Pheochromocytoma
Two types of transglutaminase in the PC12 pheochromocytoma cell line. Stimulation by sodium butyrate.
Phyllodes Tumor
Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Pityriasis
Tissue immunostaining for factor XIIIa in dermal dendrocytes of pityriasis alba skin lesions.
Plasmacytoma
Factor XIII deficiency in BALB/c mice with plasmacytoma.
Platelet Storage Pool Deficiency
The gene encoding protein 4.2 is distinct from the mouse platelet storage pool deficiency mutation pallid.
Platelet Storage Pool Deficiency
The murine pallid mutation is a platelet storage pool disease associated with the protein 4.2 (pallidin) gene.
Pleural Effusion
Erratum to Recombinant Factor XIII Reduces Severe Pleural Effusion in Children after Open-Heart Surgery.
Pleural Effusion
Management of Aortic Replacement-Induced Chylothorax by Lipiodol Lymphography.
Pleural Effusion
Recombinant Factor XIII Reduces Severe Pleural Effusion in Children after Open-Heart Surgery.
Pneumonia
A Peptide with anti-transglutaminase activity decreases lipopolysaccharide-induced lung inflammation in mice.
Pneumonia
Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice.
Pneumonia
Impact of perioperative peripheral blood values on postoperative complications after esophageal surgery.
Pneumonia
Regulation of allergic lung inflammation by endothelial cell transglutaminase 2.
Pneumothorax
The treatment of refractory pneumothorax in diffuse panbronchiolitis by intravenous administration of coagulation factor XIII concentrate.
Poliomyelitis
[Inactivation of viruses in Factor XIII concentrate by pasteurization]
Polycystic Kidney, Autosomal Dominant
Factor XIII deficiency in adult polycystic kidney disease.
Polycythemia
Coagulation factor XIII in pregnant smokers and non-smokers.
Polycythemia
Is Embolization an Effective Treatment for Recurrent Hemorrhage After Hip or Knee Arthroplasty?
Polycythemia Vera
Is Embolization an Effective Treatment for Recurrent Hemorrhage After Hip or Knee Arthroplasty?
Polydactyly
Characterization of polydactyly chondrocytes and their use in cartilage engineering.
Polyneuropathies
IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy.
Postpartum Hemorrhage
Medical and Surgical Management of Postpartum Hemorrhage in a Woman with Factor XIII Deficiency.
Pre-Eclampsia
Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia.
Pre-Eclampsia
OS057. Pathophysiological role of elevated tissue transglutaminase in autoantibody-induced features of preeclampsia in pregnant mice.
Pre-Eclampsia
Preeclampsia and its interaction with common variants in thrombophilia genes.
Pre-Eclampsia
The G-to-T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia.
Pre-Eclampsia
The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Pre-Eclampsia
Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.
Pre-Eclampsia
[Coagulation-fibrinolysis and kinin-forming systems in toxemia of pregnancy]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Effect of Tissue Transglutaminase on Steroid Resistance in T-Cell Acute Lymphoblastic Leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Expression of Coagulation Factor XIII Subunit A Correlates with Outcome in Childhood Acute Lymphoblastic Leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Expression Patterns of Coagulation Factor XIII Subunit A on Leukemic Lymphoblasts Correlate with Clinical Outcome and Genetic Subtypes in Childhood B-cell Progenitor Acute Lymphoblastic Leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Influences of clotting factors (thrombin, factor XIII) and of fibronectin on the growth of tumor cells and leukemic cells in vitro.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Influences of thrombin, factor XIII and fibronectin on the growth of tumor cells and leukemic cells in vitro.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Effect of Tissue Transglutaminase on Steroid Resistance in T-Cell Acute Lymphoblastic Leukemia.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL).
Pregnancy Complications
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications.
Pregnancy Complications
Tissue transglutaminase on trophoblast cells as a possible target of autoantibodies contributing to pregnancy complications in celiac patients.
Pregnancy, Ectopic
Proteinase and proteinase inhibitor localization in the human placenta.
Pressure Ulcer
The role of plasma transglutaminase (F XIII) in wound healing of complicated pressure sores after spinal cord injury.
Primary Myelofibrosis
[Acute malignant myelofibrosis complicated by factor XIII deficiency, protein C decrease and skin necroses]
Prostatic Hyperplasia
Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines.
Prostatic Hyperplasia
Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma.
Prostatic Neoplasms
?-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins.
Prostatic Neoplasms
Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells.
Prostatic Neoplasms
Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer.
Prostatic Neoplasms
Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Prostatic Neoplasms
Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer.
Prostatic Neoplasms
Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines.
Prostatic Neoplasms
Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers.
Prostatic Neoplasms
Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.
Prostatic Neoplasms
Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes.
Prostatic Neoplasms
Pan-cadherin as a high level phenotypic biomarker for prostate cancer.
Prostatic Neoplasms
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.
Prostatic Neoplasms
Prostate Transglutaminase (TGase-4) Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells.
Prostatic Neoplasms
Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain.
Prostatic Neoplasms
Prostate transglutaminase: a unique transglutaminase and its role in prostate cancer.
Prostatic Neoplasms
The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.
Prostatic Neoplasms
The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells.
Prostatic Neoplasms
The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancer.
Prostatic Neoplasms
Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.
Prostatic Neoplasms
Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer.
Prostatic Neoplasms
Tissue-type transglutaminase expression in the Dunning tumor.
Prostatitis
Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma.
Protein Deficiency
Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population.
Protein Deficiency
Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency.
Protein Deficiency
Red cell membrane protein deficiencies in Mexican patients with hereditary spherocytosis.
Protein-Energy Malnutrition
Intestinal Pseudo-Obstruction and Total Villous Atrophy of the Terminal Ileum: An Unusual Presentation of Untreated Celiac Disease.
protein-glutamine gamma-glutamyltransferase deficiency
A case of congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
A case of deficiency of plasma plasminogen activator inhibitor-1 related to Ala15Thr mutation in its signal peptide.
protein-glutamine gamma-glutamyltransferase deficiency
A case of factor XIII deficiency in an adult male.
protein-glutamine gamma-glutamyltransferase deficiency
A case of giant expanding cephalhematoma: does the administration of blood coagulation factor XIII reverse symptoms?
protein-glutamine gamma-glutamyltransferase deficiency
A child with acquired factor XIII deficiency: case report and literature review.
protein-glutamine gamma-glutamyltransferase deficiency
A clinical and family study of factor XIII deficiency in a New Zealand family.
protein-glutamine gamma-glutamyltransferase deficiency
A common F13A1 intron 1 variant IVS1+12(A) is associated with mild FXIII deficiency in Caucasian population.
protein-glutamine gamma-glutamyltransferase deficiency
A contribution to the pathology of acquired plasma factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
protein-glutamine gamma-glutamyltransferase deficiency
A fluorescent spot test for coagulation factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
A large case series on surgical outcomes in congenital factor XIII deficiency patients in Iran.
protein-glutamine gamma-glutamyltransferase deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
protein-glutamine gamma-glutamyltransferase deficiency
A new era of therapy for congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
A novel compound heterozygous mutation in the F13A gene causing hereditary factor XIII deficiency in a Chinese family.
protein-glutamine gamma-glutamyltransferase deficiency
A novel Cys328-terminator mutant implicated in severe coagulation factor XIII deficiency: a case report.
protein-glutamine gamma-glutamyltransferase deficiency
A novel mutation causing an aberrant splicing in the protein 4.2 gene associated with hereditary spherocytosis (protein 4.2Notame).
protein-glutamine gamma-glutamyltransferase deficiency
A novel mutation in the erythrocyte protein 4.2 gene of Japanese patients with hereditary spherocytosis (protein 4.2 Fukuoka).
protein-glutamine gamma-glutamyltransferase deficiency
A Rare Case of Factor XIII Deficiency in the Setting of Cancer Immunotherapy.
protein-glutamine gamma-glutamyltransferase deficiency
A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
A tentative classification of factor XIII deficiency in two groups.
protein-glutamine gamma-glutamyltransferase deficiency
Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosis.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired coagulation factor XIII deficiency: a case report.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired factor XIII deficiency after desensitization as a potential contributor to postoperative bleeding: more than meets the eye.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired factor XIII deficiency in a child with pure erythroid leukemia.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired factor XIII deficiency in patients under therapeutic plasma exchange: A poorly explored etiology.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired factor XIII deficiency in two patients with bleeding events during veno-venous extracorporeal membrane oxygenation treatment.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired Factor XIII Deficiency Inducing Recurrent and Fatal Bleeding, Description of a Case.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired factor XIII deficiency with chronic myelomonocytic leukemia.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired factor XIII deficiency: A review.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired factor XIII deficiency: a therapeutic challenge.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired Factor Xiii Deficiency: An Uncommon But Easily Missed Cause Of Severe Bleeding
protein-glutamine gamma-glutamyltransferase deficiency
Acquired factor XIII deficiency: still a clinical challenge in the era of novel therapy.
protein-glutamine gamma-glutamyltransferase deficiency
Acquired plasma factor XIII deficiencies.
protein-glutamine gamma-glutamyltransferase deficiency
Activation of Molecular Signatures for Antimicrobial and Innate Defense Responses in Skin with Transglutaminase 1 Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Acute Abdomen in a Young Girl with Factor XIII Deficiency Perianesthetic Issues.
protein-glutamine gamma-glutamyltransferase deficiency
Acute abdomen in a young girl with factor XIII deficiency: Perianesthetic issues.
protein-glutamine gamma-glutamyltransferase deficiency
Acute and diffuse postoperative bleeding after free latissimus dorsi flap--Factor XIII deficiency: a case report and review of the literature.
protein-glutamine gamma-glutamyltransferase deficiency
Acute kidney injury is associated with low factor XIII in decompensated cirrhosis.
protein-glutamine gamma-glutamyltransferase deficiency
Acute promyelocytic leukaemia associated Factor XIII deficiency presenting as retro-bulbar haematoma.
protein-glutamine gamma-glutamyltransferase deficiency
An acquired inhibitor to factor XIII A case report.
protein-glutamine gamma-glutamyltransferase deficiency
An electrophoretic and quantitative analysis of coagulation factor XIII in normal and deficient subjects.
protein-glutamine gamma-glutamyltransferase deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
protein-glutamine gamma-glutamyltransferase deficiency
An unusual case of factor xiii deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.
protein-glutamine gamma-glutamyltransferase deficiency
An update of the mutation profile of Factor 13 A and B genes.
protein-glutamine gamma-glutamyltransferase deficiency
Analytical and clinical utility of a photometric assay for blood coagulation factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
Application of HUMF13A01 (AAAG)n STR polymorphism to the genetic diagnosis of coagulation factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Arg260-Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics.
protein-glutamine gamma-glutamyltransferase deficiency
Arthropathy associated with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan.
protein-glutamine gamma-glutamyltransferase deficiency
Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine.
protein-glutamine gamma-glutamyltransferase deficiency
Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients.
protein-glutamine gamma-glutamyltransferase deficiency
Autoimmune Acquired Factor XIII Deficiency: A Case Report.
protein-glutamine gamma-glutamyltransferase deficiency
Autoimmune factor XIII deficiency with unusual laboratory and clinical phenotype.
protein-glutamine gamma-glutamyltransferase deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
protein-glutamine gamma-glutamyltransferase deficiency
Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies.
protein-glutamine gamma-glutamyltransferase deficiency
Benefits of thromboelastometry for monitoring replacement therapy in patients with severe inherited factor XIII deficiency: 3 illustrative cases.
protein-glutamine gamma-glutamyltransferase deficiency
Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature.
protein-glutamine gamma-glutamyltransferase deficiency
Blood coagulation factor XIII and factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Blood factor XIII deficiency: review of literature and report of case.
protein-glutamine gamma-glutamyltransferase deficiency
Case report of an acquired factor XIII inhibitor: diagnosis and management.
protein-glutamine gamma-glutamyltransferase deficiency
Central nervous system bleeding in pediatric patients with factor XIII deficiency: A study on 23 new cases.
protein-glutamine gamma-glutamyltransferase deficiency
Cerebral thrombosis associated with heterozygous factor V Leiden mutation and high lipoprotein(a) level in a girl with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder.
protein-glutamine gamma-glutamyltransferase deficiency
Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population.
protein-glutamine gamma-glutamyltransferase deficiency
Choroid Plexus Papilloma and Factor XIII Deficiency: Case Report.
protein-glutamine gamma-glutamyltransferase deficiency
Claw toes correction and factor XIII deficiency--a case report.
protein-glutamine gamma-glutamyltransferase deficiency
Clinical and laboratory features of congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
protein-glutamine gamma-glutamyltransferase deficiency
Clinical audit of inherited bleeding disorders in a developing country.
protein-glutamine gamma-glutamyltransferase deficiency
Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK mallorca.
protein-glutamine gamma-glutamyltransferase deficiency
Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
protein-glutamine gamma-glutamyltransferase deficiency
Coagulation factor XIII in pregnant smokers and non-smokers.
protein-glutamine gamma-glutamyltransferase deficiency
Coagulation management in patients undergoing mechanical circulatory support.
protein-glutamine gamma-glutamyltransferase deficiency
Combined occurrence of von Willebrand's disease and factor XIII deficiency: a case report.
protein-glutamine gamma-glutamyltransferase deficiency
Comparison of 2 Methods of Clot Solubility Testing in Detection of Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Concurrent hematoma and venous thrombosis in a patient with autoimmune acquired factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital afibrinogenemia in a new born: a rare cause for bleeding.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital blood coagulation factor XIII deficiency and perinatal management.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital deficiency of factor XIII with normal subunit S and lack of subunit A. Report of a new family.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency and increased fibrinolysis. A case report.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency associated with von Willebrand disease.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency in a neonate.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency in women: a systematic review of literature.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital Factor XIII Deficiency With the Presence of Inhibitor: A Case Study.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency. A family report.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency. Report of 2 cases.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency: a case report and review of literature.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency: A commentary on 'Homozygous intronic mutation leading to inefficient transcription combined with a novel frame-shift mutation in F13A1 gene causes FXIII deficiency'.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency: a patient report and review of the literature.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency: report of a case and literature review.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency: two case reports.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital factor XIII deficiency: type I and type II disease.
protein-glutamine gamma-glutamyltransferase deficiency
Congenital hemorrhagic disorders in Jordan.
protein-glutamine gamma-glutamyltransferase deficiency
Corifact/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
protein-glutamine gamma-glutamyltransferase deficiency
Corpus luteal hemorrhage: an unusual manifestation of congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
COVID-19 is Associated with an Acquired Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Cranial hemophilic pseudotumor associated with factor IX deficiency: case report.
protein-glutamine gamma-glutamyltransferase deficiency
Current understanding in diagnosis and management of factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
De Novo Precursor B-Lymphoblastic Leukemia/Lymphoma With Double-Hit Gene Rearrangements (MYC/BCL-2) Presented With Spinal Cord Compression and Acquired Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Defective ?2 antiplasmin cross-linking and thrombus stability in a case of acquired factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Defective fibrin crosslinking in acute leukemia.
protein-glutamine gamma-glutamyltransferase deficiency
Deficiency of factor XIII gene in Chinese: 3 novel mutations.
protein-glutamine gamma-glutamyltransferase deficiency
Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding.
protein-glutamine gamma-glutamyltransferase deficiency
Delayed umbilical bleeding--a presenting feature for factor XIII deficiency: clinical features, genetics, and management.
protein-glutamine gamma-glutamyltransferase deficiency
Dental Management of Factor XIII Deficiency Patients: A Case Series.
protein-glutamine gamma-glutamyltransferase deficiency
Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories.
protein-glutamine gamma-glutamyltransferase deficiency
Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
protein-glutamine gamma-glutamyltransferase deficiency
Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes.
protein-glutamine gamma-glutamyltransferase deficiency
Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.
protein-glutamine gamma-glutamyltransferase deficiency
Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1.
protein-glutamine gamma-glutamyltransferase deficiency
Diagnosis and management of severe congenital factor XIII deficiency in the Emergency Department: lessons from a "model" family.
protein-glutamine gamma-glutamyltransferase deficiency
Diagnosis of factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders.
protein-glutamine gamma-glutamyltransferase deficiency
Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran.
protein-glutamine gamma-glutamyltransferase deficiency
DNA methylation in promoter regions of red cell membrane protein genes in healthy individuals and patients with hereditary membrane disorders.
protein-glutamine gamma-glutamyltransferase deficiency
Documentation of the plasma factor XIII deficiency in man.
protein-glutamine gamma-glutamyltransferase deficiency
Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
protein-glutamine gamma-glutamyltransferase deficiency
Effect of four missense mutations in the factor XIII A-subunit gene on protein stability: studies with recombinant proteins.
protein-glutamine gamma-glutamyltransferase deficiency
Effect of Social Factors on the Highest Global Incidence of Congenital Factor XIII Deficiency in Southeast of Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests.
protein-glutamine gamma-glutamyltransferase deficiency
Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
protein-glutamine gamma-glutamyltransferase deficiency
Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Electroimmunoassay of plasma subunits-a and -s in a case of congenital fibrin stabilizing factor deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Erythropoiesis: Hereditary Spherocytosis in Greece: Collective Data on a Large Number of Patients.
protein-glutamine gamma-glutamyltransferase deficiency
Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran.
protein-glutamine gamma-glutamyltransferase deficiency
ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group.
protein-glutamine gamma-glutamyltransferase deficiency
Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47.
protein-glutamine gamma-glutamyltransferase deficiency
Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage.
protein-glutamine gamma-glutamyltransferase deficiency
Factor concentrates for the treatment of factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII and its deficiency - review literature and the case report of a Thai boy with congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII as a modulator of plasma fibronectin alterations during experimental bacteremia.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency (fibrin stabilizing factor).
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency and head trauma: management and therapy.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency and intracranial hemorrhages in infancy.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency as a potential cause of supratentorial haemorrhage after posterior fossa surgery.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency associated with Klippel-Weber disease, platelet dysfunction and cryofibrinogenemia.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Deficiency Associated With Noonan Syndrome.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency associated with valproate treatment.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency causing mutation, Ser295Arg, in exon 7 of the factor XIIIA gene.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency diagnosis: Challenges and tools.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency does not prevent FeCl3-induced carotid artery thrombus formation in mice.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit-a gene in three unrelated Palestinian Arab families.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency in adult polycystic kidney disease.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency in antibiotic-associated pseudomembranous colitis and its treatment with factor XIII concentrate.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency in BALB/c mice with plasmacytoma.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Deficiency in Children-Clinical Presentation and Outcome.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency in Henoch-Schönlein purpura - report on two cases and literature review.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Deficiency in Iran: A Comprehensive Review of the Literature.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency in Pakistan.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Deficiency in Siblings: Importance of Prophylactic Replacement.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency in south of Tunisia.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency in south-east Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency in two Melanesian families from Papua New Guinea.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Deficiency in Western Afghanistan due to a Novel F13A Gene Mutation.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency leading to preseptal haematoma post-strabismus surgery.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency management: a review of the literature.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency mistaken for battered child syndrome: case of "correct" test ordering negated by a commonly accepted qualitative test with limited negative predictive value.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency presenting with intracerebral bleed.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency related recurrent spontaneous intracerebral hemorrhage: A case and literature review.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency revealed by spontaneous intramedullary hemorrhage: confirmation of a severe mutation.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Deficiency with a Novel Nonsense Mutation.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency with intracranial haemorrhage.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency. A family study by measurement of factor XIII subunits A and S.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency. A rare haemorrhagic disease.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency. Treatment with monthly plasma infusions.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency: a differential diagnosis to be considered in suspected nonaccidental injury presenting with intracranial hemorrhage.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency: a genetic study of two affected kindreds in Finland.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency: a rare cause of repeated abortions.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII Deficiency: An Update.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency: new nonsense and deletion mutations in the human factor XIIIA gene.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency: pathogenic mechanisms and clinical significance.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency: report of a case complicated by splenic rupture.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII deficiency: report of two cases.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII levels in five families of patients with inherited factor XIII deficiency: support for an autosomal recessive inheritance.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII mutation spectrum in Iranian patients with hereditary factor XIII deficiency: Detection of 3 novel mutations.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
Factor XIIIA Calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit.
protein-glutamine gamma-glutamyltransferase deficiency
Fibrin cross-linking in congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Fibrinogen but not factor XIII deficiency is associated with bleeding after craniotomy.
protein-glutamine gamma-glutamyltransferase deficiency
Fibronectin and wound healing.
protein-glutamine gamma-glutamyltransferase deficiency
First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Fracture neck of femur in Factor XIII deficiency: Was better outcome possible?
protein-glutamine gamma-glutamyltransferase deficiency
Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
FXIII deficiency due to base exchange Thr 449 (ACT) --> Ile (ATT) in exon 11 of the factor 13A gene. A cause of bleeding?
protein-glutamine gamma-glutamyltransferase deficiency
Gene defects in congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Genetic aspects of factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Genetic basis of severe factor XIII deficiency in a large cohort of Indian patients: Identification of fourteen novel mutations.
protein-glutamine gamma-glutamyltransferase deficiency
Genetic heterogeneity of factor XIII deficiency: first description of unstable A subunits.
protein-glutamine gamma-glutamyltransferase deficiency
Glanzmann's thrombasthenia in a Melanesian.
protein-glutamine gamma-glutamyltransferase deficiency
Guidelines for laboratory diagnosis of factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Hemophiliacs--a picture from a developing country: Karnataka, a south Indian state.
protein-glutamine gamma-glutamyltransferase deficiency
Hemorrhagic Shock after Neonatal Circumcision: Severe Congenital Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.
protein-glutamine gamma-glutamyltransferase deficiency
Hemostasis in Crohn's disease: low factor XIII levels in active disease.
protein-glutamine gamma-glutamyltransferase deficiency
Hereditary factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Hereditary factor XIII deficiency: report of four families and definition of the carrier state.
protein-glutamine gamma-glutamyltransferase deficiency
Hereditary spherocytosis with spectrin deficiency due to an unstable truncated beta spectrin.
protein-glutamine gamma-glutamyltransferase deficiency
Homozygous missense mutation (band 3 Fukuoka: G130R): a mild form of hereditary spherocytosis with near-normal band 3 content and minimal changes of membrane ultrastructure despite moderate protein 4.2 deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
How to deal with medical and social aspects of bleeding disorders--preparing women and the family in developing countries.
protein-glutamine gamma-glutamyltransferase deficiency
Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40glutamic acid-->lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore).
protein-glutamine gamma-glutamyltransferase deficiency
Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies.
protein-glutamine gamma-glutamyltransferase deficiency
Identification and characterization of two missense mutations causing factor XIIIA deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Identification of a new Leu354Pro mutation responsible for factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Identification of a new mutation (Gly420Ser), distal to the active site, that leads to factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Identification of a Novel Mutation Combination in Factor XIII Deficiency: Genetic Update to the First Reported Case in the United States.
protein-glutamine gamma-glutamyltransferase deficiency
Identification of a novel nonsense mutation leading to congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy.
protein-glutamine gamma-glutamyltransferase deficiency
Identification of an inframe deletion and a missense mutation in the factor XIIIA gene in two Turkish patients.
protein-glutamine gamma-glutamyltransferase deficiency
Identification of novel pathogenic F13A1 mutation and novel NBEAL2 gene missense mutation in a pedigree with hereditary congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Identification of two novel missense mutations causing severe factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Immunotolerance approach to refractory CNS bleeding in a patient with congenital factor XIII deficiency and acquired alloantibody.
protein-glutamine gamma-glutamyltransferase deficiency
Impact of Rare Bleeding Disorders during Pregnancy on Maternal and Fetal Outcomes: Review of 29 Pregnancies at a Single Center.
protein-glutamine gamma-glutamyltransferase deficiency
Impaired dimer assembly and decreased stability of naturally recurring R260C mutant A subunit for coagulation factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis.
protein-glutamine gamma-glutamyltransferase deficiency
In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
protein-glutamine gamma-glutamyltransferase deficiency
Induction of hemodialysis therapy in a case with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
protein-glutamine gamma-glutamyltransferase deficiency
Inherited bleeding disorders in pregnancy.
protein-glutamine gamma-glutamyltransferase deficiency
Inherited factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
International registry on factor XIII deficiency: a basis formed mostly on European data.
protein-glutamine gamma-glutamyltransferase deficiency
Intracranial haemorrhage in patients with congenital haemostatic defects.
protein-glutamine gamma-glutamyltransferase deficiency
Intracranial hemorrhage in congenital deficiency of factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
Intracranial hemorrhage pattern in the patients with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Intracranial Hemorrhage: A Devastating Outcome of Congenital Bleeding Disorders-Prevalence, Diagnosis, and Management, with a Special Focus on Congenital Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Intraspinal hemorrhage in a child with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Investigating the key membrane protein changes during in vitro erythropoiesis of protein 4.2 (-) cells (mutations Chartres 1 and 2).
protein-glutamine gamma-glutamyltransferase deficiency
Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening tests.
protein-glutamine gamma-glutamyltransferase deficiency
Is Embolization an Effective Treatment for Recurrent Hemorrhage After Hip or Knee Arthroplasty?
protein-glutamine gamma-glutamyltransferase deficiency
Is extracorporeal CO2-Removal really "safe" and "less" invasive? Observation of blood injury and coagulation impairment during ECCO2R.
protein-glutamine gamma-glutamyltransferase deficiency
Laboratory Diagnosis of Factor XIII Deficiency in Developing Countries: An Iranian Experience.
protein-glutamine gamma-glutamyltransferase deficiency
Laboratory Diagnosis of Factor XIII Deficiency, Routine Coagulation Tests with Quantitative and Qualitative Methods.
protein-glutamine gamma-glutamyltransferase deficiency
Laboratory testing for bleeding disorders: strategic uses of high and low-yield tests.
protein-glutamine gamma-glutamyltransferase deficiency
Lobar Hemorrhage Induced by Acquired Factor XIII Deficiency in a Patient with Cerebral Amyloid Angiopathy.
protein-glutamine gamma-glutamyltransferase deficiency
Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®.
protein-glutamine gamma-glutamyltransferase deficiency
Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.
protein-glutamine gamma-glutamyltransferase deficiency
Low levels of fibrin-stabilizing factor (factor XIII) in human Plasmodium falciparum malaria: correlation with clinical severity.
protein-glutamine gamma-glutamyltransferase deficiency
Low prevalence of antibodies against human immunodeficiency virus in Finnish haemophiliacs.
protein-glutamine gamma-glutamyltransferase deficiency
Male fertility in factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Management of acute myocardial infarction in a patient with factor XIII deficiency using prophylactic factor replacement therapy.
protein-glutamine gamma-glutamyltransferase deficiency
Management of Dilutional Coagulopathy during Pediatric Major Surgery.
protein-glutamine gamma-glutamyltransferase deficiency
Management of Neuraxial Analgesia in a Parturient with Factor XIII Deficiency: A Case Report and Proposed Management Algorithm.
protein-glutamine gamma-glutamyltransferase deficiency
Management of pregnancy and delivery in women with inherited bleeding disorders.
protein-glutamine gamma-glutamyltransferase deficiency
Massive recurrent post-tonsillectomy bleedings revealing a transient factor XIII deficiency in a 10-year-old boy. A case report.
protein-glutamine gamma-glutamyltransferase deficiency
Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell.
protein-glutamine gamma-glutamyltransferase deficiency
Medical and Surgical Management of Postpartum Hemorrhage in a Woman with Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Melanoma associated with subacute primitive fibrinolysis.
protein-glutamine gamma-glutamyltransferase deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
protein-glutamine gamma-glutamyltransferase deficiency
Mild Acquired Factor XIII Deficiency and Clinical Relevance at the ICU-A Retrospective Analysis.
protein-glutamine gamma-glutamyltransferase deficiency
Mild factor XIII deficiency and concurrent hypofibrinogenemia: effect of pregnancy.
protein-glutamine gamma-glutamyltransferase deficiency
Mining of mortality-related findings in rare bleeding disorders: a retrospective study from two centers.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular analysis in factor XIIIA deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular and genetic mechanisms of factor XIII A subunit deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular Basis of Congenital Factor XIII Deficiency in Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular characterization of five Italian families with inherited severe factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular diagnosis of factor XIII deficiency, data from comprehensive coagulation laboratory in Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular genetic analysis of ten unrelated Iranian patients with congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular mechanisms of mutations in factor XIII A-subunit deficiency: in vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system.
protein-glutamine gamma-glutamyltransferase deficiency
Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Mutations causing coagulation factor XIII subunit A deficiency: characterization of the mutant proteins after expression in yeast.
protein-glutamine gamma-glutamyltransferase deficiency
Mutations in coagulation factor XIII A gene in eight unrelated Indians. Five novel mutations identified by a novel PCR-CSGE approach.
protein-glutamine gamma-glutamyltransferase deficiency
Mutations in coagulation factor XIII subunit A in severe factor XIII deficiency patients: five novel mutations detected.
protein-glutamine gamma-glutamyltransferase deficiency
Neonatal factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Neoplasm-induced bleeding in inherited, heterozygous FXIII-A deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
New developments in the management of congenital Factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
New mutations causing the premature termination of translation in the A subunit gene of coagulation factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
Nonhemophiliac musculoskeletal pseudotumor.
protein-glutamine gamma-glutamyltransferase deficiency
Nonimmune-acquired factor XIII deficiency: a cause of high volume and delayed postoperative hemorrhage.
protein-glutamine gamma-glutamyltransferase deficiency
Nonsyndromic types of ichthyoses - an update.
protein-glutamine gamma-glutamyltransferase deficiency
Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Novel aspects of factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Novel deep intronic mutation in the coagulation factor XIII a chain gene leading to unexpected RNA splicing in a patient with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Novel deletion and insertion mutations cause splicing defects, leading to severe reduction in mRNA levels of the A subunit in severe factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Novel Factor XIII variant identified through whole-genome sequencing in a child with intracranial hemorrhage.
protein-glutamine gamma-glutamyltransferase deficiency
Novel human pathological mutations. Gene symbol: F13A1. Disease: Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk.
protein-glutamine gamma-glutamyltransferase deficiency
Novel Y283C mutation of the A subunit for coagulation factor XIII: molecular modelling predicts its impaired protein folding and dimer formation.
protein-glutamine gamma-glutamyltransferase deficiency
Occurrence and recurrence of spontaneous chronic subdural haematoma is associated with a factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Ocular complications of factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
On the retraction of collagen and fibrin induced by normal, defective and modified platelets.
protein-glutamine gamma-glutamyltransferase deficiency
Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection.
protein-glutamine gamma-glutamyltransferase deficiency
Optimisation of a new continuous UV assay for the determination of blood coagulation factor XIII activity in human plasma.
protein-glutamine gamma-glutamyltransferase deficiency
Original tandem duplication in FXIIIA gene with splicing site modification and four amino acids insertion causes factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Ovarian haemorrhage: a rare presentation and diagnostic dilemma in factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Pathogenicity analysis of variations and prenatal diagnosis in a hereditary coagulation factor XIII deficiency family.
protein-glutamine gamma-glutamyltransferase deficiency
Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies.
protein-glutamine gamma-glutamyltransferase deficiency
Patient-centered approach to managing factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report.
protein-glutamine gamma-glutamyltransferase deficiency
Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement.
protein-glutamine gamma-glutamyltransferase deficiency
Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations.
protein-glutamine gamma-glutamyltransferase deficiency
Physiopathology and regulation of factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
Platelet aggregation in congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Platelet and coagulation studies in Ehlers-Danlos syndrome.
protein-glutamine gamma-glutamyltransferase deficiency
Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman--reply.
protein-glutamine gamma-glutamyltransferase deficiency
Post-infectious acute glomerulonephritis and transient coagulation factor XIII deficiency associated with acute parvovirus B19 infection in a young woman.
protein-glutamine gamma-glutamyltransferase deficiency
Postoperative bleeding in a patient with normal screening coagulation tests.
protein-glutamine gamma-glutamyltransferase deficiency
Posttraumatic subgaleal and orbital hematoma due to factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Pregnancy complications and obstetric care in women with inherited bleeding disorders.
protein-glutamine gamma-glutamyltransferase deficiency
Premarital Screening Program for Congenital Factor XIII Deficiency in Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Prenatal diagnosis in factor XIII-A deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Prenatal diagnosis of factor 13 deficiency and its recurrence.
protein-glutamine gamma-glutamyltransferase deficiency
Prevalence of factor XIII deficiency in patients presenting with a bleeding disorder in Pakistan.
protein-glutamine gamma-glutamyltransferase deficiency
Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta.
protein-glutamine gamma-glutamyltransferase deficiency
Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study.
protein-glutamine gamma-glutamyltransferase deficiency
Proceedings: Factor XIII concentrate in the long term management of congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Procoagulant platelets form an ?-granule protein-covered 'cap' on their surface that promotes their attachment to aggregates.
protein-glutamine gamma-glutamyltransferase deficiency
Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency: reply to a rebuttal.
protein-glutamine gamma-glutamyltransferase deficiency
Prophylaxis in factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Protein 4.2: a complex linker.
protein-glutamine gamma-glutamyltransferase deficiency
Pubertal Menorrhagia - A Rare Presentation of Congenital Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Quality of life of people with hereditary factor XIII deficiency treated at a reference centre.
protein-glutamine gamma-glutamyltransferase deficiency
Rare bleeding disorders in children: identification and primary care management.
protein-glutamine gamma-glutamyltransferase deficiency
Rare inherited coagulation disorders in India.
protein-glutamine gamma-glutamyltransferase deficiency
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss.
protein-glutamine gamma-glutamyltransferase deficiency
Recurrent bleeding following rhinoplasty due to factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Recurrent episodes of severe bleeding caused by congenital factor XIII deficiency in a dog.
protein-glutamine gamma-glutamyltransferase deficiency
Recurrent Hematomas following a Revision Total Hip Arthroplasty in Acquired Coagulation Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update.
protein-glutamine gamma-glutamyltransferase deficiency
Recurrent Post Tonsillectomy Secondary Hemorrhage in Patients with Factor XIII Deficiency: A Case Series and Review of Literature.
protein-glutamine gamma-glutamyltransferase deficiency
Recurrent Spontaneous Splenic Rupture in a Patient With Congenital Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Recurrent ulcerations on both legs since early childhood due to a factor V gene mutation.
protein-glutamine gamma-glutamyltransferase deficiency
Reduced difference of ?(2)-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies.
protein-glutamine gamma-glutamyltransferase deficiency
Reduced levels of coagulation factor XIII in patients with advanced tumor disease.
protein-glutamine gamma-glutamyltransferase deficiency
Reduced transglutaminase-catalyzed cross-linking of exogenous amines to membrane proteins in sickle erythrocytes.
protein-glutamine gamma-glutamyltransferase deficiency
Relevant bleeding diathesis due to acquired factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.
protein-glutamine gamma-glutamyltransferase deficiency
Rotational thromboelastometry can detect factor XIII deficiency and bleeding diathesis in patients with liver cirrhosis.
protein-glutamine gamma-glutamyltransferase deficiency
Rotational Thromboelastometry for Assessing Bleeding Complications and Factor XIII Deficiency in Cardiac Surgery Patients.
protein-glutamine gamma-glutamyltransferase deficiency
Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available.
protein-glutamine gamma-glutamyltransferase deficiency
Segmental uniparental disomy as a rare cause of congenital severe factor XIII deficiency in a girl with only one heterozygous carrier parent.
protein-glutamine gamma-glutamyltransferase deficiency
Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families.
protein-glutamine gamma-glutamyltransferase deficiency
Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Severe bleeding in a patient with factor XIII deficiency and COVID-19.
protein-glutamine gamma-glutamyltransferase deficiency
Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines.
protein-glutamine gamma-glutamyltransferase deficiency
Solubility fo fibrin clots in monochloroacetic acid. A reflection of serum pepsinogen levels.
protein-glutamine gamma-glutamyltransferase deficiency
Spectrum of hereditary coagulation factor deficiencies in eastern province, Saudi Arabia.
protein-glutamine gamma-glutamyltransferase deficiency
Spinal anaesthesia and caesarean section in a patient with hypofibrinogenaemia and factor XIII deficiency*
protein-glutamine gamma-glutamyltransferase deficiency
Spontaneous Acute Cerebral Hematoma in a Child with Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Spontaneous Epidural Hematoma in a Child With Inherited Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Spontaneous intracerebral hematoma in a adolescent with factor XIII deficiency. Case report.
protein-glutamine gamma-glutamyltransferase deficiency
Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Spontaneous rupture of the spleen in Factor XIII deficiency: A report of two cases.
protein-glutamine gamma-glutamyltransferase deficiency
Spontaneous splenic rupture in a patient with factor XIII deficiency and a novel mutation.
protein-glutamine gamma-glutamyltransferase deficiency
State of the art in factor XIII laboratory assessment.
protein-glutamine gamma-glutamyltransferase deficiency
Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups.
protein-glutamine gamma-glutamyltransferase deficiency
Subgaleal hematoma presenting as a manifestation of Factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Subunits A and S inheritance in four families with congenital factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Successful completion of transurethral lithotripsy in a patient with factor XIII deficiency: A case report.
protein-glutamine gamma-glutamyltransferase deficiency
Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study.
protein-glutamine gamma-glutamyltransferase deficiency
Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case.
protein-glutamine gamma-glutamyltransferase deficiency
Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm.
protein-glutamine gamma-glutamyltransferase deficiency
Successful treatment of severe gastrointestinal manifestations of Henoch-Schonlein Purpura and factor XIII deficiency using cryoprecipitate transfusion.
protein-glutamine gamma-glutamyltransferase deficiency
Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Surgery in severe factor XIII deficiency: report of a case of epilepsy neurosurgery and review.
protein-glutamine gamma-glutamyltransferase deficiency
Symptomatic factor XIII deficiency with normal urea solubility test.
protein-glutamine gamma-glutamyltransferase deficiency
The first case report of a patient with acquired factor XIII deficiency in the context of autoimmune encephalitis.
protein-glutamine gamma-glutamyltransferase deficiency
The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose.
protein-glutamine gamma-glutamyltransferase deficiency
The normal and abnormal genes of the a and b subunits in coagulation factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
The perioperative course of factor XIII and associated chest tube drainage in newborn and infants undergoing cardiac surgery.
protein-glutamine gamma-glutamyltransferase deficiency
The rare inherited coagulation disorders.
protein-glutamine gamma-glutamyltransferase deficiency
The role of fibrin matrices and tissue factor in early-term trophoblast proliferation and spreading.
protein-glutamine gamma-glutamyltransferase deficiency
The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunoelectrophoresis.
protein-glutamine gamma-glutamyltransferase deficiency
Therapeutic factor XIII preparations and perspectives for recombinant factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
Thromboelastometric detection of clotting Factor XIII deficiency in cardiac surgery patients.
protein-glutamine gamma-glutamyltransferase deficiency
Thromboelastometry Identified Alteration of Clot Stabilization and Factor XIII Supplementation Need in a Patient with Decompensated Liver Disease Undergoing Liver Biopsy.
protein-glutamine gamma-glutamyltransferase deficiency
Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
protein-glutamine gamma-glutamyltransferase deficiency
Tooth extraction in two patients who had a congenital deficiency of factor XIII.
protein-glutamine gamma-glutamyltransferase deficiency
Total absence of protein 4.2 and partial deficiency of band 3 in hereditary spherocytosis.
protein-glutamine gamma-glutamyltransferase deficiency
Training Program for Home Therapy of People With Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Transglutaminase 1 deficiency and corneocyte collapse: an indication for targeted molecular screening in autosomal recessive congenital ichthyosis.
protein-glutamine gamma-glutamyltransferase deficiency
Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
protein-glutamine gamma-glutamyltransferase deficiency
Transglutaminase cross-linking properties of the small proline-rich 1 family of cornified cell envelope proteins. Integration with loricrin.
protein-glutamine gamma-glutamyltransferase deficiency
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection.
protein-glutamine gamma-glutamyltransferase deficiency
Treatment of factor XIII deficiency with cryoprecipitate.
protein-glutamine gamma-glutamyltransferase deficiency
Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation.
protein-glutamine gamma-glutamyltransferase deficiency
Two cases of haemorrhagic disease arising from fibrin stabilizing factor deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Type I and type II disease in congenital factor XIII deficiency. A further demonstration of the correctness of the classification.
protein-glutamine gamma-glutamyltransferase deficiency
Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain.
protein-glutamine gamma-glutamyltransferase deficiency
Unusual presentation of factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery.
protein-glutamine gamma-glutamyltransferase deficiency
Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding.
protein-glutamine gamma-glutamyltransferase deficiency
Valproic Acid-Induced Coagulopathy.
protein-glutamine gamma-glutamyltransferase deficiency
Viral markers and use of factor products among Finnish patients with bleeding disorders.
protein-glutamine gamma-glutamyltransferase deficiency
[2 patients with congenital factor XIII deficiency. Contribution to the problem of factor XIII determination]
protein-glutamine gamma-glutamyltransferase deficiency
[A case of congenital factor XIII deficiency and acquired factor XIII deficiency (author's transl)]
protein-glutamine gamma-glutamyltransferase deficiency
[A clinical study of congenital factor XIII deficiency (author's transl)]
protein-glutamine gamma-glutamyltransferase deficiency
[A novel genetic defect in a Chinese family with inherited coagulation factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[A report of two cases with congenital factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Acquired coagulation disorders].
protein-glutamine gamma-glutamyltransferase deficiency
[Acquired factor XIII deficiency and chronic myeloid splenomegaly]
protein-glutamine gamma-glutamyltransferase deficiency
[Acquired factor XIII deficiency and clinical surgery]
protein-glutamine gamma-glutamyltransferase deficiency
[Acquired factor XIII deficiency and postoperative aseptic wound healing disorders]
protein-glutamine gamma-glutamyltransferase deficiency
[Acquired von Willebrand syndrome in a patient with immune thrombocytopenic purpura].
protein-glutamine gamma-glutamyltransferase deficiency
[Acute malignant myelofibrosis complicated by factor XIII deficiency, protein C decrease and skin necroses]
protein-glutamine gamma-glutamyltransferase deficiency
[An infant with umbilical cord and intracranial hemorrhage--severe factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Anesthesia for a patient with Ehlers-Danlos syndrome and factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Bleeding and coagulation disorders in tonsillectomies.]
protein-glutamine gamma-glutamyltransferase deficiency
[Blood clotting factor XIII substitution in acute leukaemia: result of a randomized and controlled study]
protein-glutamine gamma-glutamyltransferase deficiency
[Blood coagulation factor XIII and fibrin stabilization (author's transl)]
protein-glutamine gamma-glutamyltransferase deficiency
[Case of factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Case suspected to be factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Cephalohemoatoma as the first manifestation of congenital factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Characteristics of red cell membrane disorders in the Japanese population]
protein-glutamine gamma-glutamyltransferase deficiency
[Characterization of a large deletion that leads to congenital factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Clinical course and management of severe congenital factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Congenital factor XIII deficiency in pregnancy. A case report]
protein-glutamine gamma-glutamyltransferase deficiency
[Congenital factor XIII deficiency in the south of Tunisia]
protein-glutamine gamma-glutamyltransferase deficiency
[Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy]
protein-glutamine gamma-glutamyltransferase deficiency
[Congenital factor XIII deficiency. Report of a new family (author's transl)]
protein-glutamine gamma-glutamyltransferase deficiency
[Congenital factor XIII deficiency: studies in an infant and his family]
protein-glutamine gamma-glutamyltransferase deficiency
[Congenital factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Cytoskeleton anomalies in disorders of red cell membrane proteins]
protein-glutamine gamma-glutamyltransferase deficiency
[Detection of factor XIII deficiency in acute leukemia with resonance thrombography]
protein-glutamine gamma-glutamyltransferase deficiency
[Factor XIII deficiency as the cause of postoperative hemorrhage]
protein-glutamine gamma-glutamyltransferase deficiency
[Factor XIII deficiency due to lack of both the S and A subunits. (Classification of factor XIII deficiency in 2 groups)]
protein-glutamine gamma-glutamyltransferase deficiency
[Factor XIII deficiency in a newborn]
protein-glutamine gamma-glutamyltransferase deficiency
[Factor XIII deficiency in adults with acute leukemia: results of a substitution therapy with factor XIII (author's transl)]
protein-glutamine gamma-glutamyltransferase deficiency
[Factor XIII deficiency in burns]
protein-glutamine gamma-glutamyltransferase deficiency
[Factor XIII deficiency in various patients with acute leukemia]
protein-glutamine gamma-glutamyltransferase deficiency
[Factor XIII deficiency: blood coagulation defect in pregnancy]
protein-glutamine gamma-glutamyltransferase deficiency
[Factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Factor XIII-guided treatment algorithm reduces blood transfusion in burn surgery].
protein-glutamine gamma-glutamyltransferase deficiency
[Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)]
protein-glutamine gamma-glutamyltransferase deficiency
[Hereditary coagulation factor XIII deficiency: three cases report and literaure review].
protein-glutamine gamma-glutamyltransferase deficiency
[Identification of a novel mutation of F (13) A gene in a pedigree with factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Identification of genetic defects in a Chinese pedigree with factor XIII deficiency: case report and literature review].
protein-glutamine gamma-glutamyltransferase deficiency
[Identification of two novel mutation in two Chinese hereditary coagulation factor XIII deficiency families]
protein-glutamine gamma-glutamyltransferase deficiency
[Importance, diagnosis and substitution in acquired factor XIII deficiency in the postoperative course]
protein-glutamine gamma-glutamyltransferase deficiency
[Intracranial hematoma accompanying bleeding tendency: therapeutic practice and analysis of literature]
protein-glutamine gamma-glutamyltransferase deficiency
[Intradural hematoma of the foramen magnum associated with factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Is the use of factor XIII for delayed wound healing in patients with head-neck tumors of value?]
protein-glutamine gamma-glutamyltransferase deficiency
[Leukocytoclastic vasculitis and factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate]
protein-glutamine gamma-glutamyltransferase deficiency
[Molecular mechanisms of two novel mutations of factor XIII gene resulting in hereditary coagulation deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Pathogenesis of tracheal stenosis following long-term intubation of patients with multiple injuries]
protein-glutamine gamma-glutamyltransferase deficiency
[Plasma transglutaminase activity in congenital total and partial factor XIII deficiency (a contribution to the problem of factor XIII determination)]
protein-glutamine gamma-glutamyltransferase deficiency
[Postoperative complications due to acquired factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Pre-hospital diagnosis of nosebleed in children]
protein-glutamine gamma-glutamyltransferase deficiency
[Presence of a plasma antigen indispensable to the stabilization of fibrin in 2 cases on congenital factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Primary myelofibrosis with fatal mesenteric arterial thromboembolism caused by antiphospholipid syndrome]
protein-glutamine gamma-glutamyltransferase deficiency
[Recurrent hematomas and normal standard hemostasis tests]
protein-glutamine gamma-glutamyltransferase deficiency
[Role of thrombelastometry for the monitoring of factor XIII. A prospective observational study in neurosurgical patients.]
protein-glutamine gamma-glutamyltransferase deficiency
[Severe factor XIII-deficiency. Studies on subunits and turnover of the fibrin stabilizing factor (author's transl)]
protein-glutamine gamma-glutamyltransferase deficiency
[Simplified radiologic factor XIII determination and its clinical use in congenital factor XIII deficiency (I)]
protein-glutamine gamma-glutamyltransferase deficiency
[Spontaneous splenic rupture in a patient with congenital factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Stenosing ureteritis and factor XIII deficiency in anaphylactoid purpura]
protein-glutamine gamma-glutamyltransferase deficiency
[Studies on abnormal protein in seven patients with congenital factor XIII deficiency (author's transl)]
protein-glutamine gamma-glutamyltransferase deficiency
[Studies on congenital factor XIII deficiency and detection of the carrier in his family (author's transl)]
protein-glutamine gamma-glutamyltransferase deficiency
[Study on the molecular mechanisms of a novel large deletion of FXIIIA mRNA in a new hereditary factor XIII deficiency].
protein-glutamine gamma-glutamyltransferase deficiency
[Substitution treatment of factor XIII deficiency with a new factor XIII concentrate]
protein-glutamine gamma-glutamyltransferase deficiency
[Surgical treatment of intracranial hematoma with congenital factor XIII deficiency. Case report]
protein-glutamine gamma-glutamyltransferase deficiency
[Thrombelastometric detection of factor XIII deficiency]
protein-glutamine gamma-glutamyltransferase deficiency
[Wound healing disorders and factor XIII deficiency after tumor operations in the floor of the mouth]
Proteinuria
Acquired glomerular lesions in patients with Down syndrome.
Proteinuria
Celiac Disease and Secondary Amyloidosis: A Possible Causal Association?
Proteinuria
Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression.
Proteinuria
Plasma fibronectin and factor XIII in nephrotic syndrome.
Proteinuria
Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura.
Proteinuria
Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.
Psoriasis
Abnormal Bcl-2 and "tissue" transglutaminase expression in psoriatic skin.
Psoriasis
Abnormal epidermal barrier in the pathogenesis of psoriasis.
Psoriasis
Biochemistry of transglutaminases and cross-linking in the skin.
Psoriasis
Celiac disease-associated antibodies in patients with psoriasis and correlation with HLA Cw6.
Psoriasis
Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
Psoriasis
Distinctive dendritic cell subsets expressing factor XIIIa, CD1a, CD1b and CD1c in mycosis fungoides and psoriasis.
Psoriasis
Elevated transglutaminase-2 expression in the epidermis of psoriatic skin and its role in the skin lesion development.
Psoriasis
Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream.
Psoriasis
Estimation of (IgA) anti-gliadin, anti-endomysium and tissue transglutaminase in the serum of patients with psoriasis.
Psoriasis
Expression of transglutaminase 5 in normal and pathologic human epidermis.
Psoriasis
Factor XIII insufficiency in a patient with severe psoriasis vulgaris, arthritis, and infirmity.
Psoriasis
Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): a population control study.
Psoriasis
Gluten-free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67+ cells in the dermis.
Psoriasis
Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions.
Psoriasis
IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.
Psoriasis
Increased membrane-associated transglutaminase activity in psoriasis.
Psoriasis
Increased nuclear beta-catenin in suprabasal involved psoriatic epidermis.
Psoriasis
Influence of calcium on the proteolytic degradation of the calmodulin-like skin protein (calmodulin-like protein 5) in psoriatic epidermis.
Psoriasis
Is the search for serum antibodies to gliadin, endomysium and tissue transglutaminase meaningful in psoriatic patients? Relationship between the pathogenesis of psoriasis and coeliac disease.
Psoriasis
Keratinocyte transglutaminase expression varies in squamous cell carcinomas.
Psoriasis
Levels of proelafin peptides in the sera of the patients with generalized pustular psoriasis and pustulosis palmoplantaris.
Psoriasis
Localization of transglutaminase 1 mRNA in normal and psoriatic epidermis by non-radioactive in situ hybridization.
Psoriasis
Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated via endothelial cells followed by intra-epidermal T-cell activation.
Psoriasis
Psoriasis in autoimmune polyendocrine syndrome type I: A possible complication or a non-endocrine minor component?
Psoriasis
Serologic markers of celiac disease in psoriatic patients.
Psoriasis
Transglutaminase 3 Reduces the Severity of Psoriasis in Imiquimod-Treated Mouse Skin.
Psoriasis
Triggered psoriasis.
Psoriasis
Type I keratinocyte transglutaminase: expression in human skin and psoriasis.
Psoriasis
Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa.
Psoriasis
Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death.
Psoriasis
[Pre-hospital diagnosis of nosebleed in children]
Pulmonary Arterial Hypertension
Cystamine slows but not inverses the progression of monocrotaline-induced pulmonary arterial hypertension in rats.
Pulmonary Disease, Chronic Obstructive
Lung tissue proteomics identifies elevated transglutaminase 2 levels in stable chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Pharmaceutical approval update.
Pulmonary Embolism
Combined measurement of factor XIII and D-dimer is helpful for differential diagnosis in patients with suspected pulmonary embolism.
Pulmonary Embolism
Frequency of the TAFI -438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolism.
Pulmonary Embolism
Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk.
Pulmonary Embolism
Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.
Pulmonary Embolism
Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness.
Pulmonary Embolism
The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism.
Pulmonary Fibrosis
Cells containing factor XIIIa and pulmonary fibrosis induced by bleomycin.
Pulmonary Fibrosis
Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat.
Pulmonary Fibrosis
Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules.
Pulmonary Fibrosis
Metformin attenuates TGF-?1-induced pulmonary fibrosis through inhibition of transglutaminase 2 and subsequent TGF-? pathways.
Pulmonary Fibrosis
Spatially Resolved Identification of Transglutaminase Substrates by Proteomics in Pulmonary Fibrosis.
Pulmonary Fibrosis
Transglutaminase 2 and its Role in Pulmonary Fibrosis.
Purpura
A patient with Henoch-Schönlein purpura manifesting unusual symptoms and clinical course.
Purpura
Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura. Efficacy of factor XIII substitution.
Purpura
Adult Henoch-Schönlein purpura with severe abdominal pain treated with dapsone and factor XIII concentrate.
Purpura
Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura. Japanese Pediatric Group.
Purpura
Clinical Significance of Blood Coagulation Factor XIII Activity in Adult Henoch-Schönlein Purpura.
Purpura
Could measurement of factor XIII level detect the vasculitic process of Henoch-Schönlein purpura without skin rash?
Purpura
Diagnostic value of plasma factor XIII in Henoch-Schönlein purpura.
Purpura
Factor XIII (fibrin stabilising factor) in Henoch-Schönlein's purpura.
Purpura
Factor XIII as a potential predictor of severe gastrointestinal involvement in Henoch Schoenlein purpura: A case study research.
Purpura
Factor XIII deficiency in Henoch-Schönlein purpura - report on two cases and literature review.
Purpura
Factor XIII in Henoch-Schönlein purpura with isolated gastrointestinal symptoms.
Purpura
Henoch-Schönlein purpura in a child with Guillain-Barré syndrome.
Purpura
Idiopathic testicular infarction in a boy initially suspected to have acute epididymo-orchitis associated with mycoplasma infection and Henoch-Schönlein purpura.
Purpura
Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura.
Purpura
Severe Large-Intestine Involvement in Adult-Onset Henoch-Schönlein Purpura: Successful Treatment with Factor XIII Concentrate.
Purpura
Successful treatment of adult Henoch-Schönlein purpura with factor XIII concentrate.
Purpura
Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and henoch-Schönlein purpura nephritis.
Purpura
[The prognostic value of factor XIII in Schönlein-Henoch purpura in childhood (author's transl)]
Purpura, Thrombocytopenic, Idiopathic
Prevalence of Autoantibodies Related to Some Autoimmune Disorders in Patients With Chronic Idiopathic Thrombocytopenic Purpura.
Pyoderma Gangrenosum
Treatment of pyoderma gangrenosum with topical factor XIII.
Radicular Cyst
Distribution of factor XIIIa-containing cells and collagenous components in radicular cysts: histochemic and immunohistochemic studies.
Renal Insufficiency
Acquired glomerular lesions in patients with Down syndrome.
Renal Insufficiency
Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis.
Renal Insufficiency
Early response as shown by enhancement of transglutaminase 1 expression after cisplatin-induced acute kidney injury.
Renal Insufficiency
Insights on the heparan sulphate-dependent externalisation of transglutaminase-2 (TG2) in glucose-stimulated proximal-like tubular epithelial cells.
Renal Insufficiency
Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy.
Renal Insufficiency
Structure of fibrin and fibrinmonomer in renal and hepatic failure.
Renal Insufficiency
Transglutaminases: the missing link in nephrogenic systemic fibrosis.
Renal Insufficiency
Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure.
Renal Insufficiency, Chronic
Coagulation factor XIII in patients with acute and chronic renal disease.
Renal Insufficiency, Chronic
Feline chronic kidney disease is associated with upregulation of transglutaminase 2: a collagen cross-linking enzyme.
Renal Insufficiency, Chronic
Interplay between transglutaminases and heparan sulphate in progressive renal scarring.
Renal Insufficiency, Chronic
Transglutaminase 2 Accelerates Vascular Calcification in Chronic Kidney Disease.
Renal Insufficiency, Chronic
Transglutaminase 2 as a novel target in chronic kidney disease - Methods, mechanisms and pharmacological inhibition.
Renal Insufficiency, Chronic
Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease.
Reperfusion Injury
Does Recombinant Factor XIII Eliminate Early Manifestations of Multiple-Organ Injury After Experimental Burn Similarly to Gut Ischemia-Reperfusion Injury or Trauma-Hemorrhagic Shock?
Reperfusion Injury
Recombinant factor XIII diminishes multiple organ dysfunction in rats caused by gut ischemia-reperfusion injury.
Respiratory Distress Syndrome
Factor XIII Activity Might Already Be Impaired before Veno-Venous ECMO in ARDS Patients: A Prospective, Observational Single-Center Cohort Study.
Retinal Artery Occlusion
Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
Retinal Detachment
Blood coagulation factor XIII contributes to the development of traction retinal detachment.
Retinal Detachment
Feasibility of using gelatin-microbial transglutaminase complex to repair experimental retinal detachment in rabbit eyes.
Retinal Diseases
[Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases]
Retinal Dystrophies
Tissue transglutaminase in apoptosis of photoreceptor cells in rat retina.
Retinoblastoma
Dermal plexiform spindle cell lipoma.
Retinoblastoma
Induction of retinoblastoma gene expression during terminal growth arrest of a conditionally immortalized fetal rat lung epithelial cell line and during fetal lung maturation.
Retinoblastoma
Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.
Retinoblastoma
Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein.
Rhabdomyosarcoma
Transglutaminase activity and putrescine-binding capacity in cloned cell lines with different metastatic potential.
Rhabdomyosarcoma
Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells.
Rheumatic Diseases
Asymptomatic celiac sprue in juvenile rheumatic diseases children.
Rheumatic Diseases
Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Rheumatic Fever
Fibrin dissolution in synovial fluid.
Rubella
Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome.
Rubella
[Inactivation of viruses in Factor XIII concentrate by pasteurization]
Sarcoidosis
Factor XIIIa expression in granulomatous lesions due to sarcoidosis or mycobacterial infection.
Sarcoma
Alterations in the distribution and activity of transglutaminase during tumour growth and metastasis.
Sarcoma
Correlation of changes in transglutaminase activity and polyamine content of neoplastic tissue during the metastatic process.
Sarcoma
Factor XIIIa expression in pseudo-Kaposi sarcoma.
Sarcoma
Influences of clotting factors (thrombin, factor XIII) and of fibronectin on the growth of tumor cells and leukemic cells in vitro.
Sarcoma
Influences of thrombin, factor XIII and fibronectin on the growth of tumor cells and leukemic cells in vitro.
Sarcoma
[Thrombin, factor XIII and fibronectin as regulators of the proliferation of tumor cells and vascular wall cells]
Sarcoma, Kaposi
Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1.
Sarcoma, Kaposi
Dendrocyte population in cutaneous and extracutaneous Kaposi's sarcoma.
Sarcoma, Kaposi
Factor-XIIIa-expressing dermal dendrocytes in Kaposi's sarcoma. A comparison between classical and immunosuppression-associated types.
Sarcoma, Kaposi
HIV-1 infection and modulation of cytokine and growth factor expression in Kaposi's sarcoma-derived cells in vitro.
Sarcoma, Kaposi
Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma.
Sarcoma, Kaposi
The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes.
Sarcoma, Kaposi
Ultrastructural localization of factor XIIIa.
Schistosomiasis japonica
Contribution of tissue transglutaminase to the severity of hepatic fibrosis resulting from Schistosoma japonicum infection through the regulation of IL-33/ST2 expression.
Schistosomiasis japonica
Involvement of IL-13 and tissue transglutaminase in liver granuloma and fibrosis after schistosoma japonicum infection.
Scleredema Adultorum
Scleredema of Buschke: remission with factor XIII treatment.
Scleroderma, Diffuse
Factor XIII in scleroderma: in vitro studies.
Scleroderma, Diffuse
Favorable effects of plasma factor XIII on lower esophageal sphincter pressure of progressive systemic sclerosis.
Scleroderma, Diffuse
Treatment of progressive systemic sclerosis using factor XIII.
Scleroderma, Diffuse
[Treatment of systemic scleroderma with factor XIII in 86 patients, with long-term follow-up]
Scleroderma, Localized
CD34 stromal expression is inversely proportional to smooth muscle actin expression and extent of morphea.
Scleroderma, Localized
Decreased expression of the human progenitor cell antigen (CD34) in morphea.
Scleroderma, Localized
Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon.
Scleroderma, Systemic
Coagulation factor XIII, endothelial damage and systemic sclerosis.
Scleroderma, Systemic
Dermal Dendritic Cell Population and Blood Vessels Are Diminished in the Skin of Systemic Sclerosis Patients: Relationship With Fibrosis Degree and Disease Duration.
Scleroderma, Systemic
[Bronchiolo-alveolar carcinoma complicating systemic scleroderma under long-term treatment with factor XIII]
Scleroderma, Systemic
[Desmofibrinogenic activity of factor XIII and plasma concentration of thiol groups in the course of systemic scleroderma]
Scleroderma, Systemic
[Long-term treatment of systemic scleroderma with coagulation factor XIII. Developmental monitoring, especially of respiratory function]
Scleroderma, Systemic
[Treatment of systemic scleroderma with factor XIII in 86 patients, with long-term follow-up]
Scleromyxedema
Adult variant of self-healing papular mucinosis in a patient with rheumatoid arthritis: Predominant proliferation of dermal dendritic cells expressing CD34 or factor XIIIa in association with dermal deposition of mucin.
Scoliosis
The Effect of Ex Vivo Factor XIII Supplementation on Clot Formation in Blood Samples From Cardiac and Scoliosis Surgery Patients.
Sepsis
Divergent results induced by different types of septic shock in transglutaminase 2 knockout mice.
Sepsis
Effects of coagulation factor XIII on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation in experimental endotoxemia.
Sepsis
Factor XIII in severe sepsis and septic shock.
Sepsis
Imaging of the ex vivo transglutaminase activity in liver macrophages of sepsis mice.
Sepsis
The effect of four hemostatic gene polymorphisms on the outcome of septic critically ill patients.
Sepsis
Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis.
Shock, Septic
Disturbances of selected plasma proteins in hyperdynamic septic shock.
Shock, Septic
Divergent results induced by different types of septic shock in transglutaminase 2 knockout mice.
Shock, Septic
Factor XIII in severe sepsis and septic shock.
Shock, Septic
Human mononuclear leukocyte transglutaminase activity is enhanced by streptococcal erythrogenic toxin and a staphylococcal mitogenic factor associated with toxic shock syndrome.
Shock, Septic
The effect of four hemostatic gene polymorphisms on the outcome of septic critically ill patients.
Shock, Septic
Treatment for necrotizing enterocolitis perforation in the extremely premature infant (weighing less than 1,000 g).
Shwartzman Phenomenon
Depletion of plasma factor XIII prevents disseminated intravascular coagulation-induced organ damage.
Skin Diseases
Assays for transglutaminases in cell death.
Skin Diseases
Evaluation of a Bi-Analyte Immunoblot as a Useful Tool for Diagnosing Dermatitis Herpetiformis.
Skin Diseases
Increased membrane-associated transglutaminase activity in psoriasis.
Skin Diseases
Influence of calcium on the proteolytic degradation of the calmodulin-like skin protein (calmodulin-like protein 5) in psoriatic epidermis.
Skin Diseases
Lamellar ichthyosis associated with pseudoainhum of the toes and eye changes.
Skin Diseases
Novel interactions between dermal dendrocytes and mast cells in human skin. Implications for hemostasis and matrix repair.
Skin Diseases
Proliferative activity of CD8(+) T cells as an important clue to analyze T cell-mediated inflammatory dermatoses.
Skin Diseases
The many-faced gluten sensitivity: Gluten-induced autoimmunity from dermatological point of view
Skin Diseases
Transglutaminase 1 Replacement Therapy Successfully Mitigates the Autosomal Recessive Congenital Ichthyosis Phenotype in Full-Thickness Skin Disease Equivalents.
Skin Diseases
[Dermatitis herpetiformis].
Skin Diseases, Genetic
Direct cutaneous gene delivery in a human genetic skin disease.
Skin Diseases, Genetic
Structural organization of cornified cell envelopes and alterations in inherited skin disorders.
Soft Tissue Infections
Local activation of coagulation factor XIII reduces systemic complications and improves the survival of mice after Streptococcus pyogenes M1 skin infection.
Spinal Cord Compression
De Novo Precursor B-Lymphoblastic Leukemia/Lymphoma With Double-Hit Gene Rearrangements (MYC/BCL-2) Presented With Spinal Cord Compression and Acquired Factor XIII Deficiency.
Spinal Cord Injuries
Intraspinal hemorrhage in a child with factor XIII deficiency.
Spinal Cord Injuries
The role of plasma transglutaminase (F XIII) in wound healing of complicated pressure sores after spinal cord injury.
Spinocerebellar Ataxias
A case report of late-onset cerebellar ataxia associated with a rare p.R342W TGM6 (SCA35) mutation.
Spinocerebellar Ataxias
Distribution of transglutaminase 6 in the central nervous system of adult mice.
Spinocerebellar Ataxias
Hispanic Spinocerebellar Ataxia Type 35 (SCA35) with a Novel Frameshift Mutation.
Spinocerebellar Ataxias
Mutations in TGM6 induce the unfolded protein response in SCA35.
Spinocerebellar Ataxias
Spinocerebellar ataxia 35: novel mutations in TGM6 with clinical and genetic characterization.
Spinocerebellar Ataxias
Spinocerebellar ataxia type 35 (SCA35)-associated transglutaminase 6 mutants sensitize cells to apoptosis.
Spinocerebellar Ataxias
TGM6 variants in Parkinson's disease: clinical findings and functional evidence.
Spinocerebellar Ataxias
Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.
Spinocerebellar Ataxias
Transglutaminase 6 interacts with polyQ proteins and promotes the formation of polyQ aggregates.
Spinocerebellar Ataxias
Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases.
Spinocerebellar Ataxias
Whole exome sequencing identifies a novel mutation in the transglutaminase 6 gene for spinocerebellar ataxia in a Chinese family.
Splenic Rupture
Factor XIII deficiency: report of a case complicated by splenic rupture.
Splenic Rupture
Recurrent Spontaneous Splenic Rupture in a Patient With Congenital Factor XIII Deficiency.
Splenic Rupture
Spontaneous splenic rupture in a patient with factor XIII deficiency and a novel mutation.
Splenic Rupture
[Spontaneous splenic rupture in a patient with congenital factor XIII deficiency]
Spondylitis, Ankylosing
Antibodies to human tissue transglutaminase and alterations of vitamin D metabolism in ankylosing spondylitis and psoriatic arthritis.
Spondylitis, Ankylosing
Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis.
Sprue, Tropical
Immunohistochemical Expression of Antitissue Transglutaminase 2 in Tissue Injuries: An Interpretation Beyond Celiac Disease.
Squamous Cell Carcinoma of Head and Neck
Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia.
Squamous Cell Carcinoma of Head and Neck
Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid.
Squamous Cell Carcinoma of Head and Neck
The expression of transglutaminase 2 (TG-2) in oral squamous cell carcinoma and its clinical significance.
Squamous Cell Carcinoma of Head and Neck
Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
ST Elevation Myocardial Infarction
The Association of Hereditary Prothrombotic Risk Factors with ST-Elevation Myocardial Infarction.
Staphylococcal Infections
iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
Starvation
Modulation of apoptosis by starvation: morphological and biochemical study of rat intestinal mucosa.
Starvation
Purification and partial characterization of transglutaminase from Physarum polycephalum.
Starvation
Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.
Starvation
Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins.
Stevens-Johnson Syndrome
Epithelial hyperproliferation and transglutaminase 1 gene expression in Stevens-Johnson syndrome conjunctiva.
Stomach Neoplasms
Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers.
Stomach Neoplasms
Novel peptide GX1 inhibits angiogenesis by specifically binding to transglutaminase-2 in the tumorous endothelial cells of gastric cancer.
Stomach Neoplasms
Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
Stomach Neoplasms
[Distribution of fibronectin and other plasma proteins in gastric cancer tissues: investigation of mechanisms of desmoplasia of the stroma]
Stomach Ulcer
Factor XIII improves gastric stress lesions in rats.
Stomach Ulcer
[Distribution of fibronectin and other plasma proteins in gastric cancer tissues: investigation of mechanisms of desmoplasia of the stroma]
Stomatitis
[Molecular markers of the oral mucosa damage in patients with leukemia.]
Stomatitis, Aphthous
Serological screening for celiac disease using IgA-tissue transglutaminase antibody in patients with recurrent aphthous stomatitis.
Stroke
Common genetic coagulation variants are not associated with ischemic stroke in a casecontrol study.
Stroke
Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
Stroke
Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men.
Stroke
Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage.
Stroke
Gene mutations and stroke in the young adult.
Stroke
Hypercoagulability as a cause of stroke in adults.
Stroke
Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor.
Stroke
Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
Stroke
Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients.
Stroke
Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
Stroke
Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation.
Stroke
Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block.
Subarachnoid Hemorrhage
Association between factor XIII single nucleotide polymorphisms and aneurysmal subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Factor XIII concentrate for prevention of recurrent subarachnoid hemorrhage: results of a multicenter pilot study. The FISAH Study Group.
Subarachnoid Hemorrhage
Fibrinolytic and factor XIII activity in subarachnoid hemorrhage.
Supranuclear Palsy, Progressive
Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.
Supranuclear Palsy, Progressive
Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
Supranuclear Palsy, Progressive
Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy.
Supranuclear Palsy, Progressive
Transglutaminase is linked to neurodegenerative diseases.
Synucleinopathies
Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies.
Tauopathies
Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
Tauopathies
Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.
Tendinopathy
Gene expression analysis in calcific tendinopathy of the rotator cuff.
Testicular Neoplasms
Evaluation of nuclear NF-?B, transglutaminase2, and ERCC1 as predictors of platinum resistance in testicular tumors.
Tetanus
Covalent modification of synapsin I by a tetanus toxin-activated transglutaminase.
Tetanus
Evidence that transglutaminase and synapsin I are involved in the neuroparalytic action of tetanus toxin.
Tetanus
Microtubules and microfilaments participate in the inhibition of synaptosomal noradrenaline release by tetanus toxin.
Tetanus
Role of transglutaminase in [3H]5-HT release from synaptosomes and in the inhibitory effect of tetanus toxin.
Tetanus
Tetanus toxin potently stimulates tissue transglutaminase. A possible mechanism of neurotoxicity.
Tetanus
The role of transglutaminase in the mechanism of action of tetanus toxin.
Tetanus
The transglutaminase hypothesis for the action of tetanus toxin.
Tetanus
Transglutaminase participates in the blockade of neurotransmitter release by tetanus toxin: evidence for a novel biological function.
Thrombasthenia
Congenital hemorrhagic disorders in Jordan.
Thrombasthenia
Correction of coagulopathy in thrombocytopenia and Glanzmann thrombasthenia models by fibrinogen and factor XIII as assessed by thromboelastometry.
Thrombasthenia
Glanzmann's thrombasthenia associated with a transient deficiency of factor XIII.
Thrombasthenia
How to deal with medical and social aspects of bleeding disorders--preparing women and the family in developing countries.
Thrombasthenia
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Thrombasthenia
On the retraction of collagen and fibrin induced by normal, defective and modified platelets.
Thrombasthenia
The in vivo effect of fibrinogen and factor XIII on clot formation and fibrinolysis in Glanzmann's thrombasthenia.
Thrombocytopenia
A patient with Henoch-Schönlein purpura manifesting unusual symptoms and clinical course.
Thrombocytopenia
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
Thrombocytopenia
Coagulation management in patients undergoing mechanical circulatory support.
Thrombocytopenia
Correction of coagulopathy in thrombocytopenia and Glanzmann thrombasthenia models by fibrinogen and factor XIII as assessed by thromboelastometry.
Thrombocytopenia
Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma.
Thrombocytopenia
Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastases.
Thrombocytopenia
Factor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit.
Thrombocytopenia
Generalized proteolysis in a young woman with Weber-Christian disease (nodular nonsuppurative panniculitis).
Thrombocytopenia
Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy.
Thrombocytopenia
In vitro evaluation of clot quality and stability in a model of severe thrombocytopenia: effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor.
Thrombocytopenia
Is extracorporeal CO2-Removal really "safe" and "less" invasive? Observation of blood injury and coagulation impairment during ECCO2R.
Thrombocytopenia
Reduction of fibrin stabilizing factor (FSF) in thrombocytopenia in childhood.
Thrombocytopenia
Valproate-associated coagulopathies are frequent and variable in children.
Thrombocytopenia
[Intracranial hematoma accompanying bleeding tendency: therapeutic practice and analysis of literature]
Thrombocytosis
Coagulation factor XIII concentration in sickle-cell disease.
Thrombocytosis
[Thrombocytosis and reduced levels of factor VIII in rheumatoid purpura in children]
Thromboembolism
Elimination of fibrin ?-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.
Thromboembolism
Low levels of fibrin-stabilizing factor (factor XIII) in human Plasmodium falciparum malaria: correlation with clinical severity.
Thrombophilia
"TEG talk": expanding clinical roles for thromboelastography and rotational thromboelastometry.
Thrombophilia
Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, ?-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.
Thrombophilia
Factor XIII polymorphisms and venous thromboembolism.
Thrombophilia
Genetic factors in fetal growth restriction and miscarriage.
Thrombophilia
Investigating Association of Three Polymorphisms of Coagulation Factor XIII and Recurrent Pregnancy Loss.
Thrombophilia
Preeclampsia and its interaction with common variants in thrombophilia genes.
Thrombophilia
ROTEM analysis: a significant advance in the field of rotational thrombelastography.
Thrombophilia
The Association of Hereditary Prothrombotic Risk Factors with ST-Elevation Myocardial Infarction.
Thrombophilia
Unusual presentation of a sarcoid patient: multiple arterial and venous thrombosis with chest lymphadenopathy.
Thrombophilia
Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.
Thrombophilia
[Diagnosis and treatment of coagulation disorders]
Thrombophilia
[Possible involvement of factor XIII in forming a trend towards thrombosis in patients with various types of thrombophilia]
Thrombosis
A novel ultrasonic method for evaluation of blood clotting parameters.
Thrombosis
Acute megakaryoblastic leukemia with erythrophagocytosis and thrombosis in a dog.
Thrombosis
Addition of a sequence from alpha2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis.
Thrombosis
Adhesion of Blood Clots Can Be Enhanced When Copolymerized with a Macromer That Is Crosslinked by Coagulation Factor XIIIa.
Thrombosis
Alternative pathways for the activation of factor XIII.
Thrombosis
Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
Thrombosis
Behaviour of fibrinolysis in the nephrotic syndrome.
Thrombosis
Catalytic life of activated factor XIII in thrombi. Implications for fibrinolytic resistance and thrombus aging.
Thrombosis
Characterization of cDNA coding for human factor XIIIa.
Thrombosis
Coagulation factor XIII and atherothrombosis. A mini-review.
Thrombosis
Coagulation factor XIII concentration in sickle-cell disease.
Thrombosis
Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.
Thrombosis
Coagulation factor XIIIa cross-links amyloid ? into dimers and oligomers and to blood proteins.
Thrombosis
Coagulation factor XIIIa is inactivated by plasmin.
Thrombosis
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli.
Thrombosis
Comparative evaluation of the elasticity and flexibility of bioimpregnated knitted grafts.
Thrombosis
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.
Thrombosis
Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.
Thrombosis
Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.
Thrombosis
Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix.
Thrombosis
Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
Thrombosis
Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen.
Thrombosis
Defective ?2 antiplasmin cross-linking and thrombus stability in a case of acquired factor XIII deficiency.
Thrombosis
Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity.
Thrombosis
Differences between binding of one-chain and two-chain tissue plasminogen activators to non-cross-linked and cross-linked fibrin clots.
Thrombosis
Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
Thrombosis
Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test.
Thrombosis
Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment.
Thrombosis
Effects of Val34Leu and Val35Leu polymorphism on the enzyme activity of the coagulation factor XIII-A.
Thrombosis
Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis.
Thrombosis
Elimination of fibrin ?-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.
Thrombosis
Enhanced thrombolysis by a factor XIIIa inhibitor in a rabbit model of femoral artery thrombosis.
Thrombosis
Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.
Thrombosis
Evaluating the Effects of Fibrinogen ?C Mutations on the Ability of Factor XIII to Crosslink the Reactive ?C Glutamines (Q237, Q328, Q366).
Thrombosis
Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis.
Thrombosis
Factor XIII activity mediates red blood cell retention in venous thrombi.
Thrombosis
Factor XIII deficiency does not prevent FeCl3-induced carotid artery thrombus formation in mice.
Thrombosis
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.
Thrombosis
Factor XIII polymorphisms and venous thromboembolism.
Thrombosis
Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.
Thrombosis
Factor XIII val34leu and the risk of myocardial infarction.
Thrombosis
Factor XIII Val34Leu polymorphism and risk of deep vein thrombosis.
Thrombosis
Factor XIII, clot structure, thrombosis.
Thrombosis
Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
Thrombosis
Feasibility of an automated coagulation factor XIIIa test using its isopeptidase activity.
Thrombosis
Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition.
Thrombosis
Fibrinogen, red blood cells, and factor XIII in venous thrombosis.
Thrombosis
Fibrinolysis in Platelet Thrombi.
Thrombosis
Fibronectin and wound healing.
Thrombosis
Generation and mechanism of action of a potent inhibitor of factor XIII function.
Thrombosis
Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype.
Thrombosis
Granulomatous reaction in mediastinal B-cell non-Hodgkin lymphoma and intracardiac thrombosis.
Thrombosis
Growth regulation of fibroblasts by thrombin, factor XIII and fibronectin.
Thrombosis
Human fibrinogen.
Thrombosis
In vivo near-infrared imaging of fibrin deposition in thromboembolic stroke in mice.
Thrombosis
Increased endothelial expression of transglutaminase in glioblastomas.
Thrombosis
Influence of factor XIIIa activity on human whole blood clot lysis in vitro.
Thrombosis
Interaction of the factor XIII activation peptide with alpha -thrombin. Crystal structure of its enzyme-substrate analog complex.
Thrombosis
Investigation of the anticoagulant and antithrombotic effects of chlorogenic acid.
Thrombosis
Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus.
Thrombosis
Molecular Imaging of Factor XIII Activity for the Early Detection of Mouse Coronary Microvascular Disease.
Thrombosis
Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi.
Thrombosis
Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent.
Thrombosis
Molecular subunits and transamidase activity of factor XIII in patients with deep vein thrombosis.
Thrombosis
Monocytes Expose Factor XIII-A and Stabilize Thrombi against Fibrinolytic Degradation.
Thrombosis
New splicing mutations in the human factor XIIIA gene, each producing multiple mutant transcripts of varying abundance.
Thrombosis
Newly-Recognized Roles of Factor XIII in Thrombosis.
Thrombosis
Non-invasive in vivo imaging of acute thrombosis: development of a novel factor XIIIa radiotracer.
Thrombosis
Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma-derived human FXIII concentrate in animals.
Thrombosis
Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk.
Thrombosis
Patient-centered approach to managing factor XIII deficiency.
Thrombosis
Pharmacokinetic studies of a novel 1,2,4-thiadiazole derivative, inhibitor of Factor XIIIa, in the rabbit by a validated HPLC method.
Thrombosis
Plasma D-dimer for the diagnosis of thromboembolic disorders in dogs.
Thrombosis
Platelet factor XIII and calpain negatively regulate integrin alphaIIbbeta3 adhesive function and thrombus growth.
Thrombosis
Poly(2-hydroxyethyl methacrylate) particles for preoperative endovascular occlusion of extensive angiodysplasias.
Thrombosis
Prevalence of the Factor XIII Val34Leu Polymorphism in Korean Patients with Deep Vein Thrombosis.
Thrombosis
Prevention of postoperative intracerebral hemorrhage with topical recombinant factor XIII in the rat.
Thrombosis
Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.
Thrombosis
Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation.
Thrombosis
Ranking reactive glutamines in the fibrinogen ?C region that are targeted by blood coagulant Factor XIII.
Thrombosis
Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele: case report.
Thrombosis
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms.
Thrombosis
Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
Thrombosis
Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers: a randomized, placebo-controlled, double-blind, multi-dose study.
Thrombosis
Safety of recombinant human factor XIII in a cynomolgus monkey model of extracorporeal blood circulation.
Thrombosis
State of the art in factor XIII laboratory assessment.
Thrombosis
Structure of the fibrinogen gamma-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization.
Thrombosis
The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots.
Thrombosis
The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism.
Thrombosis
The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.
Thrombosis
The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.
Thrombosis
Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics.
Thrombosis
Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation.
Thrombosis
Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease.
Thrombosis
[A micromethod of determining the activity of factor XIII in whole blood]
Thrombosis
[Behavior of the fibrin-stabilizing blood coagulation factor XIII in hemorrhages after tooth extractions]
Thrombosis
[Besides fibrinogen, are haemostatic, coagulation and/or fibrinolytic parameters predictors or markers of the risk of cardiovascular events?]
Thrombosis
[Diagnosis and treatment of coagulation disorders]
Thrombosis
[Hemocoagulation - New views on the old cascade].
Thrombosis
[Inhibitors of factor XIIIa]
Thrombosis
[Measurement of factor XIII (FSF) as an indicator of thrombosis risk in chronic coronary insufficiency and myocardial infarction]
Thrombosis
[Possible involvement of factor XIII in forming a trend towards thrombosis in patients with various types of thrombophilia]
Thrombosis
[Replacement of the thoracic aorta by sealed dacron prostheses (author's transl)]
Thrombosis
[Structure, function and the role of factor XIII in human pathology]
Thrombotic Microangiopathies
The Homozygous Leu Variant of the Factor XIII Val34Leu Polymorphism as a Risk Factor for the Manifestation of Thrombotic Microangiopathies.
Thyroid Diseases
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases.
Thyroid Diseases
Anti-thyroid antibodies, parietal cell antibodies and tissue transglutaminase antibodies in patients with autoimmune thyroid disease.
Thyroid Diseases
Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.
Thyroid Diseases
Celiac disease and endocrine autoimmunity - the genetic link.
Thyroid Diseases
Celiac Disease and Glandular Autoimmunity.
Thyroid Diseases
Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population.
Thyroid Diseases
Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome.
Thyroid Diseases
IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy.
Thyroid Diseases
Linear ?-(1???6)-d-glucan from Bifidobacterium bifidum BIM ?-733D is low molecular mass biopolymer with unique immunochemical properties.
Thyroid Diseases
One-Third of Patients Have Evidence for an Additional Autoimmune Disease at Type 1 Diabetes Diagnosis.
Thyroid Diseases
Prevalence of thyroid autoimmunity in first-degree relatives of patients with celiac disease.
Thyroid Diseases
Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes.
Thyroid Diseases
Tissue transglutaminase antibodies in individuals with celiac disease bind to thyroid follicles and extracellular matrix and may contribute to thyroid dysfunction.
Thyroid Nodule
Coeliac disease in patients with autoimmune thyroiditis.
Thyroiditis
A rare case of Addison's disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency.
Thyroiditis
Coeliac disease in Dutch patients with Hashimoto's thyroiditis and vice versa.
Thyroiditis
Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): a population control study.
Thyroiditis
Gliadin antibodies in adult insulin-dependent diabetes--autoimmune and immunogenetic correlates.
Thyroiditis
Gluten ataxia: passive transfer in a mouse model.
Thyroiditis
IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy.
Thyroiditis
Prolactin and autoimmunity.
Thyroiditis
The Effect of Gluten-Free Diet on Thyroid Autoimmunity in Drug-Naïve Women with Hashimoto's Thyroiditis: A Pilot Study.
Thyroiditis
THE RELATIONSHIP BETWEEN THYROID HORMONES, ANTITHYROID ANTIBODIES, ANTI-TISSUE TRANSGLUTAMINASE AND ANTI-GLIADIN ANTIBODIES IN PATIENTS WITH HASHIMOTO'S THYROIDITIS.
Thyroiditis
[Prevalence of polyglandular autoimmune syndrome in patients with diabetes mellitus type 1]
Thyroiditis, Autoimmune
Coeliac disease in patients with autoimmune thyroiditis.
Thyroiditis, Autoimmune
Does celiac disease trigger autoimmune thyroiditis?
Thyroiditis, Autoimmune
Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity.
Thyroiditis, Autoimmune
Prevalence of coeliac disease in patients with autoimmune thyroiditis in a Turkish population.
Tonsillitis
Cerebral thrombosis associated with heterozygous factor V Leiden mutation and high lipoprotein(a) level in a girl with factor XIII deficiency.
Tourette Syndrome
Intracerebral haematomas after deep brain stimulation surgery in a patient with Tourette syndrome and low factor XIIIA activity.
Toxemia
Coagulation-fibrinolytic and kinin-forming systems in toxemia of pregnancy.
Toxemia
[Coagulation-fibrinolysis and kinin-forming systems in toxemia of pregnancy]
Toxemia
[Hemocoagulatological changes in toxemia of pregnancy--in reference to birth weight (author's transl)]
Triple Negative Breast Neoplasms
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer.
Tuberculosis
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis.
Tuberculosis
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection.
Tuberculosis, Pulmonary
Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
Tuberous Sclerosis
Factor XIIIa in the hamartomas of tuberous sclerosis.
Tuberous Sclerosis
Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy.
Turner Syndrome
Increased prevalence of celiac disease in girls with Turner syndrome detected using antibodies to endomysium and tissue transglutaminase.
Turner Syndrome
Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment.
Uremia
[Deficiency in fibrin stabilizing factor (factor XIII) in uremia]
Ureteral Obstruction
Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-?B activation.
Urticaria
Cold urticaria and celiac disease.
Urticaria
Serum transglutaminase 2 activity as a potential biomarker of disease severity and response to omalizumab in chronic spontaneous urticaria.
Uterine Cervical Neoplasms
Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine.
Uterine Hemorrhage
Activity of plasma (FSF) fibrin stabilizing factor in dysfunctional uterine hemorrhages.
Uterine Hemorrhage
Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages.
Uveitis
A novel therapeutic target in inflammatory uveitis: transglutaminase 2 inhibitor.
Vaccinia
[Inactivation of viruses in Factor XIII concentrate by pasteurization]
Varicose Ulcer
Factor XIII in ulcerative leg disease: background and preliminary clinical results.
Varicose Ulcer
Topical treatment of venous ulcer with fibrin stabilizing factor: experimental investigation of effects on vascular permeability.
Varicose Ulcer
[Factor XIII: experimental and clinical results in diabetic foot ulcer]
Varicose Veins
Polymorphisms of serum proteins in Japanese patients with vascular diseases. I. Factor XIIIB, plasminogen and complement types in primary varicose veins.
Vascular Calcification
Nitric oxide regulates non-classical secretion of tissue transglutaminase.
Vascular Calcification
Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: implications for mineralization of MC3T3-E1 osteoblast cultures.
Vascular Calcification
Transglutaminase 2 Accelerates Vascular Calcification in Chronic Kidney Disease.
Vascular Calcification
Transglutaminase 2-mediated activation of ?-catenin signaling has a critical role in warfarin-induced vascular calcification.
Vascular Calcification
Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.
Vascular Diseases
Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men.
Vascular Diseases
Migraine and genetic polymorphisms: an overview.
Vascular Diseases
Nitric oxide regulates non-classical secretion of tissue transglutaminase.
Vascular Diseases
Role of blood coagulation factor XIII in vascular diseases.
Vascular Diseases
The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling.
Vascular Diseases
Transglutaminases as targets for pharmacological inhibition.
Vascular System Injuries
Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions.
Vasculitis
Autoantibody screen in inflammatory myopathies high prevalence of antibodies to gliadin.
Vasculitis
Severe gastrointestinal vasculitis in Henoch-Schoenlein purpura: pathophysiologic mechanisms, the diagnostic value of factor XIII, and therapeutic options.
Vasculitis
[Celiac disease and ischemic stroke.]
Vasculitis
[Leukocytoclastic vasculitis and factor XIII deficiency]
Vasculitis, Central Nervous System
[Celiac disease and ischemic stroke.]
Venous Thromboembolism
Association of a common polymorphism in the factor XIII gene with venous thrombosis.
Venous Thromboembolism
Combined measurement of factor XIII and D-dimer is helpful for differential diagnosis in patients with suspected pulmonary embolism.
Venous Thromboembolism
Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism.
Venous Thromboembolism
Factor XIII and Venous Thromboembolism.
Venous Thromboembolism
Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
Venous Thromboembolism
Factor XIII polymorphisms and venous thromboembolism.
Venous Thromboembolism
Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.
Venous Thromboembolism
Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Venous Thromboembolism
Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.
Venous Thromboembolism
Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease?
Venous Thromboembolism
Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk.
Venous Thromboembolism
Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness.
Venous Thrombosis
A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
Venous Thrombosis
A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis.
Venous Thrombosis
Association of a common polymorphism in the factor XIII gene with venous thrombosis.
Venous Thrombosis
Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
Venous Thrombosis
Coagulation Factor XIII in Cerebral Venous Thrombosis.
Venous Thrombosis
Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.
Venous Thrombosis
Concurrent hematoma and venous thrombosis in a patient with autoimmune acquired factor XIII deficiency.
Venous Thrombosis
Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
Venous Thrombosis
Estrogen plus progestin and risk of venous thrombosis.
Venous Thrombosis
Ethnic heterogeneity of the factor XIII Val34Leu polymorphism.
Venous Thrombosis
Factor XIII deficiency does not prevent FeCl3-induced carotid artery thrombus formation in mice.
Venous Thrombosis
Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
Venous Thrombosis
Factor XIII Val34Leu polymorphism and risk of deep vein thrombosis.
Venous Thrombosis
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
Venous Thrombosis
Fibrinogen, red blood cells, and factor XIII in venous thrombosis.
Venous Thrombosis
Molecular subunits and transamidase activity of factor XIII in patients with deep vein thrombosis.
Venous Thrombosis
Mutations in clotting factors and inflammatory bowel disease.
Venous Thrombosis
Prevalence of the Factor XIII Val34Leu Polymorphism in Korean Patients with Deep Vein Thrombosis.
Venous Thrombosis
Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.
Venous Thrombosis
Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
Venous Thrombosis
Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis.
Venous Thrombosis
The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
Venous Thrombosis
The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
Venous Thrombosis
The V34L polymorphism of factor XIII and peripheral arterial disease.
Venous Thrombosis
Unusual presentation of factor XIII deficiency.
Ventilator-Induced Lung Injury
Effects of transglutaminase 2 inhibition on ventilator-induced lung injury.
Virus Diseases
"Tissue" transglutaminase in AIDS.
Virus Diseases
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection.
Virus Diseases
Essential function of transglutaminase and clotting protein in shrimp immunity.
Virus Diseases
Role of protein modifications mediated by transglutaminase 2 in human viral diseases.
Virus Diseases
Transglutaminase regulates immune-related genes in shrimp.
Virus Diseases
Type 1 diabetes associated and tissue transglutaminase autoantibodies in patients without type 1 diabetes and coeliac disease with confirmed viral infections.
Virus Diseases
[Factor XIII and hepatitis C virus infection]
Vitamin A Deficiency
Expression of retinoic acid nuclear receptors and tissue transglutaminase is altered in various tissues of rats fed a vitamin A-deficient diet.
Vitamin A Deficiency
Vitamin A deficiency causes metaplasia in vocal fold epithelium: a rat study.
Vitamin D Deficiency
Celiac disease and severe vitamin D deficiency: the case for anti-tissue transglutaminase antibody screening.
Vitamin D Deficiency
Hormonal and dietary factors in acne vulgaris versus controls.
Vitamin K Deficiency
[Intracranial hematoma accompanying bleeding tendency: therapeutic practice and analysis of literature]
Vitreoretinopathy, Proliferative
Keratinocyte transglutaminase in proliferative vitreoretinopathy.
Vitreoretinopathy, Proliferative
[Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases]
von Willebrand Diseases
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
von Willebrand Diseases
Combined occurrence of von Willebrand's disease and factor XIII deficiency: a case report.
von Willebrand Diseases
Congenital factor XIII deficiency associated with von Willebrand disease.
von Willebrand Diseases
Congenital hemorrhagic disorders in Jordan.
von Willebrand Diseases
Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma.
von Willebrand Diseases
Hemophiliacs--a picture from a developing country: Karnataka, a south Indian state.
von Willebrand Diseases
How to deal with medical and social aspects of bleeding disorders--preparing women and the family in developing countries.
von Willebrand Diseases
Intracranial haemorrhage in patients with congenital haemostatic defects.
von Willebrand Diseases
Low prevalence of antibodies against human immunodeficiency virus in Finnish haemophiliacs.
von Willebrand Diseases
Management of pregnancy and delivery in women with inherited bleeding disorders.
von Willebrand Diseases
Occurrence of coagulation factor deficiency in post-tonsillectomy hemorrhage.
von Willebrand Diseases
On the retraction of collagen and fibrin induced by normal, defective and modified platelets.
von Willebrand Diseases
Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection.
von Willebrand Diseases
Spectrum of hereditary coagulation factor deficiencies in eastern province, Saudi Arabia.
von Willebrand Diseases
Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups.
von Willebrand Diseases
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection.
von Willebrand Diseases
Valproate-associated coagulopathies are frequent and variable in children.
von Willebrand Diseases
Vascular type Ehlers-Danlos syndrome is associated with platelet dysfunction and low vitamin D serum concentration.
von Willebrand Diseases
Viral markers and use of factor products among Finnish patients with bleeding disorders.
Waldenstrom Macroglobulinemia
Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
Whooping Cough
Pertussis toxin inhibits retinoic acid-induced expression of tissue transglutaminase in macrophages.
Whooping Cough
Retinoic acid-induced gene expression of tissue transglutaminase via protein kinase C-dependent pathway in mouse peritoneal macrophages.
Williams Syndrome
Celiac disease in Williams-Beuren syndrome.
Wilms Tumor
Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Xanthogranuloma, Juvenile
Factor XIIIa expression in juvenile xanthogranuloma.
Xanthogranuloma, Juvenile
Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
Xanthogranuloma, Juvenile
Systemic form of juvenile xanthogranuloma: report of a case with liver and bone marrow involvement.
Xanthomatosis
[Possibilities and limits of paraffin-embedded cell markers in diagnosis of primary cutaneous histiocytosis]
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2.3.2.13 protein-glutamine gamma-glutamyltransferase
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
